Download pdf - As you wish

Transcript
Page 1: As you wish

1

ื”ืคืงื•ืœื˜ื” ืœืจืคื•ืื”, ื”ืžื—ืœืงื” ืœืžื“ืขื™ ื”ื‘ืจื™ืื•ืช, ื’ื•ืจื™ื•ืŸ-ืื•ื ื™ื‘ืจืกื™ื˜ืช ื‘ืŸ

:ืžื‘ื—ืจ ืฉืืœื•ืช ื‘ื ื•ืฉื

ื”ืžื˜ื•ืœื•ื’ื™ื” 'ื’ืฉื ื”

-ื›ืœ ื”ื–ื›ื•ื™ื•ืช ื’ื ื•ื‘ื•ืช -

.ื—.ืœ.ื˜

Page 2: As you wish

2

:ื—ื•ื‘ืจืช ื–ื• ืžื›ื™ืœื” ืืช ื”ืฉื—ื–ื•ืจื™ื ื”ื‘ืื™ื

3 ............................................................................................................. 2009 ื“"ืœ ืžื—ื–ื•ืจ โ€“ ื”ืžื˜ื•ืœื•ื’ื™ื” ืฉื—ื–ื•ืจ 16 .................................................................................................. )2008(ื˜"ืชืฉืก ืœื’ ืžื—ื–ื•ืจ - ื”ืžื˜ื•ืœื•ื’ื™ื” ืฉื—ื–ื•ืจ

26 ...........................................................................................................ื‘"ืœ ืžื—ื–ื•ืจ โ€“ 2007 ื”ืžื˜ื•ืœื•ื’ื™ื” ืฉื—ื–ื•ืจ 35 ................................................................................................................ 2007 โ€“' ื‘ ืžื•ืขื“ ื”ืžื˜ื•ืœื•ื’ื™ื” ืฉื—ื–ื•ืจ 37 .............................................................................................................. 2006 ื"ืœ ืžื—ื–ื•ืจ ื”ืžื˜ื•ืœื•ื’ื™ื” ืฉื—ื–ื•ืจ

47 ...................................................................................................... 'ืœ ืžื—ื–ื•ืจ - 2005 ื”ืžื˜ื•ืื•ื ืงื•ืœื•ื’ื™ื” ื–ื•ืจืฉื— 56 .......................................................................................................... 'ื›ื˜ ืžื—ื–ื•ืจ โ€“ 2004 ื‘ื”ืžื˜ื•ืœื•ื’ื™ื” ืฉื—ื–ื•ืจ 63 .......................................................................................................... 'ื›ื— ืžื—ื–ื•ืจ โ€“ 2003 ื‘ื”ืžื˜ื•ืœื•ื’ื™ื” ืฉื—ื–ื•ืจ 72 ............................................................................................................ ื–"ื› ืžื—ื–ื•ืจ, 2002 ื‘ื”ืžื˜ื•ืœื•ื’ื™ื” ืฉื—ื–ื•ืจ

76 ........................................................................................................................ ื•"ื› ืžื—ื–ื•ืจ, 2001 ื”ืžื˜ื•ืœื•ื’ื™ื” 85 ..................................................................................................................... ื”"ื› ืžื—ื–ื•ืจ - 2000 ื”ืžื˜ื•ืœื•ื’ื™ื”

90 ................................................................................................................. 1999 ืฉื ืช ื“"ื› ืžื—ื–ื•ืจ ืœื•ื’ื™ื”ื”ืžื˜ื•

Page 3: As you wish

3

2009ื“ "ืžื—ื–ื•ืจ ืœ โ€“ืฉื—ื–ื•ืจ ื”ืžื˜ื•ืœื•ื’ื™ื”

!!!)ื›ื›ื” ืžืฉื—ื–ืจื™ื( 75ืžืชื•ื›ืŸ ืฉื•ื—ื–ืจื• , ืฉืืœื•ืช 75ื”ืžื‘ื—ืŸ ื›ืœืœ *

?ืื™ื–ื” ื—ื•ืžืจ ืžื•ืคืจืฉ ืžืชืื™ ื”ืื ื“ื•ืชืœ ื•ืžืขื›ื‘ ืฉืคืขื•ืœ ืฉืœ ื˜ืกื™ื•ืช.1

ืคืจื•ืกื˜ืฆื™ืงืœื™ืŸ .ื

ื˜ืจื•ืžื‘ื™ืŸ .ื‘

A2ื˜ืจื•ืžื‘ื•ืงืกืŸ .ื’ADP .ื“ืกืจื•ื˜ื•ื ื™ืŸ .ื”

?Acute DIC - ื‘ืื™ืœื• ืžืฆื‘ื™ื ื™ืฉ ืฉื›ื™ื—ื•ืช ื’ื‘ื•ื”ื” ืœ.2

HL .ืITP .ื‘ื–ื™ื”ื•ื ืกืคื˜ื™ ืฉืœ ื—ื™ื™ื“ืงื™ ื’ืจืื ืคืœื•ืก ืฉืžืฉื—ืจืจื™ื ืื ื“ื•ื˜ื•ืงืกื™ืŸ ืœื“ื .ื’

Amniotic Emboli .ื“

?ืื™ื–ื” ื”ืžื•ื’ืœื•ื‘ื™ืŸ ื ืžืฆื ื‘ื›ืžื•ืช ืจื‘ื” ืืฆืœ ืขื•ื‘ืจ.3

HbA1c .ืF .ื‘H .ื’HbA1 .ื“HbA2 .ื”

:ืงืฉื•ืจื” ืœื’ืŸ ืœ 11:18ื˜ืจื ืกืœื•ืงืฆื™ื” .4

BCR-abl .ืMALT1 .ื‘CD10 .ื’c-myc .ื“bcl-2 .ื”

?In Vivoืžื” ื”ื›ื™ ืžืชืื™ื ืœื‘ื“ื™ืงืช ืคืขื™ืœื•ืช ื˜ืกื™ื•ืช .5

PTT .ืADPื‘ื“ื™ืงืช ืื’ืจื’ืฆื™ื” ืขื .ื‘ื‘ื“ื™ืงืช ืื’ืจื’ืฆื™ื” ืขื ืกืจื•ื˜ื•ื ื™ืŸ .ื’

ืกื“ื™ืงืช ืื’ืจื’ืฆื™ื” ืขื ืจื™ืกื˜ื•ืฆืื™ืŸ .ื“

ื–ืžืŸ ื“ื™ืžื•ื .ื”

?ื‘ืžืชืŸ ื‘ืจื–ืœ Cืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ื”ื•ืกืคืช ื•ื™ื˜ืžื™ืŸ .6ืืกื•ืจ ื‘ื”ืจื™ื•ืŸ .ืื™ืขื›ื‘ ืืช ืกืคื™ื’ืช ื”ื‘ืจื–ืœ .ื‘ืขื•ื“ืฃ ื”ื‘ืจื–ืœ ืฉื‘ื›ื“ื•ืจื™ื’ืจื•ื ืœื—ื™ืžืฆื•ืŸ .ื’ื™ื’ื‘ื™ืจ ืืช ืกืคื™ื’ืช ื”ื‘ืจื–ืœ .ื“

Page 4: As you wish

4

?X-linkedืื™ื–ื• ื”ืžื•ืคื™ืœื™ื” ืžื•ืขื‘ืจืช ื‘ืชื•ืจืฉืช .7

Aื”ืžื•ืคื™ืœื™ื” .ืBื”ืžื•ืคื™ืœื™ื” .ื‘Bื•ื’ื ื”ืžื•ืคื™ืœื™ื” Aื”ืžื•ืคื™ืœื™ื” .ื’.X-Linkedืฉืชื™ ื”ืžื—ืœื•ืช ืœื ืžื•ืขื‘ืจื•ืช ื‘ืชื•ืจืฉืช .ื“

?HbHื‘ืื™ื–ื” ืžื˜ื•ืคืœ ื ืจืื” ื”ืžื•ื’ืœื•ื‘ื™ืŸ ืžืกื•ื’ .8

ืื“ื ื‘ื•ื’ืจ .ื

ื™ื™ืœื•ื“ .ื‘

ืื ืžื™ื” ื—ืจืžืฉื™ืช .ื’

ฮฒืชืœืกืžื™ื” .ื“ฮฑืชืœืกืžื™ื” .ื”

?ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ื’ืœื™ืงื•ืœื™ื–ื” ื‘ืชื ื“ื ืื“ื•ื.9

ืœื”ืชื—ืœืช ื”ืชื”ืœื™ืš ATPื“ืจื•ืฉ .ื

ื“ืจื•ืฉ ืื ืจื’ื™ื” ืœืคื™ืจื•ืง ื”ืœืงื˜ื˜ ืฉื ื•ืฆืจ .ื‘

ืขืœ ื›ืœ ื’ืœื•ืงื•ื– Pื•ืžื•ืœืงื•ืœืช AMP -ืž ATPืžื•ืœืงื•ืœื•ืช 32ื ื•ืฆืจื•ืช .ื’

?.....ืขื•ืฉื™ื Macronesia Body .ื“

ื”ื”ืคื˜ื•ื’ืœื•ื‘ื™ืŸ ื”ืžื™ื•ืฆืจ ื™ื•ืฆื ื‘ื“ื™ืคื•ื–ื™ื” .ื”

:ืฆืจื™ืš ืœืชืช IgAืœืื“ื ืœืคื ื™ ื ื™ืชื•ื— ืฉืื™ืŸ ืœื• .10

ืคืœืกืžื” ืœืคื™ ืกื•ื’ ื•ื”ืฆืœื‘ื” .ื

ืจื—ื•ืฅ ืœืคื™ ืกื•ื’ ื•ื”ืฆืœื‘ื” ื“ื .ื‘

ืกื•ื’ ื•ื”ืฆืœื‘ื”ื˜ืกื™ื•ืช ืœืคื™ .ื’

ื›ื“ื•ืจื™ื•ืช ื“ื ืœื‘ื ื•ืช ืœืคื™ ืกื•ื’ ื•ื”ืฆืœื‘ื” .ื“

ืคืจื–ื™ืก ืœืคื ื™ ื›ืœ ืขื™ืจื•ื™ ื“ื .ื”

?C-Proteinืขืœ ืžื” ืขื•ื‘ื“ .11

VIIaืคืงื˜ื•ืจ .ืXaืคืงื˜ื•ืจ .ื‘Vืคืงื˜ื•ืจ .ื’Iืคืงื˜ื•ืจ .ื“VIIIaืคืงื˜ื•ืจ .ื”

?Xaืื™ื–ื• ืชืจื•ืคื” ืขื•ื‘ื“ืช ื‘ืขื™ืงืจ ืขืœ ืคืงื˜ื•ืจ .12

ื”ืคืจื™ืŸ .ื

LMWH .ื‘ืงื•ืžื“ื™ืŸ .ื’

ืืกืคื™ืจื™ืŸ .ื“

Page 5: As you wish

5

?0.45%ื‘ืื™ื–ื• ืžื—ืœื” ืชื”ื™ื” ื”ืžื•ืœื™ื–ื” ืžื•ื’ื‘ืจืช ื‘ืื•ืกืžื•ืœืจื™ื•ืช ืฉืœ .13

Hereditary spherocytosis .ืืื ืžื™ื” ื—ืจืžืฉื™ืช .ื‘

PNH .ื’ITP .ื“

?ืžื” ื”ื›ื™ ื ื›ื•ืŸ ืœื’ื‘ื™ ืžื™ืืœื•ืžื” ื ืคื•ืฆื”.14

ืชืœื™ื“ื•ืžื™ื“ ื‘ืฉืœื‘ ื”ื›ืจื•ื ื™ ืžืืจื™ืš ื—ื™ื™ื .ื

ื”ืคืจื™ืคืจื™ ืฉื™ื‘ื˜ืื• ื ื•ื’ื“ืŸ ืžื•ื ื•ืงืœื•ื ืœื™ืžื’ื•ืจืขื ื™ื ื‘ื“ื ืชืื™ื 10%ืžืขืœ ืฆืจื™ืš .ื‘

ื‘ื“ื ื”ืคืจื™ืคืจื™ ืฉื™ื‘ื˜ืื• ื ื•ื’ื“ืŸ ืคื•ืœื™ืงืœื•ื ืœื™ืžื’ื•ืจืขื ื™ื ืชืื™ื 10%ืžืขืœ ืฆืจื™ืš .ื’

ื—ื•ื“ืฉื™ื 60ื”ืžืžื•ืฆืขืช ืœืœื ื˜ื™ืคื•ืœ ื”ื™ื ืชื•ื—ืœืช ื”ื—ื™ื™ื .ื“

ืœื ื ื™ืชืŸ ืœืื‘ื—ืŸ ืœืœื ื‘ื™ื•ืคืกื™ื” ืฉืœ ืžื— ืขืฆื .ื”

ื ื™ืชืŸ ืœืื‘ื—ืŸ ืขื ืฆื™ื˜ื•ื’ื ื˜ื™ืงื” ื‘ืœื‘ื“ .ื•

?ืžื” ื”ื›ื™ ืกื‘ื™ืจ, ืจื˜ื™ืงื•ืœื•ืฆื™ื˜ื™ื 18%ื ืžืฆืื• CLLื‘ื—ื•ืœื” .15

ืืคืœืกื™ื” ื‘ืžื— ื”ืขืฆื .ื

ื“ื™ืžื•ื ืžืชืžืฉืš .ื‘

ืชืžืก ื“ื .ื’

ืชื”ืœื™ืš ื“ืœืงืชื™ ื›ืจื•ื ื™ .ื“

CLLืžืขื‘ืจ ืœืฉืœื‘ ื”ืคื•ืœื™ืฆื™ื˜ืžื™ ืฉืœ .ื”

?ื•ืขืžื™ื“ื” ืœื˜ื™ืคื•ืœืื™ื–ื• ืžื”ืžื—ืœื•ืช ื”ื™ื ืื™ื ื“ื•ืœื ื˜ื™ืช .16

Follicular Lymphoma .ืDiffuse large Cell Lymphoma .ื‘Burkitt lymphoma .ื’AML .ื“CML .ื”

?ื‘ืื™ื–ื” ืžื”ืชืื™ื ื”ื‘ืื™ื ื™ืฉ ื”ื›ื™ ื”ืจื‘ื” ืคืขื™ืœื•ืช ืฉืœ ื”ืื ื–ื™ื ืคืจืื•ืงืกื™ื“ื–.17

ืืื•ื–ื™ื ื•ืคื™ืœ .ื

ืžื•ื ื•ืฆื™ื˜ .ื‘

ืœื™ืžืคื•ืฆื™ื˜ .ื’

ื ื•ื™ื˜ืจื•ืคื™ืœ .ื“

?HL -ืžื”ื™ ื”ืžืžืื™ืจื•ืช ื”ืžืฉื ื™ืช ื”ืฉื›ื™ื—ื” ื‘ื™ื•ืชืจ ืื—ืจื™ ื”ื˜ื™ืคื•ืœ ื‘ .18

SEMINOMA .ืMESOTHELIOMA .ื‘ืœื•ืงืžื™ื” ืžื™ืืœื•ืื™ื“ื™ืช .ื’

ืœื•ืงืžื™ื” ืœื™ืžืคื•ื‘ืœืกื˜ื™ืช .ื“

ืžื™ืืœื•ืžื” ื ืคื•ืฆื” .ื”

Page 6: As you wish

6

?vWFื›ื™ืฆื“ ื‘ื•ื“ืงื™ื ื—ืกืจ ืฉืœ .19

ADPืžื‘ื—ืŸ ืื’ืจื’ืฆื™ื” ืขื .ืืžื‘ื—ืŸ ืื’ืจื’ืฆื™ื” ืจื™ืกื˜ื•ืฆืื™ืŸ .ื‘

PTT .ื’PT .ื“TT .ื”

20. ืฉืชืŸ ื‘ืฆื‘ืข , 38.5ื—ื•ื ืฉืœ , ืœื—ืžื™ื•ืช ืฆื”ื•ื‘ื•ืช, ื—ื™ื•ื•ืจ, ื—ื•ื“ืฉื™ื ืžื’ื™ืข ืœืžื™ื•ืŸ ื™ืฉื ื•ื ื™ 8ืชื™ื ื•ืง ื‘ืŸ

ืื™ื–ื• ื‘ื“ื™ืงื” ืชื‘ืฆืข. ื‘ื™ืจื” ื•ืขื ื”ืžืฉื˜ื— ื“ื ืฉื‘ืชืžื•ื ื” ?ื‘ืฉื‘ื™ืœ ืœื”ื’ื™ืข ืœืื‘ื—ื ื”

ืืกืคื™ืจืฆื™ื” ืฉืœ ืžื— ืขืฆื .ื

G6PDื‘ื“ื™ืงืช ื”ืื ื–ื™ื .ื‘ืชืฉืืœ ื”ืื ื™ืฉ ืžื—ืœื•ืช ื“ื ื‘ืžืฉืคื—ื” ืžืฆื“ ื”ืื .ื’

ื‘ื“ื™ืงืช ื‘ืจื–ืœ ื‘ื“ื .ื“

21.

?ืžืžื” ื”ื•ื ืกื•ื‘ืœ, Auer Rodsื’ื‘ืจ ืขื ื›ืชืžื™ื ื™ืจื•ืงื™ื ื‘ืงืจืงืคืช ื•ืขื ืชืื™ื ื‘ืขืœื™ CML .ืAML .ื‘CLL .ื’HD .ื“

?ื‘ืื™ื–ื” ืžื ื’ื ื•ืŸ ืคื•ืขืœ ืงื•ืžื“ื™ืŸ.22

TXA2ืžืขื›ื‘ .ืKืžืขื›ื‘ ื—ื™ื–ื•ืจ ื•ื™ื˜ืžื™ืŸ .ื‘3ื ืงืฉืจ ืœืื ื˜ื™ ื˜ืจื•ืžื‘ื™ืŸ .ื’

Kื”ืชืœื•ื™ื™ื ื‘ื•ื™ื˜ืžื™ืŸ 2, 1ืžื•ื ืข ืกื™ื ืชื–ื” ืฉืœ ืคืงื˜ื•ืจื™ื .ื“

?ืžื” ืžื”ื‘ืื™ื ื”ื•ื ืชื•ืฆืจ ืฉืœ ื’ืœื™ืงื•ืœื™ื–ื” .23

AMP .ืDPG 1,2,3 .ื‘NADPH .ื’NAH .ื“

Page 7: As you wish

7

?ื‘ืื™ื–ื• ืžื—ืœื” ื™ืฉ ื”ืกื ื ื” ืœื—ื ื™ื›ื™ื™ื.24

ืฉ ื‘ืจืงื•ื˜"ืœื•ืงืžื™ื” ืข .ื

ืœื•ืงืžื™ื” ืžื•ื ื•ืฆื™ื˜ื™ืช .ื‘

HL .ื’ ALL .ื“

?ื”ืื™ื ื˜ืจื™ื ื–ื™ืชืื™ืš ื ื‘ื“ื•ืง ืืช ืคืขื™ืœื•ืช ื”ืžืขืจื›ืช .25

PT .ืTT .ื‘PTT .ื’BT .ื“

?Lymphocytic Rich CHLืžื” ื”ื›ื™ ื ื›ื•ืŸ ืœื’ื‘ื™ .26

Lymphocytic Predominant classic HL -ื–ื”ื” ืœ .ืEBVื‘ืขืœ ืื—ื•ื– ื‘ื™ื˜ื•ื™ ื ืžื•ืš ืฉืœ ื ื’ื–ืจื•ืช .ื‘ืคืจื•ื’ื ื•ื–ื” ื˜ื•ื‘ื” ื‘ืžื‘ื•ื’ืจื™ื .ื’

ื‘ืขืœ ืžื•ืคืข ื“ื™ืคื•ื–ื™ื› "ื‘ื“ .ื“

Tื’ื™ื“ื•ืœ ืฉืœ ืชืื™ .ื”

?ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ื”ืžื˜ื•ืคื•ืื–ื™ืก.27

ื ื™ืชืŸ ืœื”ืฉืชื™ืœ ืชืื™ื ืจืง ืžืžื— ื”ืขืฆื .ื

ื™ื›ื•ืœื™ื ืœื”ืชืžื™ื™ืŸ ืœืชืื™ ืœื‘ ื‘ืชื ืื™ื ืžืชืื™ืžื™ื .ื‘

ื™ื™ืฆื•ืจ ืชืื™ ื”ื“ื ืžืชื—ื™ืœ ืืฆืœ ื”ืขื•ื‘ืจ ื‘ื›ื‘ื“ .ื’

?ืžืžื” ื–ื” ื™ื›ื•ืœ ืœื ื‘ื•ืข โ€“ื—ื•ืœื” ืขื ืžืฉื˜ื— ื“ื ื‘ื• ืจื•ืื™ื ื ื•ื™ื˜ืจื•ืคื™ืœื™ื ื”ื™ืคืจืกื’ืžื ื˜ืœื™ื™ื .28

ื—ืกืจ ื‘ืจื–ืœ .ื

Eื—ื–ืจ ื‘ื•ื™ื˜ืžื™ืŸ .ื‘ื—ื•ืกืจ ืกื™ื ืชื–ืช ืชื™ืžื™ื“ื™ืŸ .ื’

ืžื—ืœื” ืžื™ืืœื•ืฆื™ื˜ื™ืช ืคืจื•ืœื™ืคืจื˜ื™ื‘ื™ืช .ื“

. Hb = 11.5% ,MCV โ€“ 102fl . ื‘ืขืงื‘ื•ืช ืฉื™ืขื•ืœืขื ืจืงืข ืฉืœ ื™ืชืจ ืœื—ืฅ ื“ื ื”ื•ืคื ื” 73ื‘ืŸ .29?ืžื” ืžื”ื‘ืื™ื ื”ื›ื™ ื”ื’ื™ื•ื ื™. ื•ืกืคื™ืจืช ืชืื™ ื“ื ืœื‘ื ื™ื ืชืงื™ื ื” ื’ื ื›ืŸ, ื˜ืกื™ื•ืช ืชืงื™ื ื•ืช

ืœืฉืœื•ื— ืœื‘ื“ื™ืงื•ืช ืœืงืจืืช ื”ืฉืชืœืช ืžื— ืขืฆื โ€“ MDS .ื

ื‘ืฉืœ ื’ื™ืœื• ื”ืžืชืงื“ื ืœื”ืชื—ื™ืœ ื˜ื™ืคื•ืœ ื›ื™ืžื•ืชืจืคื™ ื‘ืžื™ื ื•ืŸ ื ืžื•ืš โ€“ MDSื™ืฉ ืœื• .ื‘

ืœื”ืชื—ื™ืœ ื ืฉืงื•ืœ MDSืื ื–ื” ื ืฉืœื•ืœ ืืคืฉืจื•ืช ืœืื ืžื™ื” ืžืืงืจื•ืฆื™ื˜ื™ืช ืžืกื™ื‘ื•ืช ืื—ืจื•ืช ื• .ื’.ื˜ื™ืคื•ืœ ื‘ืžืฆื‘ื•

.ื ืชื—ื™ืœ ื˜ื™ืคื•ืœ ื‘ื”ื•ืจืžื•ื ื™ ื’ื“ื™ืœื” โ€“ MDSืžื“ื•ื‘ืจ ื‘ .ื“

.ื™ืฉ ืœืชืช ืฉืชื™ ืžื ื•ืช ื“ื ืžื™ื“ .ื”

Page 8: As you wish

8

?WALDENSTROMืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ .30

IgGื ื•ื’ื“ื ื™ื ืžืกื•ื’ .ืMMืžืืฉืจ ื‘ื‘ืื•ืคืŸ ืžืฉืžืขื•ืชื™ ื ืžื•ืš ื™ื•ืชืจ Hyperviscosity -ื”ืกื™ื›ื•ื™ ืœ .ื‘ืกื™ื›ื•ื™ ื’ื‘ื•ื” ืœื“ื™ืžื•ืžื™ื .ื’

.50ื‘ืขื™ืงืจ ืžืชื—ืช ืœื’ื™ืœ .ื“

?GLEEVECืžื” ืžื ื’ื ื•ืŸ ื”ืคืขื™ืœื•ืช ืฉืœ .31

ืื ื˜ื™ ืื ื’ื™ื•ื’ื ื–ื™ืก .ื

Mab .ื‘BCR-ablืฉืœ TKืคื•ื’ื ื‘ืคืขื™ืœื•ืช .ื’Tืžืขื›ื‘ ืคืขื™ืœื•ืช ืฉืœ ืชืื™ .ื“

?ื•ืžืขื‘ื™ืจ ืื•ืชื• ื“ืจืš ืžืžื‘ืจื ืช ื”ืชืื™ื ื‘ืื™ืœื™ืื•ื B12ืžื™ ืžื”ื‘ืื™ื ืžืขื‘ื™ืจ ืืช .32

Transcobalamine โ…  .ืTranscobalamine โ…ก .ื‘Transcobalamine โ…ข .ื’IF .ื“R-binder .ื”

?Starry sky patternื‘ืื™ื–ื• ืžื—ืœื” ื ืจืื” .33

Nodular Sclerosis HL .ืLymphocytic Rich HL .ื‘Lymphocyte Depleted HL .ื’Mixed Cellularity HL .ื“Burkitt's Lymphoma .ื”

:ืžื‘ื—ืŸ ืื•ืกืžื•ืœืจื™ื•ืช ืœื›ื“ื•ืจื™ื•ืช ื“ื ืื“ื•ืžื•ืช ืžืชื‘ืฆืข ื‘ืขื–ืจืช ืจื™ื›ื•ื–ื™ื ืžืฉืชื ื™ื ืฉืœ.34

ื’ืœื•ืงื•ื– .ื

ืกื•ื›ืจื•ื– .ื‘

ืกื™ืœื™ื™ืŸ .ื’

ื’ืœื•ืงื•ื–+ืกื™ืœื™ื™ืŸ .ื“

?PNHืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ .35

.ืขืœ ื”ืชืื™ื ืฉื ืคื’ืขื™ื ืžื”ืžื—ืœื” GPIื—ื•ืกืจ ื‘ื—ืœื‘ื•ื ื™ื ื”ืขื’ื•ื ื™ื ืขืœ .ื

ื‘ื›ืœ ืชืื™ ื”ื’ื•ืฃ CD55 -ื• CD59 -ื‘ื” ื™ืฉ ื—ื•ืกืจ ื‘ X-ืžื—ืœื” ืชื•ืจืฉืชื™ืช ื‘ืชืื—ื™ื–ื” ืœ .ื‘

ื•ื˜ืกื™ื•ืช RBC -ืžื—ืœื” ืื™ืžื•ื ื•ืœื•ื’ื™ืช ื”ืคื•ื’ืขืช ื‘ .ื’

ืžื—ืœื” ื›ืœื™ื™ืชื™ืช ื”ืžืชืืคื™ื™ื ืช ื‘ืื™ื‘ื•ื“ ื“ื ืœื™ืœื™ ื‘ืฉืชืŸ .ื“

CD59,CD55ื™ ื”ื“ื‘ืงื” ื‘ื•ื™ืจื•ืก ืฉืคื•ื’ืขืช ื‘ "ืžื—ืœื” ื–ื™ื”ื•ืžื™ืช ื ืจื›ืฉืช ืข .ื”

Page 9: As you wish

9

?ื‘ืจืžื™ืกื™ื” ืฉืœ ืœื•ืงืžื™ื” ืืงื•ื˜ื™ืช ืœืื™ื–ื• ื”ืคื•ื’ื” ื ืจืฆื” ืœื”ื’ื™ืขื”.36

ื”ืžื˜ื•ืœื•ื’ื™ืช .ื

ืื™ืžื•ื ื•ืœื•ื’ื™ืช .ื‘

ืžื•ืœืงื•ืœืจื™ืช .ื’

ื›ืจื•ืžื•ื–ื•ืžืœื™ืช .ื“

ืงืœื™ื ื™ืช .ื”

?ื›ืจื•ืžื•ื–ื•ื ืคื™ืœื“ืœืคื™ื” ืžื”ื•ื•ื” ื˜ืจื ืกืœื•ืงืฆื™ื” ื‘ื™ืŸ ืื™ืœื• ื›ืจื•ืžื•ื–ื•ืžื™ื.37

9:22 .ื

8:22 .ื‘

8:21 .ื’

9:21 .ื“

:ืคืขื™ืœื•ืช ื”ืคืจื™ืŸ.38

ืชืจื•ืžื‘ื™ืŸ-ืคื™ืจื•ืง ื”ืงื•ืžืคืœืงืก ืชืจื•ืžื‘ื™ืŸ ืื ื˜ื™ .ื

ืœืคืœืกืžื™ื ื•ื’ืŸื™ ื”ืคื™ื›ืชื• "ืคื™ืจื•ืง ื”ืงืจื™ืฉ ืข .ื‘

ืขื™ื“ื•ื“ ืคืขื™ืœื•ืช ืื ื˜ื™ ื˜ืจื•ืžื‘ื™ืŸ .ื’

ืขื™ื›ื•ื‘ ืกื™ื ืชื–ืช ืชืจื•ืžื‘ื™ืŸ .ื“

Kืขื™ื›ื•ื‘ ื—ื™ื–ื•ืจ ืฉืœ ื•ื™ื˜ืžื™ืŸ .ื”

?ืžื” ื ื›ื•ืŸ, %22grื›ื™ื—ืœื•ืŸ ื•ื”ืžื•ื’ืœื•ื‘ื™ืŸ , ืขื ืžื—ืœื” ื›ืจื•ื ื™ืช ืจื™ืืชื™ืช ืงืฉื” 70ืื“ื ื‘ืŸ .39

ื–ื” ืขืจืš ื ื•ืจืžืœื™ ืœื’ื™ืœื• ื•ืžืฆื‘ื• .ื

ื™ืฉ ืœืชืช ืœื• ืขื™ืจื•ื™ ื“ื ื‘ื’ืœืœ ื”ื›ื™ื—ืœื•ืŸ .ื‘

ืœื• ืคื•ืœื™ืฆื™ื˜ืžื™ื”ื™ืฉ .ื’

ื™ืจื“ ืžื™ื™ื“ื™ืช ื™ืฉ ืœืชืช ืœื• ื—ืžืฆืŸ ื•ื”ื”ืžื•ื’ืœื•ื‘ื™ืŸ .ื“

?ืื™ื–ื• ืชืจื•ืคื” ืชื’ืจื•ื ืœืฉื’ืฉื•ื’ ื›ืœื™ ื“ื, ื‘ืžื™ืืœื•ืžื” ื ืคื•ืฆื” .40

ื”ื™ื“ืจื•ืงืกื™ืื•ืจื™ืื” .ื

INFฮฑ .ื‘ืชืœื™ื“ื•ืžื™ื“ .ื’

ืกื˜ืจื•ืื™ื“ื™ื .ื“

ATRA .ื”

g/dl ,10,000 11.4ื‘ืกืคื™ืจืช ื“ื ืฉืœ ืื™ืฉื” ื”ื—ืฉื•ื“ื” ืœืื ืžื™ื” ืืคืœืกื˜ื™ืช ื ืžืฆื ื”ืžื•ื’ืœื•ื‘ื™ืŸ .41ืžื›ืš ื ื™ืชืŸ . ื•ื›ืŸ ืœื ื ืžืฆืื• ืจื˜ื™ืงื•ืœื•ืฆื™ื˜ื™ื, ืง"ืœืžืž ื ื•ื™ื˜ืจื•ืคื™ืœื™ื 300 -ืง ื•"ื˜ืกื™ื•ืช ืœืžืž

: ื”ืื™ืฉื” ืกื•ื‘ืœืช ืžืื ืžื™ื” ืืคืœืกื˜ื™ืชืœื”ืกื™ืง ืฉ

ืงืœื” .ื

ื‘ื™ื ื•ื ื™ืช .ื‘

ื—ืžื•ืจื” .ื’

ืžืื•ื“ ื—ืžื•ืจื” .ื“

.ืœื ื ื™ืชืŸ ืœืงื‘ื•ืข ืœืœื ื‘ื“ื™ืงืช ืžื— ืขืฆื .ื”

Page 10: As you wish

10

ื‘ื’ื•ืคื• ืฉืœ ืื“ื ืžื‘ื•ื’ืจ ืฉืขื‘ืจ ื–ื” ืขืชื” ืœืชื–ื•ื ื” B12ืœื›ืžื” ื–ืžืŸ ื™ืกืคื™ืงื• ืžืื’ืจื™ ื•ื™ื˜ืžื™ืŸ .42?ืฆืžื—ื•ื ื™ืช

ื™ืžื™ื ืื—ื“ื™ื .ื

ื—ื•ื“ืฉื™ื ืื—ื“ื™ื .ื‘

ืื—ื“ื•ืชืฉื ื™ื .ื’

ืชืœื•ื™ ื‘ืจืžืช ื”ื•ื™ื˜ืžื™ืŸ ื‘ืจืงืžืช ืฉื•ืžืŸ ื•ืขืฆื .ื“

ืชืœื•ื™ ื‘ืจืžืช ื”ืกื™ื“ืŸ .ื”

ืžื”ืžืขื‘ื“ื” ื”ื›ื™ืข . 80,000ื‘ื‘ื“ื™ืงืช ื“ื ืฉืœ ื—ื•ืœื” ืฆืขื™ืจื” ืžืชื’ืœื” ืกืคื™ืจืช ืชืจื•ืžื‘ื•ืฆื™ื˜ื™ื ืฉืœ .43

?ืžื” ืชืขืฉื”. EDTA induced pseudo-thrombocytopeniaืื‘ื—ื ื” ืฉืœ

.ืืฉืœื— ืื•ืชื” ืœืžืจืคืื” ื”ืžื˜ื•ืœื•ื’ื™ืช ืœื”ืžืฉืš ื™ื™ืขื•ืฅ ื‘ืงืฉืจ ืœื‘ืขื™ื” ื–ื• .ื

.ื‘ื“ื™ืงื” ืขื ื”ืคืจื™ืŸื‘ืคืขื ื”ื‘ืื” ืืฉืœื— .ื‘

ืžื—ืฉืฉ ืœื“ื™ืžื•ื ื™ืชืจ, ืื•ืžืจ ืœื” ืœื”ื™ื–ื”ืจ ืžื˜ืจืื•ืžื” .ื’

ืžื™ื“ ืืชืŸ ืœื” ืžื ื” ืฉืœ ืชืจื•ืžื‘ื•ืฆื™ื˜ื™ื .ื“

.ืืืฉืคื– ืื•ืชื” ื‘ื”ืงื“ื .ื”

. ืžื›ืฉื™ืจ ื”ื“ื™ืคืจื ืฆื™ืืœ ื”ืžืฉืžืฉ ืœืกืคื™ืจืช ื“ื ื™ื•ื“ืข ืœืžื™ื™ืŸ ืชืื™ื ืœืคื™ ืžื•ืจื›ื‘ื•ืชื ื”ืคื ื™ืžื™ืช.44? ืื™ื–ื” ืžื”ืชืื™ื ื”ื‘ืื™ื ื”ื•ื ื‘ืขืœ ื”ืžื•ืจื›ื‘ื•ืช ื”ืคื ื™ืžื™ืช ื”ื ืžื•ื›ื” ื‘ื™ื•ืชืจ

.ืœื™ืžืคื•ืฆื™ื˜ .ื

.ืืื•ื–ื™ื ื•ืคื™ืœ .ื‘

.ืืจื™ืชืจื•ืฆื™ื˜ .ื’

.ืžื•ื ื•ืฆื™ื˜ .ื“

?Fanconi's anemia -ื—ืฉื“ ืœืขืœ ืžื ืช ืœืื‘ื—ืŸ ืื™ื–ื• ืžื”ื‘ื“ื™ืงื•ืช ื”ื‘ืื•ืช ื ื‘ืฆืข .45

.ืฉื‘ื™ืจื•ืช ื›ืจื•ืžื•ื–ื•ืžืœื™ืช .ื

.ืจื’ื™ืฉื•ืช ื”ื—ื•ืœื™ื ืœืงืจื™ื ืช ืฉืžืฉ .ื‘

ื‘ื“ื™ืงืช ืžื— ืขืฆื .ื’

ื‘ื“ื™ืงื” ืœื›ืจื•ืžื•ื–ื•ื ืคื™ืœื“ืœืคื™ื” .ื“

?ื›ื“ื™ ืœื‘ื“ื•ืง ื”ืฉืคืขืช ืงื•ืžื“ื™ืŸ PTืœืžื” ื‘ื•ื“ืงื™ื .46

ื”ืื™ื ื˜ืจื™ื ื–ื™ืช' ืžื™ื“ื” ืขืœ ื”ืžืขื™ืฉืคื™ืข ื‘ืื•ืชื” ื›ื™ ืงื•ืžื“ื™ืŸ PTื•ื’ื PTTืืคืฉืจ ืœื‘ื“ื•ืง ื’ื .ื

ื•ืžืชืืคื™ื™ืŸ ื‘ื–ืžืŸ ืžื—ืฆื™ืช ื”ื—ื™ื™ื ื”ืงืฆืจ ื‘ื™ื•ืชืจ Kืชืœื•ื™ ื‘ื•ื™ื˜ืžื™ืŸ 7ืžืื—ืจ ื•ืคืงื˜ื•ืจ .ื‘

10ื‘ื’ืœืœ ื”ื”ืฉืคืขื” ืขืœ ืคืงื˜ื•ืจ .ื’

?DIC -ืžื” ื”ื“ื‘ืจ ื”ื—ืฉื•ื‘ ื‘ื™ื•ืชืจ ื‘ื˜ื™ืคื•ืœ ื‘ .47

DICื˜ื™ืคื•ืœ ื‘ื’ื•ืจื ื”ืจืืฉื•ื ื™ ืฉื’ืจื ืœ .ืDICื—ื™ื™ื“ืงื™ื ื’ืจืื ื—ื™ื•ื‘ื™ื™ื ืžืคืจื™ืฉื™ื ืื ื“ื•ื˜ื•ืงืกื™ืŸ ืฉื ืฆืžื“ ืœืคืจื•ื˜ืื™ืŸ ืกื™ ื•ื’ื•ืจื ืœ .ื‘ื•ื›ื“ื™ ื›ื“ื™ ืœื”ืงืœ ืขืœ ื”ืฆืจื™ื›ื” ื”ืžื•ื’ื–ืžืช ืฉืœ ืคืงื˜ื•ืจื™ ื”ืงืจื™ืฉื” FFPื ื™ืชืŸ ืœื• ื”ืคืจื™ืŸ ื•ื’ื .ื’

ืœืžื ื•ืข ื“ื™ืžื•ื

36-40%ื‘ื—ื•ืœื” ื”ืžื“ืžื ื ื™ืชืŸ ืขื™ืจื•ื™ื™ ื“ื ืขื“ ืœื”ื’ืขื” ืœื”ืžื˜ื•ืงืจื™ื˜ .ื“

.ื ื™ืชืŸ ื‘ืžืงืจื™ื ื‘ื”ื ืื ื• ืจื•ืฆื™ื ืœื”ืคืกื™ืง ืืช ื”ื“ื™ืžื•ื activated protein cื ื™ืชืŸ ืœื• .ื”

Page 11: As you wish

11

?ืชืœืกืžื™ื” ฮฒืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ .48

ืืœืคืื—ื•ืกืจ ื™ื™ืฆื•ืจ ืฉืจืฉืจืื•ืช .ื

ื™ื™ืฆื•ืจ ืฉืจืฉืจืื•ืช ื’ืžื ื‘ืขื•ื“ืฃ ื™ืขื–ื•ืจ ืœื—ื•ืœื” .ื‘

ื—ื•ืกืจ ื™ื™ืฆื•ืจ ืฉืจืฉืจืื•ืช ื’ืžื .ื’

ื—ื•ืกืจ ื™ื™ืฆื•ืจ ืฉืจืฉืจืื•ืช ื“ืœืชื .ื“

ื‘ืžืฉื˜ื— ื“ื ื ืจืื• ืชืื™ ืžื˜ืจื” ื•ืชืื™ื . ื›ื”ื” ืขื•ืจ ืžืžื•ืฆื ืืคืจื™ืงืื™ ืžื’ื™ืข ืœืžืจืคืื” 30ื‘ืŸ .49?ืื™ื–ื• ืžื—ืœื” ื™ืฉ ืœื• โ€“ื—ืจืžืฉื™ื™ื

ืชืœืกืžื™ื” ฮฒ .ื

HbSืชืœืกืžื™ื” ืขื .ื‘AML .ื’ื—ืกืจ ื‘ืจื–ืœ .ื“

Eื”ืžื•ื’ืœื•ื‘ื™ืŸ .ื”

?ืžื” ืžื”ื‘ืื™ื ื™ืงืจื” โ€“ื›ื™ืจื•ืจื’ื™ ืฉืœ ื”ืชืจื™ืกืจื™ื•ืŸ ืื ืžื‘ืฆืขื™ื ืžืขืงืฃ .50

ืกืคื™ื’ื” ืžื•ื’ื‘ืจืช ืฉืœ ื‘ืจื–ืœ .ื

ืกืคื™ื’ื” ืžื•ืคื—ืชืช ืฉืœ ื‘ืจื–ืœ .ื‘

ื™ืฆื™ืจืช ื”ืžื•ื’ืœื•ื‘ื™ืŸ ืื‘ื ื•ืจืžืœื™ ื‘ืžื— ืขืฆื .ื’

ื™ื”ื™ื” ืจื™ื‘ื•ื™ ื—ื™ื™ื“ืงื™ื ืืฉืจ ื™ืกืคืจ ืืช ืกืคื™ื’ืช ื”ื‘ืจื–ืœ .ื“ ?ื˜ืจื•ืžื‘ื•ืฆื™ืชื™ ื ื•ืจืžืœื™ ื“ื›ืžื” ื–ืžืŸ ืžืžืชืŸ ืืกืคื™ืจื™ืŸ ื ืจืื” ื—ื–ืจื” ืœืชืคืงื•.51

ื›ื—ื•ื“ืฉ ื™ืžื™ื .ื

ื›ืฉื‘ื•ืขื™ื™ื .ื‘

ืฉืขื•ืช' ืชื•ืš ืžืก .ื’

ืžื—ืฆื™ืช ื”ื—ื™ื™ื ืฉืœ ื”ืชืจื•ืคื” ืœืคื™ ื–ืžืŸ .ื“

52 .DIC ืชืžื•ื ืช ื”ื“ื ื”ื‘ืื”ืžืชืืคื™ื™ืŸ ื‘: .ื’ื‘ื•ื” D-DIMER, ืคื™ื‘ืจื™ื ื•ื’ืŸ ื’ื‘ื•ื”, ืžืื•ืจืš PTT, ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื•ืคื ื™ื”. ื .ื’ื‘ื•ื” D-DIMER, ืคื™ื‘ืจื™ื ื•ื’ืŸ ื ืžื•ืš, ืžืื•ืจืš PTT, ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื•ืคื ื™ื”. ื‘ .ื’ื‘ื•ื” D-DIMER, ืคื™ื‘ืจื™ื ื•ื’ืŸ ื’ื‘ื•ื”, ืžืื•ืจืš PTT, ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื•ื–ื™ืก. ื’ .ื ืžื•ืš D-DIMER, ืคื™ื‘ืจื™ื ื•ื’ื ื’ื‘ื•ื”, ืžืื•ืจืš PTT, ื™ืกื˜ืจื•ืžื‘ื•ืฆื™ื˜ื•ื–. ื“ .ื’ื‘ื•ื” D-DIMER, ืคื™ื‘ืจื™ื ื•ื’ืŸ ื ืžื•ืš, ืงืฆืจ PTT, ื˜ืจื•ืžื‘ื•ืชื™ื˜ื•ืคื ื™ื”. ื”

?ื‘ืขื–ืจืช ืื™ื–ื” ืžื”ื’ื•ืจืžื™ื ื”ื‘ืื™ื ื˜ืกื™ื•ืช ื ืฆืžื“ื•ืช ืœืจืงืžื” ืกืื‘ ืื ื“ื•ืชืœื™ืืœื™ืช.53

ืกื™ื“ืŸ. ื 2ืคืงื˜ื•ืจ .ื‘ ืคื™ื‘ืจื™ื ื•ื’ืŸ. ื’ ืžื”ื˜ืกื™ื•ืช 3ืคืงื˜ื•ืจ .ื“ ืคืงื˜ื•ืจ ืคื•ืŸ ื•ื™ืœื‘ืจื ื“. ื”

):20-43ื ื•ืจืžืœื™ ( 0ื”ื•ื LAP score -ื ื‘ื“ืงื• ืœื•ื™ืงื•ืฆื™ื˜ื™ื ื•ืžืฆืื• ืฉื”. 54

ื–ื” ืžืžืฆื ื ื•ืจืžืœื™. ื ืžื—ืœื” ืžื™ืืœื•ืคืจื•ืœื™ืคืจื˜ื™ื‘ื™ืช. ื‘ ืžื—ืœื” ืœื™ืžืคื•ืคืจื•ืœื™ืคืจื˜ื™ื‘ื™ืช. ื’

Page 12: As you wish

12

?ืื™ื–ื” ืคืงื˜ื•ืจ ืกื‘ื™ืจ ืฉื ืคื’ืข, ืžื•ืืจืš PTT,PT,TTื‘ื‘ื“ื™ืงื” ืฉืขืฉื• ืœื—ื•ืœื” ื ืžืฆื ื‘. 55

I.ื XIII.ื‘ VII.ื’ XII.ื“

?ืœื”ืฉื™ื’ ื‘ืžืชืŸ ืžื ืช ื›ื“ื•ืจื™ื•ืช ื“ื ื“ื—ื•ืกื•ืชืžื” ื”ืžื˜ืจื” ื”ืขื™ืงืจื™ืช ืฉืจื•ืฆื™ื . 56 ืœื”ืขืœื•ืช ืจื™ื•ื•ื™ื•ืŸ ื—ืžืฆืŸ ื‘ื“ื. ื oxygen carring capacityืœื”ืขืœื•ืช ื‘ืื•ืคืŸ ื™ืฉื™ืจ ืืช . ื‘ ืœื”ื—ื–ื™ืจ ื ืคื— ื“ื ืฉืื‘ื“. ื’

?Hassalls carpusclesืื•ื“ื•ืช ืžื” ื”ื›ื™ ื ื›ื•ืŸ . 57

ื ืžืฆืื™ื ื‘ืžื“ื•ืœื” ื‘ืชื™ืžื•ืก. ื ื ืžืฆืื™ื ื‘ืงื•ืจื˜ืงืก ื‘ืชื™ืžื•ืก. ื‘ Tืžื”ื•ื•ื” ืชืคืงื™ื“ ืžืคืชื— ื‘ืžื˜ื•ืจืฆื™ื™ืช ืชืื™ . ื’ Bื™ ืชืื™ "ืžื™ื•ืฆืจื™ื ืข. ื“

?ืื™ืคื” ื ื•ื›ืœ ืœืจืื•ืช ืชืื™ื ืจื˜ื™ืงื•ืœื•ืื ื“ื•ืชืœื™ืืœื™ื™ื, ืงืฉืจ ื”ืœื™ืžืคื”ื‘. 58

ื“ื•ืœืจื™ื•ืชื‘ืงื•ืจื“ื•ืช ื”ืž. ื ื‘ืงื•ืจื˜ืงืก.ื‘ ื”ืงืฉืจื‘ืกื™ื ื•ืกื™ื ืฉืœ . ื’ ื‘ืคืจืืงื•ืจื˜ืงืก. ื“ ื”ื›ืœ ื ื›ื•ืŸ. ื”

:ืื“ื ืขื ื‘ื“ื™ืงื•ืช ื”ื“ื ื”ื‘ืื•ืช ื”ื’ื™ืข ืœืžืขื‘ื“ื”. 59

WBC = 13,000/cm3, Hb = 22g%, Htc = 57%, platelets = 600,000/mm3. ?ืžื”ื™ ื”ืื‘ื—ื ื” ื”ืกื‘ื™ืจื” ื‘ื™ื•ืชืจ

Polycythemia Vera .ืEssential Thrombocytosis .ื‘Chronic myelogenous leukemia .ื’Acute leukemia .ื“

?ืžื” ืžื”ื‘ืื™ื ื ื›ื•ืŸ ืœื’ื‘ื™ ืœื•ืงืžื™ื” ื—ืจื™ืคื”. 60ืงืจื™ื•ืฆื™ื˜ื™ืช-ืžืืคื™ื™ื ื™ื ืœื•ืงืžื™ื” ืžื’ื” Auer bodies .ื

.Myelodysplasiaืœ ื”ื•ื ืกื™ื‘ื•ืš ื™ื“ื•ืข ืฉ AML .ื‘

ืฉื ื™ื 10ื”ื—ื™ื™ื ืœืื—ืจ ื’ื™ืœื•ื™ ื”ืžื—ืœื” ื”ื•ื ืื•ืจื— .ื’

ืžื” . ื•ืื™ืŸ ื–ืžืŸ ืœืขืฉื•ืช ื‘ื“ื™ืงืช ื“ื ืœื•ื•ื™ื“ื•ื ืกื•ื’ ื”ื“ื ืฉืœื•, ืื“ื ื‘ืžืฆื‘ ืงืฉื” ื”ื’ื™ืข ืœื—ื“ืจ ื ื™ืชื•ื—.61?ื ื–ืžื™ืŸ ืžื‘ื ืง ื”ื“ื ื›ื“ื™ ืœืžื ื•ืข ืชื’ื•ื‘ื” ืงืฉื”

ABื•ืชืื™ ื“ื Oืคืœืกืžื” .ืABืžื ื•ืช ืฉืœ ื˜ืกื™ื•ืช ืžืื“ื 6 .ื‘Oืžื ื•ืช ื“ื ืžืื“ื ืฉื”ื•ื 4 .ื’Oื•ืชืื™ ื“ื ABืœืกืžื” ืค .ื“

Page 13: As you wish

13

?ืžื” ื™ืงืจื” ื›ืืฉืจ ื ื–ืจื™ืง ืœืื“ื ื“ื ืฉืื™ื ื• ืชื•ืื ืืช ืกื•ื’ ื”ื“ื ืฉืœื•.62

ื™ืฉ ืกื‘ื™ืจื•ืช ื’ื‘ื•ื”ื” ืฉื”ื•ื ื™ืžื•ืช .ื

.ื™ ืกื“ืจ ื•ื‘ื“ื™ืงื•ืช ืžืขื‘ื“ื”"ืœื ื ื™ืชืŸ ืœืžื ื•ืข ืžืงืจื™ื ื›ืืœื• ืข .ื‘

.IgGืชื”ื™ื” ื”ืžื•ืœื™ื–ื” ืžืฉื ื™ืช ื‘ืขืงื‘ื•ืช ืชื’ื•ื‘ืช ื ื•ื’ื“ื ื™ .ื’

..ืชื”ื™ื” ืชื’ื•ื‘ืช ื˜ืกื™ื•ืช ืื• ืžืฉื”ื• ื›ื–ื” .ื“

, ื‘ื‘ื“ื™ืงื”. ืœืžื™ื•ืŸ ืขืงื‘ ื“ื™ืžื•ื ืขื”ื”ื’ื™, ืžืกืชื ืœื‘ ืžืœืื›ื•ืชื™ื•ื™ืฉ ืœื” , ืื™ืฉื” ืžื˜ื•ืคืœืช ื‘ืงื•ืžื“ื™ืŸ .63

.ืžื” ืžื”ื‘ืื™ื ื”ื•ื ื”ืžื“ื•ื™ืง ื‘ื™ื•ืชืจ. 3.5ืฉืœื” ื”ื•ื INR -ื ืžืฆื ื›ื™ ืขืจืš ื”

ื”ื˜ื™ืคื•ืœ ื‘ืงื•ืžื“ื™ืŸ ืื™ื ื• ืžืกืคื™ืง .ื

ื”ื˜ื™ืคื•ืœ ื‘ืงื•ืžื“ื™ืŸ ื”ื•ื ื‘ืจืžื” ื˜ื•ื‘ื” .ื‘

ื”ื˜ื™ืคื•ืœ ื‘ืงื•ืžื“ื™ืŸ ื’ื‘ื•ื” ืžื“ื™ .ื’

ืžื“ื•ื‘ืจ ืขืœ ื‘ื“ื™ืงื” ืฉืœ ื”ืคืจื™ืŸ โ€“ื”ื‘ื“ื™ืงื” ื”ื–ื• ื‘ื›ืœืœ ืœื ื˜ื•ื‘ื” ืœืงื•ืžื“ื™ืŸ .ื“

:ืœืžืจืคืื” ืขื ื‘ื“ื™ืงื•ืช ื“ื ื›ื“ืœื”ืœืŸืื“ื ื”ื’ื™ืข .64

WBC = 7000/mm3, Hb = 13.6g%, Htc = 46%, Platelets = 800,000/mm3. ?ืžื”ื™ ื”ืื‘ื—ื ื” ื”ืกื‘ื™ืจื” ื‘ื™ื•ืชืจ

PV .ืCML .ื‘ืžื—ืกื•ืจ ื‘ื‘ืจื–ืœ ืขื ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื•ื–ื™ืก .ื’

ET .ื“

ื ื•ื˜ื” AMLืžืกื ื™ืŸ ืชืื™ื ืื ALLืœืืŸ , ALL -ื• AMLื‘ื”ืฉื•ื•ืื” ืฉืœ ื”ืœื•ืงืžื™ื•ืช ื”ื—ืจื™ืคื•ืช .65?ืœืขืฉื•ืช ื–ืืช ืคื—ื•ืช

ื›ื‘ื“ .ื

ื˜ื—ื•ืœ .ื‘

ืขื•ืจ .ื’

ืžืขืจื›ืช ื”ืœื™ืžืคื” .ื“

ืžืขืจื›ืช ื”ืขืฆื‘ื™ื ื”ืžืจื›ื–ื™ืช .ื”

?ื‘ื™ืœื“ื™ื ALLื‘ืื™ื–ื” ื’ื™ืœืื™ื ื ืคื•ืฅ ืœืจืื•ืช .66

1> .ื1-9 .ื‘10-15 .ื’15< .ื“ืื™ื ื• ื ืคื•ืฅ ื‘ื™ืœื“ื™ื ALL .ื”

?ALLืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ืœื•ืงืžื™ื” ื—ืจื™ืคื” ืžืกื•ื’ .67

ื”ืชืื™ื ืžืชืจื›ื–ื™ื ื‘ืขื™ืงืจ ื‘ื›ื‘ื“ .ื

ื”ืชืื™ื ืžืชืจื›ื–ื™ื ื‘ืงืฉืจื™ ืœื™ืžืคื” ืžื‘ื•ื“ื“ื™ื .ื‘

ื™ืฉ ื”ืชืคืฉื˜ื•ืช ืฉืœ ื”ื’ื™ื“ื•ืœ ื’ื ืœื“ื .ื’

Page 14: As you wish

14

?ืืจื™ืชืจื•ืคื•ื™ื˜ื™ืŸ ื ืžื•ืš ืžืชื™ ื ืจืื” ื—ื•ืœื” ืขื.68

ืฉื ื” 20ื” ื‘ื™ื•ื ื‘ืžืฉืš ืกืื“ื ืžืขืฉืŸ ืœืคื—ื•ืช ื—ืคื™ .ื

ื—ื•ืœื” ื“ื™ืืœื™ื–ื” .ื‘

ื’ื™ื“ื•ืœ ืฉืœ ื”ื›ืœื™ื™ื” .ื’

ืื“ื ืขื ืžื—ืœืช ืจื™ืื•ืช ื›ืจื•ื ื™ืช .ื“

ื”ื™ืžื™ื ื”ืจืืฉื•ื ื™ื ื‘ืžื—ื–ื•ืจ 3- ื‘, ืืœื• ืžื”ืžื‘ื ื™ื ื”ื‘ืื™ื ื ื•ื›ืœ ืœืžืฆื•ื ื‘ืชื ืื“ื•ื ืชืงื™ืŸ ื•ื‘ืฉืœ .69?ื”ื“ื

ืฉืืจื™ื•ืช ื’ืจืขื™ืŸ. ื ื’ืจืขื™ืŸ ืฉืœื. ื‘ ืจืฉืช ืจื™ื‘ื•ื–ื•ืžื™ื. ื’ ื”ืžื•ื’ืœื•ื‘ื™ืŸื’ื•ืฉื™ . ื“ Heinzื’ื•ืคื™ืคื™ . ื”

?CMLืžื” ื”ืชืจื•ืคื” ื”ื™ืขื™ืœื” ื‘ื™ื•ืชืจ ื‘ืฉืœื‘ ื”ื›ืจื•ื ื™ ืฉืœ .70

ืฆื™ื˜ืจื‘ื™ืŸ+ ืื™ื ื˜ืจืคืจื•ืŸ .ื

ืฆื™ื˜ืืจื‘ื™ืŸ .ื‘

ื’ืœื™ื‘ืง .ื’

ื”ื™ื“ืจื•ืงื™ืื•ืจื™ืื” .ื“

ืื™ื ื˜ืจืคืจื•ืŸ .ื”

?"ืคืกื™ื ืฉืœ ืคื™ื‘ืจื•ื–ื™ืก"ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ื”ืื‘ื—ื ื” ืฉืœ ื‘ื™ื•ืคืกื™ื” ืขื .71

Lymphocyte predominantืžื“ื•ื‘ืจ ืขืœ .ืmixed cellularityืžื“ื•ื‘ืจ ืขืœ .ื‘Lymphocyte depletionืžื“ื•ื‘ืจ ืขืœ .ื’ Lacular cellsืžื“ื•ื‘ืจ ืขืœ ื“ื’ื™ืžื” ืขื .ื“

?B-symptomsืžื” ืžื”ื‘ืื™ื ื ื—ืฉื‘ ื›ื—ืœืง ืž .72

.ื›ืื‘ ืœืื—ืจ ืฉืชื™ื™ืช ืืœื›ื•ื”ื•ืœ .ื

ื”ื–ืขื” ืœื™ืœื™ืช .ื‘

ืจืขื“ ื‘ื™ื“ื™ื™ื .ื’

ื”ืงืื•ืช ืžืžื•ืฉื›ื•ืช .ื“

?indirect coombs testื”ื™ื›ืŸ ื ื™ืชืŸ ืœืจืื•ืช ื ื•ื’ื“ื ื™ื ื‘ื‘ื“ื™ืงื” ื—ื™ื•ื‘ื™ืช ืฉืœ .73

ืขืœ ืžื•ื ื•ืฆื™ื˜ื™ื .ื

ืขืœ ืœื™ืžืคื•ืฆื™ื˜ื™ื .ื‘

ื"ืขืœ ืชื“ .ื’

ื‘ืคืœืกืžื” .ื“

ืœ"ืชื“ืขืœ .ื”

Page 15: As you wish

15

?erythropoiesisื›ื™ืฆื“ ื ื™ืชืŸ ืœื”ืขืจื™ืš .74

.ืœืคื™ ื”ืžื•ื’ืœื•ื‘ื™ืŸ .ื

ืœืคื™ ื”ืžื˜ื•ืงืจื™ื˜ .ื‘

.ืœืคื™ ืจื˜ื™ืงื•ืœื•ืฆื™ื˜ื™ื .ื’

.ื‘ื“ื™ืงืช ืžื— ืขืฆื .ื“

:ื”ื™ื›ืŸ ื ืžืฆืื™ื ืชืื™ื ืื ื•ื“ืชืœื™ืืœื™ื™ื ืจื˜ื™ืงื•ืœืจื™ื™ื .75

:ืชืฉื•ื‘ื•ืช ื‘ื˜ื•ื—ื•ืช

ืชืฉื•ื‘ื”ืฉืืœื”ืชืฉื•ื‘ื”ืฉืืœื”ืชืฉื•ื‘ื”ืฉืืœื”

ื‘51ื’26ื1

ื‘52ื‘27ื“2

ื”53ื’28ื‘3

ื‘54ื’29ื‘4

ื55ื’30ื”5

ื‘56ื’31ื“6

ื‘57ื“32ื’7

ื”58ื”33ื”8

ื59ื’34ื‘9

ื‘60ื35)ื‘ื•ื ื•ืก(ื‘ 10

ื“61ื’36ื’11

ื62ื37ื‘12

ื’+ื‘63ื’38ื13

ื“64ื’39ื”14

ื”65ื‘ื•ื˜ืœ40ื’15

ื‘66ื”41ื16

ื’67ื’42ื‘+ื17

ื‘68ื‘43ื’18

ื’69ื’44ื‘19

ื’70ื45ื’20

ื“71ื‘46ื‘21

ื‘72ื47ื‘22

ื“73ื‘48ื’23

ื’74ื‘49ื‘ 24

75ื‘50ื25

Page 16: As you wish

16

ื“"ื‘ืก

)2008(ื˜"ืžื—ื–ื•ืจ ืœื’ ืชืฉืก -ืฉื—ื–ื•ืจ ื”ืžื˜ื•ืœื•ื’ื™ื” ?ืื™ื–ื” ื—ื•ืžืจ ืžื•ืคืจืฉ ืžืชืื™ ืื ื“ื•ืชืœ ื•ืžืขื›ื‘ ืฉืคืขื•ืœ ื˜ืกื™ื•ืช. 1

ืคืจื•ืกื˜ืฆื™ืงืœื™ืŸ. ื ื˜ืจื•ืžื‘ื™ืŸ. ื‘ A2ื˜ืจื•ืžื‘ื•ืงืกืŸ . ื’ ADP. ื“ ืกืจื•ื˜ื•ื ื™ืŸ. ื” ? ืžื”ื• ืžื ื’ื ื•ืŸ ื”ืคืขื•ืœื” ืฉืœ ื”ืคืจื™ืŸ . 2

ื•ืžื–ืจื– ืืช ืคืขื•ืœืชื• ืขืœ ื”ืชืจื•ืžื‘ื™ืŸ 3ื ืงืฉืจ ืœืื ื˜ื™ื˜ืจื•ืžื‘ื™ืŸ . ื ื ืงืฉืจ ืงื•ื•ืœื ื˜ื™ืช ืœืชืจื•ืžื‘ื™ืŸ ื•ืžืขื›ื‘ ืื•ืชื•. ื‘ ื”ื›ืจื—ื™ื™ื ืœืชืจื•ืžื‘ื™ืŸืžืฉื ื” ืžื˜ืขืŸ ืฉืœ ื™ื•ื ื™ื ื—ื™ื•ื‘ื™ื™ื ื›ื’ื•ืŸ ืกื™ื“ืŸ ื”. ื’ ืžืขื›ื‘ ื”ืคื™ืš ืฉืœ ืคื™ื‘ืจื™ื ื•ื’ืŸ ืœืคื™ื‘ืจื™ืŸ. ื“ ?(HSC)ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ืชืื™ ื’ื–ืข ื”ืžื˜ื•ืคื•ืื˜ื™ื™ื . 3

ืื™ื ื ื™ื›ื•ืœื™ื ืœืขื‘ื•ืจ ืืคื•ืคื˜ื•ื–ื™ืก. ื )ืคื™ื‘ืจื•ื‘ืœืกื˜ื™ื(ืžืงื•ืจื ื‘ืชืื™ ื”ืคืจื ื›ื™ืžื” ืฉืœ ืžื— ื”ืขืฆื . ื‘ )ื•ื”ืฉื ื™ ืžื—ื•ื™ื‘ ืœืฉื•ืจื” ืžืกื•ื™ื™ืžืช HSCืชื ื‘ืช ืื—ื“ ื ืฉืืจ (ืกื™ืžื˜ืจื™ืช -ื”ื—ืœื•ืงื” ืฉืœื”ื ืชืžื™ื“ ื. ื’ .ื”ืชืžื™ื™ื ื•ืช ื•ืืคื•ืคื˜ื•ื–ื™ืก, ืชืื™ื ืืœื” ื”ื™ื ื ื‘ืขืœื™ ื™ื›ื•ืœืช ื—ื™ื“ื•ืฉ ืขืฆืžื™ืช. ื“ ืืš ืœื ืœืœื™ืžืคื•ืฆื™ื˜ื™ื.....ืžื•ื ื•ืฆื™ื˜ื™ื, ืชืื™ื ืืœื” ื™ื›ื•ืœื™ื ืœื”ืชืžื™ื™ืŸ ืœื’ื ื•ืœื•ืฆื™ื˜ื™ื. ื” MDS -ื˜ื™ืคื•ืœ ื‘. 4

ืื ื˜ื™ื‘ื™ื•ื˜ื™ืงื” ื•ืคืงื˜ื•ืจื™ ื’ื“ื™ืœื”, ื˜ื™ืคื•ืœ ืชื•ืžืš ื›ื•ืœืœ ืžืชืŸ ื“ื. ื ืกื™ื•ืชืžืชืŸ ื˜. ื‘ ื”ืฉืชืœื” ืžืชื•ืจื ื–ืจ ื‘ื›ืœ ื”ื—ื•ืœื™ื ืœืœื ืงืฉืจ ืœื’ื™ืœ. ื’ ื˜ื™ืคื•ืœ ื›ื™ืžื•ืชืจืคื™ ื™ืขื™ืœ ื•ืžื‘ื™ื ืœื”ืคื•ื’ื” AL - ื‘ืžืขื‘ืจ ืœ. ื“ ืชื™ืœื•ื“ื•ืžื™ื“ ื™ืขื™ืœ ื‘ืฉืœื‘ ืžื•ืงื“ื. ื” ืœืื—ืจ . ืžื ื•ืช ื“ื ื‘ืžื”ืœืš ื”ื ื™ืชื•ื— 4ืขื‘ืจื” ื ื™ืชื•ื— ื”ื—ืœืคืช ื‘ืจืš ื•ืงื™ื‘ืœื” 70ืื™ืฉื” ืžืžื•ืฆื ืจื•ืžื ื™ ื‘ืช . 5

ื›ืžื” ืœื ื ืžืฆืื• ืœื™ืžืคื•ืฆื™ื˜ื™ื ื‘ื“ืžื” ืœื ื ืžืฆื ื“ื ื•ื—ืœื‘ื•ืŸ ื‘ืฉืชืŸ .ื™ืžื™ื ื”ื—ืœื” ืœื”ืฉืชื™ืŸ ืฉืชืŸ ื‘ืฆื‘ืข ื›ื”ื”

?.ืฉืœ ื”ืื™ืฉื” ื‘ืžื” ื ื—ืฉื•ื“ ืื ืžื™ื” ื”ืžื•ืœื™ื˜ื™ืช .ืื–ื™ื”ื•ื ื‘ื“ืจื›ื™ ื”ืฉืชืŸ .ื‘ืื‘ื ื™ื ื‘ื›ื™ืก ื”ืฉืชืŸ .ื’ื’ื™ื“ื•ืœ .ื“ื ืคื™ืœืช ืจื—ื .ื”

?ืชื•ืš ื›ืžื” ื–ืžืŸ ื™ืฉืคื™ืข ืฉื™ื ื•ื™ ื”ืžื™ื ื•ืŸ ืฉืœ ืงื•ืžื“ื™ืŸ. 6

ืฉืขื•ืช 6. ื ืฉืขื•ืช 12. ื‘ ืฉืขื•ืช 24. ื’ ืฉืขื•ืช 24-48. ื“ ืฉืขื•ืช 48ืžืขืœ . ื” ?ืžื” ื”ืกืžืŸ ื”ืžื•ื‘ื”ืง ืœืคื•ืœื™ืฆื™ื˜ืžื™ื” ื•ื•ืจื” . 7

ืฆื™ื˜ื•ื’ื ื–ื™ืก . ื ื“ื™ืžื•ื ืžื•ื’ื‘ืจ . ื‘

Page 17: As you wish

17

ืืจื™ืชืžื•ืœืœืœืœืœืœืœืœืœืœืœืœืœืœืœื’ื™ื”. ื’ ื“ ืžืกืช ืชืื™ ื“ื ืื“ื•ืžื™ื

:ืกืคื™ื’ืช ื—ื•ืžืฆื” ืคื•ืœื™ืช ื ืขืฉื™ืช ื‘ืขื™ืงืจ ื‘. 8

ืžืขื™ ื’ืก. ื Ileum โ€“ืžืขื™ ื“ืง ืžืจื•ื—ืง . ื‘ Jejunum โ€“ืžื™ ื“ืง ืงืจื•ื‘ . ื’ ืงื™ื‘ื”. ื“ ื•ืฉื˜. ื” :ื”ื•ื CLLื”ื’ื•ืจื ื”ืขื™ืงืจื™ ืœืžื•ื•ืช ื‘ื—ื•ืœื™ . 9

hypercalcemia. ื Uric acid nephropathy. ื‘ ื–ื™ื”ื•ื ื—ื™ื™ื“ืงื™. ื’ ืฉืœื•ื—ืฅ ืขืœ ืื™ื‘ืจื™ื bulky mass. ื“ CNS -ื”ืกื ื ื” ืœ. ื”

?ืžื” ื”ืชืกืžื•ื ืช ื”ื”ืžื˜ื•ืœื•ื’ื™ืช ื”ื›ื™ ืฉื›ื™ื—ื” ืฉืื™ืชื ืžื’ื™ืขื™ื ื—ื•ืœื™ ืžื™ืืœื•ืžื”. 10 ื ื•ื™ื˜ืจื•ืคื ื™ื”. ื ืœื™ืžืคื•ืคื ื™ื”. ื‘ ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื•ืคื ื™ื”. ื’ ืื ืžื™ื”. ื“ ื”ืคืจืขื” ื‘ืคืงื˜ื•ืจื™ ืงืจื™ืฉื” . ื”

:ื•ื•ืคืจื™ืŸ ืœืขื•ืžืช ื”ืคืจื™ืŸ. 11 ื‘ืžืขืจื›ืช ื”ืงืจื™ืฉื” ื”ืขื•ืจืงื™ืช ื•ื”ืคืจื™ืŸ ื‘ื•ืจื™ื“ื™ื โ€“ื•ื•ืคืจื™ืŸ . ื ื™ืฉ ืœืชืช ื”ืคืจื™ืŸ - ื‘ื”ืจื™ื•ืŸ ืœื ื ื™ืชืŸ ื•ื•ืคืจื™ืŸ. ื‘ ื•ืœื”ืคืจื™ืŸ ืขืœ ื™ื“ื™ ื–ืžืŸ ื“ื™ืžื•ื) ืื• ืžืฉื”ื• ื›ื–ื” PTT (ื’ ืขื•ืฉื™ื ื ื™ื˜ื•ืจ ืœื•ื•ืคืจื™ืŸ ืขืœ ื™ื“ื™

)ืžืกืคืจื™ื ืžืฉื•ืชืคื™ื 3ื ื™ืชื ื• ืžืกืคืจื™ื ืฉืœ ื—ื•ืœื” ื•ืชื•ืจื ืฉืžืชื•ื›ื ื”ื™ื• (ื‘ื‘ื“ื™ืงืช ืจืงืžื•ืช ื ืžืฆื .12 ืื™ืŸ ื”ืชืืžื” -ืœื ื ื™ืชืŸ ืœื‘ืฆืข ื”ืฉืชืœื”. ื ื ื™ืชืŸ ืœื‘ืฆืข ื”ืฉืชืœื” ืืœื•ื’ื ืื™ืช ืจื’ื™ืœื”. ื‘ match donor. ื’ Tืง ืชืื™ ื ื™ืชืŸ ืœื‘ืฆืข ื”ืฉืชืœื” ืขื ืฉื™ืชื•ืง ืื• ืกื™ืœื•. ื“

?ืžื” ื”ืกื™ื›ื•ืŸ ื”ืฉืืจื™ ืฉื”ื“ื’ื™ืžื” ืžื–ื•ื”ืžืช ELISA - ื‘ื”ื ื—ื” ืฉืžื ืช ื”ื“ื ื ื‘ื“ืงื” ื‘.13 1:1000. ื 1:10000. ื‘ 1:100000-500000. ื’ ืื™ืŸ ืกื™ื›ื•ื™ ืฉื”ื“ื’ื™ืžื” ืžื–ื•ื”ืžืช. ื“ ืื™ื ื” ืฉื™ื˜ื” ื˜ื•ื‘ื” ื•ืœื›ืŸ ืœื ื ื”ื•ื’ื” ื›ืœืœ ื‘ืืจืฅ ELISA. ื”

?ื›ืจื•ื ื™ DIC -ืžื” ื’ื•ืจื ืœ.14Rocky mountain.ื spotted fever metastatic malignancy. ื‘ ืชืกืžื•ื ืช ืขื•ื‘ืจ ืžืช. ื’ ืกืคืกื™ืก ืžื’ืจื ืฉืœื™ืœื™. ื“ placental abruptio. ื”

ืขื‘ืจ ื‘ืจื™ืช ืžื™ืœื” ืœืœื , ื›"ื‘ืจื™ื ื‘ื“. ืžื’ื™ืข ืœืžื™ื•ืŸ ืขื ื“ื™ืžื•ื ื‘ืืฃ ืœืจืืฉื•ื ื” ื‘ื—ื™ื™ื• 5ื™ืœื“ ื‘ืŸ .15

ืžื” ื”ืกื™ื‘ื” ื”ื›ื™ ื”ื’ื™ื•ื ื™ืช ืœื“ื™ืžื•ื. ื‘ืกืคื™ืจืช ื“ื ื˜ืกื™ื•ืช ืชืงื™ื ื•ืช. ืกื™ื‘ื•ื›ื™ืacute ITP .ืื‘ืขื™ื™ืช ื˜ืกื™ื•ืช ืžื•ืœื“ืช .ื‘

Page 18: As you wish

18

ื™ืžื™ื ืงื•ื“ื ืœื›ืŸ ื‘ืฉืœ ืขืœื™ื™ืช ื—ื•ื 3ื”ื™ืœื“ ืงื™ื‘ืœ ื ื•ืจื•ืคืŸ .ื’ืฉืœื‘ ืจืฉื•ื ื™ ืฉืœ ืœื•ืงื™ืžื™ื” ื—ืจื™ืคื” .ื“

?ืžื” ื™ืขืœื” ืกืคื™ืจืช ืืจื™ืชืจื•ืžื™ื˜ื™ื ื‘ื“ื’ื™ืžื” .16

a.ืงืจื™ืฉ ื“ื ื‘ื“ื’ื™ืžื” b.ื˜ืกื™ื•ืช ื’ื“ื•ืœื•ืชc. ืžื™ืงืจื•ืฆื™ื˜ื™ืd.ืื’ืจื’ืฆื™ื” ืฉืœ ื˜ืกื™ื•ืชe.

?ืžื‘ื™ืŸ ื”ืžืžืื™ืจื•ื™ื•ืช ื”ื”ืžื˜ื•ืœื•ื’ื™ื•ืช MM -ืžื” ืื—ื•ื– ื”.17

a.10% b.30%c.75%d.90%

. ืœื˜ืขื ืช ื”ืžืฉืคื—ื” ื™ืฉื ื•ื ื™ืช. ื› ื”ื’ื™ืขื” ืœืžืจืคืื” ืขืงื‘ ื›ืื‘ื™ ืจืืฉ"ื‘ืจื™ืื” ื‘ื“ 35ืื™ืฉื” ื‘ืช .18

, ืื ืžื™ื” ื ื•ืจืžื•ืฆื™ื˜ื™ืช. ื‘ื“ื™ืงื” ืคื™ื–ื™ืงืœื™ืช ืชืงื™ื ื” ืœืžืขื˜ื—ื™ื•ื•ืจื•ืŸ ื•ืฆื”ื‘ืช ื‘ืœื—ืžื™ืชืžืฉื˜ื— ืขื ื˜ืกื™ื•ืช . ืกืคื™ืจื” ืœื‘ื ื” ืชืงื™ื ื” ื•ืชื™ืคืงื•ื“ื™ ื›ืœื™ื•ืช ื’ื‘ื•ื”ื™ื, 50000ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื•ืคื ื™ื”

.ื•ืฉื‘ืจื™ ืชืื™ืa.ืžื“ื•ื‘ืจ ื‘, ืฉื‘ืจื™ ืืจืชืจื•ืฆื™ื˜ื™ื, ื™ืฉ ื—ืกืจ ื˜ืกื™ื•ืช- TTP . ื™ืฉ ืœืขืฉื•ืช ืคืœืกืžื” ืคืจืกื™ืก

ื‘ื”ืงื“ืb.ืฆืจื™ืš ืœืขืฉื•ืช . ืžื“ื•ื‘ืจ ื‘ืืžื ื™ื” ืืคืœืกื˜ื™ืช. ื—ื•ืกืจ ื‘ืชืื™ ื“ื ืื“ื•ืžื™ืMBT.c.ืื™ืŸ ืขื“ื•ืช ืœื˜ืกื™ื•ืช .ITP ืงืœืืกื™.d.ื™ืฉ ืœืฉืœื•ื— ืœื”ืขืจื›ื” ื ื•ื™ืจื•ืœื•ื’ื™ืช ื•ืœื”ืžืฉื™ืš ื‘ืจื•ืจ . ืžื“ื•ื‘ืจ ื‘ืชืื™ื ืฉืขื‘ืจื• ืฉื‘ืฅ ืžื•ื—ื™

.ืœืื—ืจ ืžื›ืŸ

?ืœ ื‘ืœื•ืงื™ืžื™ื” ื—ืจื™ืคื”ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ื”ื˜ื™ืคื•.19a.ื™ืฉ ืœื”ื’ื™ืข ืœืจื™ืžื™ืกื™ื” ืžืœืื” ืขืœ ืžื ืช ืœื”ื’ื™ืข ืœื”ื‘ืจืื” b.ื”ื˜ื™ืคื•ืœ ื‘- ALL ื•- CLL ื–ื”ื”c. 80%ืื—ื•ื–ื™ ื”ื”ืฆืœื—ื” ื‘ืจื™ืคื•ื™ ืœื•ืงื™ืžื™ื” ื”ื™ื ื ืžืขืœ

?ืžื” ื”ืกื™ื‘ื” ื”ืกื‘ื™ืจื”) 0.39-0.43ื˜ื•ื•ื— ืชืงื™ืŸ ( 0.54ืžื‘ื—ืŸ ืฉื‘ื™ืจื•ืช ืื•ืกืžื•ื˜ื™ .20

a.ืกืคืจื•ืฆื™ื˜ื•ื–ื™ืก b.ื”ืจืขืœืช ืขื•ืคืจืชc.ื—ืกืจ ื‘ื—ื•ืžืฆื” ืคื•ืœื™ืชd.DICe.ื–ื™ื”ื•ื ืžื™ืงื•ืคืœืกืžื”

?ืžื” ืžื‘ืฆืขื™ื ืืช ืžื‘ื—ืŸ ื”ืฉื‘ื™ืจื•ืช ื”ืื•ืกืžื•ื˜ื™ืช ืขื.21

a.ื’ืœื•ืงื•ื– b.ืกืœื™ื™ืŸc.ืกื•ื›ืจื•ื–d.ื’ืœื•ืงื•ื– ืขื ืกืœื™ื™ืŸ

ืฆื•ืจืฃ (ื‘ืžืฉื˜ื— ืจืื™ื ื• ืชื ืื•ืคื™ื™ื ื™ ืœืžื—ืœื”. ืœื•ื™ืงื•ืฆื™ื˜ื•ื–ื™ืก ื•ื”ื’ื“ืœืช ื˜ื—ื•ืœ, ืขื ื—ื•ืœืฉื” 70ื‘ืช .22

?ืžื”ื• ื”ืชื). 25ืกืœื™ื™ื“ ืžื“ื™ื•ืŸ ืงืœื™ื ื™ ืขืœ ืœื•ืงืžื™ื•ืช ืฉืงืฃ a.ื‘ื–ื•ืคื™ืœ b.ืคืจื•ืžื™ืืœื•ืฆื™ื˜c.STABd.SMUDG

Page 19: As you wish

19

e. ------

ื‘ื‘ื“ื™ืงื” ื’ื•ืคื ื™ืช ื”ืชื’ืœื• ื’ื™ื“ื•ืœื™ื ื™ืจื•ืงื™ื ื‘ืขื•ืจ . ืžื›ืื‘ื™ ืจืืฉ ื•ื—ื•ืœืฉื”ื”ืกื•ื‘ืœ 40ื—ื•ืœื” ื›ื‘ืŸ .23 ?ืžื” ื”ืื‘ื—ื ื” ื”ืกื‘ื™ืจื”. ื•ื”ืชื ืคื—ื•ืช ื—ื ื™ื›ื™ื™ื

a.CLL b.CMLc.ALLd.AMLe.MALT

ืื™ืš ืชื‘ื“ื•ืง ืื‘ื—ื ื” ืฉืœ ืžื—ืœื” , ื”ืชื’ืœืชื” ืกืคื™ืจืช ืœื™ืžืคื•ืฆื™ื˜ื™ื ื’ื‘ื•ื”ื” ? ื‘ืืฉื” ื‘ืช . 24

? ืœืžืคื•ืคืจื•ืœื™ืคืจื˜ื™ื‘ื™ืช ืฆื‘ื™ืขื” ืœ ืงืืคื” ื•ืœืžื‘ื“ื” . ื amyloidืฆื‘ื™ืขื” ืœ . ื‘ ืฆื‘ื™ืขื” ืœืฉื•ืžืŸ . ื’ ืฆื‘ื™ืขื” ืœืจืงืžืช ื—ื™ื‘ื•ืจ . ื“

ื” ืฆื‘ื™ืขื” ืœืื ื–ื™ื ืคืจ ืื•ืงืกื™ื“ื–

?ืžืžื” ืžื•ืจื›ื‘ ื”ื”ืžื•ื’ืœื•ื‘ื™ืŸ ื” ืคื˜ืืœื™ . 25 ื’ืžื 2ืฉืจืฉืจืื•ืช ืืœืคื 2. ื ืœืžื“ื 2ืฉืจืฉืจืื•ืช ืืœืคื 2. ื‘ ื‘ื™ื˜ื 2ืฉืจืฉืจืื•ืช ืืœืคื 2. ื’ ืฉืจืฉืจืื•ืช ื‘ื™ื˜ื 4. ื“

? BMืžื™ ื–ืงื•ืง ืœื”ืฉืชืœืช . 26

ื‘ื”ืคื•ื’ื” ืฉื ื™ื™ื” 30ื‘ืŸ AMLื—ื•ืœื” . ื ื‘ื”ืคื•ื’ื” ืจืืฉื•ื ื” 40ื‘ืŸ APLื—ื•ืœื” .ื‘ T) 8:21 (ืขื AML.ื’ .ื‘ืœืกื˜ื™ื ื‘ื“ื 0.01%ืขื ) ?70ื‘ืŸ (ื—ื•ืœื” . ื“

? ืื™ืคื” ื ืกืคื’ ื‘ืจื–ืœ . 27

ื”ืชื—ืœืช ืžืขื™ ื“ืง + ื˜ืจื™ืกืจื™ื•ืŸ . ื ืžืขื™ ื’ืก . ื‘ ืžืขื™ ื“ืง ืžืื•ื—ืจ . ื’ ืœืื•ืจืš ืžืขืจื›ืช ื”ืขื™ื›ื•ืœ ื›ื•ืœื” . ื“

. mantle cell lymphomaืžื” ืžื”ืฆื™ืจื•ืคื™ื ื”ื‘ืื™ื ื”ื›ื™ ืžืชืื™ื ืœ . 28

t(14:18) ,bcl-2. ื t(11:18) ,cd43 ,cd3. ื‘ t(9:22) ,cd20. ื’ t(11:14) ,cd23 ,cd5. ื“ t(8:14) ,TdT. ื”

? t(2:5)ื”ื™ื›ืŸ ื ืžืฆื . 29

large b cell diffusion. ื fullicular. ื‘Anaplastic lymphoma. ื’ ) NHืกื•ื’ื™ื ืื—ืจื™ื ืฉืœ ( .ื“

? ืžื” ื”ืฉื›ื™ื—ื•ืช ื”ืฉื ื™ื™ื” ื‘ืกืจื˜ืŸ ืืฆืœ ื ืฉื™ื . 30

ืจื™ืื•ืช . ื ืฉื—ืœื” . ื‘ ืžืขื™ ื’ืก . ื’

Page 20: As you wish

20

ืฉื“. ื“

Page 21: As you wish

21

.ื”ืกื™ื‘ื” ื”ืฉื›ื™ื—ื” ืœืื ืžื™ื” ืืคืœืกื˜ื™ืช . 31

ื“ืœืงืช ื›ื‘ื“ื™ืช. ื ืื“ื™ื•ืคื˜ื™ . ื‘ ืชืจื•ืคื•ืช. ื’

? TTPื›ื™ืฆื“ ื ื˜ืคืœ ื‘ื—ื•ืœื™ . 32

ื”ื—ืœืคืช ืคืœืกืžื” . ื ื”ืฉืชืœืช ืžื— ืขืฆื . ื‘ ื›ื“ื•ืจื™ื•ืช ื“ื ืื“ื•ืžื•ืช ื“ื—ื•ืกื•ืช . ื’

ื“ ืกื˜ืจื•ืื™ื“ื™ื

? popcornื”ื™ื›ืŸ ื ืžืฆื ืชืื™ . 33pre dominante HL. ื n-sclerosis HL. ื‘mixed cellularity. ื’ HLืกื•ื’ื™ื ืื—ืจื™ื ืฉืœ . ื“

?ืžื” ื”ื›ื™ ืžืชืืจ ืืช ื”ืคืจื“ื•ืงืก ืฉืœ ืœื™ืžืคื•ืžื” ืคื•ืœื™ืงื•ืœืจื™ืช ืื™ื ื“ื•ื•ืœื ื˜ื™ืช. 34 .ืคืจื•ืœื™ืคืจืฆื™ื” ืžื•ื’ื‘ืจืช ื•ืขื™ื›ื•ื‘ ืืคื•ืคื˜ื•ื–ื™ืก ืคื•ื’ืžื™ื ื‘ื™ื›ื•ืœืช ื”ื˜ื™ืคื•ืœ. ื ืคืจื•ืœื™ืคืจืฆื™ื” ื’ื‘ื•ื”ื” ืืš ืืคื•ืคื˜ื•ื–ื™ืก ืžื•ื’ื‘ืจ . ื‘ ืคืจื•ืœื™ืคืจืฆื™ื” ื’ื‘ื•ื”ื” ื•ืืคื•ืคื˜ื•ื–ื™ืก ื ืžื•ืš. ื’

ื“ ืงื™ื™ื ืงืฉืจ ื‘ื™ืŸ ืคืจื•ืœื™ืคืจืฆื™ื” ืžื•ื’ื‘ืจืช ืœืขื™ื›ื•ื‘ ืืคื•ืคื˜ื•ื–ื™ืก

?ืžื™ ืžื”ื‘ืื™ื ืกื•ื‘ืœ ืžืคื•ืœื™ืฆื™ื˜ืžื™ื” ื•ืจื” . 35 ืกื•ื‘ืœ ืžื›ืื‘ื™ ืจืืฉ ื’ื™ื“ื•ืœ ื‘ื›ืœื™ื” ืขื ื”ืคืจืฉืช ืืจื™ืชืจื•ืคื•ืื˜ื™ืŸ ืžื•ื’ื‘ืจืช 50ื‘ืŸ . ื ืื™ืŸ ื ื•ื™ื˜ืจื•ืคื™ืœื™ื” ื•ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื•ื–ื™ืก 50%ืจื™ื˜ ืžืขืฉืŸ ื›ื‘ื“ ื”ืžื˜ื•ืง 60ื‘ืŸ . ื‘ 50%ื”ืžื˜ื•ืงืจื™ื˜ , ื’ืจื“ ืื—ืจื™ ืžืงืœื—ืช ื—ืžื” , ืกื•ื‘ืœ ืžืื•ื“ื ื•ื ืคื™ื—ื•ืช ื‘ืคืจืงื™ื 50ื‘ืŸ . ื’

ื ื™ื˜ื•ืจื•ืคื™ืœื™ื” ื•ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื•ื–ื™ืก ื ื•ื™ื˜ืจื•ืคื™ืœื™ื” 56ื”ืžื˜ื•ืงืจื™ื˜ COPDืกื•ื‘ืœ ืž 70ื‘ืŸ . ื“

? ืžืื™ื–ื” ื’ื™ื“ื•ืœื™ื ืกื•ื‘ืœื™ื ื™ืœื“ื™ื ืขื ืคื ืงื•ื ื™ ืื ืžื™ื”. 36

ื’ื™ื“ื•ืœื™ื ื‘ืœืฉื•ืŸ. ื ื•ืงืžื™ื•ืช ืœ. ื‘ ืกืจืงื•ืžื•ืช ื‘ืขืฆืžื•ืช . ื’ ื’ื™ื“ื•ืœื™ื ื‘ืจื™ืื” . ื“ ื’ื™ื“ื•ืœื™ื ื‘ืžืขืจื›ืช ื”ืขื™ื›ื•ืœ . ื”

?ืœืื—ืจ ืฉื ื” CMLื‘ GLIVACืžื” ื”ืื™ื ื“ื•ืงืฆื™ื” ื”ื›ื™ ื˜ื•ื‘ื” ืœื”ืฆืœื—ืช ื”ื˜ื™ืคื•ืœ ื‘ . 37

ื”ืคื•ื’ื” ื‘ืฆื™ื˜ื• ื’ื ื˜ื™ืงื” . ื ื”ืขืœืžื•ืช ื›ืจื•ืžื•ื–ื•ื ืคื™ืœื“ืœืคื™ื” . ื‘ FLOW. cytoื”ืคื•ื’ื” ื‘ . ื’ Bcr-Ablืฉืœ logื™ืจื™ื“ื” ื‘ืฉืœื•ืฉื” . ื“

ืœืขืจืš ืชืงื™ืŸ LAP-ื—ื–ืจืช ื”. ื”

ืกื•ื‘ืœืช ืžื›ืื‘ื™ื ื‘ื’ื‘ ื•ื‘ืฆืœืขื•ืช ื‘ืขื™ืงืจ ื‘ืชื ื•ืขื” ื‘ื‘ื“ื™ืงื” ื ืžืฆื ืจืžืช ื—ืœื‘ื•ืŸ ื’ื‘ื•ื”ื” 70ืืฉื” ื‘ืช . 38ืื™ื–ื• ื‘ื“ื™ืงืช ื”ื“ืžื™ื” ืชืขืฉื” ื›ื—ืœืง ืžื”ื‘ื“ื™ืงื” , ื‘ืขื™ืงืจ ื‘ื™ืœื™ืจื•ื‘ื™ืŸ ืžื•ื ื•ืงืœื•ื ืืœื™ ื•ืชืคืงื•ื“ื™ ื›ืœื™ื” ืœืงื•ื™ื™ื

? ื”ืจืืฉื•ื ื™ืช pet โ€“ct. ื MRI. ื‘ CT. ื’ ืจื ื˜ื’ืŸ ืขืœ ืขืžื•ื“ ื”ืฉื“ืจื” ื•ื”ืฆืœืขื•ืช . ื“ ืžื™ืคื•ื™ ืขืฆืžื•ืช . ื”

Page 22: As you wish

22

?ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ืืจื™ืชืจื•ืฆื™ื˜ื™ื . 39

ื ื—ืกืจื™ ื’ืจืขื™ืŸ ื™ ื•ืื™ืŸ ื’ืจืขื™ืŸ 'ื‘ ื™ืฉ ื’ื•ืœื’

ื’ ื‘ืขืœื™ ื’ืจืขื™ืŸ ืื—ื“ ื“ ืงื‘ื•ืฆืช ืื™ื™ื ื‘ืืคืจื™ืงื”

?ืคืœืกื˜ื™ืช -ืžื” ื”ืกื™ื‘ื” ื”ืฉื›ื™ื—ื” ื‘ื™ื•ืชืจ ืœืื ืžื™ื” ื. 40 ืื“ื™ื•ืคื˜ื™ . ื ืชื–ื•ื ื” ืœืงื•ื™ื” . ื‘ ื“ืœืงืช ื›ื‘ื“ื™ืช . ื’ ืื‘ื™ ื ืžื ื™ . ื“

?ื ืžื•ืš LAP SCOREื”ื™ื›ืŸ ื™ืฉ .. 41AML .ืALL .ื‘CML .ื’ CLL .ื“

?ืกื™ืžื ื™ื ืฉืœืžื•ืœื˜ื™ืคืœืžื™ืืœื•ืžื” ืžื”ื™ ื”ื‘ื“ื™ืงื” ื”ืจืืฉื•ื ื™ืช ืฉื ื‘ืฆืข. .42 PET-CT.ื CT.ื‘ ืžื™ืคื•ื™ ืขืฆืžื•ืช.ื’ .ืจื ื˜ื’ืŸ ืขืžื•ื“ ืฉื“ืจื”.ื“

, ืขื•ื‘ืจืช ื”ืงืจื ื•ืช ืžืงื•ืžื™ื•ืช ื‘ืื™ื–ื•ืจ ื–ื” -ื‘ืื™ื–ื•ืจ ื”ืื’ืŸ ืื™ืฉื” ื—ื•ืœื” ื‘ืžืžืื™ืจื•ืช ื›ืœืฉื”ื™ ืขื ื’ื•ืฉ 43?ืžื” ื”ืกื™ื‘ื”. ืœื“ืžื ืงืœื•ืชื”ื—ืœื” .)?ืื•ืœื™ื™ืžื™ื(ืฉืขื•ืช ' ื•ืœืื—ืจ ืžืก

ื ื“ื™ื›ื•ื™ ื›ืœื™ื™ืชื™ ืœืืจื™ืชืจื•ืคื•ืื˜ื™ืŸ ื‘ ื”ืžื•ืœื™ื–ื”

ื’ ืคื•ืœื™ืคื™ื ืžื“ืžืžื™ื

:ืฉื•ืืคื™ื ืœื”ื’ื™ืข ืœ) ?(ื‘ื˜ื™ืคื•ืœ ื‘ืœื•ืงืžื™ื” ื—ืจื™ืคื” 44ื”ืคื•ื’ื” ื”ืžื˜ื•ืœื•ื’ื™ืช .1ื”ืคื•ื’ื” ืงืœื™ื ื™ืช .2ื”ืคื•ื’ื” ืฆื™ื˜ื•ื’ื ื˜ื™ืช .3 ื”ืคื•ื’ื” ืžื•ืœืงื•ืœืืจื™ืช .4

?ืžื” ื”ืžื“ื“ ื”ืื‘ื—ื ืชื™ ืœืคื•ืœื™ืฆื™ื˜ืžื™ื” ื•ื•ืจื” 45ื’ื‘ื•ื”ื”ืžืกืช ื›ื“ื•ืจื™ื•ืช ื“ื . ื EPOื™ืจื™ื“ื” ื‘. ื‘ ืขืœื™ื™ื” ื‘ื”ืžื•ื’ืœื•ื‘ื™ืŸ. ื’

? 11ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ื—ื•ืกืจ ื‘ืคืงื˜ื•ืจ . 46X-LINKED. ื

ืœื ื’ื•ืจื ืœื“ื™ืžื•ืžื™ืื‘ ื’ ื ืคื•ืฅ ื‘ืžื–ืจื— ื”ืชื™ื›ื•ืŸ

ื“ ืžื•ื›ืจ ื›ื”ืžื•ืคื™ืœื™ื”

? ITPืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ 47ื›ืจื•ื ื™ ื™ืฉ ืœืจื•ื‘ ื”ื’ื“ืœืช ื˜ื—ื•ืœ ืžืฉืžืขื•ืชื™ืช ITPื ื‘")ืœืคืขืžื™ื"ื”ื—ืœืง ื‘ื’ื•ืฃ ืœื = ืœืคืจืงื™ื( ืืงื•ื˜ื™ ื™ืชื›ืŸ ื“ื™ืžื•ื ืœืคืจืงื™ื ITPื‘ ื‘

ืœื›ืจื•ื ื™ ITPืืงื•ื˜ื™ ื™ื”ืคื›ื• ืœ ITPื’ ืจื•ื‘ ื”ื™ืœื“ื™ื ืขื

Page 23: As you wish

23

? HLืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ื—ื•ืœื” ืขื 48CHOPื”ื˜ื™ืคื•ืœ ื›ื•ืœืœื

ื‘ ื”ื˜ื™ืคื•ืœ ื›ื•ืœืœ ืจื™ื˜ื•ืงืกื™ืžื‘ ืขื ืคืจื•ื’ื ื•ื–ื” ื’ืจื•ืขื” 65ื’ ื—ื•ืœื” ืžืขืœ ื’ื™ืœ

?ืžื” ื”ื”ืฉืœื›ื” ืœื˜ื•ื•ื— ืืจื•ืš -ืชื™ื ื•ืง ืขื ืื ืžื™ื” ืฉืžื˜ื•ืคืœ ื‘ื‘ืจื–ืœ 49ื˜ืจื•ืžื‘ื•ืฆื™ื˜ืคื ื™ื”ื ื—ื•ืกืจ ื‘ืจื–ืœื‘ ื”ืคืจืขื” ื‘ืื™ื ื˜ื™ืœื™ื’ื ืฆื™ื”ื’ ื“

?ื—ื•ืœื” ืขื ืื ืžื™ื” ื•ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื•ืคื ื™ื” ืžื” ื”ืื‘ื—ื ื” -ืฉื‘ืจื™ ืชืื™ื -ืชืžื•ื ื” ืฉืœ ืžืฉื˜ื— ื“ื 50ITPื TTPื‘ MDSื’ DICื“

"?ืžื” ื”ื”ื‘ื“ืœ ื‘ื™ืŸ ืงื‘ื•ืฆื•ืช ื”ื“ื" 51ื ืฉื™ื™ืจ ืกื•ื›ืจื™

ืื ื–ื™ื ื”ืžื•ืกื™ืฃ ืืช ื”ืฉื™ื™ืจ ื”ืกื•ื›ืจื™ .ื‘ ื’ ื“

:ื”ื’ื•ืจื ื”ืกื‘ื™ืจ ื‘ื™ื•ืชืจืžื” -ืžื’ื™ืข ืขื ืื ืžื™ื” CLLื—ื•ืœื” 52ื ื—ื•ืกืจ ื‘ืจื–ืœ

ื‘ ืชืžืก ื“ื ื’ ื“ื™ืžื•ื

?ืœ ืคืจื™ื˜ื™ืŸ ื ืžื•ืš ืžื” ื”ืกื™ื‘ื”"ื‘ื‘ื“ื™ืงื•ืช ื”ืชื’ืœื” ืœื—ื•ืœื” ื”ื  53 ื ื—ืกืจ ื‘ืจื–ืœ

?ื‘ ื’

?ืžื” ืขื•ืฉื™ื ืขื ืชืจื•ืžืช ื”ื“ื HBs-ABื‘ืชืจื•ืžืช ื“ื ื ืžืฆื 54ืžื–ืžื™ื ื™ื ืืช ื”ืื“ื ืœื‘ื“ื™ืงื”, ืื™ ืืคืฉืจ ืœื”ืฉืชืžืฉ ื‘ืžื ืช ื”ื“ื. ืืื™ ืืคืฉืจ ืœื”ืฉืชืžืฉ ื‘ืžื ืช ื”ื“ื ืžืœื‘ื“ ืคืœืกืžื”. ื‘.ืœื ื ืขืฉื” ื“ื‘ืจ. ืื™ ืืคืฉืจ ืœื”ืฉืชืžืฉ ื‘ืžื ืช ื“ื ื›ืœืœ. ื’.ื ื™ืชืŸ ืœื”ืฉืชืžืฉ ื‘ืžื ื” ืื™ืŸ ืฆืŸืจืš ื‘ืคืขื™ืœื•ืช ื ื•ืกืคืช. ื“ ื ื“ื—ื•ืกื•ืช"ื‘ื ื™ืชืŸ ืœื”ืฉืชืžืฉ ื‘ืžื ื” ืœืฆื•ืจืš ื›ื“. ื”

:ื”ื‘ืื™ื HLAืœืื“ื ื”ื–ืงื•ืง ืœื”ืฉืชืœื” ื‘ืขืœ ืžืืคื™ื™ื ื™ 55: A3, B7, B59, CW2, DW1,DQ2

A3, B7, B59, CW1, DW4, DR4, DQ4:ื”ื‘ืื™ื HLAื ืžืฆื ืชื•ืจื ืขื ืžืืคื™ื™ื ื™?ืžื” ื ื›ื•ืŸ ืœื•ืžืจ ืœื’ื‘ื™ ื”ื”ืฉืชืœื”

ื”ื”ืชืืžื” ืžืกืคื™ืง ื˜ื•ื‘ื”. ื ื™ืชืŸ ืœื‘ืฆืข ืืช ื”ื”ืฉืชืœื” ืœืœื ื—ืฉืฉ. ืื”ื”ืฉืชืœื” ืชื“ื—ื” ืœื›ืŸ ืืกื•ืจ ืœื‘ืฆืขื”. ื‘ืฉืœ ื”ืžื˜ื•ืคืœ Tื ื™ืชืŸ ืœื‘ืฆืข ืืช ื”ื”ืฉืชืœื” ืืš ืงื•ื“ื ืฆืจื™ืš ืœืขืฉื•ืช ื“ื™ื›ื•ื™ ืœืชืื™. ื’ ืœื ื–ื•ื›ืจ. ื“

Page 24: As you wish

24

Bืžื”ื ื”ืกืžื ื™ื ืฉืœ ืชืื™ 56 DR-HLA, CD34, CD19, CD10. ืื•ืขื•ื“ ืฉื ื™ ืžืฉื”ื•ื™ื™ื DR-HLA, CD34ื‘ DR-HLA,CD5, CD10, CD34.ื’ TdT, CD34, CD10, CD13 .ื“

, ืœื ื™ื“ื•ืข ืขืœ ื‘ืขื™ื” ื‘ืžืฉืคื—ืช ื”ื‘ืขืœ, ื‘ืขืช ื”ื‘ืจื™ืช ื”ื—ืœ ื“ื™ืžื•ื ื—ื–ืง ื•ื‘ืœืชื™ ืคื•ืกืง, ื‘ืžื–ืœ ื˜ื•ื‘ ื ื•ืœื“ ื‘ืŸ 57?ืื™ื–ื” ืคืงื˜ื•ืจ ืกื‘ื™ืจ ืœื‘ื“ื•ืง

1ื 2ื‘ 8ื’ 12 .ื“

ื” ืกื™ื“ืŸ ื‘ื“ื

-ื”ื”ืžื•ืœื™ื–ื” ื”ืื™ื–ื” ืžืฉืคื˜ ืžืกื‘ื™ืจ ืืช ืชื•ืคืขืช 58 intravasculrื”ื”ืžื•ื’ืœื•ื‘ื™ืŸ ื‘ื•ืจื— ืžื”ืชืื™ื ื”ืœื‘ื ื™ื. ืื”ื”ืžื•ื’ืœื•ื‘ื™ืŸ ื ืงืฉืจ ืœื”ืคื˜ื•ื’ืœื•ื‘ื™ืŸ ื‘ืคืœืกืžื”. ื‘ื”ื”ืžื•ื’ืœื•ื‘ื™ืŸ ืขื•ื‘ืจ ื‘ืฆื•ืจืช ื˜ื˜ืจืžืจ ื“ืจืš ื”ื’ืœื•ืžืจื•ืœื™. ื’ ืžืฉืชื—ืจืจ ื”ื•ืžื•ืกื™ื“ืจื™ืŸ ื‘ื“ื. ื“

?ืื™ื–ื• ื‘ื“ื™ืงื” ื ืขืฉื”, ืฉืืœื” ืžืฉื•ื—ื–ืจืช ืขืœ ื”ืื“ื ื”ืžืจื—ืฃ ื•ื”ื˜ืจื˜ื’ื•ืœ 59B6. ื ืฉื™ืœื™ื ื’. ื‘ื‘ืจื–ืœ. ื’ ืžืฆื” ืคื•ืœื™ืชื—ื•. ื“

? xWFืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ื—ื•ืกืจ ื‘ 60 ื‘ืžืงืจื™ื ืงืœื™ื DDAVPื ื™ืชืŸ ืœื˜ืคืœ ื‘ .1

:ืคื’ื™ืขื” ื‘ืื ืžื™ื” ืฉืœ ื—ื•ืกืจ ื‘ืจื–ืœ ืืฉืจ ืื™ื ื ื” ื”ืคื™ื›ื” 61 ื ื–ืง ื ื•ื™ืจื•ืœื•ื’ื ? ืžื” ื”ื‘ืขื™ื™ื” ืฉืœ ื”ื™ืœื“ , ื•ืžืฉื”ื• 6ื•ืžืฉื”ื• ื›ืฉื”ื ื•ืจืžื” ื”ื™ื 3ืขืจื›ื™ ืคืจื™ื˜ื™ืŸ . 62

Page 25: As you wish

25

:ืชืฉื•ื‘ื•ืช ืžืฉื•ืขืจื•ืช

ืชืฉื•ื‘ื” ืฉืืœื” ืชืฉื•ื‘ื” ืฉืืœื” ื 32 1 ื 33 23 34 ื’ 35 4 ื‘ 36 5 ื‘ 37 6 ื“ 38 ื’ 7 39 ื‘ 89 40

41 ื“ 10 42 ื‘ 1112 43 13 44 14 45 46 ื’ 1516 47 17 48 18 49 50 ื 19 51 ื 2021 52 53 ื 2223 54 55 ื 24 56 ื 2526 57 58 ื 27 59 ื 28 60 ื’ 29 61 ื’ 30 62 ื‘ 31

Page 26: As you wish

26

ื‘"ืžื—ื–ื•ืจ ืœ โ€“ 2007ืฉื—ื–ื•ืจ ื”ืžื˜ื•ืœื•ื’ื™ื”

Xืžื™ ืžื”ื‘ืื•ืช ืžืฉืคื™ืขื” ื”ื›ื™ ื”ืจื‘ื” ืขืœ ืคืงื˜ื•ืจ )1 ืงื•ืžืื“ื™ืŸ )ื ืืกืคื™ืจื™ืŸ )ื‘ ื”ืคืจื™ืŸ )ื’ LMWH )ื“

? ETืžื” ืžืืคื™ื™ืŸ )2 ืžื—ืœื” ืจืืฉื•ื ื™ืช ืฉืœ ืžื— ื”ืขืฆื )ื ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื•ืคื ื™ื” ื•ื“ื™ืžื•ืžื™ื )ื‘ ืžื™ืืœื•ืคืจื•ืœื™ืคืจื˜ื™ื‘ื™ืช ืžืฉื ื™ืช ืœืžื—ืœื” ื“ืœืงืชื™ืช )ื’

8-14ืฆื™ื•ืจ ืฉืœ ื˜ืจื ืกืœื•ืงืฆื™ื” (ืœืื™ื–ื• ืžื”ืžื—ืœื•ืช ื”ื‘ืื•ืช ืžืชืื™ื ื”ืฉื™ื ื•ื™ ื”ื’ื ื˜ื™ ื”ืžื•ืฆื’ )3 14;8ื–ื” ื”ื™ื” โ€“) mycื•ื”ื—ืœืคื” ืฉืœ

...) ืœื‘ื“ื•ืง( 14-18ื™ืฉ ื’ืจืกืื•ืช ื”ื˜ื•ืขื ื•ืช ืฉื–ื”

) acute myelomegakaryoblastic leukemia (M7 )ื- nodular sclerosis )ื‘ HL ALL-L3 )ื’ CML )ื“- NHL )ื” SLL

? ืžืื•ืจืš PTTื™ื ืชื’ืจื•ื ืœื‘ืขื™ื” ื‘ืื™ื–ื” ืžื”ืคืงื˜ื•ืจื™ื ื”ื‘ื)4 II )ื VII )ื‘ VIII )ื’ IX )ื“ X )ื”

? TTPืœื‘ื™ืŸ VWFืžื” ื”ืงืฉืจ ื‘ื™ืŸ ืคืงื˜ื•ืจ )5 ื”ื™ื•ื•ืฆืจื•ืช ืžื•ืœื˜ื™ืžืจื™ื )ื ื”ืคื™ื›ื” ืฉืœ ืžื•ืœื˜ื™ืžืจื™ื ืžืฆื•ืจืชื ื”ื›ื“ื•ืจื™ืช ืœืฆื•ืจืชื ื”ืคืชื•ื—ื” )ื‘ ื”ืคื™ื›ื” ืฉืœ ืžื•ืœื˜ื™ืžืจื™ื ืœื“ื™ืžืจื™ื )ื’ ืคื™ืจื•ืง ืฉืœ ืžื•ืœื˜ื™ืžืจื™ื )ื“ ืคื™ื ื•ื™ ื”ืคืงื˜ื•ืจ ืžื”ื’ื•ืฃ )ื”

? ืื™ืš ื‘ื•ื“ืงื™ื ืžืขืจื›ืช ืื™ื ื˜ืจื™ื ื–ื™ืช)6 ื‘ื“ื™ืงืช ืคื™ื‘ืจื™ื ื•ื’ืŸ )ื PPT )ื‘ ื–ืžืŸ ื“ื™ืžื•ื )ื’ ื–ืžืŸ ืชืจื•ืžื‘ื™ืŸ )ื“ ื”ืชื›ื•ื•ืฆื•ืช ื”ืงืจื™ืฉ )ื”

Page 27: As you wish

27

? ืžื” ื ื›ื•ืŸ)7 Bื”ื•ื ื’ื™ื“ื•ืœ ื‘ืœืขื“ื™ ืฉืœ ืชืื™ CLL )ื ืžืชื‘ื˜ื ื‘ื’ื™ื“ื•ืœ ืžื“ื™ืืกื˜ื™ื ืœื™ ืืฆืœ ืงืฉื™ืฉื™ื Follicular B lymphoblastic leukemia )ื‘ ื”ื™ื ื”ืฉื›ื™ื—ื” ื‘ื™ื•ืชืจ ื‘ืœื•ื™ืงืžื™ื” ืžืฉื ื™ืช Acute non-lymphoblastic leukemia )ื’ ื ื’ืจืžืช ื›ืชื•ืฆืื” ืžืžืขื•ืจื‘ื•ืช ืฉืœ ื”ื›ืœื™ื” ื‘ืชืกื ื•ืŸ ื”ืœื•ื™ืงืžื™ Uric acid nephropathy )ื“ ื“ื™ืžื•ื ื—ืจื™ืฃ ื”ื•ื ืกื™ื‘ื” ืžื•ื•ืช ืฉื›ื™ื—ื” ื‘ืœื•ื™ืงืžื™ื” )ื”

? )ื’"ืง 1(ื‘ืื™ื–ื• ืžื—ืœื” ืื•ืคื™ื™ื ื™ ื˜ื—ื•ืœ ืžื•ื’ื“ืœ ืžืื•ื“ )8 AML )ื CML )ื‘ ALL )ื’ CLL )ื“ NHL )ื”

? ืžื” ื”ืชืคืงื™ื“ ืฉืœ ื—ืœื‘ื•ื ื™ ื”ืฉืœื“ ืฉืœ ืืจื™ืชืจื•ืฆื™ื˜ื™ื)9 ืžื”ืจื™ืื•ืช ืœืจืงืžื” CO2- ื”ืขื‘ืจืช ื—ืžืฆืŸ ื• )ื

ื "ืจื•ืœื™ื˜ื™ื ื•ื’ืœื•ืงื•ื– ืืœ ืชื•ืš ื”ื›ื“ื”ืขื‘ืจืช ืืœืงื˜ )ื‘ ืžืชืŸ ืืœืกื˜ื™ื•ืช ืœื›ื“ื•ืจื™ืช )ื’ ื”ื’ื ื” ื ื’ื“ ืžืœืจื™ื” )ื“ ืžืื’ืจ ืฉืœ ื—ื•ืžืฆื•ืช ืืžื™ื ื• )ื”

? ืžื” ืžื”ื‘ืื™ื ืœื ื™ื•ืจื“, ื‘ืื ืžื™ื” ื‘ืขืงื‘ื•ืช ืžื—ืœื” ื›ืจื•ื ื™ืช ื“ืœืงืชื™ืช)10 ืคืจื™ื˜ื™ืŸ )ื ื”ืžื•ื’ืœื•ื‘ื™ืŸ )ื‘ ื‘ืจื–ืœ ื‘ืกืจื•ื )ื’ ื˜ืจื ืกืคืจื™ืŸ )ื“ MCV )ื”

ืื™ื–ื• ื‘ื“ื™ืงื” . ืœืœื ื—ืจื™ื’ื•ืช ื ื•ืกืคื•ืช, ืœื™ื˜ืจ/ื˜ืกื™ื•ืช 109*20ืœื’ื‘ืจ ื ืขืฉืชื” ืกืคื™ืจืช ื“ื ื•ื ืžืฆืื• )11 ? ื ื•ืกืคืช ื™ืฉ ืœื‘ืฆืข

PT + PTT )ื ื‘ื“ื™ืงืช ืžื— ืขืฆื )ื‘ ืžื‘ื—ื ื™ ืื’ืจื’ืฆื™ื” )ื’ ื–ืžืŸ ื“ื™ืžื•ื )ื“ . ื”ืžืฆื‘ ื ื•ื‘ืข ืžื‘ืขื™ื” ื˜ื›ื ื™ืช ืฉืœื ืงืฉื•ืจื” ืœื‘ืจื™ืื•ืช ื”ื—ื•ืœื”. ืื™ืŸ ืฆื•ืจืš ืœื‘ืฆืข ื‘ื“ื™ืงื•ืช )ื”

: ื’ื•ืจื ืœืคื’ื™ืขื” ื‘ืžืขืจื›ืช ื” B12ื—ืกืจ ืฉืœ )12 ื˜ืขื )ื ืจื™ื— )ื‘ ืจืื™ื” )ื’ ืฉืžื™ืขื” )ื“ ) ื™ืฆืจ ืžื™ื ื™(ืœื™ื‘ื™ื“ื• )ื”

Page 28: As you wish

28

: ืžืชืจื—ืฉืช ื‘ B12ืกืคื™ื’ื” ืฉืœ )13 ืงื™ื‘ื” )ื ืชืจื™ืกืจื™ื•ืŸ )ื‘ ืžืขื™ ื“ืง ืžืงื•ืจื‘ )ื’ ืžืขื™ ื“ืง ืžืจื•ื—ืง )ื“ ืžืขื™ ื’ืก )ื”

14(ET ื ื’ืจืžืช ื›ืชื•ืฆืื” ืž : ื‘ืขื™ื” ื‘ื”ืชืžื™ื™ื ื•ืช ื‘ืชืื™ ื”ืื‘ )ื IL6ืขื•ื“ืฃ ื‘ )ื‘ ืงืจื™ื•ืฆื™ื˜ื™ื ื‘ื“ื ืคืจื™ืคืจื™ - ืžื’ื” )ื’ ืชื’ื•ื‘ื” ืœืžื—ืœื” ืžืžืืจืช )ื“

? ืžื” ื”ืกื›ื ื”. INR=7ื™ืžื™ื ื•ื”ื’ื™ืข ืขื 10ื—ื•ืœื” ืžื˜ื•ืคืœ ื‘ืงื•ืžื–ื™ืŸ )15 ื–ื”ื• ืขืจืš ื”ื™ืขื“ , ืื™ืŸ ืกื›ื ื” )ื skin necrosis- ื’ื•ืจื ืœ )ื‘ ื“ื™ืžื•ื ืœืชื•ืš ืื™ื‘ืจ ื—ื™ื•ื ื™ )ื’

? ืžื” ื”ื˜ื™ืคื•ืœ). t(15, 17ื˜ืจื ืกืœื•ืงืฆื™ื” , AMLื—ื•ืœื” ืขื )16 ATRA )ื ื’ืœื™ื•ื•ืง )ื‘ ืœื ืฆืจื™ืš ื˜ื™ืคื•ืœ )ื’ Cyclophosphamide )ื“

? ืื™ื–ื” ืžืžืฆื ืื•ืคื™ื™ื ื™ ื ืจืื” ื‘ืžืฉื˜ื— ื“ื ื”ื™ืงืคื™ ื‘ืื ืžื™ื” ื—ืจืžืฉื™ืช)17 ืฉื™ื ื•ื™ื™ื ื“ื™ืกืืจื™ืชืจื•ืคื•ืื˜ื™ื™ื )ื ืจื˜ื™ืงื•ืœื•ืฆื™ื˜ื•ื–ื™ืก )ื‘ ืชืื™ ืžื˜ืจื” )ื’ ) schizocytes(ืฉื‘ืจื™ ืชืื™ื )ื“ ืงืจื™ื•ืฆื™ื˜ื™ื - ืžื’ื” )ื”

? ืžืื™ื–ื” ื—ืกืจ ื”ืื ืฉืœ ื”ืชื™ื ื•ืง ืกื‘ืœื”. spina bifidaืชืžื•ื ื” ืฉืœ )18 ื—ื•ืžืฆื” ืคื•ืœื™ืช )ื B12 )ื‘ ืืฉืœื’ืŸ )ื’ ื‘ืจื–ืœ )ื“ ืกื™ื“ืŸ )ื”

? ืžื” ื ื›ื•ืŸ ืœื—ืกืจ ื‘ืคื™ืจื•ื‘ื˜ ืงื™ื ืื–)19 ืฆื”ื‘ืช ื”ื™ื™ืœื•ื“ )ื DPG 2,3ื”ืžื•ืœื™ื–ื” ื‘ื’ืœืœ )ื‘ X-linked )ื’ ื”ืžื•ืœื™ื–ื” ื‘ืื›ื™ืœืช ืคื•ืœ )ื“

Page 29: As you wish

29

? ืžื” ื”ืกื™ื‘ื” ื”ืฉื›ื™ื—ื” ื‘ื™ื•ืชืจ ืœื—ื•ืกืจ ื‘ืจื–ืœ ื‘ืื ืฉื™ื ืžื‘ื•ื’ืจื™ื)20 ื‘ืขื™ื” ืชื–ื•ื ืชื™ืช )ื ืื™ื‘ื•ื“ ื“ื ื›ืจื•ื ื™ )ื‘ ื ื™ืฆื•ืœ ืžื•ื’ื‘ืจ ื‘ืžื— ื”ืขืฆื )ื’ ื‘ืขื™ื” ื‘ืกืคื™ื’ื” )ื“

? ื™ื“ื•ืข ืžื’ื™ืข ืœืžื™ื•ืŸ ืขื ืื™ื–ื• ืชืœื•ื ื” hereditary spherocytosisื—ื•ืœื” ืขื )21 ืฆื•ืื” ืœื‘ื ื” )ื ื“ืœืงืช ืื•ื–ื ื™ื™ื )ื‘ ืฆืคืฆื•ืคื™ื ื‘ืื•ื–ื ื™ื™ื )ื’ ื—ื™ื•ื•ืจื•ืŸ )ื“

? ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ืœื•ื™ืงืžื™ื•ืช ื—ืจื™ืคื•ืช)22 ืžืจืื™ื ืฉื™ื ื•ื™ื™ื ื›ืจื•ืžื•ื–ืžืœื™ื™ื 40% )ืื”ื ื™ืกื•ื— ื”ื™ื” ืžืื“ ืœื ื‘ืจื•ืจ ื•ื”ืœืš ื‘ืขืจืš DICื•) t(15, 17ื ืคื•ืฅ ืขื AML )ื‘

) ื™ืขืจื”" (DICืขื ื ื˜ื™ื” ืœ t15:17. ื˜ืจื ืกืœื•ืงืฆื™ื” ื ืคื•ืฆื”:"ื›ื›ื” ื ื•ืชื ื™ื ื˜ื™ืคื•ืœ ื›ื™ืžื•ืชืจืคื™ื” ื‘ืœื™ ืœื—ื›ื•ืช ืœื‘ื“ื™ืงื” ืฆื™ื˜ื•ื’ื ื˜ื™ืช )ื’ ืžืจืื™ื ืจื™ืคื•ื™ ืžืœื 30% )ื“

Aื ื™ ืœื”ืžื•ืคื™ืœื™ื” ืžื” ืื•ืคื™ื™)23 VIIื—ืกืจ ื‘ืคืงื˜ื•ืจ )ื ื ืชืงืŸ ืขื ืขื™ืจื•ื™ ืฉืœ ื”ืคืงื˜ื•ืจ )ื‘ ืื•ืคื™ื™ื ื™ ืœื ืฉื™ื )ื’

24(APTT ื›ืœ ื”ืฉืืจ ืชืงื™ืŸ. ืžื•ืืจืš ืœืœื ื“ื™ืžื•ื . XIIื—ื•ืกืจ ื‘ืคืงื˜ื•ืจ )ื VWFื—ื•ืกืจ ื‘ )ื‘ IIื—ื•ืกืจ ื‘ืคืงื˜ื•ืจ )ื’ IXืื• VIIIื—ื•ืกืจ ื‘ืคืงื˜ื•ืจ )ื“ Sืื• Cื—ื•ืกืจ ื‘ืคืจื•ื˜ืื™ืŸ )ื”

25(DIC ืžืชืืคื™ื™ืŸ ื‘ : ื’ื‘ื•ื” D-dimer, ืคื™ื‘ืจื™ืŸ ื’ื‘ื•ื”, ืžื•ืืจืš PTT, ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื•ืคื ื™ื” )ื ื’ื‘ื•ื” D-dimer, ืคื™ื‘ืจื™ืŸ ื ืžื•ืš, ืžื•ืืจืš PTT, ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื•ื–ื™ืก )ื‘ ื ืžื•ืš D-dimer, ืคื™ื‘ืจื™ืŸ ื ืžื•ืš, ืžื•ืืจืš PTT, ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื•ืคื ื™ื” )ื’ ื’ื‘ื•ื” D-dimer, ืคื™ื‘ืจื™ืŸ ืชืงื™ืŸ, ืชืงื™ืŸ PTT, ื˜ืจื•ืžื•ื‘ืฆื™ื˜ื•ื–ื™ืก )ื“ ื ืžื•ืš D-dimer, ืคื™ื‘ืจื™ืŸ ื’ื‘ื•ื”, ืชืงื™ืŸ PTT, ื˜ืจื•ืžื•ื‘ืฆื™ื˜ื•ืคื ื™ื” )ื”

? ื™ื‘ื“ืง ื‘ื‘ื ืง ื”ื“ืืื™ื–ื” ืžื”ื’ื•ืจืžื™ื ื”ื‘ืื™ื ื—ื™ื™ื‘ื™ื ืœื”)26 ื•ื™ืจื•ืกื™ื )ื ื—ื™ื™ื“ืงื™ื )ื‘ ืคืจื–ื™ื˜ื™ื )ื’ ืคื˜ืจื™ื•ืช )ื“ ืคืจื™ื•ื ื™ื )ื”

Page 30: As you wish

30

? ืื™ื–ื” ื—ื•ืžืจ ืžื•ืคืจืฉ ืžื•ื–ื™ืงื•ืœื•ืช ืžื˜ืกื™ื•ืช ื•ืžืคื•ืจืง ืžื”ืจ ื‘ืคืœืกืžื” ืขืœ ื™ื“ื™ ืื ื–ื™ืžื™ื)27 ADP )ื ืกืจื•ื˜ื•ื ื™ืŸ )ื‘ A2ื˜ืจื•ืžื‘ื•ืงืกืืŸ )ื’ ื˜ืจื•ืžื‘ื™ืŸ )ื“

ื‘ืฉืืœื” ื”ื–ื• ืœื )! ืฉืืœื” ืื—ืจืช(ืžื˜ืกื™ื•ืช ื•ื™ืฉ ืœื• ื–ืžืŸ ื—ื™ื™ื ืงืฆืจ ื‘ืกืจื•ื ืื™ื–ื” ื—ื•ืžืจ ืžื•ืคืจืฉ)28 !! ื”ื™ื” ื›ืชื•ื‘ ื•ื•ื–ื™ืงื•ืœื•ืช

ADP )ื ืกืจื•ื˜ื•ื ื™ืŸ )ื‘ A2ื˜ืจื•ืžื‘ื•ืงืกืืŸ )ื’ ื˜ืจื•ืžื‘ื™ืŸ )ื“

? ืžื” ืชื–ืžื™ืŸ. ื•ืื™ืŸ ื–ืžืŸ ืœื”ืฆืœื‘ื”, ืžื™ืฉื”ื• ืžื’ื™ืข ืœืžื™ื•ืŸ ืขื ืื•ื‘ื“ืŸ ื“ื ืžืฉืžืขื•ืชื™)29 Oื›ื“ื•ืจื™ื•ืช , Oืคืœื–ืžื” )ื ABืคืœื–ืžื” , Oื›ื“ื•ืจื™ื•ืช )ื‘ ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื™ื )ื’ ABื“ื )ื“ ืคืœื–ืžื” )ื”

? ืื™ื–ื” ืžื”ื‘ืื™ื ื™ื’ืจื•ื ืœืžื—ืœื” ื—ืžื•ืจื” ื‘ื—ื•ืœื” ืœืื—ืจ ื”ืฉืชืœื”)30 CMV )ื EBV )ื‘ HSV )ื’ ื”ืจืคืก )ื“ ื›ื•ืœื )ื”

ื‘ืœืกื˜ื™ื ืฉื ืžืฆืื• ื—ื™ื•ื‘ื™ื™ื 90%, ื”ื’ื™ืข ืขื ืœื•ื™ืงื•ืฆื™ื˜ื•ื–ื™ืก, ื’ื‘ืจ ื‘ืŸ ืฉื™ืฉื™ื)31 ? ืื™ื–ื” ื˜ื™ืคื•ืœ ื ื™ืชืŸ. Auer bodiesื‘ื‘ื“ื™ืงื” ื”ืชื’ืœื• . ืœืžื™ืืœื•ืคืจืื•ืงืกื™ื“ืื–

ืฆื™ื˜ื•ื–ืืจ +ืคืœื•ื“ืืจืื‘ื™ืŸ )ื ื’ืœื™ื•ื•ืง )ื‘ ืœื•ื™ืงื•ื•ืจื™ืŸ )ื’ BMT )ื“ ืคืœื•ื“ืืจืื‘ื™ืŸ )ื”

? ืžื”ื• ื”ืžื˜ื•ืคื•ืื–ื™ืก)32 ื™ื™ืฆื•ืจ ื›ืœ ื”ืชืื™ื ื‘ื“ื )ื ) 'ื›ื•, ืžื•ื ื•ืฆื™ื˜ื™ื, ื’ืจื ื•ืœื•ืฆื™ื˜ื™ื(ื™ื™ืฆื•ืจ ืชืื™ ื“ื ืื“ื•ืžื™ื ื•ื›ืœ ืชืื™ ื”ืžืขืจื›ืช ื”ื—ื™ืกื•ื ื™ืช )ื‘ื”ื ื™ืกื•ื— ื”ื™ื•ืชืจ ืกื™ื’ื ืœื™ื ื—ื™ืฆื•ื ื™ื™ื ืžืฉืคื™ืขื™ื ืขืœ ื›ื™ื•ื•ืŸ ื”ื”ืชืžื™ื™ื ื•ืช ืฉืœ ืชืื™ ื’ื–ืข )ื’

)ื™ืขืจื”" (ื™ ืกื™ื’ื ืืœื™ื ื—ื™ืฆื•ื ื™ื™ื"ืขื”ืชืžื™ื™ื ื•ืช ืชืื™ ื’ื–ืข ืžื•ืฉืคืขืช ื‘ืขื™ืงืจ :"ืžื“ื•ื™ื™ืง ื™ืฉ ืชื ืื‘ ืœื›ืœ ืกื•ื’ ืชื )ื“

Page 31: As you wish

31

? ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ืžืชืŸ ื›ื“ื•ืจื™ื•ืช ื“ื ืื“ื•ืžื•ืช ื“ื—ื•ืกื•ืช)33 %gr 5-ืžืขืœื” ืืช ื”ื”ืžื•ื’ืœื•ื‘ื™ืŸ ื‘ )ื

200ื”ื—ื“ืจ ' ื™ืฉ ืœืฉืžื•ืจ ื‘ื˜ืžืค )ื‘ ื™ืžื™ื 35-42ื–ืžืŸ ื”ืื—ืกื•ืŸ ื‘ื‘ื ืง ื”ื“ื )ื’ ืžื›ื™ืœ ืืช ื›ืœ ืคืงื˜ื•ืจื™ ื”ืงืจื™ืฉื” ื”ื“ืจื•ืฉื™ื )ื“

ื "ื›ื“ 107ืžื ื” ืžื›ื™ืœื” )ื”

) ื“ื•ืจืฉ ืชื™ืงื•ืŸ(? ืžื” ื”ื–ื•ื’ื•ืช ื”ื‘ืื™ื ื ื›ื•ืŸ)34 MALT โ€“ื’ื•ืฉ ืžื“ื™ืืกื˜ื™ื ืœื™ )ื ื›ืื‘ ืžืืœื›ื•ื”ื•ืœ โ€“ NHL )ื‘ post-transplant myeloproliferative diseaseื”ืจืคืก ื• )ื’ diffuse large B cell lymphoma- ื• EBV )ื“ mantle cell lymphoma- ื”ืœื™ืงื•ื‘ืงื˜ืจ ืคื™ืœื•ืจื™ ื• )ื” diffuse large B cell lymphoma- ืฉืขื•ื‘ืจืช ื˜ืจื ืกืคื•ืจืžืฆื™ื” ืœ Follicular lymphoma )ื•

ืœื ืžืงื‘ืœ ืžื•ืฆืจื™ . ืกืคื™ืจื•ืช ื“ื ืชืงื™ื ื•ืช ื‘ืฉืœื•ืฉื” ื—ื•ื“ืฉื™ื ื”ืื—ืจื•ื ื™ื. MDSืขื 40ื—ื•ืœื” ื‘ืŸ )35 ? ืžื” ื”ื˜ื™ืคื•ืœ. ืžื™ืืœื•ื‘ืœืกื˜ื™ื 10%ื ืžืฆืื• . ื“ื

) ืืœื•ื’ื ืื™ืช(ื ืชื—ื™ืœ ืœื—ืคืฉ ืชื•ืจื ืœื”ืฉืชืœืช ืžื— ืขืฆื )ื ืจืง ืžืขืงื‘ , ืœื ื ื˜ืคืœ )ื‘ ื’ืœื™ื•ื•ืง )ื’ ื ืชื—ื™ืœ ื˜ื™ืคื•ืœ ื›ื™ืžื•ืชืจืคื™ ืžื™ื“ )ื“

? ื‘ืื™ื–ื• ืžื—ืœื” ื ืคื•ืฆื” ื”ืกื ื ื” ืœื—ื ื™ื›ื™ื™ื)36 MM )ื M5ืžืกื•ื’ AML )ื‘ Nodular sclerosis HL )ื’ Burkitt's lymphoma )ื“ ืคื•ื ื’ื•ื™ื“ื•ื–ื™ืก )ื”

? ื›ื™ืฆื“ ื ื—ืกืŸ ื™ืœื“ ื—ื•ืœื” ื‘ืœื•ื™ืงืžื™ื” ืืงื•ื˜ื™ืช)37 ืœืคื™ ื”ืžืœืฆืช ื˜ื™ืคืช ื—ืœื‘ , ื›ืจื’ื™ืœ )ื ืจืง ืขืœ ื™ื“ื™ ื•ื™ืจื•ืกื™ื ื—ื™ื™ื )ื‘ ืจืง ืขืœ ื™ื“ื™ ื•ื™ืจื•ืกื™ื ืžื•ืžืชื™ื )ื’ ืื™ืŸ ืœื—ืกืŸ ื™ืœื“ ืœื•ื™ืงืžื™ ื›ืœืœ )ื“ ื—ื™ืกื•ืŸ ืฆืœื•ืœืจื™ ื‘ืœื‘ื“ )ื”

? ืื™ื–ื” ื‘ื“ื™ืงื•ืช ื ื‘ืฆืข, VWFDื‘ื—ืฉืฉ ืœืžื—ืœืช )38 PT )ื PTT )ื‘ ADAMTS-13ื‘ื“ื™ืงืช ืœ )ื’ ื‘ื“ื™ืงืช ื–ืžืŸ ื“ื™ืžื•ื )ื“

Page 32: As you wish

32

. ืชืงื™ืŸ RBC, ื˜ืกื™ื•ืช ืชืงื™ืŸ, 109*60ื•ืœื™ืžืคื•ืฆื™ื˜ื™ื ื’ื‘ื•ื”ื™ื CMLืขื 56ื—ื•ืœื” ื‘ืŸ )39 ืคืœื•ื“ืืจืื‘ื™ืŸ )ื ? ื›ืœื•ืจื•ืžื™ืฆื™ืœ )ื‘ Mabthera+ ืคืœื•ื“ืืจืื‘ื™ืŸ )ื’ ื”ืฉืชืœืช ืžื— ืขืฆื )ื“ ืื™ืŸ ื˜ื™ืคื•ืœ )ื”

? ื‘ืื™ื–ื” ืชืื™ื ืชืชื‘ื˜ื ื”ืžื—ืœื”. diamond-blackfan- ืž ื‘ืŸ ืื“ื ืกื•ื‘ืœ)40 ืืจื™ืชืจื•ืฆื™ื˜ื™ื )ื ื ื•ื™ื˜ืจื•ืคื™ืœื™ื )ื‘ ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื™ื )ื’ ืžื™ืืœื•ืฆื™ื˜ื™ื )ื“ ืœื™ืžืคื•ืฆื™ื˜ื™ื )ื”

? ื‘ืื™ื–ื• ืžื”ืžื—ืœื•ืช ื”ื‘ืื•ืช ืžืขื•ืจื‘ ื ื’ื™ืฃ)41 MALT )ื CLL/SLL )ื‘ ื“ื•ืžื™ื ื ื˜ - ืœื™ืžืคื•ืฆื™ื˜ื•ื–ื™ืก ืคืจื” )ื’ Large diffuse B-cell lymphoma )ื“ Endemic burkitt's lymphoma )ื”

? ื•ืฆื” ื‘ื™ื•ืชืจ ืœืื ืžื™ื” ื”ืžื•ืœื™ื˜ื™ืชืžื” ื”ืกื™ื‘ื” ื”ื ืค)42 warm )ื cold )ื‘ ืขื™ืจื•ื™ ื“ื )ื’ ืชืจื•ืคื•ืช )ื“

- ืžืืฉืจ ื‘ Waldenstrom macroglobulinemia- ืื™ื–ื• ืชื•ืคืขืช ืœื•ื•ืื™ ืฉื›ื™ื—ื” ื™ื•ืชืจ ื‘)43multiple myeloma ืžืกื•ื’IgG ?

ื‘ืขื™ื•ืช ื‘ื›ืœื™ื•ืช )ื ื›ืื‘ื™ ืขืฆืžื•ืช )ื‘ ื‘ืขื™ื•ืช ื ื•ื™ืจื•ืœื•ื’ื™ื•ืช )ื’ ื ื˜ื™ื™ื” ืœื–ื™ื”ื•ืžื™ื )ื“ ืกื™ื“ืŸ ื’ื‘ื•ื” )ื”

? ABOืžื” ื”ื”ื‘ื“ืœ ื‘ื™ืŸ ืงื‘ื•ืฆื•ืช )44 ืžื‘ื ื” ื“ื•ืžื” ืœื—ื™ื™ื“ืง )ื ืœื™ืคื•ืคืจื•ื˜ืื™ื ื™ื ืขื ืกื•ื›ืจื™ื )ื‘ ื”ื‘ื“ืœ ืฉืœ ืกื•ื›ืจ ืื—ื“ )ื’ ื™ื›ื•ืœ ืœื”ืฉืชื ื•ืช ื‘ืžื”ืœืš ื”ื—ื™ื™ื )ื“

Page 33: As you wish

33

? AML- ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ื—ื•ืœื” ื”ืžืื•ื‘ื—ืŸ ื›ืกื•ื‘ืœ ืž)45 ) 'ื›ื•, ืื ืžื™ื”(ื™ืฉ ืœื—ื›ื•ืช ืœื”ื™ืขืœืžื•ืช ื”ืกื™ื‘ื•ื›ื™ื ืœืคื ื™ ื›ื™ืžื•ืชืจืคื™ื” )ื ื›ื™ื•ื•ืŸ ืฉื™ืฉ ื”ืกื ื ื” CNSื™ืฉ ื”ืฆื“ืงื” ืœืžืชืŸ ืžืชื•ื˜ืจื•ืงืกื˜ )ื‘ ืžื•ืžืœืฅ ืœื”ืฉืชืžืฉ ื‘ืžื•ืฆืจื™ ื“ื ืžื•ืงืจื ื™ื ื•ืกื˜ืจื™ืœื™ื™ื )ื’ . ื™ืฉ ืœื—ื›ื•ืช ืœืงื‘ืœืช ืชื•ืฆืื•ืช ืžืขื‘ื“ื” ื›ื“ื™ ืœื”ืชื—ื™ืœ ื˜ื™ืคื•ืœ ืื ื˜ื™ื‘ื™ื•ื˜ื™, ืื ื™ืฉ ืœื—ื•ืœื” ื—ื•ื )ื“

109*100ื™ืฉ ืœืฉืžื•ืจ ืขืœ ืจืžืช ื˜ืกื™ื•ืช ืžืขืœ )ื”

? ืžื” ื”ื’ื•ืจื ื”ืžืงื•ืจื™ ืœื‘ืขื™ื”. ืืจื™ืชืจื•ืžืœืœื’ื™ื”, ื ืคื™ื—ื•ืช, ื™ืœื“ ืฉืกื•ื‘ืœ ืžืื•ื“ื)46 ืชืื™ ืื‘ )ื ื ื•ื™ื˜ืจื•ืคื™ืœื™ื )ื‘ ืืจื™ืชืจื•ืฆื™ื˜ื™ื )ื’ ื˜ืกื™ื•ืช )ื“ ืœื™ืžืคื•ืฆื™ื˜ื™ื )ื”

ื‘ืœื•ื˜ื•ืช . ืœืœื ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื•ืคื ื™ื”, ืœืœื ืื ืžื™ื”, ืœื™ืžืคื•ืฆื™ื˜ื™ื 109*50-ื• CLLื—ื•ืœื” ืื•ื‘ื—ืŸ ืขื )47 ? ืžื” ื”ื˜ื™ืคื•ืœ. ืž ื‘ืงืฉืจื•ื ื™ื ื‘ืฆื•ื•ืืจ"ืก 2ืžื•ื’ื“ืœื•ืช

ืคื•ืœื“ืืจืื‘ื™ืŸ )ื ื›ืœื•ืจืืžื‘ืฆื™ืœ )ื‘ ืื“ืจื™ืžื™ืฆื™ืŸ + Mabthera )ื’ ื”ืฉืชืœืช ืžื— ืขืฆื )ื“ ืื™ืŸ ืฆื•ืจืš ื‘ื˜ื™ืคื•ืœ )ื”

? PRCืžื” ืื•ืคื™ื™ื ื™ ืœ)48

ืืจื™ืชืจื•ืฆื™ื˜ื™ื 106 )ื ื‘ื•ื” ื”ืžื˜ื•ืงืจื™ื˜ ื’ )ื‘

? ืžื” ื”ืคืขื™ืœื•ืช ืฉืœ ืงื•ืžืื“ื™ืŸ)49 ? ืžืขื›ื‘ ืงืจื‘ื•ืงืกื™ืœืฆื™ื” ืฉืœ ืคืงื˜ื•ืจื™ ืงืจื™ืฉื” )ื ... ืžืขื›ื‘ )ื‘ IIIื˜ืจื•ืžื‘ื™ืŸ - ืžืขื›ื‘ ืื ื˜ื™ )ื’ ? )ื“

ืœื ื–ื•ื›ืจืช ืืช ืคืจื˜ื™ ื”ืฉืืœื” ืื‘ืœ ื”ื™ื” ื ืจืื” ืฉื”ื•ื ืžืจื’ื™ืฉ ืœื ืจืข , 40ื‘ืŸ , NHLื—ื•ืœื” ืขื )50 ?ื‘ืžื” ื ื˜ืคืœ. ื™ื—ืกื™ืช

CHOP. ื ืžื‘ื˜ืจื”. ื‘ ื”ืงืจื ื•ืช. ื’ .ื“

ื•ื”ื™ื• ืื•ืคืฆื™ื•ืช ื˜ื™ืคื•ืœื™ื•ืช ืฉืื—ืช ืžื”ืŸ ื”ื™ืชื” , ืœื ื–ื•ื›ืจืช ืขื ืžื”, ืฉืืœื” ืขืœ ื—ื•ืœื” ื›ืœืฉื”ื•)51 .ืžื™ ืฉื–ื•ื›ืจ ืžื•ื–ืžืŸ ืœื”ืฉืœื™ื. ืกื˜ืจื•ืื™ื“ื™ื ื•ืื—ืช ื”ื™ืชื” ืฉื ืกืคืฆื™ืคื™ ืฉืœ ืชืจื•ืคื” ืื ื˜ื™ืื™ืžื•ื ื™ืช

Page 34: As you wish

34

?)ืฉืืœื” ืžืฉื—ื–ื•ืจื™ื(ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ืชืกืžื•ื ืช ื”ืžื•ืœื™ื˜ื™ืช ืฉืœ ื”ื™ื™ืœื•ื“ )52 .ืฉืœื™ืœื™ื•ืช ื‘ืœื‘ื“ Rhื™ืงืจื” ืœืืžื”ื•ืช . ื .ื‘ .ื’, ื–ื” ืœื ื”ื ื™ืกื•ื— ื”ืžื“ื•ื™ืง(ื™ ื”ืื "ื”ื™ื™ืฆื•ืจ ื”ื˜ื‘ืขื™ ืขืœืคื ื™ Rhื™ ืžืชืŸ ืžื ืช ื ื•ื’ื“ื ื™ื ืœ"ื ื™ืชืŸ ืœืžื ื•ืข ืข. ื“

)ืื‘ืœ ื–ื” ื”ืงื•ื ืกืคื˜ ืœื“ืขืชื™

?Tื‘ื”ืฉืชืœื” ืืœื•ื’ื ืื™ืช ื›ืืฉืจ ืกื•ืœืงื• ืชืื™ ื”ื—ืฉื•ื‘ืžื” ื”ืกื™ื›ื•ืŸ )53)1(GVHD ื“ื—ื™ื™ืช ืฉืชืœ )2( ื–ื™ื”ื•ืžื™ื )3(

? ื”ื’ื•ืจื ื”ื ืคื•ืฅ ืœืื ืžื™ื” ืืคืœืกื˜ื™ืช)54 ืื™ื“ื™ื•ืคื˜ื™ )ื Cื”ืคื˜ื™ื˜ื™ืก )ื‘ ืฉื™ืžื•ืฉ ื‘ืชืจื•ืคื•ืช )ื’ืื™ื™ื“ืก )ื“

? ืžื” ื™ืฉ ืœื“ื•ื“ +CD20+ / Ki-67, ืขื™ื›ื•ืœ' ื—ื•ืœื” ืขื ื’ื™ื“ื•ืœ ื‘ืžืข โ€“ื”ืจื•ืฉ - ืฉืืœื” ืฉืœ ื‘ืŸ)55 ื‘ื•ืจืงื™ื˜ )ื MANTLE )ื‘ Follicular lymphoma )ื’ Polyposis coli )ื“

ืื• ืžืฉื”ื• ) ???(ื”ืขื™ื›ื•ืœ ื•ื“ื ืกืžื•ื™ ' ื‘ืื™ื–ื• ืžื”ืœืžืคื•ืžื•ืช ื”ื‘ืื•ืช ื™ืฉ ื”ืชืคืชื—ื•ืช ืคื•ืœื™ืคื™ื ื‘ืžืข)56 ... ื›ื–ื”

Familial polyposis coli )ื Marginal cell lymphoma )ื‘ Waldenstrom )ื’ Lymphoplasmacytic lymphoma )ื“

? ื—ื™ื•ื‘ื™ CD30ืœืžื™ ืžื”ื‘ืื™ื ื™ืฉ ืกืžืŸ )57 Anaplastic large cell lymphoma )ื Follicular lymphoma )ื‘ Burkitt lymphoma )ื’ Lymphoplasmacytic lymphoma )ื“

Splenic Marginal Zone ื•ื”ืคืชื•ืœื•ื’ ืงื‘ืข ืื‘ื—ื ื” ืฉืœ 54ื ื›ืจืช ื˜ื—ื•ืœ ืœื—ื•ืœื” ื‘ืช )58

Lymphoma. ื”ืชืžื•ื ื” ื”ืงืœื™ื ื™ืช ื”ืžืชืื™ืžื” ืœืื‘ื—ื ื” ื–ื•ืžื”? ITP=Immuno thrombocytopenic purpura )ื Miliated Tuberculosis )ื‘ Splenic Lymphoma with villous lymphocytes )ื’ Hairy Cell Leukemia )ื“ Chronic Granulocytic Leukemia )ื”

Page 35: As you wish

35

2007 โ€“' ืฉื—ื–ื•ืจ ื”ืžื˜ื•ืœื•ื’ื™ื” ืžื•ืขื“ ื‘

ืขืžื›ื ... ืฉืžืžืฉ ืžืžืฉ ื”ืฉืชื“ืœ ืฉื ืขื‘ื•ืจ โ€“ื•ืžืจืฆื” ืื—ื“ , ืกื›ื ื™ืืฉื ื™ ื ื‘ื—ื ื™ื ืž, ืฉืืœื•ืช 61ื”ืžื‘ื—ืŸ ื›ืœืœ . ื”ืชื ืฆืœื•ืช ืขืœ ื”ื ื™ืกื•ื—ื™ื ื”ืงืœื•ืงืœื™ื

:ื ืจืื” ื‘ืื™ื–ื” ืžืŸ ื”ืžื—ืœื•ืช ื”ื‘ืื•ืช 2,5ื˜ืจื ืกืœื•ืงืฆื™ื” .1

Anaplastic large cell lymphoma .ืSmall cell symphoma .ื‘Cll .ื’Aml .ื“

... ื”ื•ืฆื’ื” ืชืžื•ื ื” ืฉืœ ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื™ื ื‘ืงื‘ื•ืฆื•ืช.2ืœ ื™ืฉ ืœืชืช ืขื™ืจื•ื™ ื“ื ื“ื—ื•ืฃ"ืœื—ื•ืœื” ื”ื  .ืื–ื”ื• ืžืฆื‘ ืชืจื•ื ืกืจื˜ื ื™ .ื‘)pseudotrombocytopenia(ื–ื•ื”ื™ ืชื•ืฆืืช ืžืขื‘ื“ื” ืฉื’ื•ื™ื” ื•ืื™ืŸ ืœื”ืชื™ื™ื—ืก ืืœื™ื” .ื’

:ื’ื•ืจื ื”ืžื•ื•ืช ื”ืžื•ื‘ื™ืœ ืฉืœ ื—ื•ืœื™ ืื ืžื™ื” ืืคืœืกื˜ื™ืช ื”ื•ื.3.ื“ื™ืžื•ื .ื.ืงืจื™ืฉ ื“ื .ื‘.ื–ื™ื”ื•ื .ื’.ืื™ ืกืคื™ืงืช ืœื‘ .ื“

:ื”ืœื•ืงืžื™ื” ื”ื›ื™ ืฉื›ื™ื—ื” ื‘ืžื‘ื•ื’ืจื™ื.4Cml .ืAml .ื‘Amd .ื’...ื•ืขื•ื“ ืชืฉื•ื‘ื•ืช .ื“

:ื”ื‘ืื™ื ืคืจื˜ ืœืืจื™ืชืจื•ืคื•ืืชื™ืŸ ื™ืจื•ื“ ื™ื›ื•ืœ ืœื”ื’ืจื ืžื›ืœ .5ืขื™ืฉื•ืŸ .ืืžื—ืœืช ื›ืœื™ื•ืช ื›ืจื•ื ื™ืช .ื‘ื˜ื™ืคื•ืก ื”ืจื™ื .ื’ืื™ ืกืคื™ืงืช ืœื‘ .ื“

:ืžื” ืงื•ืจื” ืœืžืจื‘ื™ืช ื—ื•ืœื™ ืื ืžื™ื” ื—ืจืžืฉื™ืช.6.ืื™ ืกืคื™ืงืช ืœื‘ .ื.ื›ืจื™ืชืช ื˜ื—ื•ืœ ืขืฆืžื™ืช .ื‘

?Bืžื”ื ื”ืกืžื ื™ื ืฉืœ ืชืื™ .7cyt79a 22 20 19 .ื10 9 7 3 .ื‘179 33 .ื’

ืžืืคื™ื™ื ื™ื ืฉืœ ื‘ืจืงื™ื˜ ืœื™ืžืคื•ืžื”.8ื’ื™ื“ื•ืœ ื‘ืขืœ ื–ืžืŸ ื”ื›ืคืœื” ื”ืงืฆืจ ื‘ื™ื•ืชืจ .ืcd20ื‘ืขืœื™ Tื’ื™ื“ื•ืœ ืชืื™ .ื‘amlืชืžื™ื“ ืžื•ื—ืžืจื™ื ืœ .ื’

Page 36: As you wish

36

?ืžื”ื• ื”ื’ื™ื“ื•ืœ ื”ื ืคื•ืฅ ื‘ื™ื•ืชืจ ื‘ืžื—ืœื” โ€“ืคื ืงื•ื ื™ืก ืื ืžื™ื” .9ืœื™ืžืคื•ืžื” .ืื’ื™ื“ื•ืœ ื‘ืขืฆื .ื‘ื’ื™ื“ื•ืœ ื‘ืžืขืจื›ืช ื”ืขื™ื›ื•ืœ .ื’

?ื‘ืžืขื™ ื”ื“ืง ื•ืขื•ื‘ืจ ืื™ืชื• ืืช ื”ืชื ืขื“ ืœื›ืœื™ ื”ื“ื b12ืžื™ ืงื•ืฉืจ .101ื˜ืจื ืกืงื•ื‘ืœืžื™ืŸ .ื2ื˜ืจื ืกืงื•ื‘ืœืžื™ืŸ .ื‘3ื˜ืจื ืกืงื•ื‘ืœืžื™ืŸ .ื’IF .ื“SC .ื”

11.marginal zone lymphoma โ€“ ืžื” ื”ืืชื™ื•ืœื•ื’ื™ื” ื”ืฉื›ื™ื—ื”? .ื

Page 37: As you wish

37

2006ื "ืฉื—ื–ื•ืจ ื”ืžื˜ื•ืœื•ื’ื™ื” ืžื—ื–ื•ืจ ืœ

ื™ืฉ ืฉืืœื•ืช ืฉืœื , ืฉื—ื–ืจื• ื˜ื•ื‘ ื˜ื•ื‘: ื”ืžืœืฆื” ืฉืœื ื•. ืฉืืœื•ืช 72ืฉืืœื•ืช ืžืชื•ื›ืŸ ืฉื•ื—ื–ืจื• 75ื‘ืžื‘ื—ืŸ ื”ื™ื• !!!!!ืจืœื•ื•ื ื˜ื™..... ื ืœืžื“ื• ื‘ื›ื™ืชื” ืื‘ืœ ื”ื•ืคื™ืข ืื– ื›ืœ ืžื” ืฉื ืจืื” ืœื ืจืœื•ื•ื ื˜ื™ ืืœื™ื›ื

?ืžืชื™ ื ืจืื” ืกืคื™ืจ ืฉื’ื•ื™ื” ืฉืœ ืืจื™ืชืจื•ืฆื™ื˜ื™ื.1 ื“ื ืงืจื•ืฉื“ื’ื™ืžืช .ื ื˜ืกื™ื•ืช ื’ื“ื•ืœื•ืช .ื‘ ื ืžื™ืงืจื•ืฆื™ื˜ื™ื•ืช"ื›ื“ .ื’ืกืคื™ืจื” ื ืžื•ื›ื” ืฉืœ ืœื•ื™ืงื•ืฆื™ื˜ื™ื .ื“ ?ืžื” ื—ืฉื•ื‘ ืœื’ื‘ื™ ื˜ื™ืคื•ืœ ื˜ืจื•ืžื‘ื•ืœื™ื˜ื™.2 ืื™ืŸ ืกื›ื ื” ืœื“ื™ืžื•ื .ืื”ืžื•ืจื’ื™ CVA-ืื™ืŸ ืกื›ื ื” ื‘ื˜ื™ืคื•ืœ ื‘ .ื‘ื”ืขื™ืชื•ื™ ื”ื•ื ืคืงื˜ื•ืจ ื—ืฉื•ื‘ ื‘ื”ืฆืœื—ืช ื”ื˜ื™ืคื•ืœ .ื’ื ื™ืชืŸ ื›ืœ ื™ื•ื ื‘ืžืฉืš ืฉื‘ื•ืข .ื“ื˜ื™ืคื•ืœ ืžื ื™ืขืชื™ ื•ืœื ืืงื•ื˜ื™ .ื” ?ื›ื™ืฆื“ ื ื˜ืคืœ. ืื‘ืœ ื–ืžืŸ ื“ื™ืžื•ื ืชืงื™ืŸ) 20,000(ื˜ืจื•ื‘ืจื•ืฆื™ื˜ื•ืคื ื™ื” ืขื 15ืžื’ื™ืข ื ืขืจ ื‘ืŸ . 3 ืœืชืช ืœื• ื˜ืกื™ื•ืช ืขื“ ืœื”ื’ืขื” ืœืจืžื” ืชืงื™ื ื” .ืื ื™ืงื•ื– ื“ื ื‘ื›ื“ื™ ืœืขื•ืจืจ ื™ื™ืฆื•ืจ ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื™ื ืื ื“ื•ื’ื ื™ .ื‘ื ื“ื—ื•ืกื•ืช ื›ื“ื™ ืœืขื•ื“ื“ ื™ื™ืฆื•ืจ ื˜ืกื™ื•ืช ื‘ืžื— ื”ืขืฆื"ืœืชืช ืœื• ื›ื“ .ื’ืœืชืช ืœื• ืขื™ืจื•ื™ื™ ืœื•ื™ืงื•ืฆื™ื˜ื™ื ืœืžื ื•ืข ื“ื™ืžื•ื .ื“.ืœื”ืžืฉื™ืš ื‘ืžืขืงื‘ ืœืœื ื˜ื™ืคื•ืœ ืžื™ื•ื—ื“ .ื•

?ืื™ืคื” ืžืชื—ื™ืœ ื”ืขืฅ ื”ื•ืจื™ื“ื™ ื‘ื˜ื—ื•ืœ. 4 ืคื•ืœืคื” ืื“ื•ืžื” .ืืคื•ืœืคื” ืœื‘ื ื” ื‘ื›ืœ ืžืงื•ื .ื‘ื‘ืคื•ืœืคื” ื”ืœื‘ื ื” Tืžื•ืงื“ื™ ืชืื™ .ื’ื‘ื”ื™ืœื™ื•ื .ื“ื”ืื™ื–ื•ืจ ื”ืžืจื’ื ืœื™ .ื” ?ื”ื™ื›ืŸ ื™ื•ืฉื‘ื™ื ื”ืชืื™ื ื”ืจื˜ื™ืงื•ืœื•ืื™ื“ื™ื ื‘ืงืฉืจื™ ื”ืœื™ืžืคื”. 5 ืกื‘ ืงื•ืจื˜ืงืก. ื ืงื•ืจื˜ืก. ื‘ ืงื•ืจื“ื•ืช ืžื“ื•ืœืจื™ื•ืช. ื’ ืกื™ื ื•ืกื•ืื™ื“ื™ื. ื“ ื”ื›ืœ. ื”

?ืžื” ื™ื’ืจื•ื ืœื™ืจื™ื“ื” ื‘ืืจื™ืชืจื•ืคื•ืื˜ื™ืŸ. 6 ืžื—ืœืช ื›ืœื™ื” ื›ืจื•ื ื™ืช. ื ืขื™ืฉื•ืŸ. ื‘ ื—ื™ื™ื ื‘ื’ื•ื‘ื”. ื’ ืื ืžื™ื” ืืคืœืกื˜ื™ืช. ื“ ืžื—ืœืช ืจื™ืื” ืฉื’ื•ืจืžืช ืœื”ื™ืคืงืกื™ื”. ื” ?ืžืชื™ ื ืขื“ื™ืฃ ื”ืคืจื™ืŸ ืขืœ ื•ื•ืคืจื™ืŸ. 7 ืžื—ืœืช ื›ื‘ื“. ื ืžื—ืœืช ื›ืœื™ื”. ื‘ ื˜ืจื™ืžืกื˜ืจ ืจืืฉื•ืŸ ืฉืœ ื”ืจื™ื•ืŸ. ื’ ื›ื™ื‘ ืงื™ื‘ื”. ื“ืฉื™ืžื•ืฉ ื ืจื—ื‘ ื‘ืืกืคืจื™ืŸ. ื”

Page 38: As you wish

38

. ื‘ืžืฆื‘ ืžื‘ื•ืœื‘ืœ, ืžื’ื™ืขื” ืขื ื›ืื‘ ืจืืฉ, ื‘ื”ืจื™ื•ืŸ, 35ื‘ื—ื•ืจื” ื‘ืช . 8 . ื‘ื‘ื“ื™ืงื” ื’ื•ืคื ื™ืช ื ืžืฆื ื—ื•ื ื•ืคื˜ื›ื™ื•ืช :ื‘ื‘ื“ื™ืงื•ืช ืžืขื‘ื“ื”

ืชืงื™ื ื™ื WBC, ืื™ื ื“ืงืกื™ื ืชืงื™ื ื™ื, Hb 7.8: ืกืคื™ืจืช ื“ื ืงืจื™ืื˜ื™ืŸ Urea: ื›ื™ืžื™ื” )ืกื›ื™ืกื˜ื•ื ื™ื(ื”ืจื‘ื” ืฉื‘ืจื™ ืชืื™ื : ืžืฉื˜ื— ื“ื

?ื™ืจ ืœื”ื ื™ื— ืฉื™ืฉ ืœื”ืžื” ืกื‘ ื—ืกืจ ื‘ืจื–ืœ+ ITP. ื

ืื ืžื™ื” ื”ืžื•ืœื™ื˜ื™ืช ืื™ืžื•ื ื™ืช ืขืงื‘ ื”ืคืจืขื” ืื•ื˜ื•ืื™ืžื•ื ื™ืช ื—ืžื•ืจื” ITP+. ื‘ TTP. ื’ DIC. ื“ .ืขื ื”ืคืจืขื•ืช ืžื˜ืื‘ื•ืœื™ื•ืช ืงืฉื•ืช B12ื—ื•ืกืจ . ื”

?Hืœืžื™ ื™ืฉ ื”ืžื•ื’ืœื•ื‘ื™ืŸ . 9 ืื“ื ื‘ื•ื’ืจ. ื ืชื™ื ื•ืง. ื‘ ืกื›ืจืช. ื’ ฮฑืชืœืกืžื™ื” . ื“ ฮฒืชืœืกืžื™ื” . ื” ?ืื™ื–ื” ืชื ื ืžืฆื ื‘ื™ืชืจ. CMLืชืžื•ื ื” ืฉืœ . 10 ื‘ืื–ื•ืคื™ืœ. ื ืืื•ื–ื™ื ื•ืคื™ืœื™ื. ื‘ ืคืจื•ืžื™ืืœื•ืฆื™ื˜. ื’ STAB. ื“ ื‘ืœืืกื˜. ื” ?ื‘ืื™ื–ื” ืžื—ืœื” ืื•ืคื™ื™ื ื™ืช ืชืžืกื•ื ืช ืจื™ื›ื˜ืจ. 11 AML. ื CLL. ื‘

MDS. ื’ Nodular sclerosis HD. ื“ NHL. ื” ?ืžื” ืขื•ืฉื™ื ืขื ืชืจื•ืžืช ื”ื“ื HBs-Abื‘ืชืจื•ืžืช ื“ื ื ืžืฆื . 12

ืžื–ืžื™ื ื™ื ืืช ื”ืื“ื ืœื‘ื“ื™ืงื”. ืื™ ืืคืฉืจ ืœื”ืฉืชืžืฉ ื‘ืžื ืช ื”ื“ื. ื ืื™ ืืคืฉืจ ืœื”ืฉืชืžืฉ ื‘ืžื ืช ื”ื“ื ืžืœื‘ื“ ื‘ืคืœืกืžื”. ื‘ .ืœื ื ืขืฉื” ื“ื‘ืจ, ืื™ ืืคืฉืจ ืœื”ืฉืชืžืฉ ื‘ืžื ืช ื“ื ื›ืœืœ. ื’ ื ื™ืชืŸ ืœื”ืฉืชืžืฉ ื‘ืžื ื” ืื™ืŸ ืฆื•ืจืš ื‘ืคืขื™ืœื•ืช ื ื•ืกืคืช. ื“ ื ื“ื—ื•ืกื•ืช"ื ื™ืชืŸ ืœื”ืฉืชืžืฉ ื‘ืžื ื” ืœืฆื•ืจืš ื›ื“. ื” ืขื - )5000-10000ืชืงื™ืŸ ( 11,000ืกืคื™ืจืช ื“ื ืœื‘ื ื” , Hb=13.6: ื‘ืžืžืฆืื™ ื‘ื“ื™ืงื” ืฉืœ ื—ื•ืœื”. 13

?ืžื” ื”ืื‘ื—ื ื”). 140,000-400,000ืชืงื™ืŸ ( 850,000 -ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื™ื. ืกืคื™ืจื” ืžื‘ื“ืœืช ืชืงื™ื ื” ืคื•ืœื™ืฆื™ื˜ืžื™ื” ื•ืจื”. ื CML. ื‘ CLL. ื’ ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื•ืคื ื™ื”+ ื—ื•ืกืจ ื‘ืจื–ืœ. ื“ ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื•ืคื ื™ื” ืจืืฉื•ื ื™ืช. ื”

Page 39: As you wish

39

?ื—ื™ื•ื‘ื™ CD30ื‘ืžื™ ืžื”ืชืื™ื ื™ื”ื™ื” . 14 -LYMPHOCYTIC RICH. ื HL ืกืจื˜ืŸ ืจื™ืื•ืช. ื‘ CLL. ื’ AML. ื“ MALT. ื”

? AT 3ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ื—ืกืจ ืฉืœ . 15

Xื ืžืฆื ื‘ืชื ืื—ื™ื–ื” ืœ. ื ืชืจ ืœืงืจื™ืฉืชื™ื•ืช ื™ืชืจื”ืกื™ื‘ื” ื”ืฉื›ื™ื—ื” ื‘ื™ื•. ื‘ ื ื•ื˜ื” ืœืขืฉื•ืช ื˜ืจื•ืžื‘ื•ื˜ื™ื ื‘ืขื•ืจืงื™ื. ื’

ื™ ืงื•ืžื“ื™ืŸ"ืคืขื™ืœื•ืชื• ืขื•ืœื” ืข. ื“ ืืฃ ืชืฉื•ื‘ื” ืื™ื ื” ื ื›ื•ื ื”. ื”

? GERMINAL CENTERื‘ืžื™ ืžื”ื‘ืื™ื ืื™ืŸ . 16 ืงืฉืจื•ื ื™ ืœื™ืžืคื”. ื ืงืฉืจื™ ืœื™ืžืคื”. ื‘ ื˜ื—ื•ืœ. ื’ ืชื™ืžื•ืก. ื“ ืฉืงื“ื™ื. ื”

ืžืื™ื–ื” ื—ืกืจ ืชื–ื•ื ืชื™ ืกื•ื‘ืœืช ). ื‘ื™ืคื™ื“ื”ืกืคื™ื ื” (ืชืžื•ื ื” ืฉืœ ื™ืœื“ ืขื ื‘ืขื™ื” ื‘ืกื’ื™ืจืช ืขืžื•ื“ ืฉื™ื“ืจื” . 17

?ืื™ืžื• ื—ื•ืžืฆื” ืคื•ืœื™ืช. ื B12. ื‘ ื‘ืจื–ืœ. ื’ ืื•ืžื’ื”. ื“ ื‘ืจื–ืœ. ื”

.ื˜ืกื™ื•ืช 20,000, ื‘ืœืกื˜ื™ื WBC 60X109 ,90%, ื™ืจื™ื“ื” ื‘ืžืฉืงืœ, 38ื—ื•ื , 30ื’ื‘ืจ ื‘ืŸ . 18 ?ืžื” ื”ื˜ื™ืคื•ืœ ื‘ืฉื‘ื•ืข ื”ืจืืฉื•ืŸ

ืื ื˜ื™ื‘ื™ื•ื˜ื™ืงื” ืจื—ื‘ืช ื˜ื•ื•ื— ื“ืจืš ื”ื•ืจื™ื“. ื GCSF+ ื“ืจืš ื”ืคื” ืื ื˜ื™ื‘ื™ื•ื˜ื™ืงื” ืจื—ื‘ืช ื˜ื•ื•ื—. ื‘ ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื™ื+ GCSF+ ื›ื™ืžื•ืชืจืคื™ื”. ื’ ื›ื™ืžื•ืชืจืคื™ื”+ ืžื•ืฆืจื™ ื“ื+ ืื ื˜ื™ื‘ื™ื•ื˜ื™ืงื”. ื“ .ื›ื™ืžื•ืชืจืคื™ื” ื•ืžื•ืฆืจื™ ื“ื. ื”

. ืžื•ืืจื›ื™ื PT, PTT, TTื‘ืžื‘ื—ื ื™ ืžืขื‘ื“ื” ื ืžืฆื . 19 ?ื—ืกืจ ื‘ืžื™ ืžื”ื‘ืื™ื ื”ื›ื™ ืกื‘ื™ืจ ืฉื’ืจื ืœืชื•ืคืขื”

vWF. ื 8ืคืงื˜ื•ืจ . ื‘ 7ืคืงื˜ื•ืจ . ื’ 1ืคืงื˜ื•ืจ . ื“ 13ืคืงื˜ื•ืจ . ื”

?Dermacation vesiclesื”ื™ื›ืŸ ืžื•ืคื™ืขื™ื . 20

ื‘ืคืจื•ืžื™ื™ืœื•ืžื™ื˜. ื ืžื˜ื” ืžื™ืืœื•ืฆื™ื˜. ื‘ ืžื™ืืœื•ืฆื™ื˜. ื’ ืžื’ืืงืจื™ื•ืฆื™ื˜. ื“

Page 40: As you wish

40

21 .t (11:18) ืœืžื™ ื–ื” ืฉื™ื™ืš?

cmyc. ื bcl2. ื‘

MALT1. ื’ CD 10. ื“

bcr-abl. ื”

?ื‘ืžื™ ืžื”ืžื—ืœื•ืช ื”ื‘ืื•ืช ืชื•ืคืขื” ื–ื• ืžื•ืคื™ืขื”. cmycืฆื™ื•ืจ ืฉืœ ื˜ืจื ืœื•ืงืฆื™ื” . 22nodular sclerosis. ื ALL-L3. ื‘ HL. ื’ -ALK. ื“ NHL

?. ื”

?ื ืžื–ื“ืงื ื•ืช"ืžื” ืœื ืงื•ืจื” ืœื›ื“. 23 . Hb A1cื™ืจื™ื“ื” ื‘ืจืžืช . ื ื”ื›ื“ื•ืจื™ืช ื ืฉืืจืช ื‘ืฆื•ืจื” ื“ื™ืกื˜ื•ืื™ื“ื™ืช. ื‘ ื™ืจื™ื“ื” ื‘ืคืขื™ืœื•ืช ืžื˜ืื‘ื•ืœื™ืช. ื’ ื™ืจื™ื“ื” ื‘ืื—ื•ื– ืžื™ื. ื“ .ื”ื•ืคื›ืช ืœื”ื™ื•ืช ื™ื•ืชืจ ืงืฉื™ื—ื”. ื”

?ืžื™ืืœื•ืื™ื“ื™ื™ืืื™ืœื• ืžื”ืกืžื ื™ื ืื•ืคื™ื™ื ื™ื ืœืชืื™ื . 24

CD 2. ื CD 5. ื‘CD 10. ื’CD 13. ื“

CD 33. ื”

? CLLืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ื”ื˜ื™ืคื•ืœ ื‘. 25 ื”ืžื˜ืจื” ื”ื™ื ืœื”ืฉื™ื’ ื”ืคื•ื’ื” ืžืœืื” ื‘ื”ืงื“ื. ื ื•ืคืจื‘ื™ื ื™ื–ื•ืŸ ื“ืจืš ื”ืคื”) ?(ืžืงื•ื‘ืœ ืœื˜ืคืœ ื‘ืฉื™ืœื•ื‘ ืฉืœ ื›ืœื•ืจื‘ื ืฆื•ืœ . ื‘ ืžืงื•ื‘ืœ ืœืชืช ื‘ื”ืงื“ื ื‘ื™ืคื•ืกืคื ื˜ื™ื ื ื’ื“ ืœื™ื–ื™ื•ืช ืœื™ื˜ื™ื•ืช ื‘ืขืฆืžื•ืช . ื’ .ืกื™ื‘ื•ืš ื ืคื•ืฅ ืฉืœ ื”ืžื—ืœื” ื”ื•ื ืื™ ืกืคื™ืงื” ื›ืœื™ืชื™ืช. ื“ ืœื˜ื™ืคื•ืœ ื‘ืื ืžื™ื” GCSFืžืงื•ื‘ืœ ืœืชืช . ื”

?Bืœ Aืžื” ื”ื”ื‘ื“ืœ ื‘ื™ืŸ ืกื•ื’ ื“ื . 26

ืื™ื ื–ื™ื ื”ืคื•ืขืœ ืขืœ ืฉืจืฉืจืช ื”ื‘ืกื™ืก. ื ืฉื™ื™ืจ ืกื•ื›ืจื™ ืื—ื“. ื‘ .Bืœ Aืฉื™ื ื•ื™ ื‘ื‘ืกื™ืก ืื—ื“ ืฉืžืงื•ื“ื“ ืœืื™ื ื–ื™ื ืฉื”ื•ืคืš ืื•ืชื• ืž. ื’ ืฉื™ื ื•ื™ ื‘ื—ื•ืžืฆื” ืืžื™ื ื™ืช. ื“ ?. ื”

?ืฉื™ื‘ืจื•ืŸ ืื•ืกืžื•ื˜ื™ ืžื•ื’ื‘ืจ ืžืชื™ ื ืจืื”. 27

ืชืœืกืžื™ื”. ื ืกืคืจื•ืฆื™ื˜ื™ื. ื‘ G6PD. ื’ ืื ืžื™ื” ืžื—ืกื•ืจ ื‘ื‘ืจื–ืœ. ื“ ืื ืžื™ื” ืžื—ืกื•ืจ ืคื•ืœื˜. ื”

Page 41: As you wish

41

?NHLื• HLืžื” ื ื›ื•ืŸ ื‘ื™ื—ืก ืœ. 28

ืžืฆื™ื’ ืขืงื•ืžื” ื‘ื™ืžื•ื“ืœื™ืช ื‘ืžื“ื™ื ื•ืช ืžืชืคืชื—ื•ืช NHL. ื ืฉื›ื™ื— ืฉื™ื”ื™ื” ืื™ื—ื•ื™ ื‘ืœื•ื˜ื•ืช ืœื™ืžืคื” HLื‘ . ื‘ . HLื ืžื•ื›ื” ืžืฉื›ื™ื—ื•ืช NHLื‘ื™ืคืŸ ืฉื›ื™ื—ื•ืช . ื’ . NHLืชืื™ ืจื™ื“ ืฉื˜ื™ื™ื ื‘ืจื’ ื ืจืื™ื ื’ื ื‘. ื“ hlืžืขื™ ื“ืง ื”ื•ื ืื—ื“ ื”ืื™ื‘ืจื™ื™ื ื”ื—ื•ืฅ ืงืฉืจื™ื™ื ื”ื™ื—ื™ื“ื™ื ื”ืžืขื•ืจื‘ื™ื ื‘. ื”

?ื”ื™ื›ืŸ ื”ื™ืฆื•ืจ ื”ื›ื™ ืจื‘ ืฉืœ ืจืงืžื” ื”ืžื˜ื•ืคื•ืื˜ื™ืช. 29

ื—ื•ืœื™ื•ืช. ื ืกื˜ืจื ื•ื. ื‘ ืขืฆื ื”ื™ืจืš. ื’ ืฆืœืข. ื“ ?. ื”

ืื™ื–ื” ืžื”ืงื‘ื™ืขื•ืช . ื–ืจื™ืื—ื•ืœื” ืžื™ืืœื•ืžื” ืขื ืžืกื” ื’ื™ื“ื•ืœื™ืช ื•ื–ื™ื”ื•ืžื™ื ืคื ืื•ืžื•ืงื•ืงืœื™ื ืจื™ืืชื™ื™ื ื—ื•. 30

ื”ื‘ืื•ืช ?ื ื›ื•ื ื”

ื—ื™ืกื•ืŸ ืœืื‘ืขื‘ื•ืขื•ืช ื™ืขื™ืœ ื›ื ื’ื“ ืื ื˜ื™ื’ื ื™ื ืงืคืกื•ืœืจื™ื ืฉืœ ืคื ืื•ืžื•ืงื•ืง. ื ืคื ื™ืฆื™ืœืŸ+ื ื™ืชืŸ ืคื ืื•ืžื•ื•ืงืก . ื‘ ื ื™ืชืŸ ืคื ืื•ืžื•ื•ืงืก ื•ื ื˜ืคืœ ื‘ืื ื˜ื™ื‘ื™ื•ื˜ื™ืงื” ืื ื˜ื™ ืคื ืื•ืžื•ืงื•ืงืœื™ืช ื‘ืžืงืจื” ืฉืœ ื–ื™ื”ื•ื ื—ืจื™ืฃ. ื’ .ืื—ืจ ืžืื—ืจ ื•ื”ื—ื•ืœื” ืœื ื™ื’ื™ื‘ ืœืืฃ ื˜ื™ืคื•ืœ ABื ื™ืชืŸ ืคืกืžื” ืฉืœ . ื“ ืื™ืŸ ื˜ืขื ืœืชืช ืคื ืื•ืžื•ื•ืงืก ืœื—ื•ืœื” ืžื™ืืœื•ืžื”. ื”

?ืื™ืš ืืฉืคืจ ืœื”ื‘ื—ื™ืŸ ื‘ื™ืŸ ืคื•ืœื™ืฆื™ื˜ืžื™ื” ื•ืจื” ืœื’ื™ื“ื•ืœ ืžืžืื™ืจ ื‘ื›ื‘ื“. 31

ืกื˜ื•ืจืฆื™ื” ื ืžื•ื›ื”. ื ืืจื™ืชืจื•ืคื•ืื˜ื™ืŸ ื ืžื•ืš. ื‘ ื’ื‘ื•ื” RSM. ื’ ื ืžื•ืš RSM. ื“ ืื•ืœื˜ืจืืกืื•ื ื“ ืฉืœ ื”ื‘ื˜ืŸ. ื”

?ื”ืžืจื›ื–ื™ืชื”ืขืฆื‘ื™ื ' ื‘ืื™ื–ื• ืžื—ืœื” ื ื•ืชื ื™ื ื˜ื™ืคื•ืœ ืžื•ื ืข ื”ืกื ื ื” ืœืžืข. 32

ALL. ื AML. ื‘ Hairy cell. ื’ CLL. ื“ CML. ื”

? NHLืžื” ื ื›ื•ืŸ ื‘ื˜ื™ืคื•ืœ ื‘. 33

ืœืกื•ื’ ื”ื”ื™ืกื˜ื•ืœื•ื’ื™ ื—ืฉื™ื‘ื•ืช ื‘ื˜ื™ืคื•ืœ. ื ื—ื™ื‘ ืœืขื‘ื•ืจ ื”ืฉืชืœืช ืžื— ืขืฆื NHLื›ืœ ื—ื•ืœื” . ื‘ ื”ื˜ื™ืคื•ืœ ืชืœื•ื™ ื‘ื’ื™ืœ ื”ื—ื•ืœื”. ื’ ืฆืจื™ืš ืœื”ืฉืชืžืฉ ื‘ืคืืจื“ื™ื ื–ื•ืŸ. ื“

?. ื”

?ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ืžื ื•ืช ื“ื ื‘ื‘ื ืง ื”ื“ื. 34HHVื• HHV 8ื›ืœ ื”ืžื ื•ืช ื ื‘ื“ืงื•ืช ืœ . ื 7 HHV 7ื• HHV 6ืœ ื›ืœ ื”ืžื ื•ืช ื ื‘ื“ืงื•ืช . ื‘ ื’ื•ืจืžื™ื ืœืืคืœื–ื™ื” ืฉืœ ื”ืฉื•ืจื” ื”ืื“ื•ืžื” ื‘ื—ื•ืœื™ ืื ืžื™ื” ื”ืžื•ืœื™ื˜ื™ืช B19ืคืจื‘ื• ื•ื™ืจื•ืก ื•ื•ื™ืจื•ืก . ื’ ?. ื“

?. ื”

Page 42: As you wish

42

?ื”ื™ื›ืŸ ืžืฆื ื”ื›ื™ ื”ืจื‘ื” ื’ืจื ื•ืœื•ืช ืื–ื•ืจื•ืคื™ืœื™ื•ืช. 35

ืคืจื•ืžื™ืืœื•ืฆื™ื˜. ื ืžื™ืืœื•ืฆื™ื˜. ื‘ ืžื™ืืœื•ื‘ืœืกื˜. ื’ ืžื˜ืืžื™ืืœื•ืฆื™ื˜. ื“ . Barel form. ื”

ืœื ื‘ื˜ื•ื—ื™ื ืœื’ื‘ื™ ืฉืžื•ืช ื”ืชืจื•ืคื•ืช ืื– ื›ืœ ืžื™ (? ืžื™ ืžื”ื˜ื™ืคื•ืœื™ื ื”ื•ื ืžื›ื•ื•ืŸ ืœืกื•ื’ ืชืื™ื ื‘ื•ื“ื“. 36

.......)ืฉืจื•ืฆื” ืœืชืจื•ื ืจื™ื˜ื•ืงืกื™ืžืื‘. ื ื˜ืืœื™ื“ื•ืžื™ื“. ื‘ ื•ื™ื ืงืจื™ืกื˜ื™ืŸ. ื’ ื˜ื ื˜ืจืืฆื™ืงืœื™ืŸ. ื“ ืคืืจื‘ื ื™ื–ื•ืŸ. ื”

?PNHื ื‘"ืžื” ืžื ื’ื ื•ืŸ ื”ืจืก ื›ื“. 37

ืžืขื‘ืจ ื‘ืขื•ืจืงื™ื ืžื•ืฆืจื™ื ืขืงื‘ ื˜ืจื•ืžื‘ื•ื–ื™ืก. ื ืžืขื‘ืจ ื‘ื•ืจื™ื“ื™ื ืžื•ืฆืจื™ื ื‘ื‘ื˜ืŸ ืขืงื‘ ื˜ืจื•ืžื‘ื•ื–ื™ืก. ื‘ ื™ ืžืจื›ื™ื‘ื™ ืžืฉืœื™ื"ืขื•ื‘ืจื™ื ื”ืžื•ืœื™ื–ื” ืข. ื’ ื™ ื ื•ื’ื“ื ื™ื"ื”ืžืฉื•ืคืขืœื™ื ืข T 8ื™ ืชืื™ "ืข. ื“ ื™ ื—ื•ืžืฆืช ื”ืฉื™ืชื ืŸ ื”ื’ื‘ื•ื”ื” ื‘ื›ืœื™ื”"ืข. ื”

?MDSืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ . 38

.ืฉื ืชื™ื™ื ื›ืžืขื˜ ื‘ื›ืœ ื”ื—ื•ืœื™ื ืžืชืคืชื—ืช ืœื•ืงื™ืžื™ื” ื—ืจื™ืคื” ืชื•ืš. ื .ืื™ืŸ ื˜ืขื ืœื‘ืจื•ืจื™ื ืžื•ืจื›ื‘ื™ื ื•ืžืกื•ื‘ื›ื™ื) 70ืžืขืœ (ื‘ื’ืœืœ ืฉื”ืžื—ืœื” ื”ื™ื ืฉืœ ื”ื’ื™ืœ ืงืฉื™ืฉ . ื‘ ื›ืœ ื”ืคืจืขื” ื›ืจื•ื–ื•ืžืœื™ืช ืžื”ื•ื•ื” ืคืจื•ื’ื ื•ื–ื” ื’ืจื•ืขื”. ื’ ื”ื˜ื™ืคื•ืœ ื”ืžืจืคื” ื”ื™ื—ื™ื“ ื”ื•ื ื”ืฉืชืœืช ืžื— ืขืฆื ืžืชื•ืจื ืžืชืื™ื. ื“ .ื› ื”ืžื—ืœื” ื”ื™ื ืฉื ื™ื•ื ื™ืช ืœื˜ื™ืคื•ืœ ื›ื™ืžื•ืชืจืคื™ื” ืื• ืงืจื™ื ื”"ื‘ื“. ื”

?ืชืจื•ืคื•ืช ืœื ื›ื™ืžื•ืชืจืคื™ื•ืช ืœืžื—ืœื•ืช ืžืžืื™ืจื•ืชืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ . 39

' ื•ืžื ื’ื•ืŸ ืคืขื•ืœืชื” ื”ืขื™ืงืจื™ ื”ื•ื ื“ื™ื›ื•ื™ ื”ืžืข MMื˜ืœื™ื“ื•ืžื™ื“ ื”ื™ื ืชืจื•ืคืช ื”ืฆืœื” ื”ื ื™ืชื ืช ืœื—ื•ืœื™ . ื .ื”ื”ืžื˜ื•ืคื•ืื˜ื™ืช ื”ื ื•ืจืžืœื™ืช

ื‘ื”ื™ืฉื ื•ืช ื”ืจืืฉื•ื ื” ืืฉืจ ืœื ืžื•ืขืžื“ื™ื ืœื˜ื™ืคื•ืœ ื”ืฆืœื” ื›ื™ืžื•ืชืจืคื™ AMLื ื™ืชืŸ ืœื—ื•ืœื™ CD 33ืื ื˜ื™ . ื‘ .ืœื ืžื—ื™ื™ื‘ ืฉื”ื ื•ื’ื“ืŸ ื™ื”ื™ื” ื›ื ื’ื“ ืื ื˜ื™ื’ืŸ ื›ืœ ื”ืชื ื”ื’ื™ื“ื•ืœื™ืขื™ืงืจื•ืŸ ืคืขื•ืœืช ื”ื ื•ื’ื“ื ื™ื . ื’ -Bcrืœืœื ื—ืœื‘ื•ืŸ ื”ืื™ื—ื•ื™ AMLื’ืœื™ื•ื•ืง ื ื™ืชืŸ ืœื—ื•ืœื™ . ื“ abl . . ื“"ืชื•ืคืขื” ืฉื›ื™ื—ื” ื‘ื˜ื™ืคื•ืœ ื‘ื ื•ื’ื“ืŸ ืžื•ื ื•ืงืœื•ื ืืœื™ ื”ื™ื ืขืœื™ื” ื ื™ื›ืจืช ื‘ืœื—. ื”

?NSAID'Sืœืžื” ืžืฉืชืžืฉื™ื ืœืืกืคืจื™ืŸ ื•ืœื ื‘ . 40

ื‘ืขืœ ื–ืžืŸ ืžื—ืฆื™ืช ื—ื™ื™ื ืืจื•ืš ื™ื•ืชืจ. ื ืื•ืงืกื™ื’ื™ื ืื– ื‘ืื•ืคืŸ ื‘ืœืชื™ ื”ืคื™ืšืžืขื›ื‘ ืฆื™ืงืœื•. ื‘ ืคืขื™ืœ ื ื’ื“ ื˜ืจื•ืžื‘ื•ืงืกืŸ ืกื™ื ื˜ื˜ื–. ื’ ื™ืฉ ืœื• ืกืคืฆื™ืคื™ื•ืช ืœื˜ืกื™ื•ืช ืžืืฉืจ ืœื˜ืกื™ื•ืช. ื“ ืื—ืจื™ื NSAID'Sื™ืฉ ืœื• ืคื—ื•ืช ืชื•ืคืขื•ืช ืœื•ื•ืื™ ืžืืฉืจ . ื”

ืขื‘ืจื” ื‘ื™ื•ืคืกื™ืช ืžื— ืขืฆื ื•ืื—ืจื™ ืฉืœื•ืฉื” , ื‘ืœืกื˜ื™ื WBC 9,000 ,30%ืžื’ื™ื” ืขื 78ืืฉื” ื‘ืช . 41

ื™ืžื™ื ?ืžื” ื ื›ื•ืŸ, ื”ื•ืคื™ืข ื—ื•ื

WBC 10,000ื™ ืืคืฉืจ ืœืงื‘ื•ืข ืื‘ื—ื ืช ืœื•ืงืžื™ื” ื—ืจื™ืคื” ืขื ืคื—ื•ืช ืž ื. ื ื—ื•ืกืจ ืชืื™ ื“ื ืชืงื™ื ื™ื ื—ืฉื•ื‘ ื™ื•ืชืจ ืžืจื™ื‘ื•ื™ ืฆืื™ื. ื‘ ืžื“ื•ื‘ืจ ื‘ืœื•ืงืžื™ื” ื’ืจื ื•ืœื•ืฆื™ื˜ื™ืช ื›ืจื•ื ื™ืช. ื’ ื”ื—ื•ื ื”ื•ื ื›ื›ืœ ื”ื ืจืื” ื‘ื’ืœืœ ืœื•ืงืžื™ื” ื•ืœื ืžื”ื–ื™ื”ื•ื. ื“

Page 43: As you wish

43

?Stem cellืœ Progenitor cellืžื” ื”ื”ื‘ื“ืœ ื‘ื™ืŸ . 42

.ืจืง ื—ืœืง ืžื”ื SCื™ืฉ ืืช ื›ืœ ื”ืชื›ื•ื ื•ืช ืฉืœ ืชื ื‘ื•ื’ืจ ื•ืœ PCืœ . ื ื‘ืจื•ื‘ื ื ืžืฆืื™ื ื‘ืคืจื™ืคืจื™ื” PCื‘ืจื•ื‘ื ื ืžืฆืื™ื ื‘ืžื— ื”ืขืฆื ื•ืื™ืœื• SC. ื‘ ืžื—ื•ื™ื™ื‘ื™ื ืœื”ืชืžื™ื™ื ื•ืช ืœืชื ืื—ื“ PCื™ืฉ ื™ื›ื•ืœืช ื—ื™ื“ื•ืฉ ืขืฆืžื™ืช ื‘ืขื•ื“ ืฉ SCืœ. ื’ .PCืœื ื™ื›ื•ืœ ืœื”ืคื•ืš ืœ SCืื‘ืœ SCื™ื›ื•ืœ ืœื—ื–ื•ืจ ืœ PCื‘ื ื•ื›ื—ื•ืช ืฆื™ื˜ื•ืงื™ื ื™ื ืžืชืื™ืžื™ื . ื“ ื™ืŸ ื”ื‘ื“ืœ ืžืฉืžืขื•ืชื™ ื‘ื™ืŸ ืฉื ื™ ื”ืชืื™ื ืžื›ื™ื•ื•ืŸ ืฉืœืฉื ื™ื”ื ื™ื›ื•ืœืช ื—ื™ื“ื•ืฉ ืขืฆืžื™ืช ื•ื™ื›ื•ืœื™ื ืœื”ืคื•ืšื. ื”

.ืœืžืกืคืจ ืชืื™ื ืฉื•ื ื™ื

?)ืื• ื’ืจื•ืชื™ืช(ืื™ืš ื ื‘ื—ื™ืŸ ื‘ื™ืŸ ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื•ืคื ื™ื” ืจืืฉื•ื ื™ืช ืœื‘ื™ืŸ ืžื—ืœืช ื›ื‘ื“ ื’ื™ื“ื•ืœื™ืช . 43 ื ืžื•ื›ื” EPOืจืžืช . ื ืจืžืช ื—ืžืฆืŸ ื‘ื“ื. ื‘ ื’ื‘ื•ื”ื” ืœืคื™ ืžื™ืคื•ื™ RBCืžืกืช . ื’ ื›ื” ืœืคื™ ืžื™ืคื•ื™ื ืžื• RBCืžืกืช . ื“ ?. ื”

?ืžืฆื‘ื™ืข ืขืœ T Cell receptor rearrangementื‘ื“ื™ืงืช . 44

Bืœื™ืžืคื•ืžื” ืฉืœ ืชืื™ . ื Tืœื™ืžืคื•ืžื” ืฉืœ ืื™ . ื‘ Tืฉืคืขื•ืœ ืชืื™ . ื’ Pre Tืœื™ืžืคื•ืžื” ืฉืœ ืชืื™ . ื“ ื‘ื“ื™ืงื” ืฉื‘ืื” ื‘ืžืงื•ื ืฆื‘ื™ืขื•ืช ื”ื™ืกื˜ื•ื›ื™ืžื™ื•ืช . ื”

?ืœืืžื”ื•ืช Anti Dืžื”ื™ ื”ื”ืชื•ื•ื™ื” ืœืžืชืŸ . 45

Anti Dื‘ืจื›ื™ืฉืช ื ื•ื’ื ื™ื . ื ื—ื™ื•ื‘ื™ RHื”ืื . ื‘ ืฉืœื™ืœื™ RHื”ืื . ื’ ืฉืœื™ืœื™ RHืชื™ื ื•ืง . ื“ .ื‘ืกืจื•ื ื”ืชื™ื ื•ืง Anti Dื‘ืžืฆื™ืืช ื ื•ื’ื“ื ื™ . ื”

?ื‘ืกืจื•ื ืžืขื™ื“ ืขืœ DDimerืžืฆื™ืืช ืงืฉืจ . 46

ืคื™ืจื•ืง ืงืจื™ืฉ ืคื™ื‘ืจื™ืŸ. ื .ืฉื—ืจื•ืจ ืคื™ื‘ืจื™ื ื•ื’ืŸ ื‘ื“ื. ื‘ ืฉื—ืจื•ืจ ืžืขื›ื‘ื™ ืคืœืกืžื™ื ื•ื’ืŸ. ื’ .ื‘ืคื™ืจื•ืง ืคื™ื‘ืจื™ืŸ Dื—ื™ื‘ื•ืจ . ื“ ?. ื”

:ื ืจืื” ื‘ AUER RODSื”ื•ืคืขืช . 47

CLL. ื ALL. ื‘ AML. ื’ ืžื™ืืœื•ืžื”. ื“ ื” ืžื™ืืœื•ืฆื™ื˜ ืชืงื™ืŸ

ืžื” ื™ื›ื•ืœื” ืœื”ื™ื•ืช . ื—ื•ืœื” ื”ืžื•ืคื™ืœื™ื” ืžื’ื™ืข ืขื ืฉื•ืง ืฉืžืืœื™ ื ืคื•ื— ื•ื›ืื‘ื™ื ืœืœื ืกื™ืžื ื™ ื—ื‘ืœื”. 48

?ื”ืกื™ื‘ื” ื—ืกื™ืžืช ื‘ืœื•ื˜ื•ืช ืœื™ืžืคื” ื‘ืžืคืฉืขื”. ื ืฉื‘ืจ ื‘ืฉื•ืง. ื‘ ื“ื™ืžื•ื ืœืชื•ืš ืจืงืžืช ื”ืฉืจื™ืจ. ื’ DVT. ื“ DIC. ื”

Page 44: As you wish

44

?ืกืคื™ืจืช ื ื•ื™ื˜ืจื•ืคื™ืœื™ื ื‘ื“ื ื”ื”ื™ืงืคื™ ืขืœ ืžื” ืžืขื™ื“ื”. 49

TGP โ€“ Total granulocyte pool. ื CGP- Circulating granulocytic pool. ื‘ MGP โ€“ Marginating granulocytic pool. ื’ MMP- Marginating monocyt pool. ื“ .MGR โ€“ Marrow granulocyt reserve. ื”

?RBCื’ืœื™ืงื•ืœื™ื–ื” ื‘ืื™ื–ื” ืžื”ืžืฉืคื˜ื™ื ื”ื‘ืื™ื ื ื›ื•ืŸ ืœื’ื‘ื™ . 50

ืž ืœื”ืชื—ื™ืœ ืืช ื”ืชื”ืœื™ืš"ืข ATPื™ืฉ ืฆื•ืจืš ื‘. ื ื‘ื›ื“ื™ ืœืกืœืง ืืช ื”ืœืงื˜ื˜ ื”ืžืฆื˜ื‘ืจ ATPื™ืฉ ืฆื•ืจืš ื‘. ื‘ ืขืœ ื›ืœ ืžื•ืœืงื•ืœืช ื’ืœื•ืงื•ื– NADPืžื•ืœืงื•ืœื•ืช 2ื‘ืžื•ื ื•ืคื•ืกืคื˜ ืฉืื ื˜ ื ื•ืฆืจื•ืช . ื’ ื•ืคืกื•ืคื˜ ืžื›ืœ ืžื•ืœืงื•ืœืช ื’ืœื•ืงื•ื– ADPืž ATPืžื•ืœื•ืงื•ืœื•ืช 38ื ื•ืฆืจื•ืช . ื“ Xืจื•ื‘ ื”ืžื—ืœื•ืช ื”ื ื‘ืชื ืื—ื™ื–ื” ืœ. ื”

?CMLืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ .51

.ื”ืžืฉื‘ืจ ื”ื‘ืœืกื˜ื™ ืžืงื“ื™ื ืืช ืฉืฉืœื‘ ื”ื”ืืฆื”. ื .ืžื”ืžืงืจื™ื 30%ืžื˜ื•ืคืœื™ื ื‘ืื™ื˜ืจืคืจื•ืŸ ื™ื’ื™ืขื• ืœืžืฉื‘ืจ ื‘ืœืกื˜ื™ ืœื™ืžืคื•ืฆื™ื˜ื™ ื‘ . ื‘ .ื—ื•ืœื™ื ื‘ืฉืœื‘ ืžืฉื‘ืจ ื‘ืœืกื˜ื™ ืžื™ืืœื•ืื™ื“ื™ ืžื’ื™ื‘ื™ื ื”ื™ื˜ื‘ ืœื•ื™ื ืงืจื™ืกื˜ื™ืŸ ื•ืคืืจื‘ื ื™ื–ื•ืŸ. ื’ ื˜ื™ืคื•ืœ ื‘ื’ืœื™ื‘ืง ืื™ื ื” ื™ืขื™ืœ ื‘ืฉืœื‘ ื”ืžืฉื‘ืจ ื”ื‘ืœืกื˜ื™. ื“ ื‘ืจื•ื‘ ื”ืžืงืจื™ื ื˜ื™ืคื•ืœ ื›ื™ืžื™ ื‘ืฉืœื‘ ื”ืžืฉื‘ืจ ื”ื‘ืœืกื˜ื™ ื™ื›ื•ืœ ืœื”ื—ื–ื™ืจ ืœืฉืœื‘ ื”ื›ืจื•ื ื™. ื”

?ื ืžื•ืš ื‘ืžื™ื•ื—ื“ LAPื™ "ืื™ื–ื• ืžื—ืœื” ืžืื•ืคื™ื™ื ืช ืข. 52AML. ื CLL. ื‘ ALL. ื’CML .ื“ ?. ื”

ืœื ื›ืœ ื›ืš ื‘ื˜ื•ื—ื” ืœื’ื‘ื™ ื”ืชืฉื•ื‘ื•ืช ื”ืœื ื ื›ื•ื ื•ืช ื›ื™ ? ื ืจื›ืฉ ืžื•ืœ ืžื•ืœื“ 8ื›ื™ืฆื“ ืžื–ื”ื™ื ื—ืกืจ ืคืงื˜ื•ืจ . 53 ....ื– ื‘ืžื™ื“ื” ื•ืœืžื™ืฉื”ื• ื™ืฉ ืจืขื™ื•ื ื•ืช ืื—ืจื™ื ืœืงื—ืชื™ ืžื”ืฉื™ื—ื–ื•ืจ ื

7ืžื“ื™ื“ืช ืคืงื˜ื•ืจ . ื 9ืžื“ื™ื“ืช ืคืงื˜ื•ืจ . ื‘ ืขื™ืจื‘ื•ื‘ ืฉืœ ืคืœืกืžืช ื”ื—ื•ืœื” ืขื ืคืœืกืžืช ืื“ื ื‘ืจื™ื -Mixing test. ื’ ื˜ื™ื˜ืจ ื ื•ื’ื“ื ื™ื . ื“ ืจืงื•ืžื‘ื™ื ื ื˜ ืคืงื˜ื•ืจ. ื”

?MDSืžื” ืœื ื ื›ื•ืŸ ืœื’ื‘ื™ . 54

...ืฉืืœื” ืขืœ ื‘ืจื ืจื“ ืกื•ืœื™ื™ื”. 55

?ื ื›ื•ื ื” ืฉืœ ื”ืจื‘ื” ืชืื™ ื“ื ืื“ื•ืžื™ืืžื” ื™ื›ื•ืœ ืœื’ืจื•ื ืœืงืจื™ืื” ืœื . 56 ืžืืงืจื•ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื™ื. ื ืžื™ืงืจื•ืฆื™ื˜ื™ื. ื‘

. ื˜ืกื™ื•ืช 20,000ื‘ืจื™ืื” ืกืคื™ืจืช ื“ื 25ื‘ืช . ืชืžื•ื ื” ืžื™ืงืจื•ืกืงื•ืคื™ืช ืขื ืื’ืจื’ื˜ื™ื ืฉืœ ื˜ืกื™ื•ืช. 57

ืœื‘ื“ื™ืงืช ืคืงื˜ื•ืจื™ ืงืจื™ืฉื” pttื• PTื‘ื“ื™ืงืช . ื ื‘ื“ื™ืงืช ืื’ืจื’ืฆื™ืช ื˜ืกื™ื•ืช. ื‘ ื‘ื“ื™ืงืช ื–ืžืŸ ื“ื™ืžื•ื. ื’ ืžื“ื•ื‘ืจ ื‘ื‘ืขื™ื” ื˜ื›ื ื™ืช ืฉืœ ืงืจื™ืืช ื”ืžื›ืฉื™ืจ ืคืกืื•ื“ื•ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื•ืคื ื™ื” ื•ืœื›ืŸ ื™ืฉ ืœืฉื—ืจืจื” ื”ื‘ื™ืชื”. ื“

......ืžื” ื ื‘ื“ื•ืง GP3B2Aืื“ื ื—ืกืจ . 58

Page 45: As you wish

45

?ืžื” ื ื›ื•ืŸ ื‘ืื ืžื™ื” ื”ืžื•ืœื™ื˜ื™ืช ืื™ืžื•ื ื™ืช. 59

ืฉืœื™ืœื™ DATืœื ื ื™ืชืŸ ืœื‘ืฆืข ืื‘ื—ื ื” ื›ืืฉืจ ืžื‘ื—ืŸ . ื ......ื™ืื™ื”ื™ื• ื—ื™ื•ื‘ DAT/IATืฉืืœื•ืช ื“ื•ืžื•ืช ื‘ืื—ืช ื”ื™ืชื” ื’ื ืื•ืคืฆื™ื” ืฉ 2ื”ื™ื•

?ืื™ื–ื” ืžื—ืœื” ืžืื•ืคื™ื™ื ืช ื‘ื”ืกื ื ื” ืœื—ื ื™ื›ื™ื™ื. 60

)ื ื•ืกืคื™ื AMLื”ืฉืืจ ื”ืชืฉื•ื‘ื•ืช ืœื ื”ื™ื• ืกื•ื’ื™ (ื AML โ€“ M6. ื

?ืžื” ื™ืฉ ืœื”. 13ื˜ื—ื•ืœ ืžื•ื’ื“ืœ ื•ื”ืžื•ื’ืœื•ื‘ื™ืŸ , ืžื™ืฉื”ื™ ืขื ืœื•ื™ืงื•ืฆื™ื˜ื•ื–ื™ืก. 61 CML. ื

?ืžื” ื™ืฉ ืœื•. ื›ืžื• ื‘ื“ื™ื•ืง ื”ืงืœื™ื ื™...... ืฉื™ื ื” ืชื–ื•ื ื”, ืชื™ื ื•ืง ืขื ื”ืฉืชืŸ ื”ืฆื‘ืข ื‘ื™ืจื”. 62

G6PD. ื

?ืžื” ื™ื’ืจื•ื ืœื™ืจื™ื“ื” ื‘ืžื’ืืงืจื™ื•ืฆื™ื˜ื™ื ื‘ืžื— ื”ืขืฆื. 63ITP. ื TTP. ื‘ ืœื•ืงืžื™ื”. ื’

?ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ืงืจื™ืฉืชื™ื•ืช ื™ืชืจ. 64

ื—ื•ืกืจ ืชื•ืจืฉืชื™ ืฉ ืื ื˜ื™ื˜ืจื•ืžื‘ื™ืŸ ื”ื™ื ื” ืชื•ืคืขื” ืฉื›ื™ื—ื” ื‘ืงืจื‘ ื—ื•ืœื™ื ืขื ืžืื•ืจืข ื˜ืจื•ืžื‘ื•ื˜ื™. ื ื™ ืชืจื•ืžื‘ื™ืŸ"ื”ื™ื ื• ื—ืœื‘ื•ืŸ ืฉื ืงืฉืจ ืœืคื™ื‘ืจื™ื ื•ื’ืŸ ื•ื‘ื›ืš ืžื•ื ืข ืืช ื”ืคื™ื›ืชื• ืœืคื™ื‘ืจื™ื ืข Pro C. ื‘ 35ืœื™ื™ื“ืŸ ื™ื”ื™ ืžืื•ืจืข ื˜ืจื•ืžื‘ื•ื˜ื™ ืขื“ ื’ื™ืœ 5ืจื•ื‘ ื”ืื ืฉื™ื ืขื ืžื•ื˜ืฆื™ื” ืฉืœ ืคืงื˜ื•ืจ . ื’ ื•ื‘ื›ืš ื‘ื•ืœืžื™ื ืืช ื”ืชื”ืœื™ืš ื”ืงืจื™ืฉืชื™ 2ืžื ื˜ืจืœื™ื ืืช ื’ื•ืจื ื”ืงืจื™ืฉื” Sื‘ื™ื—ื“ ืขื Cืคืจื•ื˜ืื™ืŸ . ื“ ื ื•ื’ื“ื ื™ ื•ืคื•ืก ื’ื•ืจืžื™ื ืœืงืจื™ืฉืชื™ื•ืช ื™ืชืจ . ื”

?ืžื” ื™ื•ืจื“ ื‘ืื ืžื™ื” ื”ืžื•ืœื™ื˜ื™ืช . 65

ื”ืคื˜ื•ื’ืœื•ื‘ื™ืŸ. ื

:ื”ืฉืชืœื” ืกื™ื ื’ื ื™ืช ื“ื•ืžื” ืžื‘ื—ื™ื ื” ืื™ืžื•ื ื™ืช ืœ. 66 ืื•ื˜ื•ืœื•ื’ื™ืช. ื ื”ืœื•ื’ื ื™ืช. ื‘ ื”ืคื˜ื•ื’ื ื™ืช . ื’

ื‘ืขื–ืจืช ืื™ื–ื” ืžื”ื’ื•ืจืžื™ื ื”ื‘ืื™ื ื”ื˜ืกื™ื•ืช ื ืฆืžื“ื•ืช ืœืจืงืžื•ืช ืกืื‘ ืื ื“ื•ืชืœื™ืืœื™ื•ืช. 67 ืกื™ื“ืŸ. ื 2ืคืงื˜ื•ืจ . ื‘ ืžื”ื˜ืกื™ื•ืช 3ืคืงื˜ื•ืจ . ื’ ื•ื™ืœื™ื‘ืจื ื“ืคืงื˜ื•ืจ ืคื•ืŸ . ื“ ืคื™ื‘ืจื™ื ื•ื’ืŸ. ื”

:ืžื”ื™ ื”ืคืขื•ืœื” ื”ืžืžื•ืœืฆืช.ื•ื–ืžืŸ ื“ื™ืžื•ื ืชืงื™ืŸ 20,000ื˜ืกื™ื•ืช ' ืžืก 15ื‘ืŸ . 68 ืž ืœื”ื’ื™ืข ืœืจืžืช ื˜ืกื™ื•ืช ืชืงื™ื ื”"ืœืชืช ื˜ืกื™ื•ืช ืข. ื ืœื‘ืฆืข ื”ืงื–ืช ื“ื ืœื’ื™ืจื•ื™ ื™ืฆื•ืจ ื˜ืกื™ื•ืช ืื ื“ื•ื’ื ื™. ื‘ ืœืชืช ืขื™ืจื•ื™ ืชืื™ ื“ื ืื“ื•ืžื™ื ื“ื—ื•ืกื™ื ืœืžื ื•ืข ื™ื™ืฆื•ืจ ื˜ืกื™ื•ืช ืœืงื•ื™ื•ืช. ื’ ื“ื™ืžื•ื ืœืชืช ืขื™ืจื•ื™ ืœื•ื™ืงื•ืฆื™ื˜ื™ื ืœืžื ื•ืข. ื“ ืœืขืงื•ื‘ ืื—ืจื™ ื”ื ืขืจ ืœืœื ื˜ื™ืคื•ืœ. ื”

ืžื ื’ื ื•ืŸ ื”ืคืขื•ืœื” ืฉืœ ืงื•ืžื“ื™ืŸ ื”ื•ื. 69 Kืžืคืจื™ืข ืœืกืคื™ื’ื” ืฉืœ ื•ื™ื˜ืžื™ืŸ . ื ื™ ื›ืš ืžื ื˜ืจืœ ืืช ืคืขื™ืœื•ืชื•"ื•ืข Kืงื•ืฉืจ ืืช ื•ื™ื˜ืžื™ืŸ . ื‘ ืจื“ื•ืงื˜ืื– Kืžืขื›ื‘ ืืช ืคืขื™ืœื•ืช ื•ื™ื˜ืžื™ืŸ . ื’ ื‘ื˜ืกื™ื•ืช COXืžืฉืคื™ืข ืขืœ ืคืขื™ืœื•ืชื• ืฉืœ . ื“ ?. ื”

Page 46: As you wish

46

?ื”ืขืฆื ื‘ื—ื•ืœื” ืขื ืื ืžื™ื” ืืคืœืกื˜ื™ืช ืžื“ื•ืข ื—ืฉื•ื‘ ืœื‘ืฆืข ื‘ื“ื™ืงื” ืฆื™ื˜ื•ื’ื ื™ืช ืžืžื—. 70 ื™ื›ื•ืœ ืœื”ืขื™ื“ ืขืœ ืžื—ืœื” ื•ื™ืจืืœื™ืช ื”ื’ื•ืจืžืช ืœืฉื™ื ื•ื™ื™ื ื’ื ื˜ื™ื™ื. ื MDSืœืฉืœื•ืœ ืžื—ืœื” ืื—ืจืช ื›ืžื• ืœื•ืงืžื™ื” ื”ื•ื . ื‘ .ืœืงื‘ื•ืข ืืช ื—ื•ืžืจืช ื”ืื ืžื™ื” ื”ืืคืœืกื˜ื™ืช. ื’ ืฉื™ื ื•ื™ื™ื ืฆื™ื˜ื•ื’ื ื˜ื™ื ืฉื›ื™ื—ื™ื ื‘ืื ืžื™ื” ืืคืœืกื˜ื™ืช. ื“ .ื ื™ืชืŸ ืœื‘ืฆืข ืžื“ื ืคืจื™ืคืจื™,ืื™ืŸ ืฆื•ืจืš ืœื‘ืฆืข ื‘ื“ื™ืงืช ืžื— ืขืฆื. ื”

ืจืžื•ืช ื”ื˜ืกื™ื•ืช ื•ืชืื™ื ืœื‘ื ื™ื , MCV 72, 10ื”ืžื•ื’ืœื•ื‘ื™ืŸ , ื‘ื‘ื“ื™ืงื” ื—ื™ื•ื•ืจ, ืขื ืขืฆื™ืจื•ืช 55ื‘ืŸ . 71ืจืžืช . ืจืžืช ื”ื‘ืจื–ืœ ื‘ื ืกื™ื•ื‘ ื ืžื•ื›ื” ื›ืืฉืจ ื›ื•ืฉืจ ืงืฉื™ืจืช ื”ื‘ืจื–ืœ ื’ื‘ื•ื” ื•ื”ืกื˜ื•ืจืฆื™ื” ื ืžื•ื›ื”, ืชืงื™ื ื”

. ืคืจื™ื˜ื™ืŸ ื ืžื•ื›ื” ? ืžื” ื”ืฆืขื“ ื”ื‘ื

ื‘ื“ื™ืงืช ืจืžืช ื—ื•ืžืฆื” ืคื•ืœื™ืช. ื ื‘ื“ื™ืงืช ืกืคื™ื’ืช ื‘ืจื–ืœ. ื‘ืงื•ืœื•ื ื•ืกืงื•ืคื™ื”. ื’ื‘ื“ื™ืงืช ืžื— ื”ืขืฆื ื›ื•ืœืœ ืฆื‘ื™ืขื” ืœื‘ืจื–ืœ. ื“ ืžื‘ื—ืŸ ืฉื™ืœื™ื ื’. ื”

ืื™ื–ื” ืžื”ื‘ื“ื™ืงื•ืช ื”ื‘ืื•ืช ืขืฉื•ื™ื” ืœืฉืงืฃ ื˜ื™ืคื•ืœ ื–ื”ื”, ืื™ื ื”ื™ื‘ื˜ื•ืจื™ GP2b/3aื—ื•ืœื” ืžืงื‘ืœ ื˜ื™ืคื•ืœ ื‘ . 72 PTTื‘ื“ื™ืงืช . ื PTT+PTื‘ื“ื™ืงืช . ื‘ ื–ืžืŸ ื“ื™ืžื•ื ื•ื‘ื“ื™ืงืช ืื’ืจื’ืฆื™ื” ืฉืœ ื˜ืกื™ื•ืช. ื’ ื‘ื“ื™ืงืช ืžืฉื˜ื— ื“ื ื”ื™ืงืคื™.ื“ .ื‘ื“ื™ืงืช ืจืžืช ืกื™ื“ืŸ ื‘ืคืœืกืžื”. ื”

:ื‘ื•ืช ื›ืžืขื˜ ื‘ื˜ื•ื—ื•ืชืžืคืชื— ืชืฉื• ื”. 64 ื. 43 ื‘. 22 ื‘. 1 -. 65 ื‘. 44 ื‘. 23 ื’. 2 ื. 66 ื’. 45 ื”. 24 ื”. 3 ื“. 67 ื. 46 ื‘. 25 ื. 4 ื”. 68 ื’. 47 ื‘. 26 ื”. 5 ื’. 69 ื’. 48 ื‘. 27 ื. 6 .70 ื‘. 49 ื“. 28 ื’. 7 .71 ื. 50 ื. 29 ื’. 8 ื’. 72 ื‘. 51 ื’. 30 ื“ .9

ื“. 52 ื‘. 31 ื. 10 ื’. 53 ื. 32 ื‘. 11 -. 54 ื. 33 ื“. 12 -. 55 ื’. 34 ื”. 13 . 56 ื. 35 ื. 14 ื“. 57 ื. 36 ื”. 15 -. 58 ื’. 37 ื“. 16 -. 59 ื“. 38 ื. 17 . -. 60 ื‘. 39 ื“. 18 -. 61 ื‘. 40 ื“. 19 -. 62 ื‘. 41 ื“ 20 ื’. 63 ื” . 42 ื’.21

Page 47: As you wish

47

' ืžื—ื–ื•ืจ ืœ - 2005 ื”ืžื˜ื•ืื•ื ืงื•ืœื•ื’ื™ื”ืฉื—ื–ื•ืจ

?ืœืžื” ืžื”ื‘ืื™ื ื’ื•ืจื ืจื™ื‘ื•ื™ ืœื•ื™ืงื•ืฆื™ื˜ื™ื ื‘ื“ื ืฉืœ ื—ื•ืœื” ืœื•ืงืžื™ื”.1 ืžืจืžื– ืขืœ ื”ืคื•ื’ื” ื‘ืžื—ืœื” .ืื’ื•ืจืžืช ืœืฆืžื™ื’ื•ืช ืžื•ื’ื‘ืจืช ืฉืœ ื”ื“ื ื•ืœื‘ืขื™ื” ื‘ืžื— ื•ื‘ืจื™ืื•ืช .ื‘ื’ื•ืจื ืœืขืœื™ื™ื” ื‘ืกื‘ื™ืจื•ืช ืœืžื—ืœื” ืžืžืืจืช ืžื—ื•ืฅ ืœื›ืœื™ ื”ื“ื .ื’ืœืขืœื™ื” ื‘ืจื’ื™ืฉื•ืช ืœืืื•ื–ื™ื ื•ืคื™ืœื™ืื’ื•ืจื .ื“ื–ื” ืชืงื™ืŸ ื•ืื™ืŸ ืฆื•ืจืš ืœืขืฉื•ืช ื›ืœื•ื .ื” ? ื™ืฉื™ืจ coombsืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ืžื‘ื—ืŸ .2 ื‘ื•ื“ืง ื ื•ื›ื—ื•ืช ื ื•ื’ื“ื ื™ื ืคื™ื–ื™ื•ืœื•ื’ื™ื™ื ื‘ืคืœืกืžื” .ืื "ื‘ื•ื“ืง ื ื•ื›ื—ื•ืช ืื ื˜ื™ื’ื ื™ื ื•ืžืฉืœื™ื ืขืœ ืชื“ .ื‘ืœื ืžื“ื•ื™ืง ื‘ื–ืžืŸ ื‘ื™ื•ืฅ .ื’ :ื”ืžื•ื’ืœื•ื‘ื™ืŸ.3 ืžืฉื•ื—ืจืจ ืžืœื•ื™ืงื•ืฆื™ื˜ื™ื .ืื ืงืฉืจ ืœื”ืคื˜ื•ื’ืœื•ื‘ื™ืŸ .ื‘apo-bื ืงืฉืจ ืœ .ื’ื”ืžื•ืกื™ื“ืจื™ืŸ ื‘ืคืœืกืžื” ื‘ืžืฆื‘ื™ ื—ื•ืœื™ืžืขืœื” .ื“ 4.CD30 ื—ื™ื•ื‘ื™ ื‘- malt lymphoma. ื lymphocytic rich HL. ื‘ CLL. ื’diffused large B cell lymphoma. ื“

4x5ื’ื•ืฉ ื‘ืจื™ืื” ื™ืžื™ืŸ , 5x5ื ืžืฆืื• ื‘ืœื•ื˜ื•ืช ืœื™ืžืคื” ืžื•ื’ื“ืœื•ืช ื‘ื’ื•ื“ืœ . ื’ื‘ืจ ืขื ื’ื™ื“ื•ืœ ื‘ืืฉืš.5ืžื” . ื”ื‘ืœื•ื˜ื•ืช ืœืœื ืฉื™ื ื•ื™, ืœืื—ืจ ื›ื™ืžื•ืชืจืคื™ื” ื ืขืœืžื• ื”ื’ื•ืฉื™ื ืžื”ืจื™ืื•ืช. 2x2ื•ื‘ืจื™ืื” ืฉืžืืœ

?ื”ื”ื’ื“ืจื” ื”ื ื›ื•ื ื” PR .ืCR .ื‘No evidence of disease-NED .ื’ืžื—ืœื” ืคืจื•ื’ืจืกื™ื‘ื™ืช .ื“ืžื—ืœื” ื™ืฆื™ื‘ื” .ื”

?ืกื•ืœื™ื”- ืžื”ื• ื”ืคื’ื ื‘ื‘ืจื ืจื“.6 ื—ื•ืกืจ ื‘ืคืงื˜ื•ืจ ืคืœืกื˜ื™ .ืื—ื•ืกืจ ื‘ืจืฆืคื˜ื•ืจ ืœืคื™ื‘ืจื™ื ื•ื’ืŸ .ื‘GP1B -ื—ื•ืกืจ ื‘ .ื’GP2B3A -ื—ื•ืกืจ ื‘ .ื“

? TARGETEDืื™ื–ื” ืžื”ืชืจืคื™ื•ืช ื”ืœืœื• ื”ืŸ .7 taxol .ื methotroxate .ื‘tmoxifen .ื’vincristine .ื“fu-5 .ื”

Page 48: As you wish

48

?ื‘ืžื” ื ื˜ืคืœ NHLืขื 30ืื“ื ื‘ืŸ .8)ืจื˜ื•ืงืกื™ืžืื‘(ืžื‘ื˜ืจื” + CHOPP .ืMOPP .ื‘ABVD .ื’ื”ืฉืชืœืช ืžื— ืขืฆื .ื“ืกื˜ืจื•ืื™ื“ื™ื .ื” ? ืžื” ืชื˜ืคืœ ืขื›ืฉื™ื•. ื”ื™ื™ืชื” ืจืžืกื™ื” ื•ืœืื—ืจ ืฉื ื” ื”ื™ื™ืชื” ื”ืฉื ื•ืช.9 ื›ื™ืžื•ืชืจืคื™ื” .ืืงืจื™ื ื” .ื‘ื”ืฉืชืœืช ืžื— ืขืฆื .ื’ืกื˜ืจื•ืื™ื“ื™ื .ื“ืžื‘ื˜ืจื”+ CHOPP .ื”

ืžืชื™ ื ืฉืชืžืฉ ื‘ืงืจื™ื ืช ืืœืงื˜ืจื•ื ื™ื ื‘ืžืงื•ื ืคื•ื˜ื•ื ื™ื.10 ื•ื–ื” ื™ืกืคื™ืง xื‘ื“ืจืš ื›ืœืœ ืœื ื ืขืฉื” ืืช ื–ื” ืืœื ื ืงืจื™ืŸ ื‘ืงืจื ื™ .ืื‘ืจื›ื™ืชืจืคื™ื” ืคื•ืœื˜ ืืœืงื˜ืจื•ื ื™ื ื‘ืขื•ื“ ืฉื˜ืœืชืจืคื™ื” ืคื•ืœื˜ ืคื•ื˜ื•ื ื™ื .ื‘)ืจืื” ื’ืจืฃ( ืงืจืŸ ืืœืงื˜ืจื•ื ื™ื ืžืืคืฉืจืช ื”ื•ืจื“ื” ื‘ืžื“ืจื•ืŸ ืžื ื” ื‘ื”ืงืจื ื” ืฉืœ ื”ืขื•ืจ .ื’ ืžื‘ื—ื™ื ืช ื”ืืคืงื˜ ื”ืจื“ื™ื•ื‘ื™ื•ืœื•ื’ื™ xืงืจืŸ ืืœืงื˜ืจื•ื ื™ื ื—ื–ืงื” ื™ื•ืชืจ ืžืงืจื ื™ .ื“

ื›ืžื• ื›ืŸ ื’ื ื—ื•ื ื•ื—ื•ื•ืจื•ืŸืช ืžื” ื™ืฉ . ื•ืื ืžื™ื” 50000ื‘ืœืกื˜ื™ื ืžืขืœ , ื—ื•ืœื” ืขื ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื•ืคื ื™ื”.11 ?ืœื•

AML .ืALL .ื‘ืขืœ ืžื ืช ืœืงื‘ื•ืข ืื‘ื—ื ื” ื—ื™ื™ื‘ื™ื ืœืขืฉื•ืช ืฆื‘ื™ืขื” ืื™ืžื•ื ื•ืœื•ื’ื™ืช ื•ื‘ื“ื™ืงื” ื›ืจื•ืžื•ื–ื•ืžืœื™ืช .ื’ื ื™ืชืŸ ืœื• ืื•ืคื˜ืœื’ื™ืŸ .ื“

ื™ ื”ื’ื“ืœืช ืžืกืคืจ ืžื ืŸืช "ืžื” ื”ืขื™ืงืจื•ืŸ ื”ืจื“ื™ื•ื‘ื™ื•ืœื•ื’ื™ ื”ืžืืคืฉืจ ืฉื™ืคื•ืจ ื˜ื™ืคื•ืœ ืจื“ื™ื•ืชืจืคื™ ืข.12 ื”ื”ืงืจื ื”

REPAIR .ื REPOPULATION .ื‘RECALL .ื’REASSORTMENT .ื“REOXYGENATE .ื”

? ืื™ืš ืžืื‘ื—ื ื™ื ืคื•ืœื™ืฆื™ื˜ืžื™ื” ื•ื•ืจื”.13 ืžื•ืฆื ื”ื—ื•ืœื” .ืืžืจืื” ื”ื—ื•ืœื” .ื‘ื”ื™ืกื˜ื•ืจื™ื” ืฉืœ ืขื‘ื•ื“ื” ื’ื•ืคื ื™ืช ืžืื•ืžืฆืช .ื’ื’ื‘ื•ื” WBCืžืกืคืจ .ื“ืžืกืช ืชืื™ ื“ื ืื“ื•ืžื™ื ื’ื‘ื•ื” .ื”

?ื‘ืื™ื–ื” ืžื”ื’ื™ื“ื•ืœื™ื ื”ื‘ืื™ื ื—ืœื” ื™ืจื™ื“ื” ื‘ืฉื›ื™ื—ื•ืช ื‘ืฉื ื™ื ื”ืื—ืจื•ื ื•ืช.14 ืขืจืžื•ื ื™ืช .ืืฉื“ .ื‘ืงื•ืœื•ืŸ .ื’ืงื™ื‘ื” .ื“ืœื™ืžืคื•ืžื” ืžืžืืจืช .ื”

Page 49: As you wish

49

)150,000-300,000 -ื ื•ืจืžื”( 56,000ืขื ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื™ื 60ืื™ืฉื” ื‘ืช .15 ืžืกืคืจ ืชืงื™ืŸ ืœื’ื™ืœื” .ืDICื™ืฉ ืœื‘ื“ื•ืง ื—ืฉื“ ืœ .ื‘ื”ืžืกืคืจ ื ืžื•ืš ืœื’ื™ืœื” .ื’ื™ืฉ ืœืชืช ืขื™ืจื•ื™ ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื™ื .ื“

?ืžื” ื ืกื’ืจ. ืœืื•ืชื” ืื™ืฉื” ื—ืฉ ื˜ื—ื•ืœ ืžื•ื’ื“ืœ. 16 ืžืžืฆื ืชืงื™ืŸ ืœืื™ืฉื” ื‘ื’ื™ืœื”. ื ื™ื›ื•ืœ ืœื”ื™ื•ืช ื”ืกื™ื‘ื” ืœื˜ืจื•ืžื‘ื•ืฆื™ื˜ื•ืคื ื™ื”. ื‘ืื™ืŸ ืงืฉืจ ื‘ื™ืŸ ื”ืžืžืฆืื™ื. ื’

?ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ืžื ื•ืช ื“ื. 17 ABื‘ื ืง ื‘ื“ื ืœื ืฆืจื™ืš ืกื•ื’ ื“ื .ืOื‘ืžืงืจื™ ื—ื™ืจื•ื ื ื™ืชืŸ ืœืชืช ืขื™ืจื•ื™ ืขื ื“ื .ื‘ืœืขื™ืจื•ื™ ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื™ื ืื™ืŸ ืฆื•ืจืš ื‘ื”ืชืืžืช ืกื•ื’ ื”ื“ื .ื’

-ื’ื ื•ืœื•ืฆื™ื˜ื™ื ื‘ื•ื’ืจื™ื ื™ืฉ ื‘. 18 ืžื— ืขืฆื. ื ื“ื ืคืจื™ืคืจื™. ื‘ ื“ื+ ืžื— ืขืฆื . ื’ ื˜ื—ื•ืœ + ื“ื . ื“ ื›ื‘ื“+ ื“ื . ื”

?ืžื” ืžืืคื™ื™ืŸ ืชืื™ื ืžื™ื•ืœื•ืื™ื“ื™ื™ื. 19 CD33. ื CD10. ื‘ CD13. ื’CD2. ื“CD5. ื”

20 .CD5 ื—ื™ื•ื‘ื™ ื‘ - MANTEL. ื AML. ื‘ ืœื™ืžืคื•ืคืœืกืžืฆื™ื˜ื™ืง ืœื™ืžืคื•ืžื”. ื’

( ื‘ืจื™ืื” ืฉืžืืœ 2x2 -ื‘ืจื™ืื” ื™ืžื™ืŸ ื• 4x3ื‘ืŸ ืื“ื ืขื ืกืจื˜ืŸ ืืฉื›ื™ื ืขื ื’ืจื•ืจื” ื‘ื’ื•ื“ืœ . 21 ?ืžื” ื”ื“ื™ืจื•ื’, ื‘ืœื•ื˜ื•ืช ืœื™ืžืคื” ื ื’ื•ืขื•ืช ื‘ืื™ื–ื•ืจ ื”ื‘ื˜ืŸ, )ื”ืžืกืคืจื™ื ืœื ืžื“ื•ื™ืงื™ื ื‘ื”ื›ืจื—

stage 1. ื stage 2. ื‘ stage 3a. ื’ stage 3c. ื“ stage 4. ื”

?ืžื”ื• ืžืฉืš ื”ื”ื›ืคืœื” ืฉืœ ืกืจื˜ืŸ ื”ืืฉื›ื™ื. 22 ื™ืžื™ื 2-3. ื ื™ื•ื 21. ื‘ ื™ื•ื 60. ื’ ื™ื•ื 129. ื“ ื™ื•ื 250. ื”

Page 50: As you wish

50

?ืžื”ื™ ืชื•ืคืขืช ื”ืœื•ื•ืื™ ืฉืื ื—ื ื• ื™ื›ื•ืœื™ื ืœืฆืคื•ืช ืœืื—ืจ ืฉื ื™ื BEPื ืชื ื• ืœื• . 23 ืื™ ืกืคื™ืงื” ื›ืœื™ืชื™ืช. ื ื ื•ื™ืจื•ืคืชื™ื”. ื‘ ืกืคื™ืงืช ืœื‘ืื™ . ื’ ืฆืจื•ื–ื™ืก ื‘ื›ื‘ื“. ื“

?ืื™ืคื” ืœื ืขื•ื–ืจ ื˜ื™ืคื•ืœ ื”ื›ื™ืžื•ืชืจืคื™ื”. 24 lung small cell carcinoma. ื ืกืจื˜ืŸ ื”ืจืงื˜ื•ื. ื‘ ืœื™ืžืคื•ืžื”. ื’

?ืื™ืคื” ืœื ืžืงื•ื‘ืœ ืœืชืช ืงืจื™ื ื” ื›ื˜ื™ืคื•ืœ ืžืฉืžืจ. 25 ืกืจื˜ืŸ ื”ืฉื“. ื ืกืจื˜ืŸ ื”ืขืจืžื•ื ื™ืช. ื‘ ืกืจื˜ืŸ ื”ื—ืœื—ื•ืœืช. ื’ ืกืจื˜ืŸ ืžื™ืชืจื™ ื”ืงื•ืœ. ื“

-ื ื•ื‘ืขืช ืž CLLื™ืฆื™ืจืช ื”ืžืกื” ื”ื’ื™ื“ื•ืœื™ืช ื‘. 26 ืงืฆื‘ ื—ืœื•ืงืช ืชืื™ ื”ื’ื™ื“ื•ืœ ื–ื”ื” ืœื–ื” ืฉืœ ืชื ืจื’ื™ืœ. ื ืื•ืจืš ื—ื™ื™ื ื‘ืœืชื™ ืžื•ื’ื‘ืœ ืฉืœ ืชืื™ ื”ื’ื™ื“ื•ืœ. ื‘ ื—ื•ืžืจ ื”ืžื•ืคืจืฉ ื•ื’ื•ืจื ืœืชืžื•ืชื” ืฉืœ ืชืื™ ื”ื’ื™ื“ื•ืœ. ื’ ื•ืœื ื™ืชืจื—ืฉ ืœืœื ื–ื™ื”ื•ื ืฉื›ื–ื” A' ื™ ืกื˜ืจืค"ื™ ื—ื•ืžืจ ื”ืžื•ืคืจืฉ ืข"ืžื•ืฉืจื” ืข. ื“ ืชืจืงืฆื‘ ื—ืœื•ืงืช ืชืื™ ื”ื’ื™ื“ื•ืœ ืžื”ื™ืจ ืžื–ื” ืฉืœ ืชื ืจื’ื™ืœ ื•ืžืฉืš ื—ื™ื• ืืจื•ืš ื™ื•. ื”

?ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ืฉื›ื™ื—ื•ืช ื”ืกืจื˜ืŸ ื•ืกื™ื‘ืช ื”ืžื•ื•ืช ืžืกืจื˜ืŸ ื”ืฉื›ื™ื—ื” ื‘ื™ื•ืชืจ ื‘ื’ื‘ืจื™ื. 27 ืกื™ื‘ืช ื”ืžื•ื•ืช ื”ืฉื›ื™ื—ื” ื‘ื’ื‘ืจื™ื ืžืกืจื˜ืŸ ื”ื™ื ืกืจื˜ืŸ ื”ืจื™ืื•ืช. ื ืกื™ื‘ืช ื”ืžื•ื•ืช ื”ืฉื ื™ื” ื‘ืฉื›ื™ื—ื•ืชื” ืžืกืจื˜ืŸ ื‘ื’ื‘ืจื™ื ื”ื™ื ืกืจื˜ืŸ ื”ืจื™ืื”. ื‘ ื”ืกืจื˜ืŸ ื”ืฉื ื™ ื‘ืฉื›ื™ื—ื•ืชื• ื‘ื’ื‘ืจื™ื ื”ื•ื ืกืจื˜ืŸ ื”ืงื•ืœื•ื ืจืงื˜ื•ื. ื’

? ืžื•ืœื˜ื™ืคืœ ืžื™ืœื•ืžื”ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ื˜ื™ืคื•ืœ ื‘. 28 65ื”ืฉืชืœืช ืžื— ืขืฆื ืžืฆื™ืœื” ื—ื™ื™ื ืœืฆืขื™ืจื™ื ืžืชื—ืช ืœื’ื™ืœ . ื 50ื”ืฉืชืœืช ืžื— ืขืฆื ืžืกื•ื›ื ืช ืžืขืœ ื’ื™ืœ . ื‘ ื“ืงืกืžื˜ื–ื•ืœ ื’ื•ืจื ืœืื•ืกื˜ืื•ืคืจื•ื–ื™ืก ื•ืœื›ืŸ ืœื ื™ื ืชืŸ ื›ื˜ื™ืคื•ืœ. ื’ ื•ืœืงื“ ื”ื™ื ื” ืชืจื•ืคื” ืฆื™ื˜ื•ื˜ื•ืงืกื™ืช ืžืกื•ื’ ืื ื˜ืจืฆื™ืงืœื™ื ื™ื . ื“

? ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ื”ืžื•ื’ืœื•ื‘ื™ืŸ ืขื•ื‘ืจื™. 29 ืงื•ืฉืจ ื—ืžืฆืŸ ื˜ื•ื‘ ื™ื•ืชืจ ืžื”ืžื•ื’ืœื•ื‘ื™ืŸ ืจื’ื™ืœ.ื

ืงื•ืฉืจ ื—ืžืฆืŸ ืคื—ื•ืช ื˜ื•ื‘ ืžื”ืžื•ื’ืœื•ื‘ื™ืŸ ืจื’ื™ืœ. ื‘ ืื™ืŸ ืฉื•ื ื™ ื‘ืงืฉื™ืจืช ื”ื—ืžืฆืŸ ื‘ื™ืŸ ื”ืžื•ื’ืœื•ื‘ื™ืŸ ืขื•ื‘ืจื™ ืœืžื‘ื•ื’ืจ. ื’ ื˜ื•ื‘ ื™ื•ืชืจ ืžื”ืžื•ื’ืœื•ื‘ื™ืŸ ืจื’ื™ืœ co2ืงื•ืฉืจ . ื“ ื˜ื•ื‘ ื™ื•ืชืจ ืžื”ืžื•ื’ืœื•ื‘ื™ืŸ ืจื’ื™ืœ coืงื•ืฉืจ . ื”

? ื˜ืœืกืžื™ื” ืžื™ื ื•ืจื™ืช ฮฒ-ืื™ื–ื” ื”ืžื•ื’ืœื•ื‘ื™ืŸ ืขื•ืœื” ื‘. 30HbA1. ื HbA2. ื‘ HbS. ื’ HbH. ื“ HbA1c .ื“

ื‘ื‘ื“ื™ืงื” ืžื™ืงืจื•ืกืงื•ืคื™ืช . ื˜ืกื™ื•ืช ืœืœื ืกื™ืžื ื™ื ื ื•ืกืคื™ื 20,000ื‘ืกืคื™ืจืช ื“ื . ื‘ืจื™ื 20ื‘ื• . 31 ?ืžื” ืชืขืฉื”, ืื’ืจื’ื˜ื™ื ืฉืœ ื˜ืกื™ื•ืช

ืœื‘ื“ื™ืงืช ืคืงื˜ื•ืจื™ ืงืจื™ืฉื” PTT-ื• PTื‘ื“ื™ืงืช . ื ื‘ื“ื™ืงืช ืื’ืจื’ืฆื™ื” ืฉืœ ื˜ืกื™ื•ืช. ื‘ ื‘ื“ื™ืงืช ื–ืžืŸ ื“ื™ืžื•ื. ื’ .ื™ืฉ ืœืฉืœื•ื— ืื•ืชื• ื”ื‘ื™ืชื”. ืœื›ืŸ ืœื ืžืกื›ืŸ ื—ื™ื™ื, ืจืžื“ื•ื‘ืจ ื‘ื‘ืขื™ื” ื˜ื›ื ื™ืช ืฉืœ ืงืจื™ืืช ื”ืžื›ืฉื™. ื“

Page 51: As you wish

51

?SLLืžื” ืžืืคื™ื™ืŸ . 32 ืœืœื ืžืขื•ืจื‘ื•ืช ืžื— ืขืฆื. ื ืฉื›ื™ื—ื” 12ื˜ืจื™ื–ื•ืžื™ื” . ื‘ 9:22ื˜ืจื ืกืœื•ืงืฆื™ื” . ื’

?ืื™ื–ื” ืชืจื•ืคื” ืกืคืฆื™ืคื™ืช ืœืชื ืžืกื•ื™ื. 33 ืจื™ืชื•ืงืกื™ืžืื‘. ื ื˜ืœื™ื“ื•ืžื™ื“. ื‘ ืคืจื“ื ื™ื–ื•ืœ. ื’

? Tืื™ื–ื• ืœื™ืžืคื•ืžื” ื”ื™ื ืฉืœ ืชืื™ . 34 ื‘ื•ืจืงื™ื˜ืก ืœื™ืžืคื•ืžื”. ืmediastinal (thymic) large cell lymphoma. ื‘ ืคื•ื ื’ื•ืื™ื“ื•ื–ื™ืก. ื’

?ืžื” ืื•ืคื™ื™ื ื™ ืœืื ืžื™ื” ื”ืžื•ืœื™ื˜ื™ืช. 35 ืชืื™ ื“ื ืœื‘ื ื™ื ืžืฉื—ืจืจื™ื ื”ืžื•ื’ืœื•ื‘ื™ืŸ. ื ื”ืžื•ื’ืœื•ื‘ื™ืŸ ืžื•ืคืจืฉ ื›ื˜ื˜ืจืžืจ ื‘ื’ืœื•ืžืจื•ืœื™ ื‘ื›ืœื™ื”. ื‘ ื”ืžื•ื’ืœื•ื‘ื™ืŸ ื ืงืฉืจ ืœื”ืคื˜ื•ื’ืœื•ื‘ื™ืŸ. ื’ ื‘ื”ืžื•ืœื™ื–ื” ื›ืจื•ื ื™ืช ื”ืžื•ืกื™ื“ืจื™ืŸ ื‘ื“ื. ื“

?ืื ืžื™ื” ืžื” ื”ืคืชื•ื’ื ื–ื” ืฉืœ ืคื ืงื•ื ื™ืก. 36 ืฉื‘ื™ืจื•ืช ื›ืจื•ืžื•ื–ื•ืžืœื™ืช. ื ืจื’ื™ืฉื•ืช ื™ืชืจ ืœืื ื“ืจื•ื’ื ื™ื. ื‘ GCSFื—ื•ืกืจ ืจื’ื™ืฉื•ืช ืœ. ื’ ืจื’ื™ืฉื•ืช ืœืฉืžืฉ. ื“

?ื‘ืžื™ื ื•ืŸ ื”ืงืจื™ื ื” ื”ื ืžื•ืš ื‘ื™ื•ืชืจ late toxicityื‘ืื™ื–ื” ืžื”ืื‘ืจื™ื ื”ื‘ืื™ื ื™ื•ืคื™ืข . 37 ืืฉื›ื™ื. ื ืจื™ืื”. ื‘ ืจื˜ื™ื ื”. ื’ ืžื—. ื“ ืœื‘. ื”

ืžื’ื™ืข ืœืจื•ืคื ืขื ืชืœื•ื ื” ืขืœ . ืœืื—ืจ ืœืงื™ื—ืช ื˜ืจื˜ื’ื•ืœ ื‘ืžืฉืš ืฉื ืชื™ื™ื, ืขื ืคืจืงื•ืกื™ื 27ื‘ืŸ . 38ืื™ื–ื” ืžื‘ื—ืŸ ). ืžื•ื™ื˜ืจื•ืคื™ืœ ื”ื™ืคืจืกื’ืžื ื˜ื™: ( ื‘ืžืฉื˜ื— ื“ื ื ืžืฆื. ืชื—ื•ืฉืช ืจื™ื—ื•ืฃ ื•ืขื™ื™ืคื•ืช, ื“ื™ืกืคื ื™ืื”

?ื ื‘ืฆืข B6ืจืžืช . ื ืžื‘ื—ืŸ ืฉื™ืœื™ื ื’. ื‘ ื‘ื“ื™ืงื” ืœืคื•ืœืื˜. ื’

?ืžื” ื ื›ื•ืŸ, ื‘ื’ืœื™ืงื•ืœื™ื–ื” ืฉืœ ืชืื™ ื“ื. 39 ืœื”ืชื—ืœืช ื”ืชื”ืœื™ืš ATPื™ืฉ ืฆื•ืจืš ื‘. ื NADH' ืžื•ืœืง 2ื• ATPืžื•ืœืงื•ืœื•ืช 32ื™ืฉ ื™ื™ืฆื•ืจ ืฉืœ . ื‘ ืฆืจื™ืš ืœื”ืฉืงื™ืข ืื ืจื’ื™ื” ื‘ืคื™ืจื•ืง ืœืงื˜ื˜. ื’

?" dose dense"ืžื”ื• ื”ื˜ื™ืคื•ืœ ื”ืžืชืื™ื ื‘ื™ื•ืชืจ ืœื˜ื™ืคื•ืœ . 40 3ืฉื‘ื•ืขื•ืช ืœืขื•ืžืช ืžื ื” ืื—ืช ืคืขื ื‘ 3ื ืชื™ื ืช ื”ืชืจื•ืคื” ื”ืžืฉืื‘ื” ื“ืจืš ืงื˜ื˜ืจ ืœื•ื•ืจื™ื“ ื‘ืžืฉืš . ื

ืฉื‘ื•ืขื•ืชืคืขืžื™ื 8ืช ืฉื‘ื•ืขื• 3ืœืขื•ืžืช ื›ืœ ) ืฉื‘ื•ืขื•ืช 16ื› "ืกื”(ืคืขืžื™ื 8ืฉื‘ื•ืขื•ืช 2ื ืชื™ื ืช ืื•ืชื• ืžื™ื ื•ืŸ ื›ืœ . ื‘ )ืฉื‘ื•ืขื•ืช 24ื› "ืกื”( ื ืชื™ื ืช ืชืจื•ืคื” ื‘ืื•ืชื” ืชื“ื™ืจื•ืช ืืš ื‘ืžื™ื ื•ืŸ ื’ื‘ื•ื” ื™ื•ืชืจ. ื’

Page 52: As you wish

52

) 20000ืคื—ื•ืช ืž -4ื“ืจื’ื” (ืคื™ืชื— ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื•ืคื ื™ื” ืขืžื•ืงื” carboplatinืื“ื ืฉืงื™ื‘ืœ . 41 ?ืœืื—ืจ ื›ืžื” ื–ืžืŸ ืžืœืงื™ื—ืช ื‘ืชืจื•ืคื” ื ืจืื” ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื•ืคื ื™ื”

ื™ืžื™ื 5. ื ื™ืžื™ื 7-10. ื‘ ืฉื‘ื•ืขื™ื™ื. ื’ ืฉื‘ื•ืขื•ืช 3 .ื“

?ื›ื™ืฆื“ ื™ืฉ ืœื”ื‘ื™ื ื‘ืœื•ื˜ืช ืœื™ืžืคื” ืœื‘ื“ื™ืงื” ืคืชื•ืœื•ื’ื™ืช. 42 ืœื”ื•ืฆื™ืื” ืฉืœืžื” ื•ืœื”ื‘ื™ื ืœืœื ืคื™ืงืกืฆื™ื”. ื ืœื”ื•ืฆื™ืื” ืฉืœืžื” ื•ืœื”ื›ื ื™ืก ืžื™ื“ ืœืคื•ืจืžืœื™ืŸ ื•ืœื”ืขื‘ื™ืจ ืœืคืชื•ืœื•ื’ื™ื”. ื‘ frozen section-ืœื”ื•ืฆื™ื ื—ืœืง ืžื”ื‘ืœื•ื˜ื” ื•ืœืฉืœื•ื— ื‘. ื’ ืœืงื‘ืข ื•ืœืฉืœื•ื— ืœืคืชื•ืœื•ื’ื™ื”, ืœื”ื•ืฆื™ื ื•ืœื—ืชื•ืš ืœืคืจื•ืกื•ืช. ื“

?ื‘ืื™ื–ื” ืชืจื•ืคื” ืชื˜ืคืœ. 3Aื“ืจื’ื” NHLื—ื•ืœื” ืื•ื‘ื—ืŸ ื›ืกื•ื‘ืœ ืž. 43 ืžืขืงื‘ ื‘ืœื‘ื“. ื CHOPP. ื‘ ืคืจื“ื ื™ืกื•ืŸ. ื’ ื”ืฉืชืœืช ืžื— ืขืฆื. ื“ ?ืžื” ื”ื˜ื™ืคื•ืœ ืขื›ืฉื™ื•. ื”ื—ื•ืœื” ื”ื’ื™ื‘ ื‘ื”ืคื•ื’ื” ื•ืœืื—ืจ ื›ืฉื ื” ื”ื•ืคื™ืขื” ื”ืชืœืงื—ื•ืช ืžืคื•ืฉื˜ืช. 44 CHOPP. ื ืžื‘ื˜ืจื”+ CHOPP. ื‘ BMT. ื’ . ื ื™ืชืŸ ื˜ื™ืคื•ืœ ืคืœื™ื˜ื™ื‘ื™, ืื™ืŸ ืืคืฉืจื•ืช ืœื˜ืคืœ. ื“ ?ืื™ื–ื” ืžื—ืœื” ืชื•ืคื™ืข, MOPPืฉืงื™ื‘ืœ ื˜ื™ืคื•ืœื™ ืงืจื™ื ื” ืขื HLื‘ื—ื•ืœื” ืขื . 45 AML. ื ALL. ื‘ HL. ื’ NHL. ื“ mesothelioma. ื”

:ื”ืจืฆืคื˜ื™ืŸ ืคื•ืขืœ ื‘ื“ืจืš ืฉืœ. 46 ื ื•ื’ื“ื ื™ื ืœืจืฆืคื˜ื•ืจ. ื ืžืžื‘ืจื ืœื™ ืฉืœ ื˜ื™ืจื•ื–ื™ืŸ ืงื™ื ืื–-ืœ ื”ื—ืœืง ื”ืคื ื™ืืคืขื™ืœื•ืช ืข. ื‘ ืคืขื™ืœื•ืช ืขืœ ื”ื—ืœืง ื”ื—ื™ืฆื•ื ื™. ื’

:ืœื—ื‘ืจ. 47 ืžื˜ื•ื˜ืจืงืกืื˜ ืžืขื›ื‘ ืคื•ืœื™ืžืจื™ื–ืฆื™ื” ืฉืœ ืกื™ื‘ื™ ื›ื™ืฉื•ืจ

ื•ื™ื ืงืจื™ืกื˜ื™ืŸ ืžืขื›ื‘ ื™ื™ืฆื•ื‘ ืฉืœ ืกื™ื‘ื™ ื›ื™ืฉื•ืจ 1ืฆื™ืงืœื•ืคื•ืกืคืžื™ื“ ืขื™ื›ื•ื‘ ื˜ื•ืคื•ืื™ื–ื•ืžืจืื–

S-ืื™ืจื™ื ื•ื˜ืงืืŸ ืงืฉื•ืจ ืœืฉืœื‘ ื” ื˜ืงืกื•ืœ

? targeted therapyืžื™ ืžื‘ืฆืข . 48 ื˜ืงืกื•ืœ. ื ื•ื™ื ืงืจื™ืกื˜ื™ืŸ. ื‘ FU-5. ื’ ื˜ืžื•ืงืกื™ืคืŸ. ื“ ืžื˜ื•ื˜ืจืงืืกื˜. ื”

Page 53: As you wish

53

? ืžืชื™ ืœื, ื˜ื™ืคื•ืœ ืžืฉืžืจ ื‘ืงืจื ื•ืช. 49 ืขืจืžื•ื ื™ืช . ื ืฉื“ . ื‘ ืžื™ืชืจื™ ืงื•ืœ . ื’ ื›ื‘ื“. ื“

ืชื•ืคืขื•ืช ืœื•ื•ืื™ ื›ื™ืžื•ืชืจืคื™ื”. 50 ื ื•ื™ืจื•ืคืชื™ื” ื•ื™ื ืงืจื™ืกื˜ื™ืŸ

ื‘ืขื™ื•ืช ื›ืœื™ื” ืฆื™ืกืคืœื˜ื™ืŸ FU-5ืฉืœืฉื•ืœ

vp16ื ื•ื™ื˜ืจื•ืคื ื™ื” ืงืจื“ื™ื•ืžื™ืคืชื™ื” ืื“ืจื™ืืžื™ืฆื™ืŸ

?ืจื•ื’ื ื•ืกื˜ื™ ื‘ืกืจื˜ืŸ ื”ืฉื“ืื™ื–ื” ืžื”ื‘ืื™ื ืื™ื ื• ื’ื•ืจื ืค. 51 ื’ื™ืœ. ื ืœื™ื“ื” ืจืืฉื•ื ื” ื‘ื’ื™ืœ ืžื•ืงื“ื. ื‘ ืœื™ื“ื•ืช ื—ื™' ืžืก. ื’ ืกื™ืคื•ืจ ืžืฉืคื—ืชื™. ื“ ื—ืฉื™ืคื” ืžื•ืงื“ืžืช ืœืงืจื™ื ื”. ื”

?ืื™ื–ื” ืžื”ื’ื™ื“ื•ืœื™ื ื”ื‘ืื™ื ืื™ื ื• ืงืฉื•ืจ ื‘ื ื’ื™ืฃ. 52 ื‘ื•ืจืงื™ื˜ืก ืœื™ืžืคื•ืžื”. ื HD. ื‘ MALT. ื’ FULLICULAR. ื“

?MDSืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ . 53 ื˜ื™ืคื•ืœ/ื“ื•ืจืฉืช ื‘ื™ืจื•ืจ ืื™ื ื”, ืื ืžื™ื” ืคื™ื–ื™ื•ืœื•ื’ื™ืช ืฉืœ ื–ืงื ื™ื. ื ื™ ืืจื™ืชืจื•ืคื•ืืชื™ืŸ"ืชืกืžื•ื ืช ื ื“ื™ืจื” ื”ื ื™ืชื ืช ืœืจื™ืคื•ื™ ืข. ื‘ ื™ืฉ ืœื‘ืฆืข ื˜ื™ืคื•ืœ ื—ื™ืจื•ื ืžื™ื“ ืœืžื ื•ืข ืœื•ืงืžื™ื”. ื’ ืœื ืชืžื™ื“ ื“ื•ืจืฉืช ื˜ื™ืคื•ืœ, 60ืชืกืžื•ื ืช ื ืคื•ืฆื” ื‘ืžื‘ื•ื’ืจื™ื ืžืขืœ ื’ื™ืœ . ื“ ืชื•ืคืขื” ืกืชืžื™ืช ื”ื—ื•ืœืคืช ืขื ื”ื–ืžืŸ. ื”

54 .protein c ืžืฉืคื™ืข ืขืœ ืื™ื–ื” ืคืงื˜ื•ืจื™ ืงืจื™ืฉื”? 5+8. ื 13+ 10. ื‘ 7+5. ื’ 1+2. ื“

- ื•ืœ TdTื‘ื‘ื“ื™ืงืช ืžื— ืขืฆื ื ืžืฆืื• ื—ื™ื•ื‘ื™ื™ื ืœ. ืื•ื‘ื™ื ื• ื‘ืœืกื˜ื™ื ืจื‘ื™ื 7ื‘ืžืฉื˜ื— ื“ื ืฉืœ ื™ืœื“ ื‘ืŸ . 55CD10 .ืžื” ื ื™ืชืŸ ืœื•ืžืจ . ื“ืœืงืช ืฉืœ ื”ืื•ื–ืŸ ื”ืชื™ื›ื•ื ื” ื•ื—ื•ื ื’ื‘ื•ื”, ื”ื™ืœื“ ืกื•ื‘ืœ ืžื“ื™ืžื•ืžื™ื ื‘ืขื™ืŸ ืฉืžืืœ

?ื‘ื•ื•ื“ืื•ืช DIC. ื ื–ื™ื”ื•ื ื‘ืื•ื–ืŸ ืขืงื‘ ื”ื™ืคื•ื’ืืžื’ืœื•ื‘ื™ื ืžื™ื”. ื‘ B-ื”ื‘ืœืกื˜ื™ื ื”ื™ื ื ืคืจื”. ื’ bcr-ablืžื•ื˜ืฆื™ื™ืช . ื“ Tืœื™ืžืคื•ืžืช . ื”

?ืื™ืœื• ืžืŸ ื”ืžื—ืœื•ืช ื”ื‘ืื•ืช ื™ืชืืคื™ื ื• ื‘ืชื•ืคืขื•ืช ืื•ื˜ื•ืื™ืžื•ื ื™ื•ืช ื”ื—ืžื•ืจื•ืช ื‘ื™ื•ืชืจ. 56 CLL. ื CML. ื‘ AML. ื’ ALL. ื“

Page 54: As you wish

54

?ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ืžื™ืืœื•ืžื”. 57 65ื”ืฉืชืœืช ืžื— ืขืฆื ืžืืจื™ื›ื” ื—ื™ื™ ื”ื—ื•ืœื” ืžืขืœ ื’ื™ืœ . ื 50ื”ืฉืชืœืช ืžื— ืขืฆื ืืกื•ืจื” ืžืขืœ ื’ื™ืœ . ื‘ ื›"ืœืืจื™ืชืจื•ืคื•ืืชื™ืŸ ื‘ื“ืจื”ื—ื•ืœื™ื ืœื ืžื’ื™ื‘ื™ื . ื’ ื”ื™ื ื” ืชืจื•ืคื” ืฆื™ื˜ื•ื˜ืงืกื™ืช ื”ืฉื™ื™ื›ืช ืœืžืฉืคื—ืช ื”ืื ื˜ืจืฆื™ืงืœื™ื ื™ื velcade. ื“

ื‘ื‘ื“ื™ืงืช ืžื—ื˜ ืขื“ื™ื ื” ืžื”ื’ื•ืฉ ื ืžืฆื ื›ื™ ื”ื•ื . %5grื”ืžื•ื’ืœื•ื‘ื™ืŸ , ืž ืžื“ืžื"ืก 9ืื™ืฉื” ืขื ื’ื™ื“ื•ืœ ืฉืœ . 58 ?ืžื”ื• ื”ื˜ื™ืคื•ืœ ื”ืžื•ืžืœืฅ. ื—ื™ื•ื‘ื™ ืœืจืฆืคื˜ื•ืจื™ื ืœืืกื˜ืจื•ื’ืŸ

ืงืจื™ื ื”. ื ื›ื™ืžื•ืชืจืคื™ื”. ื‘ ื”ืจืฆืคื˜ื™ืŸ. ื’(mastectomy)ืœืื” ื“ื—ื•ืคื” ื›ืจื™ืชืช ืฉื“ ืž. ื“

?ืžื” ืžืืคื™ื™ืŸ ืžื—ืœื•ืช ื”ืžื˜ื•ืื•ื ืงื•ืœื•ื’ื™ื•ืช. 59 ืžื—ืœื•ืช ืœื™ืžืคื•ืคืจื•ืœืจื˜ื™ื‘ื™ื•ืช ืฉืœ ืžื— ื”ืขืฆื. ื ื›ืฉืœื•ืŸ ืžื— ื”ืขืฆื. ื‘ ืžื—ืœื•ืช ืžื•ื ื•ืงืœื•ื ืœื™ื•ืช ืœื™ืžืคื•ืคืจื•ืœืจื˜ื™ื‘ื™ื•ืช. ื’ ืžื—ืœื•ืช ืชื’ื•ื‘ืชื™ื•ืช. ื“ ืžื—ืœื•ืช ืžื˜ื‘ื•ืœื™ื•ืช. ื”

ื—ื•ืœื” ืฉืงื™ื‘ืœ ื”ืคืจื™ืŸ ืคื™ืชื— ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื•ืคื ื™ื”. 60 ืืกืคื™ืจื™ืŸ ืืฉืจ ื’ื•ืจื ืœื”ืืจื›ืช ื–ืžืŸ ื”ืงืจื™ืฉื”ื”ื˜ื™ืคื•ืœ ื ื™ืชืŸ ืขืค . ื ื•ืื ื›ืŸ ืœื”ืคืกื™ืง ื˜ื™ืคื•ืœ ื‘ื”ืคืจื™ืŸ HITืฆืจื™ืš ืœื‘ื“ื•ืง ื”ืื ื”ืชืงื™ื™ืžื” ืชืกืžื•ื ืช . ื‘ ื”ืคืจื™ืŸ ืื™ื ื• ื’ื•ืจื ืœื˜ืจื•ืžื‘ื•ืฆื™ื˜ื•ืคื ื™ื”. ื’ ื”ื˜ื™ืคื•ืœ ืื™ื ื• ืžืฉืคื™ืข ืขืœ ื›ืŸ ื™ืฉ ืœื”ื’ื“ื™ืœ ืืช ืžื™ื ื•ืŸ ื”ื”ืคืจื™ืŸ. ื“

? ืžื” ืชืจืื” B12ื‘ื—ื•ืกืจ ืงืฉื” ืฉืœ . 61 ืžื’ืœื•ื‘ืœืกื˜ื™ื ื‘ืžื— ืขืฆื ื‘ื›ืœ ื”ืฉื•ืจื•ืช. ื ืื ืžื™ื” ืืคืœืกื˜ื™ืช. ื‘ ื”ื™ืคืจืคืœื–ื™ื” ืฉืœ ื”ืฉื•ืจื” ื”ืืจื™ืชืจื•ืื™ื“ื™ืช ื•ื—ื•ืกืจ ืžื•ื—ืœื˜ ื‘ืฉื•ืจื” ื”ืœื‘ื ื”. ื’

?ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ื”ืชื‘ื’ืจื•ืช ืชืื™ ื“ื. 62 ื‘ื–ื•ืคื™ืœื™ื ื•ื˜ืกื™ื•ืช ื”ื ืืœื” ืฉืžื›ื™ืœื™ื ืกืจื•ื˜ื•ื ื™ืŸ ื‘ื“ื. ื ืžื•ื ื•ืฆื™ื˜ื™ื ื”ื ื”ื›ื™ ืงื˜ื ื™ื. ื‘ ื”ืจืืฉื•ื ื™ื ืฉืžื’ื™ืขื™ื ืœืื–ื•ืจ - ืืื•ื–ื™ื ื•ืคื™ืœื™ื. ื’

? ALL -ืœ AMLืžื” ื”ื”ื‘ื“ืœ ื‘ื™ืŸ . 63 ืขืœ ืžื ืช ืœื”ื’ื™ืข ืœืจื™ืคื•ื™ ื™ืฉ ืœื”ื’ื™ืข ืœื”ืคื•ื’ื” ืžืœืื” - AML. ื ื™ืฉ ืืช ืื•ืชื• ื˜ื™ืคื•ืœ ื‘ืฉื ื™ื”ื . ื‘ CSFื ื•ืชื ื™ื ื˜ื™ืคื•ืœ ืžื•ื ืข ืœ AML -ื‘. ื’

ืจื™ืคื•ื™ ืžืœื AML - 80% .ื”

64 .CGD ืžื” ืžืืคื™ื™ืŸ? NADPH oxidaseื‘ืขื™ื” ื‘ืื ื–ื™ื . ื ื‘ืขื™ื” ื‘ืื ื–ื™ืžื™ื ืœื™ื–ื•ื–ื•ืžืœื™ื. ื‘ ื‘ืขื™ื” ื‘ื›ื™ืžื•ืชืงืกื™ืก. ื’ ื‘ืขื™ื” ื‘ื‘ืœื™ืขื”. ื“

? FU-5ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ . 65 ื‘ื ืชื™ื ืช ืœื•ื™ืงื•ื‘ืจื™ืŸ ื ืžื ืข ืืช ืจื•ื‘ ืชื•ืคืขื•ืช ื”ืœื•ื•ืื™. ืื™ ืื ื–ื™ื ืฉืžืชื‘ื˜ื ื™ื•ืชืจ ื‘ืชืื™ "ื› ื ื™ืชืŸ ืœื•ืจื™ื“ ืืš ื™ืฉ ืชื›ืฉื™ืจ ื‘ืžืชืŸ ืคื•ืžื™ ืฉืขื•ื‘ืจ ืžื˜ื‘ื•ืœื™ื–ื ืข"ื‘ื“ืจ. ื‘

ื‘ื’ื™ื“ื•ืœ ื™ ื™ื™ืฆื•ื‘ ืกื™ื‘ื™ ื”ื›ื™ืฉื•ืจ"ืคื•ืขืœ ืข. ื’ ื’ื•ืจื ืœืขืฆื™ืจื•ืช. ื“

Page 55: As you wish

55

66 .PRC โ€“ ืชืื™ ื“ื ื“ื—ื•ืกื™ื ื ื™ืชื ื™ื ื‘ืžืงืจื” ืฉืœ: ืจืง ื‘ืžืงืจื™ื ื—ืจื™ืคื™ื. ื oxygen carrying capacity - ืž ืœืฉืคืจ ื‘ืื•ืคืŸ ื™ืฉื™ืจ ืืช ื”"ืข. ื‘ oxigen carrying capacityื•ื›ืš ืœื”ืขืœื•ืช ืืช ื” DPG-2,3ืž ืœืฉืคืจ ืืช "ืข. ื’ ืž ืœื”ื’ื“ื™ืœ ืืช ื ืคื— ื”ื“ื "ืข. ื“

? ืœืขื•ืžืช ืงืจื™ื ื” ืจื’ื™ืœื” conformal therapy -ืžื” ื”ืชื›ื•ื ื•ืช ื‘. 67 ืœืคื’ื•ืข ื‘ื’ื™ื“ื•ืœ ื•ืœื ื‘ืฉื•ืœื™ื™ื ื‘ืจืžื” ื’ื‘ื•ื”ื” . ื ืจื™ื ืฉืžืงื‘ืœื™ื ืืช ื”ืงืจื™ื ื”ื”ืงื˜ื ืช ื ืคื— ื”ืื‘. ื‘

?ืžื” ื ืขืฉื” 10000ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื™ื , ื™ืœื“ ืฉืจื•ืฆื™ื ืœืขืฉื•ืช ืœื• ื‘ืจื™ืช. 68 ื ื™ืชืŸ ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื™ื. ื ืžื ื•ืช ื“ื ื•ื ืขืฉื” ืืช ื”ื‘ืจื™ืช 2ื ื™ืชืŸ . ื‘ ื ื ืชื—. ื’ ื ืขืฉื” ื‘ื™ืจื•ืจ ื ื•ืกืฃ . ื“

?ืœืžื” ืžื”ื‘ืื™ื ื’ื•ืจื ืจื™ื‘ื•ื™ ืœื•ื™ืงื•ืฆื™ื˜ื™ื ื‘ื“ื ืฉืœ ื—ื•ืœื” ืœื•ืงืžื™ื”. 69 ืžืจืžื– ืขืœ ื”ืคื•ื’ื” ื‘ืžื—ืœื” . ื ืœืฆืžื™ื’ื•ืช ื“ื ืžื•ื’ื‘ืจืช ื•ืœื‘ืขื™ื” ื‘ืžื— ื•ื‘ืจื™ืื•ืชื’ื•ืจื . ื‘ ื’ื•ืจื ืœืขืœื™ื™ื” ื‘ืกื‘ื™ืจื•ืช ืœืžื—ืœื” ืžืžืื™ืจื” ืžื—ื•ืฅ ืœื›ืœื™ ื”ื“ื . ื’ ื’ื•ืจื ืœืขืœื™ื™ื” ื‘ืจื’ื™ืฉื•ืช ืœืืื•ื–ื™ื ื•ืคื™ืœื™ื. ื“ ื–ื” ืชืงื™ืŸ ื•ืื™ืŸ ืฆื•ืจืš ืœืขืฉื•ืช ื›ืœื•ื . ื”

70.HASSLESโ€™S CORPUSOLE - ืžื” ืœื ื ื›ื•ืŸ? ืžืกืคืจื ืขื•ืœื” ืขื ื”ื’ื™ืœ. ื ืื™ื ื ืžื›ื™ืœื™ื ืชืื™ ืืคื™ืชืœ. ื‘ ืœื”ื ืžืฆืื™ื ื‘ืžื“ื•. ื’

-ืฉืืœื•ืช ืžืฉื—ื–ื•ืจื™ื 5 -2004: ื”ืžื˜ื•ืœื•ื’ื™ื”

2003- 8 ,19 2002- 18 2001- 4,15

25, 15 -2005 -ืื•ื ืงื•ืœื•ื’ื™ื”

29, 1 -'ื‘ื—ื™ื ื” ืฉื ื” ื“

Page 56: As you wish

56

'ืžื—ื–ื•ืจ ื›ื˜ โ€“ 2004ืฉื—ื–ื•ืจ ื‘ื”ืžื˜ื•ืœื•ื’ื™ื”

ืžื” , acute hemolysisืขื ื—ืฉืฉ ืœืชืžืก ื“ื ื—ืจื™ืฃ ื• Heriditary spherocytosisื—ื•ืœื” ืขื . 1 ?ืชื‘ื“ื•ืง

ืจื˜ื™ืงื•ืœื•ืฆื™ื˜ื™ื, LDH, ื”ืคื˜ื•ื’ืœื•ื‘ื™ืŸ, ื‘ื™ืœื™ืจื•ื‘ื™ืŸ ื‘ืœืชื™ ื™ืฉื™ืจ.12.ALT ,ื‘ื™ืœื™ืจื•ื‘ื™ืŸ ื™ืฉื™ืจ ,Hbืกื•ื›ืจ ื‘ืฉืชืŸ.3

ืชืžื•ื ื” ืฉืœ ื—ื•ืœืฉื” ื•ืกื™ืžื ื™ , ื‘ื‘ื“ื™ืงืช ืงื•ืœื•ืืกืงื•ืคื™ื” ื ืžืฆืื• ืคื•ืœื™ืคื™ื ืจื‘ื™ื ื‘ืžืขื™, ื—ื•ืœื” ืœื™ืžืคื•ืžื”. 2B .ื‘ืžื” ืชื—ืฉื•ื“?

1.Familial polyposis coli2.follicular lymphoma3.adeno carcinoma4.Mantle Cell5.Marginal zone6.lymphoplasmatic lynphoma

?ืžื” ื”ื˜ื™ืคื•ืœ. ืชืื™ ืคืจืกื” ื•ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื•ืคื ื™ื”, ืžืงืจื•ืกืคืจื•ืฆื™ื˜ื™ื, ืžื’ื™ืข ืขื ืื ืžื™ื”, 78ื–ืงืŸ ื‘ืŸ . 3

MDSืœืคืกื•ืœ ืกื™ื‘ื” ื‘ืจืช ืชื™ืงื•ืŸ ืœืื ืžื™ื” ื•ืื– ืœื‘ื“ื•ืง .12.MDS- ืœื”ืชื—ื™ืœ ื›ื™ืžื•ื˜ืจืคื™ื” ืžื™ื“3.Hb ืืžื•ืจ ืœืจื“ืช ื‘ืื•ืคืŸ ื˜ื‘ืขื™ ืขื ื”ื’ื™ืœ

ืžืคืชื— ื—ื•ื , ืฉืขืชื™ื™ื ืžืžืชืŸ ื”ืขื™ืจื•ื™. ื ื•ื ืžืฆื ื‘ื‘ื™ื“ื•ื“ื—ื•ืœื” ื”ืžื˜ื•ืื•ื ืงื•ืœื•ื’ื™ ืžืงื‘ืœ ืขื™ืจื•ื™ ื“. 4

?ืžื” ืชืขืฉื”. ื•ืฆืžืจืžื•ืจื•ืชPAื˜ื™ืคื•ืœ ืื ื˜ื™ื‘ื™ื•ื˜ื™ ืจื—ื‘ ื˜ื•ื•ื— ื›ื ื’ื“ .1ื•ื”ื•ืฆืืช ืงื˜ื˜ืจ Vancomycinื˜ื™ืคื•ืœ ื‘ .2ืชืจื‘ื™ืช ืžืžื ืช ื”ื“ื ื•ืฉืœื™ื—ืชื” ืœื‘ื“ื™ืงื”.3ืœืœื ื˜ื™ืคื•ืœ ืกืคืฆื™ืคื™, ื”ืžืฉืš ืžืขืงื‘ ืื—ืจ ื”ื—ื•ืœื”.4

?ืื™ื–ื” ืžื”ื’ื™ื“ื•ืœื™ื ื”ื‘ืื™ื ืื™ื ื• ืงืฉื•ืจ ืœื ื’ื™ืฃ. 5

1.Mixed Cellularity HL2.MALT ื‘ืงื™ื‘ื”ืœื™ืžืคื•ืžื” ื‘ืžื— ืฉืœ ื—ื•ืœื” ืื™ื™ื“ืก.34.Bukitt's Lymphoma5.Nodular Sclerosis

6 .CLL ื•SLL ืžื” ืœื ื ื›ื•ืŸ?

ื™ ื‘ื™ื•ืคืกื™ืช ืžื— ืขืฆื ื‘ืœื‘ื“"ื ื™ืชืŸ ืœื”ื‘ื—ื™ืŸ ื‘ื™ื ื”ื ืข.1ืœืจื‘ ื ืขืฉื™ื ื›ืื‘ื—ื ื” ืื—ืช.2ืขื•ื‘ืจื™ื ืœืœื•ืงืžื™ื” ืืงื•ื˜ื™ืช 3.10%ื”ื™ืกื˜ื•ื›ื™ืžื™ื”-ื ื™ืชืŸ ืœื”ื‘ื—ื™ืŸ ื‘ื™ื ื”ื ื‘ืื™ืžื•ื ื•.4

:ื”ืชืื. 7

ืงื•ืžื“ื™ืŸ

ื”ืคืจื™ืŸ

ืืกืคื™ืจื™ืŸ

ืกื˜ืจืคื˜ื•ืงื™ื ืื–

ืจืžื™ ืงืจื™ืฉื”ืขื™ื›ื•ื‘ ืงืจื‘ื•ืงืกื™ืœืฆื™ื” ืฉืœ ื’ื•

ื”ื—ืฉืช ืคื™ืจื•ืง ืงืจื™ืฉ

ืขื™ื›ื•ื‘ ืืฆื™ื˜ืœืฆื™ื” ืฉืœCOXืขื™ื›ื•ื‘ ื™ืฆื™ืจืช ืงืจื™ืฉ

Page 57: As you wish

57

?Clopidogrilื”ื”ื‘ื“ืœ ื‘ืคืขื™ืœื•ืช ื ื•ื’ื“ืช ื”ื˜ืกื™ื•ืช ืฉืœ ืืกืคื™ืจื™ืŸ ื• .8cyclooxygenaseืฉื ื™ื”ื ืžืขื›ื‘ื™ื -ืื™ืŸ ื”ื‘ื“ืœ.12.Clopidogril ืžืขื›ื‘cyclooxygenase ื•ืืกืคื™ืจื™ืŸ ืžืขื›ื‘GP2b3a..Clopidogril GP2b3aื• cyclooxygenaseืืกืคื™ืจื™ืŸ ืžืขื›ื‘ .3.GP2b3aืžืขื›ื‘ื™ื Clopidogrilืืกืคื™ืจื™ืŸ ื•.4

:AMLืœืขื•ืžืช ALLื”ืกื ื ื” ืฉืžืืคื™ื™ื ืช . ื”ืกื ื ื•ืช ืฉื›ื™ื—ื•ืช ื‘ืœื•ืงืžื™ื” ืืงื•ื˜ื™ืช. 9

ืขื•ืจ.1ืžื— ืขืฆื.2ื›ื‘ื“.3ืœื‘ืœื‘.45.CNS

:ืกืคืจื•ืฆื™ื˜ื•ื–ื™ืก ืชื•ืจืฉืชื™ โ€“ HSืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ . 10

ื”ืคืจืขื” ื‘ืชื ื”ืื“ื•ื.1ื”ืื“ื•ื ื”ืคืจืขื” ื‘ืžื‘ื ื” ื”ืžืžื‘ืจื ื” ื‘ืชื.2Hbื”ืคืจืขื” ื‘ืžื‘ื ื” .3ื—ืกืจ ื—ื•ืžืฆื” ืคื•ืœื™ืช.4

:ืœื—ื•ืœื” ืชื”ื™ื”, )HS(ื‘ืžืฆื‘ ื–ื” . 11

ืื ืžื™ื” ืžื™ืงืจื•ืฆื™ื˜ื™ืช ื”ื™ืคื•ื›ืจื•ืžื™ืช.1ืื ืžื™ื” ืžืืงืจื•ืฆื™ื˜ื™ืช.2ืื ืžื™ื” ื ื•ืจืžื•ืฆื™ื˜ื™ืช ื ื•ืจืžื•ื›ืจื•ืžื™ืช.3.ื’ื‘ื•ื” MCHC+ ืื ืžื™ื” ืžื™ืงืจื•ืฆื™ื˜ื™ืช .4

-ื‘ื—ื•ืœื” ื–ื” ื‘ื—ืฉื“ ืœืชืžืก ื—ืจื™ืฃ ื™ืฉ ืœื‘ืฆืข. 12

.ืœื”ื•ืกื™ืฃ ื—ื•ืžืฆื” ืคื•ืœื™ืช .ืจื˜ื™ืงื•ืœื•ืฆื™ื˜ื™ื, LDH, ื‘ื“ื™ืงืช ื‘ื™ืœื™ืจื•ื‘ื™ืŸ ื‘ืœืชื™ ื™ืฉื™ืจ.12.CPK ,ืœื”ื•ืกื™ืฃ . ืคื•ืกืคื˜ื–ื” ืืœืงืœื™ืช ื•ืจื˜ื™ืงื•ืœื•ืฆื™ื˜ื™ืB12..ื‘ื“ื™ืงืช ืžืฉื˜ื— ื“ื ื”ื™ืงืคื™ ื•ื—ื™ืคื•ืฉ ื‘ืœืกื˜ื™ื.3.ื‘ื“ื™ืงืช ืฉืชืŸ ืœื ื•ื›ื—ื•ืช ืกื•ื›ืจ.4

?ืื™ื–ื” ืกืจื˜ืŸ ืžืชืืคื™ื™ืŸ ื‘ืชืื™ื ื‘ื”ื™ืจื™ื ื‘ืฆื™ื˜ื•ืคืœื–ืžื” ื•ื’ืจืขื™ืŸ ื‘ืœืชื™ ืกื“ื™ืจ ื•ื˜ืจื ืกืœื•ืงืฆื™ื”. 13

1.MALT2.Mantle3.Lymphoplasmatic lymphoma

ื—ื™ื•ื‘ื™ืช ืžืขื™ื“ื” ืขืœ DATื‘ื“ื™ืงืช . 14ื’ ืชืื™ ื“ื ืื“ื•ืžื™ื"ื ื•ื’ื“ื ื™ื ืข.1ื ื•ื’ื“ื ื™ื ื‘ืคืœื–ืžื”.2

:ืžืื‘ื—ื ืช ื”ื›ืœ ืคืจื˜ ืœ IGgื—ื™ื•ื‘ื™ืช ืœ DATื‘ื“ื™ืงืช . 15

ื”ืžื•ืœื™ื–ื” ื”ืžื•ืœื™ื˜ื™ืช.1LDHื‘ื™ืœื™ืจื•ื‘ื™ืŸ ื‘ืœืชื™ ื™ืฉื™ืจ ื‘ืจืžื” ื’ื‘ื•ื”ื” ื•.23.cold agglutininืื ืžื™ื” ื ื•ืจืžื•ืฆื™ื˜ื™ืช ื ื•ืจืžื•ื›ืจื•ืžื™ืช.4

Page 58: As you wish

58

ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื™ื . ื™ืžื ื™ื ืงืœื™ื ื™ื™ื ื ื•ืกืคื™ืืœืœื ืก, ื ืžื•ืš Hb 7 ,MCV, ื”ื’ื™ืข ืขืงื‘ ืฉื™ืขื•ืœ 70ื—ื•ืœื” ื‘ืŸ . 16 .ื•ืœื•ื™ืงื•ืฆื™ื˜ื™ื ืชืงื™ื ื™ื

.ื ื™ืชืŸ ืœื• ื”ื•ืจืžื•ื ื™ ื’ื“ื™ืœื”, MDSืงืจื•ื‘ ืœื•ื•ื“ืื™ ืฉื–ื” .1.ื ืชื—ื™ืœ ื‘ื›ื™ืžื•ื˜ืจืคื™ื” ื—ืœืฉื” ื‘ืฉืœ ื’ื™ืœื• MDSืงืจื•ื‘ ืœื•ื•ื“ืื™ ืฉื–ื” .2ื‘ืฉืœ ื’ื™ืœื• ืœื ื ื˜ืคืœ, MDSืงืจื•ื‘ ืœื•ื•ื“ืื™ ืฉื–ื” .3.ืžื“ื•ื‘ืจ ื‘ืื ืžื™ื” ื”ืžื•ืœื™ื˜ื™ืช.4

ื‘ื‘ื“ื™ืงื” ืขื ืžื›ืฉื™ืจ ืœืกืคื™ืจืช ืชืื™ื ืืœืงื˜ืจื•ื ื™. 17

: ื‘ื‘ื“ื™ืงืช ื“ื. ืžื•ืคื™ืข ื‘ืžืจืคืื” ื•ืžืชืœื•ื ืŸ ืขืœ ื—ื•ื 18ื‘ืŸ . 18Hgb - g%7

NPU100 1000ื‘ืœืกื˜ื™ื

20,000ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื™ื 2000ื‘ืœืกื˜ื™ื

B12ื—ื•ืกืจ .1ืกืคืกื™ืก ื—ื“.2ืœื•ืงืžื™ื” ื—ื“ื” ื•ืœื›ืŸ ื™ืฉ ืœื”ืชื—ื™ืœ ื˜ื™ืคื•ืœ ืžื™ื“.3

?ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ื—ื•ืžืฆื” ืคื•ืœื™ืช. 19

methylื ืื’ืจืช ื‘ื“ื ื‘ืฆื•ืจืช .1ื ืื’ืจืช ื‘ื“ื ื‘ืขื–ืจืช ื—ืœื‘ื•ืŸ.2ืœืฉื ืชื™ื™ืืžืื’ืจ ืžืกืคื™ืง .3ื’ื•ืจืžืช ืœืื ืžื™ื” ืžื™ืงืจื•ืฆื™ื˜ื™ืช.4

?ืžืื™ืคื” ื›ื“ืื™ ืœืชืช ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื™ื ืœืื ืžื™ื” ืืคืœืกื˜ื™ืช. 20

ื‘ื ื™ ืžืฉืคื—ื”.1HLAื˜ืจื•ืžื‘ื•ืฆื™ื˜ื™ื ืžืชืื™ืžื™ื ื‘ .2ืžื ื” ืื—ืช ืžืชื•ืจื ื–ื”ื”.3

ืขื‘ื•ืจ ืœื™ืžืคื•ืžื•ืช CTืžื” ื ื™ืชืŸ ืœืจืื•ืช ื‘ . 21

ื”ื’ื“ืœืช ื‘ืœื•ื˜ื•ืช ื‘ืžื“ื™ืืกื˜ื ื•ื ื•ืฉืขืจื™ ื”ืจื™ืื”.1ื”ื’ื“ืœืช ื›ื‘ื“.2ื”ื’ื“ืœืช ื˜ื—ื•ืœ.3ืฉื‘ืจื™ื ืœื™ื˜ื™ื™ื ื‘ืขืฆืžื•ืช.4

HCVืžื” ืžืงืฆืจ ืืช ื–ืžืŸ ื”ื—ืœื•ืŸ ื‘ื’ื™ืœื•ื™ . 22

-HCV .ื Aganti HBC .ื‘NAT .ื’TPHE .ื“

ื’_+ื‘+ื.1ื’+ื.2ื“ ื‘ืœื‘ื“.3ื›ืœ ื”ืชืฉื•ื‘ื•ืช.4

:ืคืจื˜ ืœ -ืื™ื ื“ื™ืงืฆื™ื•ืช ืœื˜ื™ืคื•ืœ ื‘ื•ื ืงื•ืžื™ืฆื™ืŸ. 23

ื–ื™ื”ื•ื ื‘ืงื˜ื˜ืจ ืžืจื›ื–ื™.1ื ื•ื›ื—ื•ืช ืคืกืื•ื“ื•ืžื•ื ืก ืขืœ ื”ืขื•ืจ.2ื“ ื ืžื•ืš"ืžื•ืงื•ื–ื™ื˜ื™ืก ื—ืจื™ืฃ ื•ืœ.3ื˜ื™ืคื•ืœ ืžื•ื ืข ื‘ืงื•ื•ื™ื ื•ืœื•ื ื™ื ืœื”ื•ืจื“ืช ื—ื•ื.4

Page 59: As you wish

59

ื”ืฆื™ื˜ื•ื’ื ื˜ื™ืงื” ื—ืฉื•ื‘ื” ืœ: ืžื” ื ื›ื•ืŸ. 24

ืœื ื—ืฉื•ื‘ื” ืœืื™ื‘ื—ื•ืŸ ื•ืคืจื•ื’ื ื•ื–ื”.1ืคืจื•ื’ื ื•ื–ื” ืื‘ืœ ืœื ืœื˜ื™ืคื•ืœ, ื—ืฉื•ื‘ื” ืœืื‘ื—ื•ืŸ.2ืคืจื•ื’ื ื•ื–ื” ื•ื˜ื™ืคื•ืœ, ื—ืฉื•ื‘ื” ืœืื™ื‘ื—ื•ืŸ.3ื—ืฉื•ื‘ื” ืจืง ืœืžื—ืงืจ.4

:ื ืขื“ื™ืฃ ืœืชืช ื˜ืกื™ื•ืช ืž, ื“ื™ืžื•ืžื™ื ื•ื—ื•ืกืจ ื‘ื˜ืกื™ื•ืช, ื‘ืื ืžื™ื” ืืคืœืกื˜ื™ืช ืงืฉื”. 25

ืžืฉืคื—ื”.12.single donorHLAืชื•ืื.34.random donors

?ื‘ื•ืฆื™ื˜ื•ืคื ื™ื” ืขื ื™ืจื™ื“ื” ื‘ืžื’ื”ืงืจื™ืฆื™ื˜ื™ื ื‘ืžื— ืขืฆืืžื” ื”ื’ื•ืจื ืœื˜ืจื•ืž. 26

ืœื•ืงืžื™ื”.1ืœื™ืžืคื•ืžื”.23.TTP4.ITPืจื™ื‘ื•ื™ ืขื™ืจื•ื™ื™ ื“ื.5

?ืžื” ืกื‘ื™ืจ ืœื”ื ื™ื— ืฉื™ืฉ ืœื•. ื“ื™ืžื•ื ื•ืคื•ืœื™ืคื™ื ืจื‘ื™ื ื‘ืžืขื™ ื”ื’ืก, HbG6, ืื“ื ืžื’ื™ืข ืขื ืื ืžื™ื”. 27

ืคื•ืœืคื•ื–ื™ืก ืงื•ืœื™.12.Follicular Lymphoma3.Mantle Lymphoma4.Marginal Zone Lymphoma

?ืœื”ื’ื“ืจืช ืœื™ืžืคื•ืžื•ืช WHOืžื” ืœื ื ื›ื ืก ื‘ื”ื’ื“ืจืช . 28ืกืคื™ืจืช ื“ื ืžืœืื”.1ืกื™ืžื ื™ื ืงืœื™ื ื™ื™ื.2ืกื™ืžื ื™ื ืฆื™ื˜ื•ืœื•ื’ื™ื.3ืกื™ืžื ื™ื ื”ื™ืกื˜ื•ืคืชื•ืœื•ื’ื™ื™ื.4ืกื™ืžื ื™ื ืžื•ืœืงื•ืœืจื™ื™ื.5

?SLLืœ CLLืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ื”ื”ื‘ื“ืœ ื‘ื™ืŸ. 29

ืžืขื•ืจื‘ื•ืช ืžื— ืขืฆื.1ื”ื ืื•ืชื” ืงื˜ื’ื•ืจื™ื” WHOืค ืงืœืกื™ืคื™ืงืฆื™ืช "ืข.2

?Heriditary Spherocytosisืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ . 30

ืฉื™ื ื•ื™ ื‘ืžื‘ื ื” ื”ืžืžื‘ืจื ื”.1ืฉื™ื ื•ื™ ื‘ื”ื‘ืฉืœืช ื”ื’ืจืขื™ืŸ.2Hbืฉื™ื ื•ื™ ื‘ .3ืฉื™ื ื•ื™ ื‘ืฆื™ื˜ื•ืคืœื–ืžื”.4

ืžื” . MCH-24, 0.1%ืจื˜ื™ืงื•ืœื•ืฆื™ื˜ื™ื , MCV =72 ,HB7, ืžื•ืคื™ืข ืขื ืงื•ืฆืจ ื ืฉื™ืžื” ื—ืจื™ืฃ 73ื‘ืŸ . 31

?ื ืจืื” ื‘ืžืฉื˜ื—ืžื™ืงืจื•ืกืคืจื•ืฆื™ื˜ื™ื ืงื˜ื ื™ื.1ืžื™ืงืจื•ืฆื™ื˜ื™ื ื”ื™ืคื•ื›ืจื•ืžื™ื.2ืžืงืจื•ืฆื™ื˜ื™ื.3ื ื•ืจืžื•ืฆื™ื˜ื™ื ื ื•ืจืžื•ืคืœืกื˜ื™ื.4

Page 60: As you wish

60

?ืœื”ื ื™ื— ื™ื’ืจื•ื ืœื›ืšืžื” ืกื‘ื™ืจ . 32ื—ืกืจ ื‘ืจื–ืœ.1ื—ืกืจ ืคื•ืœืื˜.2B12ื—ืกืจ .3

?ืžื” ื”ืžื—ืœื”, +CD5+ ,CD23+ ,CD20ืกืžื ื™ื . 33

1.SLL2.Lymphocytic lymphoblastic3.Nodular Sclerosis4.Mantle5.Hairy Cell

)ื”ืžืกืคืจื™ื ืœื ืžื“ื•ื™ืงื™ื( ? ืืคืฉืจื™ืช/ ืžื” ืชืจื•ืžืช ื”ื˜ืกื™ื•ืช ื”ืจืฆื•ื™ื”. 34ื˜ืกื™ื•ืช 10 5*5.5ืฉืœ ืžื ื” ืื—ืช.1ื˜ืกื™ื•ืช 10 5*5.5ืฉืฉ ืžื ื•ืช ืฉืœ .2 1011* 3ืžื ื” ืื—ืช ืžืชื•ืจื ื™ื—ื™ื“ ืฉืœ .34.2+3ืžื ื•ืช 3 -ืชื•ืจื ื™ื—ื™ื“.5

ื™ืžื™ื ื™ืจื™ื“ื” ื‘ื›ืœ ืžืจื›ื™ื‘ื™ ื”ื“ื 6ืื—ืจื™ . ืื“ื ืื•ืฉืคื– ื‘ืขืงื‘ื•ืช ืœื•ืงืžื™ื” ื—ื“ื” ืœื˜ื™ืคื•ืœ ื›ืžื•ื˜ืจืคื™. 35

ืฉืขืชื™ื™ื ืœืื—ืจ ืžื›ืŸ ืคื™ืชื— . ื‘ื’ืœืœ ื”ืื ืžื™ื” ืงื™ื‘ืœ ืžื ืช ื“ื. 75ื‘ืžื™ื•ื—ื“ ื ื•ื™ื˜ืจื•ืคื™ืœื™ื ืฉื”ื’ื™ืขื• ืœืขืจืš ืฉืœ ?ืžื” ืชืขืฉื”. 38.5ื—ื•ื

ืชืจื‘ื™ื•ืช ื“ื+ ืืžืคื™ืจื™ ืจื—ื‘+ ื—ื•ื ื˜ื™ืคื•ืœ ืœื”ื•ืจื“ืช.1ืชืจื‘ื™ื•ืช ื“ื, ืืžืคื™ืจื™ ืจื—ื‘, ืฆื™ืœื•ื ื—ื–ื”.2ืชืจื‘ื™ื•ืช ื“ื, ื˜ื™ืคื•ืœ ืœื”ื•ืจื“ืช ื—ื•ื ื•ืžืขืงื‘.3.ื˜ื™ืคื•ืœ ืืžืคื™ืจื™ ืจื—ื‘ ื•ืฉืœื™ื—ืช ืžื ื•ืช ื”ื“ื ืœื‘ื“ื™ืงื”.4

?ืžื” ื ื›ื•ืŸ. ืื“ื ืขื ื–ืžืŸ ื“ื™ืžื•ื ืžื•ืืจืš. 36

.ืœื™ื™ื“ืŸ ื ื“ื™ืจ ืžืื•ื“ ื•ื™ื•ืชืจ ื ื“ื™ืจ ื‘ืืจืฅ 5ืคืงื˜ื•ืจ .1.30ื•ืžื‘ื•ื˜ื™ ืขื“ ื’ื™ืœ ื› ืื™ืจื•ืข ื˜ืจ"ืœืžื™ ืฉื™ืฉ ื—ื•ืกืจ ืฉืœ ืคืงื˜ื•ืจ ื™ืขืฉื” ื‘ื“.2ืื™ื ื• ืกืคืฆื™ืื™ ืœื˜ืจื•ืžื‘ื™ืŸ ื•ืคื•ืขืœ ื ื’ื“ ืคืจื•ื˜ืื–ื•ืช ื ื•ืกืคื•ืช 3ืื ื˜ื™ ื˜ืจื•ืžื‘ื™ืŸ .3ืฉื›ื™ื— ื™ื—ืกื™ืช ื•ืงืจื•ื‘ ืœื•ื•ื“ืื™ ืฉืœื ื™ื”ื™ื• ืื™ืจื•ืขื™ื ื˜ืจื•ืžื‘ื•ื˜ื™ื™ื ืขื“ 3ื—ื•ืกืจ ื‘ืื ื˜ื™ ื˜ืจื•ืžื‘ื™ืŸ .4

. 30ื’ื™ืœ

ืกืคื™ืจื” ืžื‘ื“ืœืช , Hg 19% ,HTk 60% ,WBC 18,000. ืžื•ืขืžื“ ืœื ื™ืชื•ื— ื’ื“ื•ืœ, ื•ืžืฉื”ื• 60ื‘ืŸ . 37 ?ืžื” ืชืขืฉื”. 350,000ืฆื™ื˜ื™ื ื˜ืจื•ืžื‘ื•. ืชืงื™ื ื”.45%ื”ืงื–ื•ืช ืขื“ ืœื”ื•ืจื“ืช ื”ื”ืžื˜ื•ืงืจื™ื˜ ืžืชื—ืช ืœ.155%ืœื”ื•ืจื™ื“ ื”ืžื˜ื•ืงืจื™ื˜ ืžืชื—ืช ืœ, ื”ืงื–ื•ืช ื—ื•ื–ืจื•ืช ื‘ื™ื•ื ื”ื ื™ืชื•ื—.2ืœื˜ืคืœ ื‘ื’ืœื™ื‘ืง, CMLืกื‘ื™ืจ ืฉืžื“ื•ื‘ืจ ื‘ .3 ื™ืฉ ืฆื•ืจืš ืœื˜ืคืœ ื‘ื—ื•ืœื”, ื”ื—ื•ืœื” ืกื•ื‘ืœ ืžืกืคืกื™ืก.4

?ืžื” ื”ื”ื’ื“ืจื” ื”ืžื“ื•ื™ืงืช ื‘ื™ื•ืชืจ ืฉืœ ืœื™ืžืคื•ืžื•ืช. 38

ื’ื™ื“ื•ืœ ืจืืฉื•ื ื™ ืฉืœ ื”ืžืขืจื›ืช ื”ื—ื™ืกื•ื ื™ืช.1ื’ื™ื“ื•ืœ ืจืืฉื•ื ื™ ืฉืœ ืžืงืจื•ืคืื’ื™ื ื•ืžื•ื ื•ืฆื™ื˜ื™ื.2ื’ื™ื“ื•ืœ ืฉืคื™ืจ.3ื’ื™ื“ื•ืœ ืžืžืื™ืจ ืฉืžืขืจื‘ ื’ื ื‘ืœื•ื˜ื•ืช ืœื™ืžืคื”.4ื’ื™ื“ื•ืœ ืฉื ื™ื•ื ื™.5

Page 61: As you wish

61

?HLืื™ืš ื ื˜ืคืœ ื‘ . 39CHOPPื˜ื™ืคื•ืœ ื‘ .1ื”ืงืจื ื” ื‘ืœื‘ื“.2ื˜ื™ืคื•ืœ ืžืขื•ืจื‘ ืขื ื›ื™ืžื•ื˜ืจืืคื™ื”.3ืกื˜ืจื•ืื™ื“ื™ื.4

?ืžื” ืื™ื ื• ืžื”ื•ื•ื” ืžืงื•ืจ ืœื’ื™ื“ื•ืœ ื‘ืœื•ื˜ื•ืช ืœื™ืžืคื”. 40

1.marginal2.follicles in cortex3.medullary sinuses4.paracortical

?ืžื” ืื™ื ื• ื ื›ื•ืŸ, Bื”ืžื•ืคื™ืœื™ื” . 419ื—ืกืจ ืคืงื˜ื•ืจ .17aื ื™ืชืŸ ืœื˜ืคืœ ื‘ืžืชืŸ ืคืงื˜ื•ืจ .2cryoprecipitateื ื™ืชืŸ ืœื˜ืคืœ ื‘ .3Aื“ื•ืžื” ืงืœื™ื ื™ืช ืœ.4

?Kืžื” ืžื”ืคืงื˜ื•ืจื™ื ืชืœื•ื™ ื‘ื•ื™ื˜ืžื™ืŸ . 421.C,S, 2, 92.12, 7,5,33.C,S, 5, 124.9, 5, 10 ,S

GVHืื™ืคื” ืœื ื™ื”ื™ื” . 43

ื”ืฉืชืœื” ืืœื•ื’ื ื™ืช.12.Syngeneicื”ืฉืชืœื” ืžืชื•ืจื ืžืฉืคื—ืชื™.34.unrelated match

44 .ITP ืžื” ื™ื”ื™ื”?

ื”ืจืก ืžื•ื’ื‘ืจ ืฉืœ ื˜ืกื™ื•ืช.1ื™ืฆื•ืจ ืžื•ื’ื‘ืจ ืฉืœ ื˜ืกื™ื•ืช.2ื“ื™ื›ื•ื™ ื™ืฆื™ืจืช ื˜ืกื™ื•ืช.3ืขืœื™ื” ื‘ื›ืžื•ืช ื”ืžื’ื”ืงืจื™ื•ืฆื™ื˜ื™ื ื‘ืžื— ืขืฆื.45.1+2+4

?ืžื” ืชืคืงื™ื“ื ืฉืœ ื—ืœื‘ื•ื ื™ ื”ืฉืœื“. 45

ืœืืคืฉืจ ื”ื’ืžืฉืช ื›ื“ื•ืจื™ื•ืช -ื™ื™ืฆื•ื‘ ื”ืชื.1ืžืคืœ ืืœืงื˜ืจื•ืœื™ื˜ื™ื.2ืกื™ื ื˜ื–ืช ื”ืžื•ื’ืœื•ื‘ื™ืŸ.3ATPื”ื›ื ืกืช .4

?ื‘ืื™ื–ื” ืžื”ื‘ืื™ื ืœื ืฆืคื•ื™ ืฉื™ื”ื™ื” ืืจื™ื˜ืจื•ืคื•ืื˜ื™ืŸ ื ืžื•ืš. 46

ื—ื™ ื‘ื”ืจื™ื.1ืžืขืฉืŸ.2ืœื—ืฅ ืขืœ ืขื•ืจืง ื›ืœื™ื™ืชื™.3ื”ืžื•ื’ืœื•ื‘ื™ืŸ ืขื ืืคื™ื ื™ื•ืช ื’ื‘ื•ื”ื”.4ืืฃ ืชืฉื•ื‘ื” ืื™ื ื” ื ื›ื•ื ื”.5

Page 62: As you wish

62

?ืžื” ืœื ื ื™ืชืŸ ืœื•ืžืจ, ื—ื™ื•ื‘ื™ DATืื“ื ืขื ื—ืกืจ ื“ื ื•. 47ื™ืฉ ืœื• ืื ืžื™ื” ื”ืžื•ืœื™ื˜ื™ืช.1IGgื ื•ื’ื“ื ื™ื ื ื’ื“ ื›ื“ื•ืจื™ื•ืช ืžืกื•ื’ .23.Cold agglutinins IgGืœ"ืืฃ ืื—ื“ ืžื”ื .4

HUNืœืชื™ื ื•ืง ืขื . 48

-Rhืจืง ื‘ืื™ืžื”ื•ืช ืขื .ืืจืง ื‘ืื™ืžื”ื•ืช ืฉืงื™ื‘ืœื• ื“ื ื‘ืขื‘ืจ .ื‘ืกื•ื’ ื”ื ื•ื’ื“ืŸ ืœื ื™ื›ื•ืœ ืœื”ืขื™ื“ ืขืœ ื—ื•ืžืจืช ื”ืžื—ืœื” .ื’ืื™ืžื•ื ื•ื’ืœื•ื‘ื•ืœื™ื ื™ื RHื™ ืžืชืŸ "ืข anti Dื ื™ืชืŸ ืœืžื ื•ืข ื”ื™ื•ื•ืฆืจื•ืช .ื“

ื’+ื‘+ื.1ื’+ื.2ื“+ื‘.3ื›ืœ ื”ืชืฉื•ื‘ื•ืช ื ื›ื•ื ื•ืช.4 ืจืง ืชืฉื•ื‘ื” ื“ ื ื›ื•ื ื”.5

Page 63: As you wish

63

'ืžื—ื–ื•ืจ ื›ื— โ€“ 2003ืฉื—ื–ื•ืจ ื‘ื”ืžื˜ื•ืœื•ื’ื™ื” ?ื‘ืžื™ ืžื”ื‘ืื™ื ืื™ืŸ ืžืจื›ื–ื™ ื’ืจืžื™ื ืฆื™ื” ืœืžืจื•ืช ืฉื™ืฉ ื‘ื• ื”ืชืจื‘ื•ืช ืชืื™ื)1

ื˜ื—ื•ืœ .ืื˜ื™ืžื•ืก .ื‘ืฉืงื“ื™ื .ื’ื‘ืœื•ื˜ื•ืช ืœื™ืžืคื” .ื“

%Hgb=6.8grื—ื•ื“ืฉื™ื ื”ื•ืคื™ืข ' ืœืื—ืจ ืžืก. +B cell CD5ื ืžืฆืื• ืืฆืœื• ืชืื™ื -68ื—ื•ืœื” ื‘ืŸ )2:ืกื‘ื™ืจ ืœื”ื ื™ื— ืฉื”ืกื™ื‘ื” ืœืชื•ืคืขื•ืช. ื—ื™ื•ื‘ื™ coombsืžื‘ื—ืŸ

ื“ื™ืžื•ื .ืืื ืžื™ื” ื”ืžื•ืœื™ื˜ื™ืช .ื‘ืœืœื™ืžืคื•ืžื” ืžืžืืจืชื”ืคื™ื›ื” ืฉืœ ืžื—ืœืชื• .ื’ืกื™ื ื•ืŸ ื‘ืœืืกื˜ื™ื ืœืžื— ื”ืขืฆื .ื“

?ื‘ืžื” ืชื˜ืคืœ ื‘ื—ื•ืœื” ื–ื”)3MOPP .ืCHOP .ื‘ืคืจื“ื ื™ื–ื•ืŸ .ื’ืžืขืงื‘ ื‘ืœื‘ื“ .ื“

:Hematopoetic stem cellsืชืื™ )4ืชืื™ื ืฉื™ื›ื•ืœื™ื ืœื”ืชืžื™ื™ืŸ ืœื›ืœ ืชืื™ ื”ื’ื•ืฃ .ืืชืื™ื ืฉื™ื›ื•ืœื™ื ืœื”ืชืžื™ื™ืŸ ืœืชืื™ ื“ื ื‘ืœื‘ื“ .ื‘ืชืื™ื ืฉืื™ื‘ื“ื• ื™ื›ื•ืœืช ืžื™ื˜ื•ื˜ื™ืช .ื’... .ื“

. ื“ื ืžื•ืคื™ืขื” ื’ืžื•ืคืชื™ื” ืžื•ื ื•ืงืœื•ื ืœื™ืชื‘ื‘ื“ื™ืงืช , ืžื•ืคื™ืข ืขื ื“ืœืงืช ืจื™ืื•ืช 68ื—ื•ืœื” ื‘ืŸ )5-ืกื‘ื™ืจ ืœื”ื ื™ื— ืฉื”ื—ื•ืœื” ืกื•ื‘ืœ ืž. ืœื ื ืจืื• ืกื™ืžื ื™ ืœื™ื–ื™ืก ื‘ืขืฆืžื•ืช. 34000 - ืœื•ื™ืงื•ืฆื™ื˜ื™ื

Multiple Meyeloma .ืMonoclonal gamopathy of unknown significance .ื‘... .ื’

ืœื ืื•ื›ืœ . ื ืกืข ืœืฉื ื” ืœืกืงื ื“ื™ื ื‘ื™ื” ืฉื ืื›ืœ ืจืง ืžืžืชืงื™ื ื•ืขื•ื’ื•ืช, ืฆืžื—ื•ื ื™, ื‘ื—ื•ืจ ื‘ืŸ ืขืฉืจื™ื)6?ืžื” ืกื‘ื™ืจ ืœื”ื ื™ื— ืฉืงืจื”. ื›ืฉื ื” ืœืื—ืจ ืฉื—ื–ืจ ืืจืฆื” ื”ืชืœื•ื ืŸ ืขืœ ื—ื•ืœืฉื” .ื›ืœืœ ื‘ืฉืจ

ื—ื•ืกืจ ื™ื›ื•ืœืช ืœื”ืกืชื’ืœ ืœื—ื™ื™ื ื‘ืืจืฅ .ืื—ื•ืกืจ ื‘ื—ื•ืžืฆื” ืคื•ืœื™ืช .ื‘ื—ื•ืกืจ ื‘ื‘ืจื–ืœ ื•ื‘ื—ื•ืžืฆื” ืคื•ืœื™ืช .ื’ื•ื™ืจื•ืก ืขืœื™ื• ืœื ื”ืฆืœื™ื— ืœื”ืชื’ื‘ืจ ืžืื– ืฉื•ื‘ื• ืืจืฆื” .ื“

?ื‘ืžื” ืชื˜ืคืœ ื‘ื•, ืชืื™ ื”ื“ื ื”ืจืื• ืื ืžื™ื” ึธืžืงืจื•ืฆื™ื˜ื™ืช ื”ื™ืคื•ื›ืจื•ืžื™ืช)7ืจื’ืœื™ ื”ื—ื™ื™ื ืฉืœื•ื›ืœ ืขื•ื“ ืœื ื™ืฉื ื” ืืช ื” B12ืชื•ืกืคืช .ืืื™ืŸ ืฆื•ืจืš ื‘ื˜ื™ืคื•ืœ .ื‘ื•ื—ื•ืžืฆื” ืคื•ืœื™ืช B12 .ื’ืฉื™ืœื•ื‘ ื‘ืจื–ืœ ื•ื—ื•ืžืฆื” ืคื•ืœื™ืช .ื“

Page 64: As you wish

64

ื‘ืžืฉื˜ื— ืคืจื™ืคืจื™ ื ืจืื• ืชืื™ื ื ื•ืจืžืœื™ื™ื ื•ื›ืŸ . ืื“ื ืขื ืื ืžื™ื” ืžื™ืงืจื•ืฆื™ื˜ื™ืช ืงื™ื‘ืœ ืขื™ืจื•ื™ ื“ื)8?ืื™ื–ื” ืคืจืžื˜ืจ ื™ืจืื” ื–ืืช. ืชืื™ื ืงื˜ื ื™ื

LUC .ืRDW .ื‘MCV .ื’HgB .ื“

?ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ื”ืจื˜ื™ืงื•ืœื•ืฆื™ื˜)9ื™ื•ื 120 -ื—ื™ ื‘ืžืžื•ืฆืข ื› .ืื‘ืขืœ ื’ืจืขื™ืŸ .ื‘)ื ื‘ื•ื’ืจ"ืœืขื•ืžืช ืชื“(ื‘ืขืœ ื™ื›ื•ืœืช ืžื•ื’ื‘ืจืช ืœื™ื™ืฆื•ืจ ื—ืœื‘ื•ื ื™ื .ื’ืงื˜ืŸ ื™ื•ืชืจ .ื“

? Bืžื” ืœื ื ื›ื•ืŸ ืœื’ื‘ื™ ื”ืžื•ืคื™ืœื™ื” )10ื™ืขื–ื•ืจ 7aืžืชืŸ ืคืงื˜ื•ืจ .ืXIืžื“ื•ื‘ืจ ื‘ื—ื•ืกืจ ื‘ืคืงื˜ื•ืจ .ื‘Aืชื•ืคืขื•ืช ืงืœื™ื ื™ื•ืช ื“ื•ืžื•ืช ืœื”ืžื•ืคื™ืœื™ื” .ื’X-ื”ืขื‘ืจื” ื‘ืชืื—ื™ื–ื” ืœ .ื“

?RDWืžื” ืœื ื ื›ื•ืŸ ืœื’ื‘ื™ )11.ื’ื‘ื•ื” ื™ื›ื•ืœื™ื ืœื”ืฆื‘ื™ืข ืขืœ ื—ืกืจ ืงืœ ื•ื—ื“ืฉ ืฉืœ ื‘ืจื–ืœ RDW -ื ื•ืจืžืœื™ ื• MCV .ืื’ื‘ื•ื” ื™ื›ื•ืœื™ื ืœื”ืฆื‘ื™ืข ืขืœ ื—ื•ืกืจ ื‘ืจื–ืœ RDW - ื ืžื•ืš ื• MCV .ื‘ืชืงื™ืŸ ื™ื›ื•ืœ ืœื”ืฆื‘ื™ืข ืขืœ ื‘ืขื™ื” ื—ืžื•ืจื” ื‘ืืจื™ืชืจื•ืคื•ืื–ื™ืก MCV -ื ืžื•ืš ื• RDW .ื’.ืชืงื™ืŸ ื™ื›ื•ืœื™ื ืœื”ืฆื‘ื™ืข ืขืœ ื˜ืœืกืžื™ื” ืžื™ื™ื ื•ืจ RDW - ื ืžื•ืš ื• MCV .ื“

)ืฉื™ืœื•ื‘ื™ื(? ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ื ืฉืื™ื ืฉืœ ืื ืžื™ื” ื—ืจืžืฉื™ืช)12ื‘ื’ื‘ื”ื™ื sicklingืœื™ื ืœืคืชื— ื™ื›ื• .ืื™ื›ื•ืœื™ื ืœืคืชื— ืื™ืจื•ืขื™ ืคืจื™ืืคื™ื–ื .ื‘ื‘ืขื™ื” ื‘ื›ืœื™ื” ื™ื›ื•ืœื” ืœื”ืชืคืชื— ื‘ืžืฉืš ื”ืฉื ื™ื .ื’ืฉืœ ื”ื˜ื—ื•ืœ sequestrationืคื™ืชื•ื— .ื“

?ื’ืœื•ืžืจื•ืœืจื™ื ื‘ื›ืœื™ื”-ื•ืงืกื˜ื”'ืžื” ืžื”ื‘ืื™ื ืœื ื ื•ื‘ืข ืžื”ื™ืคืจืคืœื–ื™ื” ืฉืœ ื”ืชืื™ื ื”ื’)13ื—ื™ื™ื ื‘ืžืงื•ื ื’ื‘ื•ื” ืžืขืœ ืคื ื™ ื”ื™ื .ืืžื•ื ืžื•ืœื“ ื‘ืœื‘ .ื‘ื’ื™ื“ื•ืœ ื‘ืžื•ื— .ื’ื”ืคืจืขื” ืจื™ืืชื™ืช .ื“ื”ืขื•ืจืง ื”ื›ืœื™ื™ืชื™ืœื—ืฅ ืขืœ .ื”

- ื’ื•ืจื ืœ 10ื—ืกืจ ื‘ืคืงื˜ื•ืจ )14ืžืื•ืจื›ื™ื PTT -ื• PT .ืื–ืžืŸ ื“ื™ืžื•ื ืืจื•ืš .ื‘ื™ืจื™ื“ื” ื‘ืžืกืคืจ ื˜ืกื™ื•ืช .ื’... .ื“

ื‘ืื™ื–ื” ืฉืœื‘ ื™ืฉ ื™ื—ืกื™ืช ื”ืจื‘ื” ื’ืจื ื•ืœื•ืช ืื–ื•ืจื•ืคื™ืœื™ื•ืช)15ืคืจื•ืžื™ืœื•ืฆื™ื˜ .ืืžื™ืœื•ืฆื™ื˜ .ื‘ืžื˜ื”ืžื™ืœื•ืฆื™ื˜ .ื’)ืขื•ื“ ืฉืœื‘ ื›ืœืฉื”ื•( .ื“

Page 65: As you wish

65

?ืื™ื–ื” ืชื ื ืžืฆื ืื—ืจื™ ื”ืฉืœื‘ ื”ืžื™ื˜ื•ื˜ื™)16Basophilic Erythroblast .ืAcidophilic Erythroblast .ื‘Metamyelocyte .ื’Premyelocyte .ื“Myelocyte .ื”

?HCVืžื” ื™ื›ื•ืœ ืœืงืฆืจ ืืช ืชืงื•ืคืช ื”ื—ืœื•ืŸ ื‘ื’ื™ืœื•ื™ )17HCV Agื‘ื“ื™ืงืช ื”ืื ื˜ื™ื’ืŸ .ืAnti HCVื‘ื“ื™ืงืช ื ื•ื’ื“ืŸ .ื‘TPHA .ื’NAT .ื“ื’+ื .ื”ื“+ื‘ .ื•ื’+ื‘+ื .ื–ื“ ื‘ืœื‘ื“ .ื—

ื‘ื‘ื“ื™ืงืช ื“ื ื”ื›ืœ ื ืžืฆื ืชืงื™ืŸ ืžื” ื™ืฉ . ื‘ืŸ ืฉื‘ืขื™ื ืžื’ื™ืข ืขื ืื ืžื™ื” ืงืœื” ืžืืงืจื•ืฆื™ื˜ื™ืช)18?ืœืขืฉื•ืช

ืœืฉืœื™ืœืช ื—ืกืจ ื‘ืจื–ืœืœื‘ืฆืข ื‘ื“ื™ืงืช ืžื— ืขืฆื .ืื‘ื’ื™ืœ ื–ื” ืื ืžื™ื” ืงืœื” ื™ื›ื•ืœื” ืœื”ื™ื•ืช ืคื™ื–ื™ื•ืœื’ื™ืช -ืื™ืŸ ืฆื•ืจืš ืœืขืฉื•ืช ื“ื‘ืจ .ื‘ืœื‘ืฆืข ื‘ื“ื™ืงืช ืžื— ืขืฆื ืœืฉืœื™ืœืช ืœื•ืงืžื™ื” ื•ื›ื• .ื’... .ื“

?ืžื”ื™ ืžื—ืœืช ื‘ืจื ืจื“ ืกื•ืœื™ื™ื”)192a3bื—ืกืจ ืงื•ืžืคืœืงืก .ื1b5,9ื—ืกืจ ืงื•ืžืคืœืงืก .ื‘VWFื—ืกืจ .ื’10ื—ืกืจ ืคืงื˜ื•ืจ .ื“

?ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ื–ื™ื”ื•ื ื—ื™ื™ื“ืงื™ ืฉืœ ืžื ื•ืช ื“ื)20ื‘ื“ื™ืงื”ื ื™ืชืŸ ืœืžื ื™ืขื” ืขืœ ื™ื“ื™ .ืื ื™ืชืŸ ืœืžื ื™ืขื” ืขืœ ื™ื“ื™ ื ื™ื˜ืจื•ืœ ืžืจื›ื™ื‘ื™ ื“ื .ื‘ืžื”ื•ื•ื” ื‘ืขื™ื” ื‘ืขื™ืงืจ ื‘ืžื ื•ืช ืฉืœ ื˜ืกื™ื•ืช .ื’ืžื”ื•ื•ื” ื’ื•ืจื ืฉื›ื™ื— ื‘ืชืžื•ืชื” ืžืžื ื•ืช ื“ื ื‘ืจืคื•ืื” ื”ืžื•ื“ืจื ื™ืช .ื“...ืฉื™ืœื•ื‘ื™ื ืฉื•ื ื™ื .ื”

?ืžื” ื’ื•ืจื ืœืžื—ืœืช ื”ืฉืชืœ ื›ื ื’ื“ ื”ืžืื›ืกืŸ)21T cell .ืืžืืงืจื•ืคืื’ื™ื .ื‘B cell .ื’ืืจื™ืชืจื•ืฆื™ื˜ื™ื .ื“

?ืžื” ืžืืคื™ื™ืŸ ื˜ืœืกืžื™ื”)22ืกืคืจื•ืฆื™ื˜ื•ื–ื™ืก .ืืชืื™ ืžื˜ืจื” .ื‘ืžื™ื”ื”ื™ืคื•ื›ืจื• .ื’ืฉื™ืœื•ื‘ื™ื ืฉื•ื ื™ื .ื“

Page 66: As you wish

66

ืžืžื” , Reed Sternbergื‘ื‘ื™ื•ืคืกื™ื” ื ืชื’ืœื• ืชืื™ . ื”ื’ื™ืข ืขื ื”ื’ื“ืœืช ื‘ืœื•ื˜ื•ืช ืœื™ืžืคื” 20ื—ื•ืœื” ื‘ืŸ )23?ื”ื•ื ืกื•ื‘ืœ

NHL .ืHL .ื‘CML .ื’ALL .ื“

? NHL -ืœ HLืžื” ื ื›ื•ืŸ ื‘ื”ืฉื•ื•ืื” ื‘ื™ืŸ )24Reed Sternbergื ื™ืชืŸ ืœืจืื•ืช ืชืื™ NHLื‘ .ืื ื™ืชืŸ ืœืจืื•ืช ืื™ื—ื•ื™ ื‘ืœื•ื˜ื•ืช ืœื™ืžืคื” HL -ื‘ .ื‘ื‘ื™ืคืŸ NHL - ื™ื•ืชืจ ืฉื›ื™ื— ื‘ HL .ื’.ื”ื•ื ื”ืžืขื™ HL -ืื—ื“ ื”ืื™ื‘ืจื™ื ื”ื‘ื•ื“ื“ื™ื ืฉื ืคื’ืขื™ื ื‘ .ื“

ื›ืจื’ืข . ื‘ืขื‘ืจ ื”ื™ื• ื“ื™ืžื•ืžื™ื ืžื•ื’ื‘ืจื™ื ื‘ืžื—ื–ื•ืจ. ื—ื•ืœืฉื”, ืื™ืฉื” ื‘ื”ืจื™ื•ืŸ ืžืชืœื•ื ื ืช ืขืœ ื›ืื‘ ืจืืฉ )25:ื”ื˜ื™ืคื•ืœ. ื•ืชืื™ื ืžืืงืจื•ืฆื™ื˜ื™ื Hgb 9 - ื‘ื‘ื“ื™ืงื”. ืžืงื‘ืœืช ืชื•ืกืคื™ ื‘ืจื–ืœ

ื—ืกืจ ื‘ืจื–ืœ ื•ืœื›ืŸ ืฆืจื™ืš ืœื”ื•ืกื™ืฃ ืขื•ื“ .ืื—ืกืจ ื‘ื—ื•ืžืฆื” ืคื•ืœื™ืช ื‘ืฉืœ ืฆืจื™ื›ื” ืžื•ื’ื‘ืจืช .ื‘ืื™ืŸ ื˜ื™ืคื•ืœ - ื“ื—ืกืจ ื“ื ืžื•ืœ .ื’... .ื“

)***Heparin induced Thrombocytopenia( HIT -ื‘)26ื™ืฉ ืœื”ื’ื‘ื™ืจ ืืช ืžืชืŸ ื”ื”ืคืจื™ืŸ ืขืœ ืžื ืช ืœื”ืชื’ื‘ืจ .ืื–ื” ืจืง ืžืขื‘ื“ืชื™ ื•ืื™ืŸ ืžืฉืžืขื•ืช ืงืœื™ื ื™ืช .ื‘ื ื’ืจื ืขืงื‘ ื™ืฆื™ืจืช ื ื•ื’ื“ื ื™ื ื›ื ื’ื“ ื˜ืกื™ื•ืช .ื’ื–ืžืŸ ื“ื™ืžื•ื ื™ืชืืจืš ื›ื™ ื™ืฉ ื ื•ื’ื“ื ื™ื ื ื’ื“ ื”ื˜ืกื™ื•ืช .ื“

ื•ื ืœื™ ื‘ืฉืชืŸ ื•ืกื™ื ื•ืŸ ืชืื™ื ื ื•ื’ื“ืŸ ืžื•ื ื•ืงืœ, ืขื ืœื–ื™ื•ืช ืœื™ื˜ื™ื•ืช ื‘ืขืฆืžื•ืช 70ื—ื•ืœื” ื‘ืŸ )27:ื›ื ืจืื” ืกื•ื‘ืœ ืž. ืœื™ืžืคื•ืคืœื–ืžืชื™ื ื‘ืžื— ืขืฆื

CLL .ืCML .ื‘Multiple Meyloma .ื’NHL .ื“

?ื›ื™ืฆื“ ืชื˜ืคืœ ื‘ื—ื•ืœื” ื–ื”)28ืชืœื™ื“ื•ืžื™ื“ .ืVAC .ื‘ื”ืฉืชืœืช ืžื— ืขืฆื .ื’ืื™ื ื˜ืจืคืจื•ืŸ .ื“

?ืžื” ืžื”ื‘ืื™ื ืžืชืื™ื)29-Burkitt Lymphoma .ื Malaria-ALL .ื‘ Blast CrisisWalderstorm- CLL .ื’โ€“ Nodular lymphocyte predominant HLื”ื™ืคืจืคืœื–ื™ื” ื‘ื—ื ื™ื›ื™ื™ื .ื“-Lymphoplasmatic lymphoma .ื” DIC

Page 67: As you wish

67

?In Vivoื›ื™ืฆื“ ืชื‘ืฆืข ื‘ื“ื™ืงืช ืชืคืงื•ื“ ื˜ืกื™ื•ืช )30ADPืžื‘ื—ืŸ .ืืžื‘ื—ืŸ ืืœืงื˜ืจื•ืคื•ืจื–ื™ืก .ื‘ื–ืžืŸ ื“ื™ืžื•ื .ื’

MDSืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ )31ื”ื™ื ืชื•ืฆืื” ืฉืœ ืœื•ืงืžื™ื” ื—ืจื™ืคื” MDS .ืื”ื˜ื™ืคื•ืœ ื”ืงื•ืจื˜ื™ื‘ื™ ื”ื™ื—ื™ื“ ื”ื•ื ื”ืฉืชืœืช ืžื— ืขืฆื .ื‘ืžื ื‘ืื™ื ืคืจื•ื’ื ื•ื–ื” ื’ืจื•ืขื”ืฉื™ื ื•ื™ื™ื ื›ืจื•ืžื•ื–ื•ืžืœื™ื™ื .ื’... .ื“

Polycytemia Vera -ืžื”ื• ืคืงื˜ื•ืจ ืื‘ื—ื•ื ื™ ืœ)32ื’ื‘ื•ื” HTK .ืื”ืžื•ื’ืœื•ื‘ื™ืŸ ื’ื‘ื•ื” .ื‘ื”ื™ืคื•ืงืกื™ื” .ื’ื ื’ื‘ื•ื”ื”"ืžืกืช ืชื“ .ื“ืืจื™ืชืจื•ืžืœืœื’ื™ื” .ื”

?ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ืื ืžื™ื” ื”ืžื•ืœื˜ื™ืช ืื•ื˜ื•ืื™ืžื•ื ื™ืช)33ื—ื™ื•ื‘ื™ DATืžื‘ื—ืŸ .ืื™ืจื™ื“ื” ื‘ืจื˜ื™ืงื•ืœื•ืฆื™ื˜ื™ื ื‘ืฉืœ ื‘ืขื™ื” ื‘ืžื— ื”ืขืฆื .ื‘ Ag-Abืื™ื ื” ืžื—ื™ื™ื‘ืช ืงื™ืฉื•ืจ .ื’... .ื“

)ืฉื™ืœื•ื‘ื™ื(? Hemolitic disease of the newbornืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ )34-Rhืจืง ื‘ื ืฉื™ื .ืืจืง ื ืฉื™ื ืฉืงื™ื‘ืœื• ืขื™ืจื•ื™ื™ ื“ื .ื‘ื”ื ื•ื’ื“ืŸ ืื™ื ื• ืžื ื‘ื ื“ืจื’ืช ืคื’ื™ืขื” .ื’Anti Rh Abื‘ืื™ืฉื” ืขืœ ื™ื“ื™ ืžืชืŸ Anti Dื ื™ืชืŸ ืœื“ื›ื ื™ื™ืฆื•ืจ ื ื•ื’ื“ื ื™ .ื“

?Aืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ื”ืžื•ืคื™ืœื™ื” )35ืœื‘ื ื™ื” 50% -ืžื•ืขื‘ืจ ืขืœ ื™ื“ื™ ืื ื ืฉืื™ืช ื‘ .ืืžื•ืœื“ ื‘ืคืงื˜ื•ืจ ืงืจื™ืฉื”ืžื—ืœื” ืฉืœ ื—ืกืจ .ื‘ื™ ืžืชืŸ ื”ืคืงื˜ื•ืจ ื”ื—ืกืจ"ื ื™ืชืŸ ืœื˜ืคืœ ืข .ื’ื—ืกืจ ื‘ืคืงื˜ื•ืจ ืฉืžื•ื ื” .ื“ื›ืœ ื”ืชืฉื•ื‘ื•ืช ื ื›ื•ื ื•ืช .ื”

?Cloneืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ื”ื”ื’ื“ืจื” ืฉืœ )36ืฉื ื™ ืชืื™ื ื•ืžืขืœื” ืขื ืื•ืชื• ืฉื™ื ื•ื™ ื›ืจื•ืžื•ื–ื•ืžืœื™ .ืืชืื™ื ืขื ืฉื™ื ื•ื™ื™ื ื›ืจื•ืžื•ื–ื•ืžืœื™ื™ื ืฉื•ื ื™ื' ืžืก .ื‘ื›ืฉืžืกืคืจ ืชืื™ื ื”ื ื‘ืขืœื™ ืื•ืชื• ืฉื™ื ื•ื™ ื›ืจื•ืžื•ื–ื•ืžืœื™ Cloneืื™ืŸ ื”ื’ื“ืจื” ืฉืœ .ื’

?ืžื” ื”ืื‘ื—ื ื”. Superior Vena Cava Syndromeื’ื•ืฉ ืžื“ื™ืืกื˜ื™ื ืœื™ ืœื•ื—ืฅ ื•ื’ื•ืจื ืœ . 25ืช ื‘)37HL .ืNHL .ื‘ื˜ื™ื™ืจื•ื“ื™ื˜ื™ืก .ื’ื–ื™ื”ื•ื ื•ื™ืจืืœื™ .ื“

Page 68: As you wish

68

?ื›ื™ืฆื“ ื™ืฉ ืœื˜ืคืœ ื‘ื”)38MOPP+ืงืจื™ื ื” .ืABVD+ืงืจื™ื ื” .ื‘ื‘ืœื‘ื“ MOPP .ื’ื‘ืœื‘ื“ ABVD .ื“

?ื‘ื•ื’ืจ ืœืขื•ืžืช ืฆืขื™ืจ RBCืžื” ืžืืคื™ื™ืŸ )39ื”ื‘ื•ื’ืจ ื‘ืฆื•ืจืช ื“ื™ืกืงื™ืช .ืื”ื‘ื•ื’ืจ ืงืฉื™ื— ื™ื•ืชืจ .ื‘ื ืžื•ืš ื™ื•ืชืจ ื‘ื‘ื•ื’ืจ HbA1c .ื’ื”ืžื˜ืขืŸ ื”ื—ืฉืžืœื™ ืขืœ ืคื ื™ ื”ืชื ื”ื‘ื•ื’ืจ ืคื—ื•ืช ืฉืœื™ืœื™ .ื“

?ืจื“ื™ืื•ืืงื˜ื™ื‘ื™ Crome -ื‘ RBCืžื” ืœื ื ื›ื•ืŸ ืœื’ื‘ื™ ืกื™ืžื•ืŸ )40ื ืงืฉืจ ืœืื•ื›ืœื•ืกื™ืช ืชืื™ื ื‘ื›ืœ ื”ื’ื™ืœืื™ื .ืื”ื›ืจื•ื ืžืฉืชื—ืจืจ ืžืขื˜ ื‘ืื•ืคืŸ ื˜ื‘ืขื™ ืžื”ืืจื™ืชืจื•ืฆื™ื˜ื™ื .ื‘ื”ื›ืจื•ื ื”ืžืฉืชื—ืจืจ ืœืื—ืจ ื”ืจืก ื”ืชื ืžืชื—ื‘ืจ ืฉื•ื‘ ืœืชื ื—ื“ืฉ .ื’... .ื“

?ืžื” ืœื ื ื›ื•ืŸ)41ื‘ืžื›ืฉื™ืจ ืกืคื™ืจื” ื—ืฉืžืœื™ Hyperglycemiaืœื”ืขื™ื“ ืขืœ ื ืžื•ืš ื™ื›ื•ืœ MCV .ืื‘ืžื›ืฉื™ืจ ื”ืื•ืคื˜ื™ Hbื”ื™ืคืจืœื™ืคื™ื“ืžื™ื” ื™ื›ื•ืœื” ืœืฉื ื•ืช ืจืžื•ืช .ื‘-Cold .ื’ Agglutinins ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื•ืคื ื™ื” -ื™ื›ื•ืœื™ื ืœื’ืจื•ื ืœืคืกืื•ื“ื•ื™ืฉ ืœื˜ืคืœ ื‘ืื•ืคืŸ ืžื™ื™ื“ื™ โ€“ EDTA induced Thrombocytopenia .ื“

?ืžื” ืœื ื ื›ื•ืŸ ืœื’ื‘ื™ ื‘ื“ื™ืงืช ื”ื“ื ื”ืื•ื˜ื•ืžื˜ื™ืช)42ืกื•ืคืจ ื”ื•ื ืฉื”ืžื•ืœื™ื›ื•ืช ืฉืœ ืชื ื“ื ื–ื”ื” ืœืžื™ืกื” ื‘ื” ื”ื•ื ื”ืขื™ืงืจื•ืŸ ืขืœ ืคื™ื• ืคื•ืขืœ ื” .ื

ื ืžืฆืืœืคื™ ืžื‘ื ื ื”ืคื ื™ืžื™ ื•ื”ืžื•ืจื›ื‘ื•ืช ืฉืœื”ื WBCื‘ื•ื“ืง .ื‘ื ืžื“ื“ ื‘ืขืจื•ืฅ ืื—ืจ ืœืคื™ ืขื›ื™ืจื•ืช ืื•ืคื˜ื™ืช Hb .ื’Electric Impedance -ืคื™ื–ื•ืจ ืื•ืจ ื• -ืฉื™ื˜ื•ืช 2 -ื‘ RBCื ื™ืชืŸ ืœื‘ื“ื•ืง .ื“

?ืžื™ ืกื‘ื™ืจ ืฉื™ืžืฆื ื‘ื›ืžื•ืช ื ืžื•ื›ื” ื‘ืžื— ื”ืขืฆื)43ืืจื™ืชืจื•ื‘ืœืกื˜ ื‘ืื–ื•ืคื™ืœื™ .ืืืกื™ื“ื•ืคื™ืœื™ืืจื™ืชืจื•ื‘ืœืืกื˜ .ื‘ืจื˜ื™ืงื•ืœื•ืฆื™ื˜ .ื’ืคืจื•ืžื™ืืœื•ืฆื™ื˜ .ื“ืืจื™ืชืจื•ื‘ืœืืกื˜ ืคื•ืœื™ื›ืจื•ืžื˜ื•ืคื™ืœื™ .ื”

ืœืœื ืื ืžื™ื” ื•ืœืœื , ืžื’ื™ืขื” ื‘ื—ื•ืจื” ืœืœื ืื™ืจื•ืขื™ื ืงื•ื“ืžื™ื ืขื ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื•ื–ื™ืก)44ืขื ืคื˜ืจื™ื•ืช ื‘ื›ืคื•ืช ื”ืจื’ืœื™ื™ื. ืœื•ื™ืงื•ืฆื™ื˜ื•ื–ื™ืก

ื™ืฉ ืœืชืช ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื™ื .ืืœื›ืŸ ื ื™ืชืŸ ืกื˜ืจื•ืื™ื“ื™ื ITPื–ื” .ื‘ืœื”ืชื—ื™ืœ ื›ื™ืžื•ืชืจืคื™ื” ืžื™ื™ื“ื™ืช .ื’ืงื” ื•ืœื›ืŸ ืœื‘ืฆืข ื‘ื“ื™ืงื” ื ื•ืกืคืช ืฉื‘ื•ืขื™ื™ื ืœืื—ืจ ืžื›ืŸื™ืฉ ืœื”ื ื™ื— ื›ื™ ื™ืฉ ื˜ืขื•ืช ื‘ื‘ื“ื™ .ื“

Page 69: As you wish

69

?)ื”ื™ืจื™ื“ื” ื”ื›ื™ ืคื—ื•ืชื” ื‘ื™ื™ืฆื•ืจ ื‘ืจืงืžื” ื–ื•(ืžื” ื”ืจืงืžื” ื”ืื—ืจื•ื ื” ื”ืžื™ื™ืฆืจืช ื“ื ื‘ื‘ื•ื’ืจ )45ืกื˜ืจื ื•ื .ืืฆืœืขื•ืช .ื‘ื™ืจืš .ื’ืžืคืจืงื™ื ื•ื—ื•ืœื™ื•ืช .ื“

46(Demarcation vesicles ืงื™ื™ืžื™ื ื‘-ืžื•ื ื•ืฆื™ื˜ื™ื .ืื ื•ื™ื˜ืจื•ืคื™ืœื™ื .ื‘ืžื’ืงืจื™ื•ืฆื™ื˜ื™ื ื‘ื•ื’ืจื™ื .ื’ืžื™ื•ืœื•ืฆื™ื˜ื™ื .ื“

?ืžื” ื‘ื•ื“ืง ืžืขืจื›ืช ืื™ื˜ืจื™ื ืกื™ืช)47PT .ืPTT .ื‘ื–ืžืŸ ื“ื™ืžื•ื .ื’ืคืขื™ืœื•ืช ื˜ืกื™ื•ืช .ื“

? Aืžื” ื”ื˜ื™ืคื•ืœ ื‘ื”ืžื•ืคื™ืœื™ื” )48

?ื›ื™ืฆื“ ื ื™ืชืŸ ืœื”ื‘ื“ื™ืœ ื‘ื™ืŸ ื”ืžื•ืคื™ืœื™ื” ื ืจื›ืฉืช ื•ื’ื ื˜ื™ืช)49

ืžื˜ื•ืคืœ ื‘ื‘ื™ื˜ื ืœืงื˜ื ื ื’ื“ ืคืกื™ืื•ื“ื•ืžื•ื ืก , ื—ื•ื, 500ื ื•ื™ื˜ืจื•ืคื™ืœื™ื , ืžืืฉืคื– ืœืื—ืจ ื›ื™ืžื•ืชืจืคื™ื”)50ืžื” . ื™ืฉ ืื•ื“ื ื‘ืื™ื–ื•ืจ ื”ืงื˜ื˜ืจ ื”ืžืจื›ื–ื™. ื•ื›ืŸ ื‘ืืžื™ื ื•ื’ืœื™ืงื•ื–ื™ื“ ื•ืœืžืจื•ืช ื–ืืช ื”ื—ื•ื ื ืžืฉืš

?ื”ื˜ื™ืคื•ืœื”ืžืฉืš ื”ื•ืกืคืช ื•ื ืงื•ืžื™ืฆื™ืŸ .ืื”ื•ืฆืืช ื”ืงื˜ื˜ืจ ื•ื”ื•ืกืคืช ื•ื ืงื•ืžื™ืฆื™ืŸ .ื‘ื”ื•ืฆืืช ื”ืงื˜ื˜ืจ ื•ื”ืžืฉืš ื”ื˜ื™ืคื•ืœ ื”ื ื•ื›ื—ื™ .ื’.ื•ื ืงื•ืžื™ืฆื™ืŸ ื•ืืžื™ื ื•ื’ืœื™ืงื•ื–ื™ื“ื™ื, ืœื”ื—ืœื™ืฃ ื˜ื™ืคื•ืœ ืœืงื•ื•ื™ื ื•ืœื•ื ื™ื .ื“

ืžื” ื”ื˜ื™ืคื•ืœ . Hb=9. ืžืฆื‘ ื›ืœืœื™ ื˜ื•ื‘, 30000ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื™ื , 500ื—ื•ืœื” ืขื ื ื•ื™ื˜ืจื•ืคื™ืœื™ื )51?ื”ืจืืฉื•ื ื™

ืžืชืŸ ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื™ื .ืืจื—ื‘ืช ื˜ื•ื•ื— ืžืชืŸ ืื ื˜ื™ื‘ื™ื•ื˜ื™ืงื” .ื‘ืžืขืงื‘ ื‘ืœื‘ื“ .ื’ืขื™ืจื•ื™ื™ ื’ืจื ื•ืœื•ืฆื™ื˜ื™ื .ื“

)ื›ืœ ื”ืฉืืจ ืชืงื™ืŸ(ื˜ืกื™ื•ืช ื ืžื•ื›ื•ืช ืžืื•ื“ , 18ื‘ืช )52ื™ืฉ ืœืชืช ื˜ืกื™ื•ืช .ืื™ืฉ ืœื˜ืคืœ ื‘ืกื˜ืจื•ืื™ื“ื™ื .ื‘ืœืชืช ืคืœื–ืžื” .ื’

53(Palatine Tonsils- ืžื” ืžืืคื™ื™ืŸ?GSืจืงืžื” ืœื™ืžืคื•ืื™ื“ื™ืช ืœื ืžืกื•ื“ืจืช ื—ืกืจืช .ืืžืกื ื ื™ื ืœื™ืžืคื” ื”ืžื’ื™ืขื” ืžื›ืœื™ ืœื™ืžืคื” ืจื‘ื™ื .ื‘ืœื ืžืงื•ืจืŸืžื›ื•ืกื™ื ืืคื™ืชืœ ืžืกื•ื’ ืฉื˜ื•ื— ืจื‘ ืฉื›ื‘ืชื™ .ื’ื”ื›ืœ ื ื›ื•ืŸ .ื“

Page 70: As you wish

70

?ื‘ืื™ื–ื” ืฉืœื‘ ืื™ืŸ ืคืขื™ืœื•ืช ืžื™ื˜ื•ื˜ื™ืช)54ืืจื™ื˜ืจื•ื‘ืœืกื˜ ื‘ื–ื•ืคื™ืœื™ .ืืืจื™ื˜ืจื•ื‘ืœืกื˜ ืืกื™ื“ื•ืคื™ืœื™ .ื‘ืืจื™ืชืจื•ื‘ืœืกื˜ ืคื•ืœื™ื›ืจื•ืžื˜ื•ืคื™ืœื™ .ื’ืžื˜ืžื™ื•ืœื•ืฆื™ื˜ ืจืืฉื•ื ื™ .ื“ืžื™ืœื•ืฆื™ื˜ .ื”ืคืจื•ืžื™ืœื•ืฆื™ื˜ .ื•

?ืžื“ื•ืข ืขื•ืฉื™ื ืฆื™ื˜ื•ืœื•ื’ื™ื” ืœืื ืžื™ื” ืืคืœืกื˜ื™ืช)55ืœื•ื•ื“ื ืฉืื™ืŸ ื–ื™ื”ื ืขืœ ื™ื“ื™ ื•ื•ื™ืจื•ืก .ืB12ืœืจืื•ืช ืื ื™ืฉ ื—ื•ืกืจ .ื‘ืื• ืœื•ืงืžื™ื” MDSืœืฉืœื•ืœ ืžืฆื‘ ืฉืœ .ื’ืฆืจื™ืš ืœืขืฉื•ืช ืจืง ื“ื ืคืจื™ืคืจื™ ื•ืœื ืžื— ืขืฆื .ื“

?+CD5ืขื Bื‘ืื™ื–ื” ืžื”ื‘ืื™ื ื™ืฉ ืชืื™ )56Mantle Cell Lymphoma .ืFollicular cell lymphoma .ื‘Diffuse large B cell .ื’

?ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ืงืœื•ื ืœื™ื•ืช)57ืชืื™ื ืื• ื™ื•ืชืจ ืฉืžื›ื™ืœื™ื ืื•ืชื ืฉื™ื ื•ื™ื™ื ื’ื ื˜ื™ื™ื 2ืื ื™ืฉ .ืืื ื™ืฉ ืชืื™ื ืจื‘ื™ื ืขื ืฉื™ื ื•ื™ื™ื ืฉื•ื ื™ื .ื‘ืœื ืงืœื•ื ืœื™ -ื™ืฉ ืชืื™ื ืขื ืื•ืชื ืฉื™ื ื•ื™ื™ื ืื .ื’

?ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ืžืžืฆื ืจืืฉื•ื ื™)58

?ืžื” ืžื™ื•ืฆืจ ื‘ื’ืœื™ืงื•ืœื™ื–ื”)59DPG,2,3 .ืNADH .ื‘NAD .ื’ื’ืœื•ืงื•ื– .ื“

?ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ื–ื™ื”ื•ื ืžื ื•ืช ื“ื ื‘ื—ื™ื™ื“ืงื™ื)60ื™ื›ื•ืœ ืœื”ืจื•ื’ ืืช ื”ืžืงื‘ืœ .ืืืคืฉืจ ืœืžื ื•ืข ืขืœ ื™ื“ื™ ืื™ื ืืงื˜ื™ื‘ืฆื™ื” ืฉืœ ืžืจื›ื™ื‘ื™ ื“ื .ื‘ื‘ืขื™ื™ืชื™ ื‘ืขื™ืงืจ ื‘ื˜ืกื™ื•ืช .ื’ื‘ืจืคื•ืื” ื”ืžื•ื“ืจื ื™ืชืื™ื ื• ืžื”ื•ื•ื” ื‘ืขื™ื” ืžืฉืžืขื•ืชื™ืช .ื“

?ืœืžื” ื™ืฉ ืคื•ืœื™ืคืœื•ืื™ื“ื™ื•ืช ื‘ืžื’ืงืจื™ื•ืฆื™ื˜ื™ื)61ืจื™ื‘ื•ื™ ืฆื ื˜ืจื™ื•ืœื™ื .ืื‘ืขื™ื” ื‘ืฆื ื˜ืจื•ืžืจื™ื - ื›ื™ืฉื•ืจ ืœื ืžืชื—ื‘ืจ ืœื›ืจื•ืžื•ื–ื•ืžื™ื .ื‘ื’ืจืขื™ื ื™ื ืžืชืื—ื™ื ืœืื—ืจ ืฉื ื•ืฆืจื™ื .ื’1+2 .ื“ื›ืœ ื”ืชืฉื•ื‘ื•ืช .ื”

)ืžืฉื•ื—ื–ืจ(ืื™ืš ืžืื‘ื—ื ื™ื ืžื™ืืœื•ืžื” )62

Page 71: As you wish

71

? ืžื” ื”ืกื™ื›ื•ื ื™ื ื‘ืคื•ืœื™ืฆื™ื˜ืžื™ื” ื•ืจื”)63ALL -ื”ื•ืคื›ื™ื ืœ .ืื ื˜ื™ื” ืœืงืจื™ืฉื™ื•ืช .ื‘ื›ื™ืžื•ื˜ืจืคื™ื” -ื˜ื™ืคื•ืœ ืขื™ืงืจื™ .ื’ืคื•ืœื™ืฆื™ื˜ืžื™ื” ืžืฉื ื™ืช ืœื‘ืขื™ื” ืจื™ืืชื™ืช ืžื˜ื•ืคืœืช ื‘ื ื•ื–ืœื™ื .ื“

- ื’ื•ืจื ืœ (11,18) -ื˜ืจื ืกืœื•ืงืฆื™ื”)64C-myc .ืBcr-abl .ื‘MALT1 .ื’Bcl2 .ื“CD10 .ื”

?ืžื” ื ื›ื•ืŸ ื‘ืื ืžื™ื” ื”ืžื•ืœื™ื˜ื™ืช)65RBCืื‘ื—ื ื” ืœื ืžื—ื™ื™ื‘ืช ื”ื•ืคืขืช ื ื•ื’ื“ืŸ ืขืœ .ืื”ื™ืคื•-ืื ืžื™ื” ื”ืžื•ืœื™ื˜ื™ืช ื”ื™ื ืื ืžื™ื” ืžื™ืงืจื• .ื‘ื—ื™ื•ื‘ื™ DATื™ืฉ .ื’ืžืขืœื•ืช 4 -ื ืงืฉืจ ื‘ UgGื ื•ื’ื“ืŸ .ื“ืื™ืŸ ืจื˜ื™ืงื•ืœื•ืฆื™ื˜ื•ื–ื™ืก .ื”

ื‘ืžื— ืขืฆื , ื‘ื“ื ืคืจื™ืคืจื™ ืจื™ื‘ื•ื™ ื‘ืœืืกื˜ื™ื. ื™ืœื“ ื”ืชืงื‘ืœ ืขื ื“ืœืงืช ืžื•ื’ืœืชื™ืช ื‘ืื•ื–ืŸ ื”ืฆื™ื›ื•ื ื”)66?ืžื” ื ื›ื•ืŸ, CD10 ,tdt -ื‘ืœืกื˜ื™ื ื ืฆื‘ืขื• ื—ื™ื•ื‘ื™ ืœ

ื“ืœืงืช ื‘ืื•ื–ืŸ ื ื’ืจืžื” ืขืงื‘ ืžื—ืกื•ืจ ื‘ืื™ืžื•ื ื•ื’ืœื•ื‘ื•ืœื™ื ื™ื .ืPro Pre Bื”ื‘ืœืืกื˜ื™ื ื”ื ืชืื™ื .ื‘T .ื’ Lymphoma

Page 72: As you wish

72

ื–"ืžื—ื–ื•ืจ ื›, 2002ืฉื—ื–ื•ืจ ื‘ื”ืžื˜ื•ืœื•ื’ื™ื”

.ืฉืืœื•ืช ื”ืชืืžื” 3ืฉืืœื•ืช ืžืชื•ื›ืŸ 85ื‘ืžื‘ื—ืŸ ื”ื•ืคื™ืขื• :ืฉืงื•ืคื™ื•ืช

1.Target cell ืื ืžื™ื” ื—ืจืžืฉื™ืช.23.AML 4.Multiple myeloma

:ื"ื‘ืชื”ืœื™ืš ื™ืฆื™ืจืช ื›ื“.1 ื™ืฆื™ืจืช ื”ืžื•ื’ืœื•ื‘ื™ืŸ: 'ื ืคืœื™ื˜ืช ื’ืจืขื™ืŸ: 'ื‘

'ื ื’ืžืจ ืื—ืจื™ ื‘' ื' ืžืชื—ื™ืœ ืœืคื ื™ ื‘' ื.1'ื ื’ืžืจ ืื—ืจื™ ื' ื‘' ืžืชื—ื™ืœ ืœืคื ื™ ื‘' ื.2'ื ื’ืžืจ ืื—ืจื™ ื' ื‘ ' ืžืชื—ื™ืœ ืœืคื ื™ ื' ื‘.3'ื ื’ืžืจ ืื—ืจื™ ื‘' ื' ืžืชื—ื™ืœ ืœืคื ื™ ื' ื‘.4'ื ื’ืžืจ ืื—ืจื™ ื‘' ืฉื ื™ื”ื ืžืชื—ื™ืœื™ื ื™ื—ื“ ื.5

? LMWH -ืžื” ืœื ื ื›ื•ืŸ ืœื’ื‘ื™ ื˜ื™ืคื•ืœ ื‘.2

.ืœื ืฆืจื™ืš ื ื™ื˜ื•ืจ ืžืฆื•ื“ ืฉืœ ื”ื—ื•ืœื”.1ื‘ื‘ื™ืช SCื ื™ืชืŸ ืœื”ื–ืจื™ืง .2ืžื•ืคืจืฉ ื‘ื›ืœื™ื”.3anti xaื‘ืžืงืจื™ื ืžื™ื•ื—ื“ื™ื ื ื™ืชืŸ ืœื‘ื“ื•ืง ืคืขื™ืœื•ืช .4Kืฉ ืœื˜ืคืœ ื‘ื•ื™ื˜ืžื™ืŸ ื‘ืžื™ื“ื” ื•ื”ื—ื•ืœื” ืžื“ืžื ื™.5

?ืื™ื–ื” ืจืงืžื” ื™ื•ืจื“ ื™ืฆื•ืจ ืชืื™ ื“ื ื‘ื‘ื•ื’ืจ.3

ืกื˜ืจื ื•ื.1ื™ืจืš.2ืฆืœืขื•ืช.3ื—ื•ืœื™ื•ืช.4

?ืžื” ืœื ืžืฉืคืจ ืกืคื™ื’ืช ื‘ืจื–ืœ.4

ื‘ืจื–ืœ ืจื‘ ื‘ืžื–ื•ืŸ.1ื’ื‘ื•ื” ืœื‘ืจื–ืœ ืื—ืจ HEME โ€“ื™ื—ืก ื‘ืจื–ืœ ืงืฉื•ืจ ืœ .23.pH ื ืžื•ืšืื•ืงืกืœื˜.4

?ืžื” ื’ื‘ื•ื” ื‘ืžื—ืœื”.5

ืคืจื™ื˜ื™ืŸ.1ื˜ืจื ืกืคืจื™ืŸ.2ื‘ืจื–ืœ ื‘ืกืจื•ื.3

?ืกื•ืœื™ื™ืจ ื•ืžื—ืœืช ื–ืœื ื–ืžืŸ โ€“ืžื—ืœื•ืช ื‘ืจื ืจื“ .6

ื‘ืจืฆืคื˜ื•ืจื™ื ืฉืงื•ืฉืจื™ื ื—ืœื‘ื•ื ื™ ืงืจื™ืฉื”ืคื’ืžื™ื .1.ื˜ืกื™ื•ืช ื’ื ืœืœื ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื•ืคื ื™ื”? -ื‘ื–ืžืŸ ื“ืžื•ื .2

Page 73: As you wish

73

CHOPื”ื™ื™ืชื” ื”ื™ืฉื ื•ืช ื”ืžื—ืœื” ืœืื—ืจ diffuse large cell NHL -ื‘ 40ื—ื•ืœื” ื‘ืŸ .7CHOP -ื™ืฉ ืœื”ืžืฉื™ืš ืœื˜ืคืœ ื‘.1VEEP ,DHAPื™ืฉ ืœื˜ืคืœ ื‘ื˜ื™ืคื•ืœ ืื’ืจืกื™ื‘ื™ ื™ื•ืชืจ .2.ื”ืฉืชืœืช ืžื™ื— ืขืฆื ืื•ื˜ื•ืœื•ื’ื™ื™ืฉ ืœื˜ืคืœ ื‘ื˜ื™ืคื•ืœ ืื’ืจืกื™ื‘ื™ ื•ืื ืชื•ืคื™ืข ื”ืจืžื™ืกื™ื” ื™ืฉ ืœืขืฉื•ืช .3ื™ืฉ ืœื”ืงืจื™ืŸ ืืช ื›ืœ ื”ืžืขืจื›ืช ื”ืœื™ืžืคื˜ื™ืช.4.ื˜ื™ืคื•ืœ ืชืจื•ืคืชื™ ื‘ืœื‘ื“.5

?ื”ื™ื›ืŸ ื™ืฉ ืกื™ื ื•ืกื™ื ืœื™ืžืคื˜ื™ื™ื.8

ื›ืœื™ ืœื™ืžืคื”.1ื˜ื™ืžื•ืก.2ื˜ื—ื•ืœ.34.1+2ื”ื›ืœ ื ื›ื•ืŸ.5

ื”ืชืื™ื ื”ืืคื™ืชืœื•ืจื˜ื™ืงื•ืœืจื™ื™ื ื‘ื˜ื™ืžื•ืก.9

ืžืงื•ืจื ื‘ื›ื™ืก ื”ืคืจื™ื ื’ื™ืืœื™ ื”ืฉืœื™ืฉื™.1ืชืคืงื™ื“ ืื ื“ื•ืงืจื™ื ื™.2ืžืคืจื™ืฉื™ื ืกื™ื‘ื™ื ืจื˜ื™ืงื•ืœืจื™ื™ื.34.1+2ื”ื›ืœ ื ื›ื•ืŸ.5

10.denarcation ves. ื™ืฉ ื‘โ€“

ืžื•ื ื•ืฆื™ื˜ื™ื.1ื ื•ื™ื˜ืจื•ืคื™ืœื™ื.2ืžื’ืงืจื™ื•ืฆื™ื˜ื™ื ื‘ื•ื’ืจื™ื.3ืžื™ื•ืœื•ืฆื™ื˜ื™ื.4

ื–ืžืŸ ื“ื™ืžื•ื ืืจื•ืš. 1: ืกืžืŸ .11

ื–ืžืŸ ื“ื™ืžื•ื ืœื ืืจื•ืš. 2 VWFื—ื•ืกืจ ___.1Aื”ืžื•ืคื™ืœื™ื” ___.2Bื”ืžื•ืคื™ืœื™ื” ___.3 11ื—ื•ืกืจ ืคืงื˜ื•ืจ ___.4Cื—ืกืจ ื—ืœื‘ื•ืŸ ___.5ื—ืกืจ ื‘ืจื–ืœ___.6WARFARINืžืชืŸ ___.7ืœืื—ืจ ืžืชืŸ ื”ืคืจื™ืŸืฉืขื•ืช 8-24___.8

? CMLืœื’ื‘ื™ ] PH[ืžื” ืื•ืžืจืช ื ื•ื›ื—ื•ืช ื›ืจื•ืžื•ื–ื•ื ืคื™ืœื“ืœืคื™ื” .12

1.PH + ื™ื•ืชืจ ื˜ื•ื‘ ืžโ€“ PH-.2.PH- ื™ื•ืชืจ ื˜ื•ื‘ ืž- PH.+.PHืื™ืŸ ืžืฉืžืขื•ืช ืœื ื•ื›ื—ื•ืช ืื• ืœื—ืกืจ ืฉืœ .34.CML ืžื—ืœื” ื ื“ื™ืจื” ืื™ืŸ ืœื›ืš ืžืฉืžืขื•ืช.

?ื›ื™ืฆื“ ืžื‘ื—ื™ื ื™ื ื‘ื™ืŸ ื”ืžื•ืคื™ืœื™ื” ื ืจื›ืฉืช ืœื’ื ื˜ื™ืช.13

7ืžื“ื™ื“ืช ืคืงื˜ื•ืจ .19ืžื“ื™ื“ืช ืคืงื˜ื•ืจ .23.Mixing test โ€“ ืขืจื‘ื•ื‘ ืขื ืคืœืกืžื” ืฉืœ ืื“ื ื‘ืจื™ืื˜ื™ื˜ืจ ื ื•ื’ื“ื ื™ื.4Recombinant factorืœื‘ื“ื•ืง .5

Page 74: As you wish

74

?ื ื›ื•ืŸ ืœืืžื” โ€“ื”ื‘ื“ืœ ื‘ื™ืŸ ืชื ื“ื ืื“ื•ื ื–ืงืŸ ืœืฆืขื™ืจ .14

ื‘ืชื ื”ื–ืงืŸ ื™ืฉ ืคื—ื•ืช ืžื™ื.1ื‘ืชื ื”ื–ืงืŸ ืคืขื™ืœื•ืช ืžื˜ื‘ื•ืœื™ืช ืžื•ืคื—ืชืช.2ื’ื‘ื•ื” ื™ื•ืชืจ HbA1Cืจืžืช .3]ืคื—ื•ืช ืขื’ื•ืœ[ื”ืชื ื”ื‘ื•ื’ืจ ื”ื•ืคืš ืœืงื•ืฆื ื™ .4.ื”ืชื ื”ื‘ื•ื’ืจ ืงืฉื™ื— ื™ื•ืชืจ.5

? Kืžื”ื ื”ืคืงื˜ื•ืจื™ื ื”ื—ืœื‘ื•ื ื™ื™ื ื”ืžื•ืฉืคืขื™ื ืžื•ื™ื˜ืžื™ืŸ . 15

-ืžืื•ืคื™ื™ื ืช ื‘ืกื™ืžื ื™ื ื”ื‘ืื™ื ืคืจื˜ ืœ Aื”ืžื•ืคื™ืœื™ื” .16

8ื—ืกืจ ืคืงื˜ื•ืจ .1X โ€“ืชื•ืจืฉื” ื‘ืชืื—ื™ื–ื” ืœ .2ื“ื™ืžื•ื ืขืœ ืคื ื™ ื”ืขื•ืจ ื•ื”ืจื™ืจื™ื•ืช.3ื‘ื–ื›ืจื™ื ื™ื•ืชืจ ืžื‘ื ืงื‘ื•ืช.4.8ื”ื˜ื™ืคื•ืœ ื”ื•ื ื”ืฉืœืžืช ืคืงื˜ื•ืจ .5

?ืื™ื–ื” ื–ื™ื”ื•ื ื”ื•ื ื”ืงืฉื” ื‘ื™ื•ืชืจ ื‘ื”ืฉืชืœืช ืžื— ืขืฆื ืืœื•ื’ื ืื™ืช. 17 1.CMV2.EBV3.Herpes4.Adeno virusื›ื•ืœื.5

?C (protein c)ืžื” ืชืคืงื™ื“ื• ืฉืœ ื—ืœื‘ื•ืŸ . 18

.ื”ืคื™ื‘ืจื™ื ื•ืœื™ื˜ื™ืช' ืฉืคืขื•ืœ ื”ืžืข.1.VIII-ื• Vื ื™ื˜ืจื•ืœ ืคืงื˜ื•ืจื™ ื”ืงืจื™ืฉื” .2.ื•ื˜ืจื•ืžื‘ื•ืžื“ื•ืœื™ืŸ ATIIIื ื™ื˜ืจื•ืœ .3.X-ื• Vื ื™ื˜ืจื•ืœ ืคืงื˜ื•ืจื™ ื”ืงืจื™ืฉื” .4

BAYERืฉ "ื ื‘ื“ืง ื‘ืฉื™ื˜ืช ื”ืคืจื“ื” ืข) ื‘ืœืกื˜ื™ื 95%(ืขื ืœื•ืงืžื™ื” ื‘ืœืกื˜ื™ืช ื—ืจื™ืคื” 30ืื“ื ื‘ืŸ . 19

?ืื™ื–ื” ืžื”ืชืื™ื ื”ื‘ืื™ื ื™ื”ื™ื• ื’ื‘ื•ื”ื™ื. ื”ืžืฉืชืžืฉืช ื‘ืคืจื•ืงืกื™ื“ื– .ืืื•ื–ื™ื ื•ืคื™ืœื™ื.1.ื ื™ื•ื˜ืจื•ืคื™ืœื™ื.2.ืžื•ื ื•ืฆื™ื˜ื™ื.34.LUC (large unstainable cell).

?CLL-ืžื” ืžื”ื‘ืื™ื ื”ื•ื ืื‘ื—ื ืชื™ ืœ. 20

.Bืจืงืจื™ื ืฉืœ ืขื ืž Tื”ืกื ื ื” ืฉืœ ืœื™ืžืคื•ืฆื™ื˜ื™ื .1.ื”ืกื ื ื” ื“ื™ืคื•ื–ื™ืช ืฉืœ ืชืื™ ืคืœืกืžื” ืขื ื”ื’ื“ืœืช ื‘ืœื•ื˜ื•ืช ืœื™ืžืคื”.2 .Tืขื ืžืจืงืจื™ื ืฉืœ Bื”ืกื ื ื” ืฉืœ ืœื™ืžืคื•ืฆื™ื˜ื™ื .3

?ืžื” ืžื”ื‘ืื™ื ื”ื•ื ื”ื–ื™ื”ื•ื ื”ืฉื›ื™ื— ื‘ื™ื•ืชืจ ื‘ื”ืฉืชืœืช ืชืื™ ืื‘ ืืœื•ื’ื ื™ืช. 21

1.CML2.EBV3.HTLV-1.ืœ"ื›ืœ ื”ื .4

Page 75: As you wish

75

?DIC-ืžื” ืžื”ื‘ืื™ื ืœื ืžืชืื™ื ืœ. 22 30,000ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื™ื .1100ืคื™ื‘ืจื™ื ื•ื’ืŸ .23.D-dimer 500- ืคื—ื•ืช ืž.ื ืžื•ืš VIIIืคืงื˜ื•ืจ .4

?G6PD-ื‘ืื™ื–ื” ืžืฆื‘ื™ื ืื™ืฉื” ืขืฉื•ื™ื” ืœื—ืœื•ืช ื‘. 23

)XO(ืชืกืžื•ื ืช ื˜ืจื ืจ .1(lyonization)ืœื™ื•ื ื™ื–ืฆื™ื” .2.ืื‘ ื—ื•ืœื” ื•ืื ื ืฉืื™ืช.3.ืœ"ื›ืœ ื”ื .4

?ืื™ื–ื” ืžื”ืื ืžื™ื•ืช ื”ื‘ืื•ืช ืœื ื ื’ืจืžืช ื›ืชื•ืฆืื” ืžื”ืžื•ืœื™ื–ื” ืชื•ืš ื›ืœื™ืช. 24

1.G6PD .ืื ืžื™ื” ื”ืžื•ืœื™ื˜ื™ืช ืื•ื˜ื•ืื™ืžื•ื ื™ืช.23.mismatch ื“ื ื‘ืงื‘ื•ืฆื•ืชABO..ื˜ืœืกืžื™ื”.4

25 .Delayed transfusion reaction โ€“ ืžื” ืœื ื ื›ื•ืŸ?

.ื™ืžื™ื ืœืื—ืจ ื”ืขื™ืจื•ื™ 3-10ืžืชืจื—ืฉ .1ื ื’ืจื ื›ืชื•ืฆืื” ืžื ื•ื’ื“ื ื™ื ื ื’ื“ ืงื‘ื•ืฆื•ืช ื”ื“ื.2)ืœื ื–ื•ื›ืจืช ื”ืžืฉืš( .3

?ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ืืคื™ื•ืŸ ืฆื™ื˜ื•ื’ื ื˜ื™. 26

.ื˜ื•ื‘ื™ื ืœืคืจื•ื’ื ื•ื–ื”ื•ืฉื™ื ื•ื™ื™ื ืฉื ื™ื•ื ื™ื™ื ื•ืฉืœื™ืฉื•ื ื™ื™ื , ืฉื™ื ื•ื™ื™ื ืจืืฉื•ื ื™ื™ื ืžืœืžื“ื™ื ืื‘ื—ื ื” ื•ืคืจื•ื’ื ื•ื–ื”.1.ืจืง ืฉื™ื ื•ื™ื™ื ืฉื ื™ื•ื ื™ื™ื ืžืขื™ื“ื™ื ืขืœ ืื‘ื—ื ื”.2.ืฉื™ื ื•ื™ื™ื ืฉื ื™ื•ื ื™ื™ื ืžืขื™ื“ื™ื ืขืœ ืคืจื•ื’ื ื•ื–ื” ื˜ื•ื‘ื”.3

?ืฉืชืชืŸ ืœื• ื”ืจืืฉื•ื ื™ืžื” ื”ื˜ื™ืคื•ืœ . ITPื—ื•ืœื” ืขื ืกื™ืžื ื™ื ืงืœื™ื ื™ื™ื ืฉืœ . 27

.ืกื˜ืจื•ืื™ื“ื™ื.1.ืื™ืžื•ื ื•ื’ืœื•ื‘ื•ืœื™ื ื™ื.2Dืื ื˜ื™ .3 ืกืคืœื ื•ืงื˜ื•ืžื™.4

Page 76: As you wish

76

ื•"ืžื—ื–ื•ืจ ื›, 2001ื”ืžื˜ื•ืœื•ื’ื™ื”

ืœืื—ืจ ื˜ื™ืคื•ืœ , vancomycin - ืžืชื™ ื™ืฉ ืœืชืช ืœื—ื•ืœื” ื ื•ื™ื˜ืจื•ืคื ื™ ืขื ื—ื•ื ื˜ื™ืคื•ืœ ืจืืฉื•ื ื™ ื‘.1?ื›ื™ืžื•ื˜ืจืคื™

900 ื•ื ื•ื™ื˜ืจื•ืคื™ืœื™ื 38.4ื—ื•ืœื” ืขื ื˜ื™ืคื•ืœ ื›ื™ืžื•ื˜ืจืคื™ ืจื’ื™ืฉ ืกื•ืœื™ื“ื™ ืขื ื—ื•ื .137.8 โ€“ื•ื—ื•ื ืฉื ืžื“ื“ ืคืขื ืื—ืช 400ืขื ื ื•ื™ื˜ืจื•ืคื™ืœื™ื , ื‘ืกื“ืจื” ืœืœื™ืžืคื•ืžื” 5ื—ื•ืœื” ืขื ื˜ื™ืคื•ืœ .2ื•ืœืœื ืฉื•ื ืกื™ืžื ื™ื ืงืœื™ื ื™ื™ื 100ื ื•ื™ื˜ืจื•ืคื™ืœื™ื , 40ืขื ื—ื•ื ื™ืžื™ื ืœืื—ืจ ื˜ื™ืคื•ืœ 7, ื—ื•ืœื” ืœื•ื™ืงืžื™.3ืื“ืžื•ืžื™ื•ืช ื•ื ื•ื–ืœ ืžืกื‘ื™ื‘ , 100ื ื•ื™ื˜ืจื•ืคื™ืœื™ื , 40ืขื ื—ื•ื , ื—ื•ืœื” ืœื•ื™ืงืžื™ ืœืื—ืจ ื”ื˜ื™ืคื•ืœ ื”ืจืืฉื•ืŸ.4

.ืœื ืงื•ื“ืช ื”ื”ื›ื ืกื” ืฉืœ ื”ืงื˜ื˜ืจ ื”ืžืจื›ื–ื™

:IRPืคืขื•ืœืช ื—ืœื‘ื•ืŸ .2 .Feืžื•ื‘ื™ืœื™ื–ืฆื™ื” ืฉืœ .1ื™ื˜ื™ืŸืฉืœ ืคืจ mRNAื“ื™ื›ื•ื™ , ืฉืœ ื˜ืจื ืกืคืจื™ืŸ ืจืฆืคื˜ื•ืจ mRNAื™ื™ืฆื•ื‘ : Feื‘ืขื•ื“ืฃ .2ืฉืœ ืคืจื™ื˜ื™ืŸ mRNAื“ื™ื›ื•ื™ , ืฉืœ ื˜ืจื ืกืคืจื™ืŸ ืจืฆืคื˜ื•ืจ mRNAื™ื™ืฆื•ื‘ : Feื‘ื—ืกืจ .3ืžืขื•ื“ื“ ื˜ืจื ืกืงืจื™ืคืฆื™ื” ืฉืœ ืฉื ื™ื”ื ื‘ื—ืกืจ ื‘ืจื–ืœ.4ืžืขื›ื‘ ื˜ืจื ืกืงืจื™ืคืฆื™ื” ืฉืœ ืฉื ื™ื”ื ื‘ื—ืกืจ ื‘ืจื–ืœ.5

7ื‘ืžืฉื˜ื— ื“ื ืชืื™ื ืžืงืจื• ืื•ื‘ืœื•ืฆื™ื˜ื™ื ื•ื ื•ื™ื˜ืจื•ืคื™ืœื™ื ื‘ืขืœื™ ื’ืจืขื™ืŸ ืขื , ื—ื•ืœื” ืื ืžื™ ืžื‘ื•ื’ืจ.3

?ืžื” ื”ืกื™ื‘ื” ื”ืกื‘ื™ืจื” ืœืื ืžื™ื”. ืื•ื ื•ืช ืจื›ืช ื”ืขื™ื›ื•ืœ ื•ืœื›ืŸ ืื ืžื™ื” ืขืงื‘ ื—ื•ืกืจ ื‘ืจื–ืœื“ื™ืžื•ื ื‘ืžืข.1ื—ื•ืกืจ ื—ื•ืžืฆื” ืคื•ืœื™ืช ื‘ื’ืœืœ ื‘ืขื™ื” ื‘ื“ื™ืื˜ื”.2ื”ืžื•ืœื™ื–ื” ืืงื•ื˜ื™ืช ืขื ื™ืฆื™ืจืช ืจื˜ื™ืงื•ืœื•ืฆื™ื˜ื™ื.3ื"ื”ืžื•ืœื™ื–ื” ื›ืจื•ื ื™ืช ื‘ื’ืœืœ ืฉื‘ื™ืจื” ืฉืœ ืชื“.4

? Fanconi's Anemiaืื™ืš ื ืื‘ื—ืŸ .4 ืืฆื‘ืข ืงืฆืจื” ื•ืคื™ื’ื•ืจ ืฉื›ืœื™, ื”ืชื‘ื”ืจื•ื™ื•ืช ื‘ืขื•ืจ, ืงื•ืžื” ื ืžื•ื›ื” - ืœืคื™ ื‘ื“ื™ืงื” ืคื™ื–ื™ืงืœื™ืช .1ื›ืจื•ืžื•ื–ื•ืžื™ืืžื‘ื—ืŸ ืฉื‘ื™ืจืช .2ืจืง ืœืžื™ ืฉื™ืฉ ืœื• ืื ืžื™ื” ืืคืœืกื˜ื™ืช.3ืขืฆื- ืœืคื™ ื‘ื“ื™ืงืช ืžื—.4

?ืžื” ื”ื˜ื™ืคื•ืœ. ืœืœื ื‘ืขื™ื•ืช ืจืคื•ืื™ื•ืช ืงื•ื“ืžื•ืช, ืžื’ื™ืข ืขื ืงืจื™ืฉ ื’ื“ื•ืœ ื‘ื•ืจื™ื“ ื”ื™ืจืš 25ื‘ืŸ .5 Kื•ื™ื˜ืžื™ืŸ + ืงื•ืžื“ื™ืŸ .1Kื•ื™ื˜ืžื™ืŸ+ ืืกืคื™ืจื™ืŸ .23.LMWH +ืืกืคื™ืจื™ืŸ1.5-2.5ืคื™ PTTื”ืคืจื™ืŸ ืฉืžืืจื™ื .4ืืฃ ืชืฉื•ื‘ื” ืื™ื ื” ื ื›ื•ื ื”.5

ืžื” ื”ื”ื™ื’ื“ . PTT=30ื•ื‘ื—ื•ืœื” , PTT=27 - ื‘ื‘ืงืจื”: ืœืื—ืจ ื™ื•ืžื™ื™ื ืฉืœ ื˜ื™ืคื•ืœ ืชื•ืฆืื•ืช.6

?ื”ืกื‘ื™ืจ ื‘ื™ื•ืชืจ HITื”ื—ื•ืœื” ืคื™ืชื— .1ื”ื—ื•ืœื” ืงื™ื‘ืœ ื™ื•ืชืจ ืžื™ื“ื™ ื”ืคืจื™ืŸ ื•ืฆืจื™ืš ืœื”ื•ืจื™ื“ ืืช ื”ืžื™ื ื•ืŸ.2ื”ื—ื•ืœื” ื›ื ืจืื” ืžืงื‘ืœ ื™ื•ืชืจ ืžื™ื“ื™ ื”ืคืจื™ืŸ ื•ืืกืคื™ืจื™ืŸ.3ื˜ื™ืคื•ืœ ืœืคื™ืจื•ืง ื™ื—ื™ื“ื•ืช ืืช ื” 10000ื•ืฆืจื™ืš ืœื”ื’ื‘ื™ืจ ืคื™ PF4 - ื‘ื’ืœืœ ื’ื•ื“ืœ ื”ืคืงื™ืง ื”ื”ืคืจื™ืŸ ื ืงืฉืจ ืœ.4

.ื”ืงืจื™ืฉ ื•ื”ืžืฉืš ื˜ื™ืคื•ืœืืฃ ืชืฉื•ื‘ื” ืื™ื ื” ื ื›ื•ื ื”.5

Page 77: As you wish

77

?ืžื” ืฆืจื™ืš ืœื‘ื“ื•ืง. ืฉื ื™ื•ืช 68 -ืœ PTTืœ ืขืœื• ืขืœื• ืชื•ืฆืื•ืช "ืœืื—ืจ ื”ื˜ื™ืคื•ืœ ื”ื .7 ื’ื‘ื•ื”ื” ืžืฆื™ื™ื ืช ืฉื”ื˜ื™ืคื•ืœ ืžื•ืฆืœื— PTTืจืžืช .1TPืฆืจื™ืš ืœื‘ื“ื•ืง ื’ื .2ืฆืจื™ืš ืœื‘ื“ื•ืง ื’ื ื–ืžืŸ ื“ื™ืžื•ื.3ืืฃ ืชืฉื•ื‘ื” ืื™ื ื” ื ื›ื•ื ื”.4ื”ื›ืœ ื ื›ื•ืŸ.5

?CMLืœื’ื‘ื™ (PH)ืžื” ืื•ืžืจืช ื ื•ื›ื—ื•ืช ืฉืœ ื›ืจื•ืžื•ื–ื•ื ืคื™ืœื“ืœืคื™ื” .81.PH+ ื™ื•ืชืจ ื˜ื•ื‘ ืž :PH- 2.PH- ื™ื•ืชืจ ื˜ื•ื‘ ืž :PH+PHืื™ืŸ ืžืฉืžืขื•ืช ืœื ื•ื›ื—ื•ืช ืื• ื—ืกืจ ืฉืœ .34.CML ืœื›ืŸ ืื™ืŸ ืœื›ืš ืžืฉืžืขื•ืช, ื”ื™ื ืžื—ืœื” ื ื“ื™ืจื”.

9.PNH โ€“ ืžื” ื”ืกื™ื‘ื” ืœืžื—ืœื”? ื‘ืชืื™ื ื”ืžืขื•ืจื‘ื™ื ื‘ืžื—ืœื” IGP - ืžื—ืœื” ื ืจื›ืฉืช ื”ืคื•ื’ืขืช ื‘ื—ืœื‘ื•ื ื™ื ื”ื ืงืฉืจื™ื ืœ.1CD59 -ื• CD55ืคื•ื’ืขืช ื‘ื—ืœื‘ื•ื ื™ื โ€“ Xื•ืจืฉืช ืขืœ ื›ืจื•ืžื•ื–ื•ื ืžื—ืœื” ื .2IGP -ืคื•ื’ืขืช ื‘ื›ืœ ืชืื™ ื”ื’ื•ืฃ ื‘ื—ืœื‘ื•ื ื™ื ื”ืงืฉื•ืจื™ื ืœ, ืื•ื˜ื•ื–ื•ืžืœื™ืช, ืžื—ืœื” ื ื•ืจืฉืช.3.CD59 -ื• CD55ื™ ื•ื™ืจื•ืก ืฉืคื•ื’ืข ื‘ื—ืœื‘ื•ื ื™ื "ืข, ืžื—ืœื” ื ืจื›ืฉืช.4

?Sickle Cell Anemia -ืžื” ื”ืชื•ืคืขื•ืช ื‘.101(Acute chest syndrom ืคืจื™ืืคื™ื–ื)23(Painful Crisis4(Splenic sequestration

ื’+ื.1ื“+ื‘.2ื’+ื‘+ื.3ื“ ื‘ืœื‘ื“.4ื”ื›ืœ ื ื›ื•ืŸ.5

?ื›ื™ืฆื“ ืžื‘ื—ื™ื ื™ื ื‘ื™ืŸ ื”ืžื•ืคื™ืœื™ื” ื ืจื›ืฉืช ืœื’ื ื˜ื™ืช.11 VIIืžื“ื™ื“ืช ืคืงื˜ื•ืจ .1IXืžื“ื™ื“ืช ืคืงื˜ื•ืจ .23.Mixing Test โ€“ ืขืจื‘ื•ื‘ ืขื ืคืœืกืžื” ืฉืœ ืื“ื ื‘ืจื™ืืจืžืช ื˜ื™ื˜ืจ ื ื•ื’ื“ื ื™ื.4Recombinant Factorืœื‘ื“ื•ืง .5

?ืžื” ืœื ื ื›ื•ืŸ, ื”ื”ื‘ื“ืœ ื‘ื™ืŸ ื“ื ื‘ื•ื’ืจ ืœื“ื ืฆืขื™ืจ.12

ืžื™ื ื‘ืชื ื”ื–ืงืŸ ื™ืฉ ืคื—ื•ืช.1ื‘ืชื ื”ื–ืงืŸ ืคืขื™ืœื•ืช ืžื˜ื‘ื•ืœื™ืช ืžื•ืคื—ืชืช.2ื’ื‘ื•ื”ื” ื™ื•ืชืจ A1Cืจืžืช .3)ืคื—ื•ืช ืขื’ื•ืœ(ื”ืชื ื”ื‘ื•ื’ืจ ื”ื•ืคืš ืœืงื•ืฆื ื™ .4ื”ืชื ื”ื‘ื•ื’ืจ ืงืฉื™ื— ื™ื•ืชืจ.5

Page 78: As you wish

78

. ืžืžืฉื˜ื— ื“ื ื”ื™ืงืคื™ ืจืื• ื’ื•ืฉื™ ื˜ืกื™ื•ืช ืžื•ืฆืžื“ื™ื. ื‘ืกืคื™ืจืช ื“ื ื ืžืฆืื” ืจืžืช ื˜ืกื™ื•ืช ื ืžื•ื›ื”.13:ื”ืชื•ืคืขื” ื”ื™ื

ืžืืงืจื•ืฆื™ื˜ื•ื–ื™ืก.1ืื ืื™ื–ื•ืฆื™ื˜ื•ื–ื™ืก.2ืคืกืื•ื“ื•ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื•ืคื ื™ื”.3ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื•ื–ื™ืก.4

?ืžื” ืœื ื ื›ื•ืŸ ื‘ืœื™ืžืคื•ืžื•ืช ืžืžืื™ืจื•ืช.14 ื› ื‘ื‘ืœื•ื˜ื•ืช ืœื™ืžืคื”"ืžื•ืคืข ืจืืฉื•ืŸ ื‘ื“ืจ.1ื› ืžื•ืงื“ื™ืช"ื”ืกื ื ื” ืœืžื— ื”ืขืฆื ื‘ื“ืจ.2ืžื”ื•ื•ื” ืžื“ื“ ืœืžืžืื™ืจื•ืช (Bence Jones)ืžื•ืคืข ืคืก ืฆืจ .3ืžื˜ืกื˜ื–ื•ืช ืžืชื ื”ื’ื•ืช ื›ืžื• ืงืจืฆื™ื ื•ืžื”.4ื›ื•ืœืœื™ื ื’ื ื’ืจื“ Bืกื™ืžื ื™ .5

:ื”ืžื˜ืคืœ ื‘ืจืžื” ื”ืžื•ืœืงื•ืœืจื™ืช ื”ื•ื CML -ื”ื˜ื™ืคื•ืœ ื”ื—ื“ืฉ ื‘.151.STI 2.INF-ฮณ3.BMT4.INF-ฮฑ

?myeloid stem cellืžื” ืื™ื ื• ื ื›ื•ืŸ ืœื’ื‘ื™ .16 GM-CSF -ื• IL-3 -ืžื‘ื˜ืื™ื ืจืฆืคื˜ื•ืจื™ื ืœ.1ืžื’ื”ืงืจื™ื•ืฆื™ื˜ื™ื , ืœื™ืžืคื•ืฆื™ื˜ื™ื, ืืจื™ืชืจื•ืฆื™ื˜ื™ื(ื™ื›ื•ืœ ืœื™ื™ืฆืจ ืืช ื›ืœ ืกื•ื’ื™ ืชืื™ ื”ื“ื ื”ื‘ื•ื’ืจื™ื .2

).ื•ื’ืจื ื•ืœื•ืฆื™ื˜ื™ืHomingื‘ืขืœื™ ื™ื›ื•ืœืช .3.ื‘ืขืœื™ ื™ื›ื•ืœืช ืžื™ื˜ื•ื˜ื™ืช.4

:ื”ืกื™ื‘ื•ืช ื”ืขื™ืงืจื™ื•ืช ืœืื™ ืกืคื™ืงื” ื›ืœื™ื™ืชื™ืช ื‘ืžื™ืœื•ืžื” ื”ื™ื ืŸ.17

ื”ื™ืคืจื•ื•ื™ืกืงื•ืกื™ื˜ื™ ,ืื ืžื™ื”.1ื”ื™ืคืจืงืœืฆืžื™ื”, ื”ื™ืคืจื’ืœื•ื‘ื•ืœื™ื ืžื™ื”.2ื”ื™ืคืจืงืœืฆืžื™ื”, ื”ืคืจืฉืช ืฉืจืฉืจืื•ืช ืงืœื•ืช ื‘ืฉืชืŸ.3ืชืื™ ืคืœืกืžื” ื‘ื“ื ื”ื”ื™ืงืคื™.4.ืื ืžื™ื”, ื“ืœืงืช ื‘ื“ืจื›ื™ ื”ืฉืชืŸ.5

?ืื™ื–ื” ื˜ื™ืคื•ืœ ืื™ื ื• ื”ื’ื™ื•ื ื™.18 ืžืชืŸ ืืจื™ืชืจื•ืคื•ืื˜ื™ืŸ โ€“ื—ื•ืœื” ื“ื™ืืœื™ื–ื” .1CGDืœื—ื•ืœื” G-CSFืžืชืŸ .2ืžืชืŸ ืืจื™ืชืจื•ืคื•ืื˜ื™ืŸ ืœืื ืžื™ื” ืืคืœืกื˜ื™ืช.3ืขื ื™ืจื™ื“ื” ื‘ื˜ืกื™ื•ืช ืžืชืŸ ื˜ืจื•ืžื‘ื•ืคื•ืื˜ื™ืŸ ืœื—ื•ืœื”.4ืœื ื•ื™ื˜ืจื•ืคื ื™ ืขื ื—ื•ื GM-CSFืžืชืŸ .5

?ืžื” ืœื ื ื›ื•ืŸ โ€“ H.Dืžืืคื™ื™ื ื™ื ืฉืœ .19Lymphocytic depleted -ืคืกื™ ืคื™ื‘ืจื•ื–ื™ืก ืขื‘ื™ื ื‘.1predominant -ืชืื™ ืคื•ืคืงื•ืจืŸ ื‘.2ืชืื™ ื’ื™ื“ื•ืœ ื”ื™ื ื ืชืื™ื ืฉืœ ื“ืœืงืช โ€“ืื•ืคื™ื™ื ื™ .3ื›ื™ื•ื ืคื—ื•ืช ื ื”ื•ื’ ืœืขืฉื•ืช ืœืคื•ืจื•ื˜ื•ืžื™ื” ื—ื•ืงืจืช.4ืฉื™ืคื” ืžืื•ื—ืจืช ืœืžื—ื•ืœืœ ื–ื™ื”ื•ืžื™ ืฉื›ื™ื—ืžืืคื™ื™ืŸ ื–ื” ื— โ€“ืžื‘ื—ื™ื ื” ืืคื™ื“ื™ืžื™ื•ืœื•ื’ื™ืช .5

Page 79: As you wish

79

20.1cc ืฉืœ ื›ื“ื•ืจื™ื•ืช ื“ื ืื“ื•ืžื•ืช ืฉื•ื•ื” ืžื‘ื—ื™ื ืช ื‘ืจื–ืœ ืœ: ืžื™ืงืจื•ื’ืจื 1.1ืžื™ืœื™ื’ืจื 2.1ื’ืจื 3.1ืืฃ ืชืฉื•ื‘ื” ืื™ื ื” ื ื›ื•ื ื”.4

?ืžื” ืœื ืื•ืคื™ื™ื ื™ ืœืื ืžื™ื” ืžื’ืœื•ื‘ืœืกื˜ื™ืช.21 ืžืงืจื•ืฆื™ื˜ื•ื–ื™ืก.1ืกืคื™ืจื” ืœื‘ื ื” ื ืžื•ื›ื”.2ื”ื™ืคืจืกื’ืžื ื˜ืฆื™ื” ืฉืœ ื’ืจื ื•ืœื•ืฆื™ื˜ื™ื.3ืžื— ืขืฆื ื“ืœ ื‘ื—ื•ืœื™ื.4ืื• ืคื•ืœืื˜ ืžืงื“ื™ืžื™ื ืืช ื”ืื ืžื™ื” B12 -ื—ื•ืกืจ ื‘.5

?ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ืืจื™ื˜ืจื•ืฆื™ื˜ื™ื ื‘ื•ื’ืจื™ื ื‘ืžื—ื–ื•ืจ ื”ื“ื.22 ื™ื•ื ื‘ื“ื 12ื—ื™ .1ืื‘ืœ ืื™ืŸ ืœื• ืžื™ื˜ื•ื›ื•ื ื“ืจื™ื”, ืžื›ื™ืœ ื’ืจืขื™ืŸ.2ื›ืžื•ืชื• ื”ื›ืœืœื™ืช ื™ื•ืจื“ืช ื‘ื”ืžื•ืœื™ื–ื” ืžืฉืžืขื•ืชื™ืช.3ATP -ื’ื•ืคื™ ืงื˜ื•ืŸ ืžื”ื•ื•ื™ื ืืช ื”ืžืงื•ืจ ื”ืขื™ืงืจื™ ืœ.4

?ื”ื™ื›ืŸ ื”ื™ื ืœื ืžืชืจื—ืฉืช GVHD -ืžื—ืœืช ื”ืฉืชืœ ื›ื ื’ื“ ื”ืžืื›ืกืŸ .23 ืืœื•ื’ื ืื™ืชื”ืฉืชืœื” .1ื”ืฉืชืœื” ืžื—ื‘ืœ ื”ื˜ื‘ื•ืจ.2ืชื•ืจื ื–ืจ.3ื”ืฉืชืœื” ืื•ื˜ื•ื’ื ืื™ืช.4

:ื‘ื‘ื“ื™ืงื•ืช. ื”ื’ื™ืขื” ืœืจื•ืคื ืขื ืชืœื•ื ื” ืขืœ ืขื™ื™ืคื•ืช ื•ื—ื•ืœืฉื” 35ืื™ืฉื” ื‘ืช .24 PLT 178,000 ; WBC-4500 ; HKT โ€“ 57% ; Hg โ€“ ?ืื™ื–ื” ื‘ื“ื™ืงื” ืœื ืชื‘ืฆืข 19.7

1.U.S ื‘ื˜ืŸ ื‘ื“ื™ืงืช ื”ืจื™ื•ืŸ.2ืจืžืช ืืจื™ื˜ืจื•ืคื•ืื˜ื™ืŸ.3ืฆื™ืœื•ื ื—ื–ื”.4

: ื”ืชืื1(GPIA 2(Bp 2A/3Bื ื•ื’ื“ื ื™ื)3ืคืงื˜ื•ืจ ืคืœืกืžืชื™)4

25.VWF26.ITPืžื—ืœืช ื‘ืจื ืจื“ ืกื•ืœื™ื™ื”.27.ื’ืœื ื–ืžืŸ.28

?ืžื” ืžืืคื™ื™ืŸ ืชืื™ ื ื‘ื˜.29ื’ ื”ืชื"ื›ืœ ืชืื™ ื”ื ื‘ื˜ ืžื‘ื˜ืื™ื ืื•ืชื ืกืžื ื™ื ืข.1 S.C -ื‘ืขื•ื“ ืฉืž, ืžื—ื•ื™ื™ื‘ ืœืชื ืžืกื•ื™ื™ื P.C -ื”ืŸื ืฉ stem cell -ืœ progenitor cellื”ื”ื‘ื“ืœ ื‘ื™ืŸ .2

.ื™ื›ื•ืœื™ื ืœื”ื•ื•ืฆืจ ืžืกืคืจ ืชืื™ื ืฉื•ื ื™ื.ื˜ ื‘ืืชืจื™ื ืื—ืจื™ื ื›ืžื• ื˜ื—ื•ืœ ืื• ื›ื‘ื“ืื ื™ืฉ ื‘ืขื™ื” ื‘ืžื— ื”ืขืฆื ื™ืชื›ืŸ ื•ื™ื”ื™ื• ืชืื™ ื ื‘.3

Page 80: As you wish

80

?acute transfusion reactionืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ .30 ื”ืžืกื•ื›ื ืช ืžื‘ื™ืŸ ื”ืกื™ื‘ื•ื›ื™ื ืขืงื‘ ืžืชืŸ ืžื ืช ื“ื.1O,A,Bื ื’ืจืžืช ืขืงื‘ ืื™ ื”ืชืืžื” ื‘ื™ืŸ ืงื‘ื•ืฆื•ืช .2DIC -ื™ื›ื•ืœื” ืœื’ืจื•ื ืœ.3ื™ื›ื•ืœื” ืœื’ืจื•ื ืœืชื’ื•ื‘ื” ื”ืžื•ืœื™ื˜ื™ืช ืžืœื•ื•ื” ื‘ื—ื•ื.4ื›ืœ ื”ืชืฉื•ื‘ื•ืช ื ื›ื•ื ื•ืช.5

?Kื”ื—ืœื‘ื•ื ื™ื ื”ืžื•ืฉืคืขื™ื ืžื•ื™ื˜ืžื™ืŸ / ืžื”ื ื”ืคืงื˜ื•ืจื™ื .31 Cื—ืœื‘ื•ืŸ , ATIII, ืคืจื•ื˜ืจื•ืžื‘ื™ืŸ.1Sื—ืœื‘ื•ืŸ , 8ืคืงื˜ื•ืจ , 5ืคืงื˜ื•ืจ .2Sื—ืœื‘ื•ืŸ , Cื—ืœื‘ื•ืŸ , 7ืคืงื˜ื•ืจ .311ืคืงื˜ื•ืจ , Cื—ืœื‘ื•ืŸ , Sื—ืœื‘ื•ืŸ .4

ื‘ืกื™ื ื˜ื–ืช Heme -ื‘ื ื™ืกื•ื™ ื ืžืฆืื” ื—ื•ืžืฆื” ืืžื™ื ื™ืช ืจื“ื™ื•ืืงื˜ื™ื‘ื™ืช ืฉืžืกื•ื’ืœืช ืœื—ื‘ื•ืจ ืœ .32

?ืžื” ืื™ื ื• ื ื›ื•ืŸ. ื”ืืจื™ืชืจื•ืฆื™ื˜ ืื™ื ื” ืคื•ื’ืขืช ื‘ืชืคืงื•ื“ ื”ืืจื™ืชืจื•ืฆื™ื˜ื”ื—ื•ืžืฆื” .1ื™ืžื™ื ืžื”ื”ื”ื–ืจืงื”' ื”ืจืžื” ื”ืจื“ื™ื•ืืงื˜ื™ื‘ื™ืช ืชืขืœื” ื›ืขื‘ื•ืจ ืžืก.2ื™ื•ื ื‘ืื“ื ืœืœื ื”ืžื•ืœื™ื–ื” ื—ืจื™ืคื” 100 -ื”ืจืžื” ืชืฉืืจ ืงื‘ื•ืขื” ื‘ืžืฉืš ื›.3ื”ืชืจื•ืคื” ืžืกืžื ืช ืžื—ื–ื•ืจ ืฉืœ ืชืื™ื ื—ื“ืฉื™ื.4.ื”ื—ื•ืžืฆื” ื”ืจื“ื™ื•ืืงื˜ื™ื‘ื™ืช ืžืฉืชื—ืจืจืช ืœืื—ืจ ื”ืคื™ืจื•ืง ื•ืžืฉื•ื—ื–ืจืช ืืœ ืชื•ืš ืชืื™ื ื—ื“ืฉื™ื.5

- ืžื ื™ื ื”ื‘ืื™ื ืคืจื˜ ืœืžืื•ืคื™ื™ื ืช ื‘ืกื™ Aื”ืžื•ืคื™ืœื™ื” .33 8ื—ืกืจ ืคืงื˜ื•ืจ .1X-ืชื•ืจืฉื” ื‘ืชืื—ื™ื–ื” ืœ.2ื“ื™ืžื•ื ืขืœ ืคื ื™ ื”ืขื•ืจ ื•ื”ืจื™ืจื™ื•ืช.3ื‘ื–ื›ืจื™ื ื™ื•ืชืจ ืžื‘ื ืงื‘ื•ืช.48ื”ื˜ื™ืคื•ืœ ื”ื•ื ื”ืฉืœืžืช ืคืงื˜ื•ืจ .5

- ื”ื’ื•ืจืžื™ื ื”ื‘ืื™ื ืžื”ื•ื•ื™ื ืกืžื ื™ื ืœืคืจื•ื’ื ื•ื–ื” ื’ืจื•ืขื” ืคืจื˜ ืœ H.D -ื‘.34 65ื’ื™ืœ ืžืขืœ .1Bื—ื•ืกืจ ืกื™ืžื ื™ .2ื–ื›ืจ.3

)ื ื›ื•ืŸืœื - 2, ื ื›ื•ืŸ- 1ืกืžืŸ : (ื™"ืžืขืจื›ืช ืื™ื ื˜ืจื™ื ืกื™ืช ื ื‘ื“ืงืช ืข

ืื™ื’ื•ืจ ื˜ืกื™ื•ืช.3536.FSP (Fibrinogen split products) PTื–ืžืŸ.37XIืคืงื˜ื•ืจ .38

?ืื™ื–ื” ื–ื™ื”ื•ื ื”ื•ื ื”ืงืฉื” ื‘ื™ื•ืชืจ ื‘ื”ืฉืชืœื” ืฉืœ ืžื— ืขืฆื ืืœื•ื’ื ืื™ืช.391.CMV 2.EBV3.Herpes4.Adeno virusื›ื•ืœื.5

Page 81: As you wish

81

?ืžื” ื ื›ื•ืŸ, ื˜ืœืกืžื™ื” ฮฒ -ื‘.40 ืžืชืŸ ื“ื ืจืง ื‘ืื™ืจื•ืขื™ ื—ื•ื .ืืืจื•ืขื™ ืœื‘ ืœื ืฉื›ื™ื—ื™ื ื‘ืžื‘ื•ื’ืจื™ื .ื‘ืื ืžื™ื” ืžื•ืคื™ืขื” ืžื™ื“ ืกืžื•ืš ืœืœื™ื“ื” .ื’.ืฉืกื•ืคื—ืช ื‘ืจื–ืœ ืœืžื ื•ืข ืฉืงื™ืขื” ื‘ืื™ื‘ืจื™ื defirazoleืžืชืŸ ืชืจื•ืคื” .ื“

ื’+ื.1ื“+ื‘.2ื’+ื‘+ื.3ื“ ื‘ืœื‘ื“.4ื”ื›ืœ ื ื›ื•ืŸ.5

:ืœื ื›ื•ืœืœ ITP -ื˜ื™ืคื•ืœ ื™ืขื™ืœ ื‘.41 ืกืคืœื ื•ืงื˜ื•ืžื™.1Dืื ื˜ื™ .23.Igืคืœืกืžื” ืคืจื–ื™ืก.4ืกื˜ืจื•ืื™ื“ื™ื.5

?CML - ืžื” ืื•ืคื™ื™ื ื™ ืœ.42 ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื•ืคื ื™ื”.12.Lap Score ื’ื‘ื•ื”3.t(9,22) ื”ื’ื•ืจืžืช ืœืขืœื™ื™ื” ื‘ื˜ื™ืจื•ื–ื™ืŸ ืงื™ื ืื–.ื ืื‘ื—ื ืชื™ืžืฉื˜ื— ืžืžื— ืขืฆ.4

ืื•ื‘ื—ืŸ ื ื•ื“ื•ืœืจ ืกืงืœืจื•ื–ื™ืก . Bืžื’ื™ืข ืขื ื‘ืœื•ื˜ื•ืช ื‘ื‘ื™ืช ื”ืฉื—ื™ ืŸื‘ืžืคืฉืขื” ืœืœื ืกื™ืžื ื™ 18ื‘ืŸ .43?ืžื” ื”ื˜ื™ืคื•ืœ. ืงื™ืŸ'ื”ื•ื“ื’

1.MOPP 2.ABVD3.CHOPInverted Yื”ืงืจื ื” .4

?ืž"ื‘ืื™ื–ื” ืžื”ืœื•ื™ืงืžื™ื•ืช ื”ื‘ืื•ืช ื ื™ืชืŸ ื˜ื™ืคื•ืœ ื›ื“ื™ ืœืžื ื•ืข ื”ืกื ื ื” ืœืžืข.44

1.ALL 2.CML3.CLL4.AML5.Hairy cell leukemia

ื›ื™ืฆื“ ืชื‘ื“ื™ืœ ื‘ื™ืŸ ืื ืžื™ื” ื›ืชื•ืฆืื” ืžืชืžืก ื“ื ืœื‘ื™ืŸ ืื ืžื™ื” .ืจื˜ื™ืงื•ืœื•ืฆื™ื˜ื™ื 30%ืื‘ื—ื ืช .45?ื›ืชื•ืฆืื” ืžืื™ื‘ื•ื“ ื“ื

ื•ื—ื•ืžืฆื” ืคื•ืœื™ืช B12ืจืžืช .1ืจืžืช ืคืจื™ื˜ื™ืŸ ื‘ืกืจื•ื.2ื•ื“ื ื‘ืฆื•ืื” LDH, ื‘ื“ื™ืงืช ื‘ื™ืœื™ืจื•ื‘ื™ื™ืŸ ืœื ื™ืฉื™ืจ.3ื"ืจืžืช ืคืจื•ื˜ื•ืคื•ืจืคืจื™ืŸ ื‘ื›ื“.4ืจืžืช ื ื—ื•ืฉืช ื‘ืกืจื•ื.5

Page 82: As you wish

82

:ื›ืœ ืžื ื•ืช ื”ื“ื ื‘ืืจืฅ ื ื‘ื“ืงื•ืช ืœ.46HBs Ag .ืAnti HCV .ื‘Anti HIV 1,2 .ื’TPHA .ื“

ื’+ื.1ื“+ื‘.2ื’+ื‘+ื.3ื“ ื‘ืœื‘ื“.4ื›ืœ ื”ืชืฉื•ื‘ื•ืช ื ื›ื•ื ื•ืช.5

47.CLL ,ืžื” ื ื›ื•ืŸ? ืžื—ืœื” ื ื“ื™ืจื” ื‘ื™ื•ืชืจ.1ื‘ื›ืœ ืžืงืจื” ื“ื•ืจืฉืช ื˜ื™ืคื•ืœ ื›ื™ืžื•ื˜ืจืคื™ ืื’ืจืกื™ื‘ื™ ืขื ื”ื’ื™ืœื•ื™.2Bืœืจื•ื‘ ื‘ืขื™ื” ื‘ืชืื™ .3Tืœืจื•ื‘ ื‘ืขื™ื” ื‘ืชืื™ .4.ืขืฆื-ื‘ื“ืจืš ื›ืœืœ ืžื•ืคื™ืขื” ื‘ืฆืขื™ืจื™ื ื•ื”ื˜ื™ืคื•ืœ ื”ืžื•ืžืœืฅ ื”ืฉืชืœืช ืžื—.5

:ืขืฉื• ืœื”ื‘ื‘ื“ื™ืงื•ืช ืฉ. ืื™ืฉื” ื”ื’ื™ืขื” ืขื ื›ืื‘ื™ ืจืืฉ ื—ื•ืœืฉื” ื•ื“ื™ืžื•ืžื™ื ืžืคื•ืฉื˜ื™ื.48Hb โ€“ 8 ; WBC โ€“ 10,500 ; Bil. โ€“ 3.5 ; Creat โ€“ 2.1 ; LDH โ€“ 670 ;

Bil. Indirect โ€“ 2 ; Plt. โ€“ 30,000 ?ืื™ื–ื” ื˜ื™ืคื•ืœ ืœื ืชืชืŸ ืœื” ื‘ืฉื•ื ืคื ื™ื ื•ืื•ืคืŸ

ืคืœืกืžื” ืคืจื–ื™ืก.1ื“ื ื”ื™ืงืคื™.23.CT ืœื’ื™ืœื•ื™ ื“ื™ืžื•ื ื‘ืžื•ื—4.PT ื•- PTTืžืชืŸ ื˜ืกื™ื•ืช.5

:ืืœื• ืžื’ืœื™ื ืžืชืื™ื Lymphocytic Leukocytosis .40%ืœืคื ื™ืš ื—ื•ืœื” ืขื .49lambda light chain (-) Kappa light chain (+)

CD23 (+) CD19 (+)CD5 (+)CD3 (-)CD2 (-)

?ืžื” ืžื”ื‘ืื™ื ื ื›ื•ืŸ ืœื’ื‘ื™ ืชืื™ื ืืœื• ื ื•ืจืžืœื™ื Tืชืื™ .1ื ื•ืจืžืœื™ื Bืชืื™ .2(pro-lymphocytic leukemia)ืคืชื•ืœื•ื’ื™ื Tืชืื™ .3 (B-cell chronic lymphocytic leukemia )ืคืชื•ืœื•ื’ื™ื™ื Bืชืื™ .4

?Kืื™ื–ื” ืžื”ืคืงื˜ื•ืจื™ื ื”ื‘ืื™ื ืชืœื•ื™ื™ื ื‘ื•ื™ื˜ืžื™ืŸ .50 Cื•ืคืจื•ื˜ืื™ืŸ Xืคืงื˜ื•ืจ , Sืคืจื•ื˜ืื™ืŸ .1XIIืคืงื˜ื•ืจ , S ,AT IIIืคืจื•ื˜ืื™ืŸ .2Cืคืจื•ื˜ืื™ืŸ , IIืคืงื˜ื•ืจ , Vืคืงื˜ื•ืจ .3 Xืคืงื˜ื•ืจ , Cืคืจื•ื˜ืื™ืŸ , XIIืคืงื˜ื•ืจ .4

Page 83: As you wish

83

?VWFืžื” ืžืืคื™ื™ืŸ ืืช ืžื—ืœืช .51 VWFื™ืจื™ื“ื” ื™ื—ืกื™ืช ื‘ืจืžืช .1ืคื’ื™ืขื” ื‘ืžืขืจื›ืช ืื™ื ื˜ืจื™ื ืกื™ืช.2ืœืžืงืจื™ื ืงืœื™ื DDAVP - ื• Cryopercipitateื™ "ื˜ื™ืคื•ืœ ืข.3ื˜ื™ืคื•ืœ ื‘ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื™ื.45.1+3

?ืœืžื” ื’ื•ืจื, MTHFRื™ื–ื ืฉืœ ืคืคื•ืœื™ืžื•ืจ.52 ืžื‘ื™ื ืœื™ืจื™ื“ื” ื‘ื”ืชืงืคื™ ืœื‘.1ืžื‘ื™ื ืœืขืœื™ื” ื‘ืžืงืจื™ ืกืจื˜ืŸ ืžืขื™ ื”ื’ืก.2ื•ื‘ื›ืœ ื’ื•ืจื ืœืขืœื™ื™ื” ื‘ืฉื›ื™ื—ื•ืช ืžืžืื™ืจื•ื™ื•ืช T -ืœ nืžืฉื ื” ื™ื—ืก ื‘ื™ืŸ .3ืžื‘ื™ื ืœื™ืจื™ื“ื” ื‘ืžืงืจื™ ืกืจื˜ืŸ ืžืขื™ ื”ื’ืก.4

?ืžื” ื ื›ื•ืŸ โ€“ื‘ื’ื•ืฃ ืžืขืจื›ืช ืื ื–ื™ืžื™ื ืฉืžืชืžื•ื“ื“ืช ืขื ืงืจืฆื™ื ื•ื’ื ื™ื .53 .ื‘ื”ืชื—ืœื” ื’ื•ืจื ืœืฉืคืขื•ืœ ื”ืงืจืฆื™ื ื•ื’ืŸ, ื‘ืื•ืคืŸ ืคืจื“ื•ืงืกืœื™.1DNA adductsื ื•ื’ื•ืจืžื™ื ืœื™ืฆื™ืจืช .ื .ื“-ืื ื–ื™ืžื™ื ื•ืงืจืฆื™ื ื•ื’ืŸ ื ืงืฉืจื™ื ืœ.2.ื›ืœ ืื ื–ื™ื ื”ื•ื ืกืคืฆื™ืคื™ ืœืงืจืฆื™ื ื•ื’ื ื™ื ืžืกื•ื™ื™ืžื™ื ื•ืขืœื™ื”ื ืคื•ืขืœ.3.ืคื’ื ื‘ืžืขืจื›ื•ืช ืื ื–ื™ืžืชื™ื•ืช ืงืฉื•ืจ ืœืขืœื™ื” ื‘ืžืžืื™ืจื•ื™ื•ืช ื‘ื’ืœืœ ืงืจื™ื ื” ืžื™ื ื ืช.45.1+36.2+4ื”ื›ืœ ื ื›ื•ืŸ.7

?ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ื–ื™ื”ื•ืžื™ ืžื ื•ืช ื“ื ื‘ื—ื™ื™ื“ืงื™ื.54 ื™ื›ื•ืœ ืœื’ืจื•ื ืœืชืžื•ืชื” ืืฆืœ ื”ืžืงื‘ืœ .ืื™ ื”ืงืจื ืช ืžื ื•ืช ื”ื“ื"ื ื™ืชืŸ ืœืžื ื•ืข ืืช ื”ื‘ืขื™ื” ืข .ื‘ื‘ืขื™ืงืจ ื‘ืžื ื•ืช ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื™ื, ื‘ืขื™ื™ืชื™ .ื’ืื™ืŸ ืœื–ื” ื—ืฉื™ื‘ื•ืช ืœื˜ื™ืคื•ืœ ื‘ืžื ื•ืช ื“ื .ื“

ื’+ื.1ื“+ื‘.2ื’+ื‘+ื.3ื“ ื‘ืœื‘ื“.4ื”ื›ืœ ื ื›ื•ืŸ.5

?ืœื™ ื ื˜ื™ื™ื” ื–ื•ืžื” ื”ื”ื‘ื“ืœ ื‘ื™ืŸ ืื™ืฉื” ืขื ื ื˜ื™ื™ื” ื’ื ื˜ื™ืช ืœืงืจื™ืฉื™ื•ืช ื™ืชืจ ืœื‘ื™ืŸ ืื™ืฉื” ื‘.55 ื ื˜ื™ื™ื” ืœื™ืฆื™ืจืช ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื™ื.1ื ื˜ื™ื™ื” ืœืœื“ืช ืชืื•ืžื™ื.2ื ื˜ื™ื™ื” ืœืกื™ื‘ื•ื›ื™ื ื‘ื”ืจื™ื•ืŸ.34.1+25.2+36.1+3ื”ื›ืœ ื ื›ื•ืŸ.7

?ืžื” ืœื ื ื›ื•ืŸ ืœื’ื‘ื™ ืœื•ื™ืงืžื™ื•ืช.56 ื”ื›ื‘ื“ ื”ื•ื ืžื•ื’ื“ืœ ื™ื•ืชืจ ืžื‘ืฉืืจ ื”ืœื•ื™ืงืžื™ื•ืช CLL -ื‘.1 DIC -ื™ืฉ ื ื˜ื™ื™ื” ืœ myelo lymphocytic leukemia-ื‘.2ื™ืฉ ื˜ื—ื•ืœ ืžื•ื’ื“ืœ ื•ื ืžืงื™ CML -ื‘.34....

Page 84: As you wish

84

?ื‘ื—ื•ืœื” ื ื•ื™ื˜ืจื•ืคื ื™ ืขื ื—ื•ื ืจืืฉื•ื ื™ืžื” ืื™ื ื• ื ื”ื•ื’ ืœื˜ื™ืคื•ืœ .57 ืžืชืŸ ืื ื˜ื™ื‘ื™ื•ื˜ื™ืงื” ื‘ื›ื™ืกื•ื™ ืจื—ื‘.1ื‘ื™ื“ื•ื“.2ืžืชืŸ ืื•ื›ืœ ืžื‘ื•ืฉืœ.3ืžืชืŸ ื˜ื™ืคื•ืœ ืื ื˜ื™ ืคื˜ืจื™ื™ืชื™.4.ื‘ื“ื™ืงืช ืกื™ืžื ื™ื ื—ื™ื•ื ื™ื™ื ืœืขื™ืชื™ื ืงืจื•ื‘ื•ืช.5

:ืฉืงื•ืคื™ื•ืช58.Follicula lymphoma59.Uric acid nephropathy60.Hairy cellCML -ืื•ื˜ืžื™ ื˜ื—ื•ืœ ื‘.6162.Epithelia lesions

:ืชืฉื•ื‘ื•ืช โ€ฆ99ืžื™ ืฉื‘ื“ืง ืงื™ื‘ืœ . ื”ืชืฉื•ื‘ื•ืช ื‘ืื—ืจื™ื•ืช

1 .4 2 .3 3 .2 4 .2 5 .4 6 .4 7 .1 8 .1 9 .1

10 .5 11 .3 12 .4 13 .3 14 .5 15 .1 16 .2 17 .3 18 .2 19 .1 20 .2 21 .4 22 .3 23 .4 24 .2 25 .4 26 .3 27 . 28 . 29 .4 30 .5 31 .3 32 .5 33 .3 34 .2 35 .2 36 .2 37 .2 38 .2

39 .1 40 .4 41 .4 42 .3 43 .2 44 .1 45 .3 46 .5 47 .3 48 .5 49 .4 50 .4 51 .5 52 .4 53 .5 54 .1 55 .6 56 .2 57 .4

Page 85: As you wish

85

ื”"ืžื—ื–ื•ืจ ื› - 2000 ื”ืžื˜ื•ืœื•ื’ื™ื” .ืฉืืœื•ืช 102ื”ืžื‘ื—ืŸ ื›ืœืœ

?ืžื”ื• ื”ื”ืกื‘ืจ ื”ืกื‘ื™ืจ. ืžืื•ืจืš pt -ื—ื•ืœื” ืขื ืฉืœืฉื•ืœื™ื ืงืฉื™ื ื•.1 .ื‘ืขืงื‘ื•ืช ืชืช ืกืคื™ื’ื” ื•ื–ื™ื”ื•ื ื‘ืžืขื™ื™ื Kื™ืจื™ื“ื” ื‘ื•ื™ื˜ืžื™ืŸ .1.ื”ื–ื™ื”ื•ื ื‘ืžืขื™ื™ื ื™ื•ืฆืจ ืชื•ืฆืจื™ื ื“ืžื•ื™ื™ ืงื•ืžื“ื™ืŸ.2.ื‘ื“ื™ืงืช ื”ืžืขื‘ื“ื” ืžื•ื˜ืขื™ืช.3.ื”ื—ื•ืœื” ืœืžืขืฉื” ื ื•ื˜ืœ ืงื•ืžื“ื™ืŸ.4

?ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ืจื˜ื™ืงื•ืœื•ืฆื™ื˜ื™ื.2

.ื™ื•ื 12ื—ื™ื™ื .1.ื™ื•ืจื“ื™ื ื‘ืžืฆื‘ื™ ื”ืžื•ืœื™ื–ื”.2.ื’ืจืขื™ืŸื ื‘ืฆื™ื˜ื•ืคืœื–ืžื” ื•ืœืœื "ืžื›ื™ืœื™ื ืฉื™ื™ืจื™ ืจื .3

?ืœืžื™ ืžื”ื‘ืื™ื ื™ืฉ ื›ืœื™ ืœื™ืžืคื” ืืคืจื ื˜ื™ื.3

.ื˜ื™ืžื•ืก.1.ื˜ื—ื•ืœ.2.ืงืฉืจื™ ืœื™ืžืคื”.3.ื‘+ื.4.ื”ื›ืœ ื ื›ื•ืŸ.5

?ื•ืงืฉืจื™ ืœื™ืžืคื” tonsilsืžื” ืžืฉื•ืชืฃ ืœ .4

1.medullary cords.2.germinal centers..ืชืื™ื ืืคื™ืชืœื™ืืœื™ื ืžื›ืกื™ื ื‘ืื•ืคืŸ ื—ืœืงื™ ืืช ื”ืจืงืžื”.3.ื˜ืจื‘ืงื•ืœื•ืช ื”ืžื›ื™ืœื•ืช ืกื™ื ื•ืกื•ืื™ื“ื•ืช.4

ื‘ื‘ื“ื™ืงื” . ื‘ื™ืช ืฉื—ื™ ื•ืžืคืฉืขื”, ืžืคื” ื‘ืฆื•ื•ืืจื‘ื‘ื“ื™ืงื” ืฉื’ืจืชื™ืช ื‘ืœื•ื˜ื•ืช ืœื™ 60ื’ื‘ืจ ื‘ืŸ .5

?ื™ ื”ืกื™ืคื•ืจ ื”ืงืœื™ื ื™"ืžื” ื”ืื‘ื—ื ื” ื”ืกื‘ื™ืจื” ืขืค. ื”ื™ืกื˜ื•ืœื•ื’ื™ืช ืื•ื‘ื—ื ื” ืœื™ืžืคื•ืžื”1.low grade follicular lymphoma.2.burkitt lymphoma.3.HD.4.Diffuse large cell lymphoma.

?ืžื” ืœื ืื•ืคื™ื™ื ื™. ืœื—ื•ืœื” ืขื ืืจื™ื˜ืจื•ืฆื™ื˜ื™ื.6

.ืืจื™ื˜ืจื•ืฆื™ื˜ื•ื–ื™ืก ืฉื ื™ื•ื ื™ืชืืจื™ื˜ืจื•ืคื•ืื˜ื™ืŸ ื ื•ืจืžืœื™ ืื™ื ื• ืฉื•ืœืœ ืžื—ืœื” .1.ืกืคืœื ื•ืžื’ืœื™ื” ืฉื›ื™ื— ื‘ืžื—ืœื•ืช ืœื™ืžืคื•ืคืจื•ืœื™ืคืจื˜ื™ื‘ื™ื•ืช.2

?ืื™ื–ื” ืžื”ืžื—ืœื•ืช ื”ื‘ืื•ืช ืื™ื ื• ืขื•ื‘ืจ ื‘ืžื ื•ืช ื“ื.7

1.HAV. 2.HAB.3.HCV.4.HDV.

?ืœืื™ื–ื” ืžื”ื—ื•ืœื™ื ื”ื‘ืื™ื ืกื™ื‘ืช ื”ืื ืžื™ื” ื”ืกื‘ื™ืจื” ื‘ื™ื•ืชืจ ื”ื™ื ื—ืกืจ ื‘ืจื–ืœ.81.MCV = 70, HGB = 9.8, RDW = 14.2.MCV = 64, HGB = 7, RDW = 14.3.MCV = 100, HGB = 7.8, RDW = 22.4.2+1.5.3+2.6.3+1.

Page 86: As you wish

86

?ืคื•ืœื™ืช. ืœืื ืžื™ื” ืขืงื‘ ื—ืกืจ ื‘ื— 12Bื”ื”ื‘ื“ืœ ื‘ื™ืŸ ืื ืžื™ื” ืขืœ ืจืงืข ืฉืœ ื—ื•ืกืจ ื‘ื•ื™ื˜ืžื™ืŸ .9

.ืชืื™ื ืžืืงืจื•ืฆื™ื˜ื™ื.1.ืฉื™ื ื•ื™ื™ื ืžื˜ืื‘ืœืกื˜ื™ื.2.ืชื•ืคืขื•ืช ื ื•ื™ืจื•ืœื•ื’ื™ื•ืช.3.ื ื–ืง ืœืจื™ืจื™ืช ื“ืจื›ื™ ื”ืขื™ื›ื•ืœ.4

?ืžื” ืื™ื ื• ื”ื”ื‘ื“ืœ ื‘ื™ืŸ ืชื ื“ื ืฆืขื™ืจ ืœืชื ื“ื ื–ืงืŸ.10

.ืจื™ื›ื•ื– ืžื™ื ื’ื‘ื•ื” ื‘ืชื.1.ืืฉืœื’ืŸ ื ืžื•ืšืจื™ื›ื•ื– .2.Hba1cื ื•ื›ื—ื•ืช ื’ื‘ื•ื” ืฉืœ .3.ื ืžื•ื›ื” ื‘ืชื ื”ื–ืงืŸ G6PDืคืขื™ืœื•ืช .4.ืื›ื™ื ื•ืฆื™ื˜ ืœืขื•ืžืช ื“ื™ืกืงื™ืช ืฉื˜ื•ื—ื”.5

?ืžื” ืžื”ื‘ืื™ื ืœื ื™ืจืื” ื‘ืžื›ืฉื™ืจ ืœืกืคื™ืจืช ื“ื ืคืกืื•ื“ื•ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื•ืคื ื™ื”.11

.ื“ื’ื™ืžืช ื“ื ืงืจื•ืฉื”.1.ื ืžื™ืงืจื•ืฆื™ื˜ื™ื"ืชื“.2.ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื™ื ื“ื’ื•ืœื™ื ื‘ืžืกืคืจ ื’ื‘ื•ื”.3.EDTAืื’ืจื’ื˜ื™ื ืฉืœ ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื™ื ืขืœ ืจืงืข ืฉืœ .4

?ืžื” ืœื ื ื›ื•ืŸ, ืฉ ื’ืœื ื“ืžืŸ"ื‘ืžื—ืœืช ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื•ืคื ื™ื” ืข.12

.ื™ืฉ ื‘ืขื™ื” ื‘ืื’ืจื’ืฆื™ืช ื˜ืกื™ื•ืช.1.ื”ืคื’ื™ืขื” ื”ื™ื ื‘ืงื™ืฉื•ืจ ื‘ื™ืŸ ื”ื˜ืกื™ื•ืช ืœืคืจื•ืงื•ืœื’ืŸ.2.Gp B1 + PG IXื™ืฉื ื• ืคื’ื ื‘ืงื•ืžืคืœืงืก ื’ืœื™ืงื•ืคืจื•ื˜ืื™ื ื™ื .3.GP3a2bื™ืฉื ื• ืคื’ื ื‘ืงื•ืžืคืœืงืก ื’ืœื™ืงื•ืคืจื•ื˜ืื™ื ื™ื .4ืœ.ื–ืžืŸ ื”ื“ื™ืžื•ื ืžืื•ืจืš ืžื”ืจื’ื™.5

? progenitor cellsืœ stem cellsืžื” ืžื‘ื“ื™ืœ ื‘ื™ืŸ .13

.ื™ืฉื ื” ื™ื›ื•ืœืช ื”ืชื—ื“ืฉื•ืช ืขืฆืžื™ืช ื•ืœื›ืŸ ืื™ืŸ ื‘ื™ื ื”ื ื”ื‘ื“ืœ ืžื”ื•ืชื™ progenitorื•ื’ื ืœ stemืœ.1.ื™ืฉ ื’ืจื ื•ืœื•ืช ืื–ื•ืจื•ืคื™ืœื™ื•ืช progenitorื™ืฉ ื’ืจื ื•ืœื•ืช ืกืคื™ืฆื™ืคื™ื•ืช ื•ืื™ืœื• ืœ stemืœ.2.ืื™ืŸ progenitorื™ืฉ ื™ื›ื•ืœืช ืžื™ื˜ื•ื˜ื™ืช ื•ืื™ืœื• ืœ stemืœ.3.ื ืžืฆืื™ื ื’ื ื‘ืžื—ื–ื•ืจ ื”ื“ื progenitorืจืง ืชืื™ .4

ืชืชื›ืŸ ืื•ืชื” ืชืฉื•ื‘ื” ืคืขืžื™ื™ื -ื”ืชืื .14 8ื—ืกืจ ื‘ืคืงื˜ื•ืจ . 1ืžืื•ืจืš TP .ื10ื—ืกืจ ื‘ืคืงื˜ื•ืจ . 2ืžืื•ืจืš TTP .ื‘7ื—ืกืจ ื‘ืคืงื˜ื•ืจ . 3ืžืื•ืจื›ื™ื TTPื• TP .ื’Sืคื’ื ื‘ืคืจื•ื˜ืื™ืŸ . 4ืชืงื™ื ื™ื TTPื• TP .ื“

5 .DIC ื—ืžื•ืจ

?ื‘ืฉืœื‘ ื”ื›ืจื•ื ื™ CMLื”ืกื•ื‘ืœ ืž 30ื˜ื™ืคื•ืœ ื‘ื—ื™ืจื” ื‘ื’ื‘ืจ ื‘ืŸ . 15 .ื”ื™ื“ืจืื”.1.ื”ืœื•ื’ื ื™ืช/ื”ืฉืชืœืช ืžื— ืขืฆื ืื•ื˜ื•ืœื•ื’ื™ืช.2.ืื™ื ื˜ืจืคืจื•ืŸ.3.ืžืขืงื‘ ื‘ืœื‘ื“.4

Page 87: As you wish

87

? NHLืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ . 16 .ืฉื˜ืจื ื‘ืจื’ - ืœื ื™ื”ื™ื• ืชืื™ ืจื™ื“.1.ืฆื‘ืจื™ื ื—ื•ืฅ ืงืฉืจื™ื™ื diffuse large B cell - ืž 2.40%.NHLื› "ืœ ืฆื•ื•ืืจื™ื•ืช ื‘ื“"ื’ื™ื“ื•ืœ ื‘.3.ืฆื•ืจื” ื—ื•ืฅ ืงืฉืจื™ืช ื”ืฉื™ื›ื—ื” ื‘ื™ื•ืชืจ ื‘ืจื™ืื”.4ืฆื•ืจื” ื—ื•ืฅ ืงืฉืจื™ืช ื‘ื˜ื—ื•ืœ ืžืฉื ื™ืช ืœืžื“ื™ืืกื˜ื™ื ื•ื ืื• ืžืขื•ืจื‘ื•ืช ื”ื˜ื—ื•ืœ ืžืฉื ื™ืช ืœืžืขื•ืจื‘ื•ืช .5

.ื”ืžื“ื™ืืกื˜ื™ื ื•ื.ื—ื•ืฅ ืงืฉืจื™ื•ืช NHLืž 6.40%

?ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ื”ื’ืจื ื•ืœื•ืช ื”ืกืคืฆื™ืคื™ื•ืช ื‘ืืื–ื•ื ื•ืคื™ืœ. 17

.ื”ืžื™ื•ื‘ืœืกื˜ืžื•ืคื™ืขื•ืช ื‘ืฉืœื‘ .1.ืžื›ื™ืœื•ืช ืื ื–ื™ืžื™ื ืœื™ื–ื•ื–ื•ืžืœื™ื™ื.2.ื’ื“ื•ืœื•ืช ื™ื•ืชืจ ืžืืฉืจ ื”ื’ืจื ื•ืœื•ืช ื”ืื–ื•ืจื•ืคื™ืœื™ื•ืช.3.ื ื›ื•ื ื•ืช 4.1+2.ื›ืœ ื”ืชืฉื•ื‘ื•ืช ื ื›ื•ื ื•ืช.5

ืื ืžื™ื”ืžืฉื ื™ืช ืžื—ื•ืกืจ ื‘ืจื–ืœ ื”ื’ื™ืข ืขื ืชืœื•ื ื” ืขืœ ื›ืื‘ื™ ืจืืฉ , ืกื•ื‘ืœืช ืžื“ื™ืžื•ื ืžื”ืจื—ื 25ืืฉื” ื‘ืช . 18

?ืžื” ื”ื˜ื™ืคื•ืœ 600,000ื•ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื™ื ื™ื•ืชืจ ืž .ืื™ื ื˜ืจืคืจื•ืŸ.1.ื”ื™ื“ืจื•ืงืกื™ืื•ืจื™ืื”.2.ืื ืœื’ืจื™ื“.3.ื‘ืจื–ืœ.4.ื”ืงื–ื”.5.ื”ื™ื“ืจืื”.6

? Acute chest syndromeื›ื™ืฆื“ ืžื˜ืคืœื™ื ื‘. 19

.ื—ืžืฆืŸ .ื.ื“ื .ื‘.ืื ื˜ื™ื‘ื™ื•ื˜ื™ืงื” .ื’.ื ื•ื–ืœื™ื .ื“

.ื’+ื‘+ื.1.ื’+ื.2.ื“+ื‘.3.ื‘ืœื‘ื“ ื“.4.ื›ืœ ื”ืชืฉื•ื‘ื•ืช ื ื›ื•ื ื•ืช.5

?ืžืชื™ ืชืžื•ื ื” ืชืงื™ื ื” ื‘ืืœืงื˜ืจื•ืคื•ืจื–ื™ืก. 20

.major ืชืœืกืžื™ื” .1

2.-trait.

3. silent..ืืœืคื ืชืœืกืžื™ื”.4

?) ื•ื ื“ืœืื™ืžืจืก(ืœืื ืžื™ื™ื” ื—ืจืžืฉื™ืช ืžื’ืœื•ื‘ืœืกื˜ื™ืช ื“ืคืงื˜ ื’ื ื˜ื™ ืฉื’ื•ืจื . 21

1.pernicious anemia.2.IF ื“ืคื•ืง..ื‘ืžืขื™ ื“ืคื•ืงื™ื IFืจืฆืคื˜ื•ืจื™ื ืœ.3

Page 88: As you wish

88

22 .IDA )ืื ืžื™ื” ืžื—ื•ืกืจ ื‘ืจื–ืœ( .ืชืงื™ืŸ - RDW, ืฆื‘ืข ื”ื™ืคื•ื›ืจื•ืžื™, ืžื™ืงืจื• โ€“ื’ื•ื“ืœ .1 .ื’ื“ื•ืœ - RDW, ืฆื‘ืข ื”ื™ืคื•ื›ืจื•ืžื™, ืžื™ืงืจื• โ€“ื’ื•ื“ืœ .2 .ื’ื“ื•ืœ - RDW, ืฆื‘ืข ื”ื™ืคื•ื›ืจื•ืžื™, ืžืืงืจื• โ€“ื’ื•ื“ืœ .3.ืชืงื™ืŸ - RDW, ืฆื‘ืข ื”ื™ืคืจื›ืจื•ืžื™, ืžืืงืจื• โ€“ื’ื•ื“ืœ .4ื‘ +ื .5

?ื‘ืื™ื–ื” ืžื‘ื—ืŸ ื–ื” ื™ื‘ื•ื ืœื™ื“ื™ ื‘ื™ื˜ื•ื™ anti Gb IibIIaืื“ื ืžื˜ื•ืคืœ ื‘ . 23

1.PTT ื•PT.2.PT..ืื’ืจื’ืฆื™ื™ืช ื˜ืกื™ื•ืช ื•ื–ืžืŸ ื“ื™ืžื•ื.3.ืจืžืช ืกื™ื“ืŸ ื‘ืคืœื–ืžื”.4

?ื”ื“ืจืš ื”ื™ืขื™ืœื” ืœืื‘ื—ื ื” ื‘ื™ืŸ ื”ืžื•ืคื™ืœื™ื” ืžื•ืœื“ืช ืœื ืจื›ืฉืช. 24

.8ื‘ื“ื™ืงืช ืคืงื˜ื•ืจ .1.9ื‘ื“ื™ืงืช ืคืงื˜ื•ืจ .2.ืขืจื‘ื•ื‘ ื“ื ื”ื—ื•ืœื” ืขื ื“ื ื‘ืจื™ื ื•ืžื“ื™ื“ื™ืช ื–ืžืŸ ื”ืงืจื™ืฉื”.3 .ืจืงื•ืžื‘ื™ื ื ื˜ื™ 8ื”ื•ืกืคืช ืคืงื˜ื•ืจ .4

?) imerslund(ื—ื•ืœื” ืขื ืื ืžื™ื” ื•ื—ืœื‘ื•ืŸ ื‘ืฉืชืŸ . 25

.IFืคื’ื ื‘ .1.ื‘ืื™ืœืื•ืIFโ€“ืคื’ื ื‘ืจืฆืคื˜ื•ืจื™ื ืœ .2.ื‘ื ืกื™ื•ื‘ B 12ืคื’ื ื‘ื—ืœื‘ื•ืŸ ื”ื ื•ืฉื .3.ื‘ืงื™ื‘ื” paritel cellsืคื’ื ื‘ .4 .ืœ"ืืฃ ืื—ื“ ืžื”ื .5

:ื‘ืขื•ื‘ืจ ื”ืชื—ืœืช ื”ืคืขื™ืœื•ืช ื”ื”ืžื•ืคื•ืื˜ื™ืช. 26

.ืฉืง ื”ื—ืœืžื•ืŸ ื”ืขื•ื‘ืจื™.1.ืžื— ื”ืขืฆื.2 .ื˜ื™ืžื•ืก.3.ื›ื‘ื“.4.ื˜ื—ื•ืœ.5.ื•ืชื•ื“ื” ืœื’ืจืฉื•ืŸ ืขืœ ืื™ื›ื•ืช ื”ื”ื•ืจืื” ื”ื’ื‘ื•ื”ื”.6

PCRื‘ื“ื™ืงืช . 27

.ื–ื” ืžืฉืžืฉ ืœืžืขืงื‘ โ€“ืจืง ื›ืืฉืจ ื™ื•ื“ืขื™ื ืืฅ ื”ืžื—ืœื”

:ืžื™ื” ื”ื™ื ืœื”ืฉื™ื’ืงื”ืžื˜ืจื” ืฉืœ ื˜ื™ืคื•ืœ ื‘ืœื•. 28 .ื”ืคื•ื’ื” ืงืœื™ื ื™ืช.1.ื”ืคื•ื’ื” ืžื•ืœืงื•ืœืจื™ืช.2.ื”ืคื•ื’ื” ื›ืจื•ืžื•ื–ื•ืžืœื™ืช.3.ื”ืคื•ื’ื” ืื™ืžื•ื ื•ืœื•ื’ื™ืช.4

)ื’ื ืื ื—ื ื• ืฉืืœื ื• ืืช ืขืฆืžื ื• ืžื” ื–ื”( ?ื ืžื•ืš LAP scoreื‘ืื™ื–ื” ืžื”ืžืงืจื™ื ื”ื‘ืื™ื ื™ื”ื™ื” ืžื‘ื—ืŸ . 29

1.CML. .ืคื•ืœื™ืฆื™ื˜ืžื™ื” ื•ืจื”.23.Myelodisplastic syndrome (MDS)..ื›ื•ืœื.4

Page 89: As you wish

89

?ื˜ืจื•ืคื ื™ืื”ื™ืืฆืœ ืžื™ ืœื ืชื”ื™ื” ื ื•. 301.CGD.2.MDS..ื‘ืจื•ืฆืœื”.34.severe septic shock..ืื ืžื™ื” ืืคืœืกื˜ื™ืช.5

?ืžื” ื ื›ื•ืŸ. 31

.ืžืื•ืจืš PT 12ื—ืกืจ ื‘ืคืงื˜ื•ืจ .1.ืžืื•ืจืš PTT 12ื—ืกืจ ื‘ืคืงื˜ื•ืจ .2.ื“ื™ืžื•ืžื™ื ื‘ื’ื™ืœ ื”ืจืš 12ื—ืกืจ ื‘ืคืงื˜ื•ืจ .3.ืžืคืขื™ืœ ืคืœืกืžื™ื ื•ื’ืŸ A12ืคืงื˜ื•ืจ .4 .ืฉื™ืœื•ื‘ื™ื.5

?ืžื” ืžื”ื‘ืื™ื ื”ื•ื ืกื™ืžืŸ ืคืจื•ื’ื ื•ืกื˜ื™ ื‘ื—ื•ืœื™ ืœื™ืžืคื•ืžื”. 32 .65ื’ื™ืœ ืžืขืœ .12.LDH ื’ื‘ื•ื” ื‘ืคืœื–ืžื”. .ืฉืœื‘ ื”ื”ืชืคืชื—ื•ืช ื‘ื• ื ืžืฆืืช ื”ื‘ืœื•ื˜ื”.3 .ืชืคืงื•ื“ ื‘ื—ื™ื™ ื™ื•ืžื™ื•ื.4 .ื›ืœ ื”ืชืฉื•ื‘ื•ืช.5

:ื‘ืฉืœื‘ ื”ื›ืจื•ื ื™ CMLืขื 30ืžื”ื• ื˜ื™ืคื•ืœ ื”ื‘ื—ื™ืจื” ื‘ื’ื‘ืจ ื‘ืŸ . 33

1.INF - . .HLAื‘ื“ื™ืงืช + ืื—ื•ืช /ื”ืฉืชืœื” ืืœื•ื’ื ื™ืช ืžืื—.2 .ื”ื™ื“ืจื™ืื”.3 .ืžืขืงื‘.4

5.F - .

Page 90: As you wish

90

1999ื“ ืฉื ืช "ื”ืžื˜ื•ืœื•ื’ื™ื” ืžื—ื–ื•ืจ ื› .ืœื ื ื›ื•ืŸ ื ื—ืฉื‘ ื›ืฉืืœื”/ืฉืืœื•ืช ื›ืœ ืกืขื™ืฃ ื‘ืฉืืœื•ืช ื”ืชืืžื” ื•ืฉืืœื•ืช ื ื›ื•ืŸ 110ื”ืžื‘ื—ืŸ ื›ืœืœ

?CLLืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ .1 .ื•ืœื›ืŸ ืฆืจื™ืš ืœืขืฉื•ืช ื”ืฉืชืœืช ืžื— ืขืฆื 30-40ื‘ื ื™ ืจื•ื‘ ื”ื—ื•ืœื™ื .1 .CD5 ,CD2 -ื•ื™ืฆื‘ืขื• ื—ื™ื•ื‘ื™ ืœ Tื”ืชืื™ื ืžืงื•ืจื ื‘ืชืื™ , ืœืจื•ื‘.2 .CD5 ,CD20 ,CD21 ,CD19 -ื•ื™ืฆื‘ืขื• ื—ื™ื•ื‘ื™ ืœ Bืžืงื•ืจ ื”ืชืื™ื ื‘ืชืื™ , ืœืจื•ื‘.3 .ื•ืœื›ืŸ ื›ืœ ื”ื—ื•ืœื™ื ื™ืงื‘ืœื• ื˜ื™ืคื•ืœ ื›ื™ืžื•ื˜ืจืคื™ ืื’ืจืกื™ื‘ื™, ืฉืœื‘ ื”ืžื—ืœื” ืœื ื—ืฉื•ื‘ ืœื’ื‘ื™ ืื•ืจืš ื—ื™ื™ ื”ื—ื•ืœื”.4 .ื‘ื•ื˜ืœื”. ืœื ื ื›ื•ืŸ โ€“ 2, ื ื›ื•ืŸ โ€“ 1? ืื™ื ื˜ืจื™ื ืกื™ืช ืฉืœ ืžืขืจื›ืช ื”ืงืจื™ืฉื” ื›ื™ืฆื“ ื ื‘ื“ื•ืง ืคืขื™ืœื•ืช.2

.ืคื™ื‘ืจื™ื ื•ื’ืŸ.12.PTT. .ื–ืžืŸ ื“ื™ืžื•ื.3 .ื”ืชื›ื•ื•ืฆื•ืช ื”ืงืจื™ืฉ.4 .ื–ืžืŸ ื˜ืจื•ืžื‘ื™ืŸ.5 ?ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ืคื•ืœื™ืฆื™ื˜ืžื™ื” ื•ืจื”.3

.ืฉื ื™ื' ืจื‘ ื”ื—ื•ืœื™ื ืžืคืชื—ื™ื ืœื•ื™ืงืžื™ื” ืืงื•ื˜ื™ืช ืื—ืจื™ ืžืก.1 .ื™ืฉ ื—ืฉื™ื‘ื•ืช ืœื”ืชื—ืœืช ื˜ื™ืคื•ืœ ื‘ืืกืคื™ืจื™ืŸ ืงืจื•ื‘ ืœืžื•ืขื“ ื”ื’ื™ืœื•ื™.2 .ื”ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื™ื ืชืงื™ืŸ' ื”ื”ืžื•ื’ืœื•ื‘ื™ืŸ ื’ื‘ื•ื” ื•ืžืกื‘ืžื—ืœื” ื–ื• ืจืง .3 .ืจืžืช ื”ืืจื™ืชืจื•ืคื•ืื˜ื™ืŸ ื’ื‘ื•ื”ื” ืžื”ืจื’ื™ืœ.4 .ื‘ืขื™ืงืจ ืœืคื ื™ ื ื™ืชื•ื— 47% -ื—ืฉื•ื‘ ืœื”ื•ืจื™ื“ ื”ืžื˜ื•ืงืจื™ื˜ ืžืชื—ืช ืœ.5 HDื”ื™ืกื˜ื•ืœื•ื’ื™ืช ื ืจืื” ื›ืžื• Bืขื ื‘ืœื•ื˜ื•ืช ืžื•ื’ื“ืœื•ืช ื‘ืฆื•ื•ืืจ ื•ื‘ืžืคืฉืขื” ืœืœื ืกื™ืžื ื™ 18ื ืขืจ ื‘ืŸ .4

?ืžื” ื ื›ื•ืŸ, Nodular sclerosisืžืกื•ื’ .stagingื—ืฉื•ื‘ ืœื‘ืฆืข ื‘ื“ื™ืงืช ื’ืœื™ื•ื ืœื”ืฉืœืžืช .1 .stagingื—ืฉื•ื‘ ืœื‘ืฆืข ื‘ื“ื™ืงืช ืžื— ืขืฆื ืœื”ืฉืœืžืช .2 .stagingืœื”ืฉืœืžืช lymphangiogramื—ืฉื•ื‘ ืœื‘ืฆืข ื‘ื“ื™ืงืช .3 . ื—ืฉื•ื‘ ืœื‘ืฆืข ื‘ื“ื™ืงืช ื’ืœื™ื•ื ืžืขืงื‘.4 ?ืื™ืš ื ื˜ืคืœ ื‘ื ืขืจ ื–ื”.5

1.MOPP. 2.ABVD. 3.CHOP. 4.Inverted Y + Mantle. .ื”ืฉืชืœืช ืžื— ืขืฆื.5 ?ื•ืžื” ื ืคื•ืฆื”ื”ื’ื•ืจืžื™ื ืœืื™ ืกืคื™ืงื” ื›ืœื™ื™ืชื™ืช ื‘ืžื™ืœ.6

.ืื ืžื™ื” ื”ื™ืคืจื•ื™ืกืงื•ืกื™ื˜ื™.1 .ืื ืžื™ื” ืขื ื–ื™ื”ื•ืžื™ื.2 .ื”ื™ืคืจืงืœืฆืžื™ื” ื•ืฉืจืฉืจืื•ืช ืงืœื•ืช ื‘ืฉืชืŸ.3 .ื”ื™ืคืจืงืœืฆืžื™ื” ื•ื”ื™ืคื•ื’ืžื”ื’ืœื•ื‘ื•ืœื™ื ืžื™ื”.4.ืชืื™ ืคืœืกืžื” ื‘ื“ื ื”ื™ืงืคื™.5

.s: ื”ืชืื.7

1.HbA.

2.HbA2.

3.HbH.

4.HbF.

5.HbS.

Page 91: As you wish

91

?ืื™ืคื” ื ืžืฆืื™ื ืจื‘ ื”ื’ืจื ื•ืœื•ืฆื™ื˜ื™ื.8

1.MGR. 2.CGP. 3.MGP. .ื”ืžื“ื•ืจื™ื ื‘ืžื™ื“ื” ืฉื•ื•ื”ื ืžืฆืื™ื ื‘ื›ืœ .4 ?ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ื˜ื™ืคื•ืœ ืฆื™ื˜ื•ื˜ื•ืงืกื™.9

.ืจื‘ ื”ื˜ื™ืคื•ืœื™ื ื”ืฆื™ื˜ื•ื˜ื•ืงืกื™ื ื’ื•ืจืžื™ื ืœืืคื•ืคื˜ื•ื–ื™ืก ืฉืœ ืชืื™ ื”ื’ื™ื“ื•ืœ.1 .ื”ืกื™ื‘ื•ืš ื”ืขื™ืงืจื™ ื”ืžื’ื‘ื™ืœ ื”ื™ื ื• ืคื’ื™ืขื” ื‘ืฉืจื™ืจ ื”ืœื‘.2' ืฉื™ืœื•ื‘ ืฉืœ ืชืจื•ืคื•ืช ืฆื™ื˜ื•ื˜ื•ืงืกื™ื•ืช ืขื ื’ื•ืจืžื™ ื’ื“ื™ืœื” ื”ืžื˜ื•ืคื•ืื˜ื™ื™ื ืžื’ื“ื™ืœ ืžืฉืžืขื•ืชื™ืช ืืช ืžืก.3

stem cell )CD34 (ื‘ื“ื ื”ืคืจื™ืคืจื™. ื ื™ืชืŸ ืœื”ืฉืชืžืฉ ื‘ืชืจื•ืคื” ืื—ืจืช alkelating agentsื‘ืžื™ื“ื” ื•ื™ืฉ ืขืžื™ื“ื•ืช ื›ื ื’ื“ ืชืจื•ืคื” ืžืงื‘ื•ืฆืช .4

.ืžืื•ืชื” ืงื‘ื•ืฆื” :ืชืื™ ื“ื ืฉื‘ื•ืจื™ื ื‘ื“ื ื”ื™ืงืคื™.10 .ืชื•ืคืขื” ืชื•ืจืฉืชื™ืช ืฉืžืงื•ืจื” ื‘ื™ื™ืฆื•ืจ ืคื’ื•ื ื‘ืžื— ืขืฆื.1 .ืžื—ืกื•ืจ ื‘ื—ื•ืžืฆื” ืคื•ืœื™ืช.2 .ืชืžืก ื“ื ื›ืชื•ืฆืื” ืžื—ืกื™ืžื” ืฉืœ ืขื•ืจืงื™ืงื™ื ื•ืงืคื™ืœืจื•ืช.3 .ืžื—ืกื•ืจ ื‘ืขื•ืคืจืช.4 :ื™"ืขื ื™ื˜ื•ืจ ื”ืคืจื™ืŸ ื ืขืฉื” .111.PT. 2.PTT. 3.1+2. .ืžืกืคืจ ื˜ืกื™ื•ืช.4 .ื–ืžืŸ ื“ื™ืžื•ื.5 .HD .2 .NHL. 1: ืกืžืŸ.12 .ืžืžืื™ืจื•ืช ื‘ื‘ืœื•ื˜ื•ืช ืžื–ื ื˜ืจื™ื•ืช.1 .ืขืงื•ืžืช ื’ื™ืœ ื‘ื™ืžื•ื“ืืœื™ืช.2 .ื ื™ืชืŸ ืœื”ื•ืฆื™ื ื‘ืœื•ื˜ืช ืœื™ืžืคื” ื‘ืฆื•ืจื” ื ืงื™ื™ื”.3

13. ื™"ื˜ืœืกืžื™ื” ืœื ืžืื•ืคื™ื ืช ืข:

.majorื˜ืœืกืžื™ื” .1

.intermediateื˜ืœืกืžื™ื” .2

3.Silent carrier.

4.Hidrops fetalis. . ืืš ื”ืฉืงื“ ื ืฉืืจ ืžื•ื’ื“ืœ, ื‘ืขืงื‘ื•ืช ื˜ื™ืคื•ืœ ืื ื˜ื™ื‘ื™ื•ื˜ื™ ื”ื“ืœืงืช ืขื‘ืจื”, ื‘ื‘ื™ืจื•ืจ ืงืฉื™ื™ ื‘ืœื™ืขื”ื ืขืจ ืฆืขื™ืจ .14

?ืžื” ืœื ื ื›ื•ืŸ. ืื•ื‘ื—ื ื” ืœื™ืžืคื•ืžื”, ื ืžืง: ื‘ื‘ื™ื•ืคืกื™ื” ืฉืœ ื”ืฉืงื“ . extranodularืงื™ืŸ 'ืžื“ื•ื‘ืจ ื‘ื—ื•ืœื” ื”ื•ื“ื’.1 .diffuse small โ€“ืชืื™ื ืงื˜ื ื™ื .23.Small cleared cell. .cyclin D1ื”ื•ืคืขืช .4

Page 92: As you wish

92

:Bื•ืช ืฉืœ ืชืื™ ืขืœื™ื” ื‘ื”ืืจืขื•ืช ื•ื‘ืชืžื•ืชื” ืžืžืื™ืจื•ื™.15 .ืœืœื ืงืฉืจ ืœืžื•ืขื“ื•ืช ื’ื ื˜ื™ืช, ื›ืชื•ืฆืื” ืžืฉื™ื ื•ื™ ืกื‘ื™ื‘ืชื™.1 .ืœืœื ืงืฉืจ ืœืฉื™ื ื•ื™ ื‘ืกื‘ื™ื‘ื”, ื›ืชื•ืฆืื” ืžืฉื™ื ื•ื™ ื‘ืžื•ืขื“ื•ืช ื’ื ื˜ื™ืช.2 .ืฉื™ื ื•ื™ ื‘ืžื•ืขื“ื•ืช ื›ืชื•ืฆืื” ืžืฉื™ื ื•ื™ ืกื‘ื™ื‘ืชื™.3 .ืฉื™ื ื•ื™ ื‘ืชืžื•ืชื” ื‘ื’ืœืœ ืฉื™ื ื•ื™ื™ื ื‘ื˜ื™ืคื•ืœื™ื ื”ื›ื™ืžื•ื˜ืจืคื™ื™ื, ืฉื™ื ื•ื™ ื‘ื”ืืจืขื•ืช ื‘ื’ืœืœ ืฉื™ื ื•ื™ ืกื‘ื™ื‘ืชื™.4

:ืฉื˜ืจื•ืืฉ ื•ืœื ื“"ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ื”ืžื—ืœื” ืข .16 .IgMื”ืื™ืžื•ื ื•ื’ืœื•ื‘ื•ืœื™ืŸ ื”ื•ื .1 .ื”ืกื™ื›ื•ืŸ ืœื”ื™ืคืจื•ื™ืกืงื•ืกื™ื˜ื™ ื’ื‘ื•ื” ื™ื•ืชืจ ืžื‘ืžื™ืืœื•ืžื”.2 .ืงื™ื™ื ืกื™ื›ื•ืŸ ืœื“ื™ืžื•ืžื™ื ืกืคื•ื ื˜ื ื™ื.3 .60ืจื‘ ื”ื—ื•ืœื™ื ืžืขืœ ื’ื™ืœ .4 .ื›ืœ ื”ืชืฉื•ื‘ื•ืช ื ื›ื•ื ื•ืช.5 :ื”ืžื™ื•ื—ื“ ื‘ืชื™ืžื•ืก.17 ).ืจืง ื›ืœื™ ืœื™ืžืคื”(ืื™ืŸ ื‘ื• ื›ืœื™ ื“ื .1 .ื”ืžืจื›ื–ื™ื ื”ื’ืจืžื™ื ื˜ื‘ื™ื ื”ื ื‘ืžื“ื•ืœื”.2 .ืžืงื•ืจ ื”ืžื–ื ื›ื™ืžื” ื”ื•ื ืื ื“ื•ื“ืจืžืœื™.3 .ืœื• ืงืคืกื•ืœื” ืžืจืงืžื” ื—ื™ื‘ื•ืจื™ืชืื™ืŸ .4 . ื™ืฉื™ืจ ื—ื™ื•ื‘ื™ coombsืื•ื‘ื—ื ื” ื›ืกื•ื‘ืœืช ืžืžื—ืœื” ืื•ื˜ื•ืื™ืžื•ื ื™ืช ื ืžืฆื ืืฆืœื” ืžื‘ื—ืŸ 35ื—ื•ืœื” ื‘ืช .18

ืกืžืŸ ืืช ื”ื”ืฆื”ืจื” ื”ืœื ื ื›ื•ื ื” . ื’ื‘ื•ื” MCVื‘ื•ืฆืขื” ืกืคื™ืจืช ื“ื ื•ื ืžืฆื , ืชืœื•ื ื•ืช ืขืœ ื—ื•ืœืฉื” ื•ืกื—ืจื—ื•ืจืช .ืขื‘ื•ืจ ื—ื•ืœื” ื–ื•

.ื‘ื—ื•ืžืฆื” ืคื•ืœื™ืชื‘ืฉืœ ืฆืจื›ื™ื ืžื•ื’ื‘ืจื™ื ื‘ื–ืžืŸ ื”ืžื•ืœื™ื–ื” ืกื‘ื™ืจ ืœื”ื ื™ื— ืฉืคื™ืชื—ื” ื—ืกืจ .1 .ื‘ืจื™ืจื™ืช ื”ืื™ืœื™ื•ื ื™ื›ื•ืœื” ืœื’ืจื•ื ืœื—ืกืจ ื‘ื• B12 -ื ื•ื›ื—ื•ืช ื ื•ื’ื“ื ื™ื ืขืฆืžื™ื™ื ื›ื ื’ื“ ื”ืงื•ืœื˜ื ื™ื ืœ.2 .ืจืžืช ืคืจื•ื˜ื•ืคื•ืจืคื™ืจื™ืŸ ื‘ืชืื™ ื“ื ืื“ื•ืžื™ื ื—ื™ื•ื ื™ืช ืœืฆื•ืจืš ืื‘ื—ื•ืŸ ื”ื—ื•ืœื”.3 .ื‘ื–ืžืŸ ื”ืžื•ืœื™ื–ื” ื—ืจื™ืคื” ืงื™ื™ืžืช ืจื˜ื™ืงื•ืœื•ืฆื™ื˜ื•ื–ื™ืก.4 .ืฉื ื™ื 2-3 -ืžืกืคื™ืงื™ื ืœ B12ืžื—ืกื ื™ .5 :ืœืžืฆื•ื ื‘ืžืฉื˜ื— ื“ื ื”ื™ืงืคื™ ืฉืœ ื”ื—ื•ืœื” ืœื ืกื‘ื™ืจ.19 .ืคื•ืœื™ื›ืจื•ืžื–ื™ื”.1 .ืžืืงืจื•ืฆื™ื˜ื•ื–ื™ืก.2 .ืชืื™ ืžื˜ืจื”.3 .ื ื•ื™ื˜ืจื•ืคื™ืœื™ื ืขื ื”ื™ืคืจืกื’ืžื ื˜ืฆื™ื”.4.ืžืืงืจื•ืื•ื‘ืœื•ืฆื™ื˜.5 ืœืฆื•ืจืš ื‘ื“ื™ืงืช ืคืขื™ืœื•ืชื ื ืขืจื›ื• ืฉืชื™ . ืขืœ ื’ื‘ื™ ื”ื’ืจื ื•ืœื•ืฆื™ื˜ื™ื FC receptor -ืืฆืœ ื—ื•ืœื” ื—ืœื” ื™ืจื™ื“ื” ื‘.20

ื ื•ื™ื˜ืจื•ืคื™ืœื™ื ืฉืœ ื”ื—ื•ืœื” ืขื ื—ื™ื™ื“ืงื™ื . ื‘. ื ื•ื™ื˜ืจื•ืคื™ืœื™ื ืฉืœ ื”ื—ื•ืœื” ืขื ื—ื™ื™ื“ืงื™ื. ื: ื”ื‘ื“ื™ืงื•ืช ื”ื‘ืื•ืช .ืขื‘ื•ืจ ื›ืœ ื ื™ืกื•ื™ ื”ื™ืชื” ื‘ื™ืงื•ืจืช ืขื ื ื•ื™ื˜ืจื•ืคื™ืœื™ื ืฉืœ ืื“ื ื‘ืจื™ื, ื›ืžื• ื›ืŸ. ืฉืขื‘ืจื• ืื•ืคืกื•ื ื™ื–ืฆื™ื”

).ื”ืฉื•ื•ืื” ืจืง ืœื’ื‘ื™ ื”ื—ื•ืœื”. ('ื‘ ื’ื“ื•ืœ ื™ื•ืชืจ ืžื”ื”ืจื’ ื‘ื‘ื“ื™ืงื”' ื”ื”ืจื’ ื‘ื‘ื“ื™ืงื” ื.1 ).ืœื’ื‘ื™ ื”ื—ื•ืœื”. ('ื’ื“ื•ืœ ื™ื•ืชืจ ืžื”ื”ืจื’ ื‘ื‘ื“ื™ืงื” ื' ื”ื”ืจื’ ื‘ื‘ื“ื™ืงื” ื‘.2 . ื–ื”ื•ืช ื‘ื™ืŸ ื”ื—ื•ืœื” ื•ื”ื‘ืจื™ื' ื”ืชื•ืฆืื•ืช ื‘ื‘ื“ื™ืงื” ื.3 .ื–ื”ื•ืช ื‘ื™ืŸ ื”ื—ื•ืœื” ื•ื”ื‘ืจื™ื' ื”ืชื•ืฆืื•ืช ื‘ื‘ื“ื™ืงื” ื‘.4 ?ืžื” ืœื ื ื›ื•ืŸ, ืกืคืจื•ืฆื™ื˜ื•ื–ื™ืก ืžืฉืคื—ืชื™.21 .extracorpuscular abnormalityืžืงื•ืจ .1 .ืจืชืฉื‘ื™ืจื•ืช ืื•ืกืžื•ื˜ื™ืช ืžื•ื’ื‘.2 .ืื™ื‘ื•ื“ ื—ืœืงื™ื ืžื”ืžืžื‘ืจื ื” โ€“ื”ืžื ื’ื ื•ืŸ .3 .ืžืื—ืจ ื•ืœื˜ื—ื•ืœ ืชืคืงื™ื“ ื—ืฉื•ื‘ ื‘ืžื—ืœื” ื™ืฉ ื”ื’ื™ื•ืŸ ื‘ื”ืจื—ืงืชื•.4 .ืื•ื˜ื•ื–ื•ืžืœื™.5

Page 93: As you wish

93

:ืœื ื ื›ื•ืŸ ืœื’ื‘ื™ ืกืคื™ืจืช ื˜ืกื™ื•ืช ื ืžื•ื›ื”/ื ื›ื•ืŸ.22 .ื•ื™ืจื•ืก.1 .ื”ืจื—ืงืช ื˜ื—ื•ืœ.2 .ืขื™ืจื•ื™ื™ ื“ื ืœืขื™ืชื™ื ืงืจื•ื‘ื•ืช.3 .ืชืจื•ืคื•ืช.4 .ื‘ืขื™ื” ืื™ืžื•ื ื™ืช.5 ?ื‘ืžื’ื”ืงืจื™ื•ืฆื™ื˜ ื”ืžื‘ืฉื™ืœ demarcation vesicles -ื™ ื”"ืžื” ื ื•ืฆืจ ืข.23 .ืจื˜ื™ืงื•ืœื•ื ืื ื“ื•ืคืœืกืžืชื™ ื—ืœืง ื‘ืฉืœื‘ ื”ืืกื™ื“ื•ืคื™ืœื™ ืฉืœ ื”ืžื’ื”ืงืจื™ื•ืฆื™ื˜.1 .ืจื˜ื™ืงื•ืœื•ื ืื ื“ื•ืคืœืกืžืชื™ ืžื’ื•ืจืขืŸ ื‘ืฉืœื‘ ื”ื‘ื–ื•ืคื™ืœื™ ืฉืœ ื”ืžื’ื”ืงืจื™ื•ื‘ืœืกื˜.2 .ืžืขืจื›ืช ืชืขืœื•ืช ืขื“ื™ื ื•ืช ืกื’ื•ืจื•ืช ื‘ืฆื™ื˜ื•ืคืœืกืžื” ืฉืœ ื”ื˜ืกื™ืช.3 .ื”ืžืžื‘ืจื ื” ืฉืขื•ื˜ืคืช ื›ืœ ื˜ืกื™ืช.4

):ืœื–ื”ื•ืช ืืช ื”ืฉื™ืงื•ืคื™ืช(ืฉื™ืงื•ืคื™ื•ืช ื‘ืคืชื•ืœื•ื’ื™ื” 24-29

.NHLืžื— ืขืฆื ืขื .2425.Follicular lymphoma. .Burkittsื™ืœื“ ืขื .26 .NHLื‘ืœื•ื˜ื•ืช ืœื™ืžืคื” ืขืœ .27 .Nodular sclerosisืœ ืขื "ื‘.28 .CLLืžื— ืขืฆื ืขื .29

):ืœื–ื”ื•ืช(ืฉืงื•ืคื™ื•ืช ืฉืœ ืชืื™ ื“ื 30-34 .ื‘ืœืกื˜.30 .ืžืืงืจื•ืฆื™ื˜.31 .ืชื ืคืœืกืžื”.32 .ื ื•ื™ื˜ืจื•ืคื™ืœ ืขื ื”ื™ืคืจืกื’ืžื ื˜ืฆื™ื”.33 .ืœื™ืžืคื•ืฆื™ื˜.34 ?Acute transfusion reactionืžื” ืžื”ืžืฉืคื˜ื™ื ื”ื‘ืื™ื ื ื›ื•ืŸ ืœื’ื‘ื™ .35

.ื”ืžืกื•ื›ื ืช ืžื‘ื™ืŸ ื”ืชื’ื•ื‘ื•ืช ื”ืžื™ื™ื“ื™ื•ืช ืœืขื™ืจื•ื™ื™ ื“ื.1 .ABOืงืฉื•ืจื” ื‘ืื™ ื”ืชืืžื” ืฉืœ ืงื‘ื•ืฆื•ืช ื”ื“ื ื”ืขื™ืงืจื™ื•ืช .2 .Vasculorespiratory colapse -ื’ื•ืจืžืช ืœ.3 .DIC -ื’ื•ืจืžืช ืœ.4 .ื›ืœ ื”ืชืฉื•ื‘ื•ืช ื ื›ื•ื ื•ืช.5

?Aืžื” ืœื ื ื›ื•ืŸ ืœื’ื‘ื™ ื”ืžื•ืคื™ืœื™ื” .36 .8ื—ืกืจ ืคืงื˜ื•ืจ .1 .ืžืชืŸ ื”ืคืงื˜ื•ืจ ื”ื—ืกืจ โ€“ื”ื˜ื™ืคื•ืœ .2 .ื“ื™ืžื•ื ื‘ืขื•ืจ ื•ื‘ืจื™ืจื™ื•ืช.3 .Xืชืœื•ื™ื™ืช .4 .ืขื™ืงืจ ื‘ื’ื‘ืจื™ืื‘.5 ?ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ื‘ื“ื™ืงื•ืช ืžื ื•ืช ื“ื.37

.anti HIV 1,2ื‘ื•ื“ืงื™ื .ื .anti HCV .ื‘ .HBS Agื‘ื•ื“ืงื™ื .ื’.anti HTLVื‘ื•ื“ืงื™ื .ื“

.ื’+ื‘+ื.1 .ื’+ื.2 .ื“+ื‘.3 .ื“ ื‘ืœื‘ื“.4 .ื”ื›ืœ ื ื›ื•ืŸ.5

Page 94: As you wish

94

38. ืžื” ืœื ื ื›ื•ืŸ, ื˜ืœืกืžื™ื”?

.ืกืคืจื•ืฆื™ื˜ื•ื–ื™ืก.1 .ืชืื™ ืžื˜ืจื”.2 .ืืจื™ืชืจื•ืคื•ืื–ื™ืก ืœื ื™ืขื™ืœ.34.Iron over load. :ื—ืœื•ืŸ ื”ื–ืžืŸ ืœื˜ื™ืคื•ืœ ื˜ืจื•ืžื‘ื•ืœื™ื˜ื™.39 .ืฉืขื•ืช ืžืชื—ื™ืœืช ื”ื›ืื‘ื™ื 1.3 .ืฉืขื•ืช ืžื”ื”ื’ืขื” ืœืžื™ื•ืŸ 2.6 .ืฉืขื•ืช ืžืชื—ื™ืœืช ื”ื›ืื‘ื™ื 3.12 .ืฉืขื•ืช ืžื”ื”ื’ืขื” ืœืžื™ื•ืŸ 4.24 .ืฉืขื•ืช ืžืชื—ื™ืœืช ื”ื›ืื‘ื™ื 5.24 ื‘ื‘ื“ื™ืงื” ื’ื•ืคื ื™ืช ื ืžืฆืื• ื‘ืœื•ื˜ื•ืช ืœื™ืžืคื” . ื”ื–ืขื” ืœื™ืœื™ืช ืœืœื ื™ืจื™ื“ื” ื‘ืžืฉืงืœ, ืกื•ื‘ืœ ืžื—ื•ื 60ื—ื•ืœื” ื‘ืŸ .40

ื‘ื‘ื™ื•ืคืกื™ื” ืฉืœ ื‘ืœื•ื˜ืช ืœื™ืžืคื” ืื•ื‘ื—ื ื” ืœื™ืžืคื•ืžื” ืžืกื•ื’ . ื•ื˜ื—ื•ืœ ืžื•ื’ื“ืœ) ื›ื•ืœืœ ืžืคืฉืขื•ืช(ื‘ื›ืœ ื”ืชื—ื ื•ืช NHL ื“ื™ืคื•ื–ื™ืช ืžืชืื™ื ื’ื“ื•ืœื™ื)Diffuse large cell (ืื™ื–ื” . ื‘ื™ื•ืคืกื™ื™ืช ืžื— ืขืฆื ืœืœื ื”ืกื ื ื” ืœื™ืžืคืชื™ืช

?ื˜ื™ื ื”ื‘ืื™ื ื ื›ื•ืŸืžื”ืžืฉืค .ื›ื™ ืื™ืŸ ื™ืจื™ื“ื” ื‘ืžืฉืงืœ 4Aื”ืฉืœื‘ ื”ื•ื .1 .ื•ืœื›ืŸ ื ื™ืชืŸ ืœื”ืกืชืคืง ื‘ื˜ื™ืคื•ืœ ืจื“ื™ื•ืชืจืคื™ ื‘ืœื‘ื“ 3Aื”ืฉืœื‘ ื”ื•ื .2 .ื”ื”ื™ืกื˜ื•ืœื’ื™ื” ื”ืื’ืจืกื™ื‘ื™ืช ืžื—ื™ื™ื‘ืช ื˜ื™ืคื•ืœ ื›ื™ืžื•ืชืจืคื™ ืชื•ืš ื•ืจื™ื“ื™ ืœืœื ืงืฉืจ ืœืฉืœื‘ ื”ืžื—ืœื”.3 .ื™ ื”ืชื’ื•ื‘ื”"ื•ืœืฉืงื•ืœ ื˜ื™ืคื•ืœ ื›ืžื•ืชืจืคื™ ืขืค, ืžื•ืžืœืฅ ืงื•ื“ื ืœื˜ืคืœ ื‘ืกื˜ืจื•ืื™ื“ื™ื.4ื”ื˜ื™ืคื•ืœ , ื”ืฉืœื‘ ื”ืžืชืงื“ื ื•ื—ื•ืกืจ ืžืขื•ืจื‘ื•ืช ืžื— ื”ืขืฆื, ืจืกื™ื‘ื™ืชื‘ื’ืœืœ ื”ื”ื™ืกื˜ื•ืคืชื•ืœื’ื™ื” ื”ืื’.5

.ื”ืžื•ืžืœืฅ ื”ื•ื ื”ืฉืชืœืช ืžื— ืขืฆื ืื•ื˜ื•ืœื•ื’ื™ืช ืž "ืก 16ื”ื˜ื—ื•ืœ ืžื•ื’ื“ืœ ืขื“ : ื‘ื‘ื“ื™ืงื” ื’ื•ืคื ื™ืช. ืขื™ื™ืคื•ืช ืกื—ืจื—ื•ืจืช, ืกื•ื‘ืœืช ืžื›ืื‘ื™ ืจืืฉ 60ื—ื•ืœื” ื‘ืช .41

ืขื ืžื‘ื“ืœืช ืชืงื™ื ื” 11,000ืœื•ื™ืงื•ืฆื™ื˜ื™ื ) ื’ืจื ืœื“ืฆื™ื™ื˜ืจ( 13.6ื”ืžื•ื’ืœื•ื‘ื™ืŸ : ื‘ืกืคื™ืจืช ื“ื. ืœื ืจื’ื™ืฉ :ื”ืื‘ื—ื ื” ื”ืžืชืื™ืžื” ื‘ื™ื•ืชืจ. 850,000ืฆื™ื˜ื™ื ื•ื˜ืจื•ืžื‘ื•

.ืคื•ืœื™ืฆื˜ืžื™ื” ื•ืจื”.12.CML. .ื˜ืจื•ืžื‘ื•ืฆื™ื˜ืžื™ื” ืจืืฉื•ื ื™ืช.34.CLL. .ื—ื•ืกืจ ื‘ืจื–ืœ ืขื ื˜ืจื•ืžื‘ื•ืฆื™ื˜ื•ื–ื™ืก.5 ?ืžื” ื ื›ื•ืŸ ืœื’ื‘ื™ ืชืจื•ืคื•ืช ืฆื™ื˜ื•ื˜ื•ืงืกื™ื•ืช.42ืืžื•ืจื” ืœื’ืจื•ื ืœืคื’ื™ืขื” , ื›ืžื• ื•ื™ื ืงืจื™ืกื˜ื™ืŸ) ืžื™ื˜ื•ื–ื™ืก(ืชืจื•ืคื” ื”ืคื•ื’ืขืช ื‘ืชื ื”ืžืžืื™ืจ ื‘ืฉืœื‘ ื—ืœื•ืงืชื• .1

.ืžืฉื™ื›ืจื•ืžื•ื–ื•ืžืœื™ืช ื•ืœืชื”ืœื™ืš ืžืžืื™ืจ .ืงืฆื‘ ื—ืœื•ืงืช ื”ืชื ื”ืžืžืื™ืจ ื”ื™ื ื• ืชื ืื™ ื—ืฉื•ื‘ ืœืจื’ื™ืฉื•ืช ืฉืœื• ืœืชืจื•ืคื” ื”ืฆื™ื˜ื•ื˜ื•ืงืกื™ืช.2ื™ืฆื™ื‘ื•ืช ื”ืชื ื”ืžืžืื™ืจ ืœืชืจื•ืคื•ืช ืฆื™ื˜ื•ื˜ื•ืงืกื™ื•ืช ืงืฉื•ืจื” ืจืง ื‘ื™ื›ื•ืœืชื• ืฉืœ ื”ืชื ื”ืžืžืื™ืจ ืœื‘ื˜ื ืืช .3

).MDR )multi drug resistent - ื”ื’ืŸ ืœื”ืžื—ืœื•ืช ื˜ื™ืคื•ืœ ืฆื™ื˜ื•ื˜ื•ืงืกื™ ื—ื“ ืคืขืžื™ ื‘ื“ืจืš ื›ืœืœ ืžืกืคื™ืง ื™ืขื™ืœ ื›ื“ื™ ืœื’ืจื•ื ืœื”ืคื•ื’ื” ืžืžื•ืฉื›ืช ื‘ื›ืœ.4

.ื”ื”ืžื˜ื•ืœื•ื’ื™ื•ืช ื”ืžืžืื™ืจื•ืช ืขื•ื“ืฃ ืคื•ื˜ืกื™ื•ื ื•ื—ืกืจ ืงืœืฆื™ื•ื ื‘ื—ื•ืœื” ืื•ื ืงื•ืœื•ื’ื™ ื”ืžื˜ื•ืคืœ ื‘ื›ื™ืžื•ื˜ืจืคื™ื” ื™ื›ื•ืœื™ื , ื”ื•ืคืขืช ืื•ืจื™ืื”.43

:ืœื ื‘ื•ืข ืž .ื”ืฉืชืœืช ืžื— ืขืฆื.1 .ื”ืจืก ืชืื™ ื”ื’ื™ื“ื•ืœ ื‘ืฉืœ ื”ื˜ื™ืคื•ืœ ื”ื›ื™ืžื•ืชืจืคื™.2 .ื’ื™ื“ื•ืœ ืžืื•ื“ ืื’ืจืกื™ื‘ื™.3 .ื–ื™ื”ื•ื ื—ื™ื™ื“ืงื™ ื—ืจื™ืฃ.4

Page 95: As you wish

95

ืœื ื”ื™ื” ื—ื•ื ืื• ื”ื’ื“ืœื” ืฉืœ . ืงื™ืŸ'ื”ื•ื“ื’ ื ืžืฆืื” ืžื—ืœืช 18ื‘ื‘ื“ื™ืงืช ื‘ืœื•ื˜ื” ืฆื•ื•ืืจื™ืช ืฉืœ ื ืขืจ ื‘ืŸ .44 :ื”ื ืขืจ ื ืžืฆื ื‘ืฉืœื‘. ื‘ืœื•ื˜ื•ืช ื ื•ืกืคื•ืช

1.2B. 2.1A. 3.4A. 4.0A. 5.1B. ื”ื˜ื—ื•ืœ ื ืžืฆื ื ื’ื•ืข ื’ื ื›ืŸ . ื”ื ืขืจ ืขื‘ืจ ืชืื•ื ืช ื“ืจื›ื™ื ื•ื ืขืฉืชื” ื›ืจื™ืชื” ืฉืœ ื”ื˜ื—ื•ืœ โ€“ื—ื•ื“ืฉ ืœืื—ืจ ืžื›ืŸ .45

:ื”ื ืขืจ ื ืžืฆื ื‘ืฉืœื‘. ืงื™ืŸ'ื‘ื”ื•ื“ื’1 .2B .2 .4A .3 .3A .4 .1B .5 .1A. ืžื‘ื“ืœืช 11,000 โ€“ืœื•ื™ืงื•ืฆื™ื˜ื™ื , ืž"ืก 16ื ื™ืžื•ืฉ โ€“ื˜ื—ื•ืœ ืžื•ื’ื“ืœ , ืกื•ื‘ืœ ืžื›ืื‘ื™ ืจืืฉ 60ื’ื‘ืจ ื‘ืŸ .46

?ืžื” ื™ืฉ ืœื•. 850,000ื˜ืกื™ื•ืช , HMK 60%, 18.5ื”ืžื•ื’ืœื•ื‘ื™ืŸ , ืชืงื™ื ื”1.CML. 2.AML. .ืคื•ืœื™ืฆื˜ืžื™ื” ื•ืจื”.3 .ื˜ืจื•ืžื‘ื•ืฆื™ื˜ืžื™ื” ืจืืฉื•ื ื™ืช.45.CLL. .ALL -ืœ Blast crisisื™ืขื‘ืจื• CMLืžื—ื•ืœื™ 30%ืœื ื ื›ื•ืŸ / ื ื›ื•ืŸ.47 .Large cell lymphomaื”ื immunoblasticืŸ ืœื ื ื›ื•/ ื ื›ื•ืŸ.48 .ืขืงื•ืžืช ืฉื›ื™ื—ื•ืช ื‘ื™ืžื•ื“ืืœื™ืช - NHLืœื ื ื›ื•ืŸ / ื ื›ื•ืŸ.49 ื”ืื ืžื™ื” ืฉืกื‘ื™ืจ ืฉื ืจืื” . ื‘ืฉืœ ื›ืš ื ื’ืจื ื ื–ืง ืœืจื™ืจื™ืช ื”ืงื™ื‘ื” ื•ื”ืชืจืกืจื™ื•ืŸ. ืื“ื ืฉื‘ืœืข ื—ื•ืžืจ ืจืขื™ืœ.50

:ื‘ืฉืœ ื›ืš .ื ื•ืจืžื•ืฆื™ื˜ื™ืช ื ื•ืจืžื•ื›ืจื•ืžื™ืช.1 .ืžื™ืงืจื•ืฆื™ื˜ื™ืช ื”ื™ืคื•ื›ืจื•ืžื™ืช.2 .ืžืืงืจื•ืฆื™ื˜ื™ืช.34.MCV=70.

?ืชืชืŸืื™ื–ื” ื˜ื™ืคื•ืœ .51 .ืคืจื™ื˜ื™ืŸ+ ื‘ืจื–ืœ .12.B12. .ื—ื•ืžืฆื” ืคื•ืœื™ืช.3 ?ืื™ื–ื” ืกื•ื’. ืฉื ื™ื ืฉื•ื‘ ืžื•ืคื™ืขื” ืื ืžื™ื” 3ืื—ืจื™ , ืื—ืจื™ ื˜ื™ืคื•ืœ ืžืกืชื“ืจ ื”ืžืฆื‘.52 .ืžืืงืจื•ืฆื™ื˜ื™ืช.1 .ื”ื™ืคื•ื›ืจื•ืžื™ ืžื™ืงืจื•ืฆื™ื˜ื™.2 .ื ื•ืจืžื•ืฆื™ื˜ื™ ื ื•ืจืžื•ื›ืจื•ืžื™.34.MCV=70. ?ืื™ื–ื• ื‘ื“ื™ืงื” ืชืขืฉื” ื›ื“ื™ ืœืืฉืจ ืืช ื”ืฉืขืจืชืš.531.B12 ื‘ืกืจื•ื. .ืคื•ืœื˜ ื‘ืกืจื•ื.2 .ื‘ืจื–ืœ.3 .ื‘ื“ื™ืงืช ืžื— ืขืฆื.45.1+4.

Page 96: As you wish

96

?ืžื” ืฆืจื™ืš ืœืขืฉื•ืช, ืœืื—ืจ ื˜ื™ืคื•ืœ ื›ืžื•ืชืจืคื™ ืจืืฉื•ืŸ ื•ื”ืคื•ื’ื” ืžืœืื” AMLื‘ื—ื•ืœื” .54 .ืฆื™ื˜ื•ื–ืจ ื‘ืžื™ื ื•ืŸ ื’ื‘ื•ื”.1 .ื”ืฉืชืœืช ืžื— ืขืฆื.2 .ื”ื—ื•ืœื” ื‘ื”ืคื•ื’ื” ืžืœืื” โ€“ืื™ืŸ ืฆื•ืจืš ืœื”ืžืฉื™ืš ื‘ื˜ื™ืคื•ืœ .3 .INF -ื˜ื™ืคื•ืœ ืื—ื–ืงืชื™ ื‘.4 ?ืื ื“ื•ืชืœ-ื‘ืขื–ืจืช ืื™ื–ื” ืžื”ื‘ืื™ื ื˜ืกื™ื•ืช ื ืงืฉืจื•ืช ืœืกืื‘.55 .ื‘ื˜ืกื™ื•ืช 4ืคืงื˜ื•ืจ .12.vWF. .ืคื™ื‘ืจื™ื ื•ื’ืŸ.3 .ื™ื•ื ื™ ืกื™ื“ืŸ.4 .9ืคืงื˜ื•ืจ .5 Hairy cell -ืชื™ืื•ืจ ืงืœื™ื ื™ ืžืชืื™ื ืœ(+ื ืžืฆื ืœื™ืžืคื•ืฆื™ื˜ื™ื ืขื ืฉืขืจื•ืช 60ื‘ื“ืžื• ืฉืœ ื‘ืŸ .56

leukemia .(ื‘ืžื” ืชื˜ืคืœ? . ืคืœื•ื“ืจื‘ื™ืŸ.12.ARA-C. 3.INF. 4.2-CDA) .?( ?ื›ื™ืฆื“ ืชื‘ื“ื•ืง ื”ื—ืœืžื” ื‘ื—ื•ืœื” ื–ื”.57 .ื‘ื“ื™ืงืช ืœื™ืžืคื•ืฆื™ื˜ื™ื ื‘ื“ื ื”ื™ืงืคื™.1 .ื‘ื“ื™ืงืช ืžื— ืขืฆื.2 :ืจืคืจืคื•ื–ื™ื” ื›ืœื™ืœื™ืช ืžืชื‘ื˜ืืช ื‘.58 .ื“ ื•ืขืœื™ื™ื” ื‘ื“ื•ืคืง"ืขืœื™ื™ื” ื‘ืœ.1 .STื™ืจื™ื“ื” ื‘ืžืงื˜ืข 50%, ื™ืจื™ื“ื” ื‘ื›ืื‘ื™ื 2.50% .50% -ื‘ STื™ืจื™ื“ื” ื‘ืงื˜ืข , ื™ืจื™ื“ื” ื‘ื›ืื‘ื™ื 3.50%.CPKืฉื™ื ืžื•ืงื“ื ืฉืœ , ื™ืจื™ื“ื” ื‘ื›ืื‘ื™ื 4.50%

Page 97: As you wish

97

:ืชืฉื•ื‘ื•ืช ืžื•ืžืœืฆื•ืช1.3 48 .?

ืœื ื ื›ื•ืŸ. 49 ื‘ื•ื˜ืœื”.2

3.5 50 .2

4.4 51 .1

5.2 52 .1

6.3 53 .1

7. s .5 8.1 54 .1

9.2 ? 55 .2

10.3 56 .4

11.2 57 .2

12. 1 .NHL 2 .HD 3 .HD. 58 .4

13.4 14.1 ? 15.? 16.5 17.3 18.3 19.3 20.3 21.1 .ื”ื›ืœ ื ื›ื•ืŸ 2 -ื—ื•ืฅ ืž.2223.4 35.5 36.3 37.5 38.1 39.3 40.3 41.3 ? 42.2 43.2 44.2 45.3 46.3 ื ื›ื•ืŸ.47


Recommended